data_2it7_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2it7 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 43.7 t . . . . . 0 CA--C 1.551 0.984 0 CA-C-O 118.289 -0.862 . . . . 0.0 112.271 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -70.32 157.45 59.27 Favored 'Trans proline' 0 C--N 1.353 0.803 0 C-N-CA 123.119 2.546 . . . . 0.0 111.777 176.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -81.73 13.17 3.33 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 114.566 1.321 . . . . 0.0 114.566 -171.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 9.9 tp -80.89 141.07 15.71 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 125.566 1.547 . . . . 0.0 111.188 177.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 36.3 tp -79.66 139.12 37.51 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 123.687 0.795 . . . . 0.0 110.446 175.138 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 60.0 tpp -153.26 130.68 11.35 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.578 1.151 . . . . 0.0 109.67 -178.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 60.2 ttt180 -86.27 147.56 26.02 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.818 0.847 . . . . 0.0 110.806 179.438 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 30.2 p -154.91 161.4 41.44 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 114.517 1.303 . . . . 0.0 114.517 -169.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 63.2 pttt -123.4 -16.47 6.84 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 126.184 1.794 . . . . 0.0 112.012 168.469 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 8.1 pt20 -151.9 166.61 30.92 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 126.262 1.825 . . . . 0.0 110.62 171.012 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -62.3 -24.71 67.46 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 124.279 1.032 . . . . 0.0 112.977 -176.383 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.5 m -64.11 -19.2 65.1 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 125.264 1.426 . . . . 0.0 113.524 175.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 59.0 m-20 -79.94 -20.08 46.49 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 123.955 0.902 . . . . 0.0 112.308 174.396 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 77.6 m -88.75 165.34 14.78 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.077 1.351 . . . . 0.0 113.699 -172.411 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -72.02 172.75 9.49 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 124.567 1.147 . . . . 0.0 110.896 177.213 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.79 134.21 56.82 Favored 'General case' 0 CA--C 1.539 0.545 0 O-C-N 121.111 -0.993 . . . . 0.0 112.956 -177.33 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 75.95 -9.2 18.92 Favored Glycine 0 CA--C 1.534 1.256 0 C-N-CA 124.689 1.138 . . . . 0.0 114.323 -178.676 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 59.6 m -79.64 162.8 25.05 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 118.534 1.167 . . . . 0.0 113.976 179.038 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 19.1 m -123.61 153.27 29.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 126.332 1.853 . . . . 0.0 110.178 168.315 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 48.6 t -85.21 103.5 14.23 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 123.3 0.64 . . . . 0.0 110.006 169.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -70.08 168.16 47.99 Favored Glycine 0 CA--C 1.542 1.725 0 C-N-CA 124.752 1.168 . . . . 0.0 114.12 179.176 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -69.96 -18.02 36.33 Favored 'Trans proline' 0 CA--C 1.538 0.72 0 C-N-CA 124.241 3.294 . . . . 0.0 113.44 -175.166 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 53.5 p-10 -68.88 -10.81 59.07 Favored 'General case' 0 CA--C 1.548 0.874 0 N-CA-C 114.372 1.249 . . . . 0.0 114.372 170.471 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 85.52 12.8 71.81 Favored Glycine 0 CA--C 1.532 1.129 0 C-N-CA 124.83 1.205 . . . . 0.0 113.962 -176.573 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -125.08 157.4 36.38 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 118.544 1.172 . . . . 0.0 112.168 174.413 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 75.8 m -77.38 148.47 35.53 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.989 1.316 . . . . 0.0 113.386 -177.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.26 0 C-N-CA 126.035 1.778 . . . . 0.0 113.016 174.294 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 53.7 t . . . . . 0 CA--C 1.549 0.928 0 CA-C-O 118.47 -0.776 . . . . 0.0 112.439 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -67.03 166.9 21.38 Favored 'Trans proline' 0 C--N 1.354 0.829 0 C-N-CA 123.302 2.668 . . . . 0.0 111.946 172.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 4.7 mmp_? -100.63 18.47 19.15 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.968 1.307 . . . . 0.0 113.096 179.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 18.7 tt -69.33 141.91 16.72 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 C-N-CA 125.009 1.324 . . . . 0.0 111.001 172.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 33.3 tp -79.34 129.94 34.95 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 123.265 0.626 . . . . 0.0 109.705 173.358 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 60.7 tpp -153.56 131.02 11.36 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.383 1.073 . . . . 0.0 110.196 -173.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -80.97 153.96 27.2 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 123.998 0.919 . . . . 0.0 111.776 177.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 28.7 p -158.32 156.0 29.8 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 124.408 1.083 . . . . 0.0 113.792 -175.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -111.17 -26.34 9.25 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 125.885 1.674 . . . . 0.0 111.002 168.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 8.0 pt20 -150.61 169.48 21.47 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 126.629 1.972 . . . . 0.0 110.453 173.465 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -61.39 -25.43 67.18 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 124.479 1.112 . . . . 0.0 112.875 -176.426 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 7.3 m -64.96 -18.93 65.69 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.288 1.435 . . . . 0.0 113.566 175.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 59.8 m-20 -81.83 -18.8 42.69 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 123.929 0.892 . . . . 0.0 112.35 174.526 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 75.1 m -86.88 167.57 14.21 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.114 1.365 . . . . 0.0 113.692 -175.125 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -72.24 175.36 6.15 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 124.527 1.131 . . . . 0.0 111.028 177.507 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.39 133.14 55.8 Favored 'General case' 0 CA--C 1.54 0.562 0 O-C-N 121.079 -1.013 . . . . 0.0 113.2 -176.107 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 74.45 -8.2 14.88 Favored Glycine 0 CA--C 1.534 1.243 0 C-N-CA 124.815 1.198 . . . . 0.0 114.529 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 61.5 m -76.55 163.8 26.55 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 114.009 1.115 . . . . 0.0 114.009 -179.25 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 21.6 m -121.68 152.17 25.33 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 125.681 1.593 . . . . 0.0 110.534 168.575 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 47.6 t -89.12 103.89 16.48 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 123.772 0.829 . . . . 0.0 109.811 169.55 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -71.94 166.55 53.33 Favored Glycine 0 CA--C 1.544 1.881 0 C-N-CA 124.333 0.968 . . . . 0.0 114.059 -178.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -58.12 -26.32 75.26 Favored 'Trans proline' 0 C--N 1.353 0.771 0 C-N-CA 124.407 3.404 . . . . 0.0 114.782 -178.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 52.5 p-10 -68.97 -9.87 54.41 Favored 'General case' 0 CA--C 1.549 0.907 0 N-CA-C 114.764 1.394 . . . . 0.0 114.764 175.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 83.62 13.59 75.38 Favored Glycine 0 CA--C 1.534 1.234 0 C-N-CA 124.633 1.111 . . . . 0.0 113.965 -176.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -118.75 155.61 30.81 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.9 1.28 . . . . 0.0 112.097 173.333 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 70.2 m -76.22 153.11 36.32 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.804 1.242 . . . . 0.0 113.134 177.276 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.219 0 CA-C-O 116.861 -2.077 . . . . 0.0 113.566 175.683 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 48.9 t . . . . . 0 CA--C 1.549 0.913 0 CA-C-O 118.424 -0.798 . . . . 0.0 112.34 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -66.62 151.2 83.25 Favored 'Trans proline' 0 C--N 1.353 0.773 0 C-N-CA 122.616 2.211 . . . . 0.0 111.125 174.526 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 71.7 mmt-85 -81.95 44.79 0.86 Allowed 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 124.89 1.276 . . . . 0.0 113.109 -171.554 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 1.2 pp -79.87 168.04 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 126.004 1.721 . . . . 0.0 113.177 177.002 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 38.0 tp -118.85 66.08 0.77 Allowed 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.723 1.609 . . . . 0.0 108.139 169.569 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 63.3 tpp -94.48 126.62 39.87 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 125.095 1.358 . . . . 0.0 109.745 -172.336 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 95.5 mtt-85 -72.33 149.54 44.32 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 118.752 0.706 . . . . 0.0 111.862 178.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 30.0 p -154.82 157.78 38.43 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 124.278 1.031 . . . . 0.0 113.728 -176.009 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 59.5 mtmt -119.05 -20.01 8.23 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.936 1.694 . . . . 0.0 111.901 169.422 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -150.48 167.94 25.66 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 126.4 1.88 . . . . 0.0 110.506 169.853 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -61.31 -25.45 67.13 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.363 1.065 . . . . 0.0 112.668 -178.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 15.5 m -65.88 -15.98 63.42 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.279 1.432 . . . . 0.0 113.702 175.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 60.6 m-20 -81.55 -18.05 46.27 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 123.792 0.837 . . . . 0.0 112.422 172.349 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 72.2 m -91.04 165.37 13.56 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.813 1.245 . . . . 0.0 114.106 -171.448 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -73.53 174.88 7.62 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 125.211 1.405 . . . . 0.0 111.043 178.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.43 133.58 56.22 Favored 'General case' 0 CA--C 1.539 0.542 0 O-C-N 121.096 -1.003 . . . . 0.0 113.125 -177.355 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 75.13 -8.89 14.27 Favored Glycine 0 CA--C 1.534 1.248 0 C-N-CA 124.808 1.194 . . . . 0.0 114.329 -179.031 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 61.6 m -79.11 161.25 26.63 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 114.139 1.162 . . . . 0.0 114.139 -179.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 18.8 m -123.32 152.86 28.48 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 C-N-CA 126.337 1.855 . . . . 0.0 109.796 167.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 48.5 t -84.93 102.13 12.89 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.243 0.617 . . . . 0.0 110.16 170.21 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -71.77 168.24 51.74 Favored Glycine 0 CA--C 1.541 1.705 0 C-N-CA 124.774 1.178 . . . . 0.0 114.208 -179.251 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -70.09 -17.79 35.86 Favored 'Trans proline' 0 CA--C 1.539 0.736 0 C-N-CA 124.208 3.272 . . . . 0.0 113.479 -176.024 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 52.9 p-10 -69.38 -9.39 53.26 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 124.746 1.218 . . . . 0.0 114.286 171.087 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 86.24 8.67 77.85 Favored Glycine 0 CA--C 1.533 1.2 0 C-N-CA 125.11 1.338 . . . . 0.0 114.309 -177.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 75.0 m-85 -119.38 158.53 25.97 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 122.487 1.137 . . . . 0.0 112.317 174.573 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 68.2 m -73.52 147.39 44.07 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.094 1.358 . . . . 0.0 112.797 174.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.191 0 C-N-CA 125.934 1.731 . . . . 0.0 113.041 174.808 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 49.2 t . . . . . 0 CA--C 1.549 0.914 0 CA-C-O 118.431 -0.795 . . . . 0.0 112.797 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_exo -55.8 142.9 82.91 Favored 'Trans proline' 0 C--N 1.353 0.804 0 C-N-CA 123.637 2.891 . . . . 0.0 112.069 170.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 69.3 mmt-85 -81.04 16.19 1.6 Allowed 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 114.115 1.154 . . . . 0.0 114.115 -174.327 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 17.8 tt -73.87 142.94 14.19 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 125.637 1.575 . . . . 0.0 111.317 176.318 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 37.9 tp -80.6 132.42 35.63 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.342 0.657 . . . . 0.0 109.92 172.396 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 60.9 tpp -152.58 126.06 8.78 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 124.344 1.058 . . . . 0.0 109.932 -175.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 1.9 tmt_? -84.72 135.78 34.0 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.971 0.908 . . . . 0.0 109.714 178.658 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 26.3 p -136.85 164.27 28.7 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 125.268 1.427 . . . . 0.0 113.144 -172.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -119.97 -25.96 5.69 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 125.993 1.717 . . . . 0.0 111.11 169.247 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -145.88 169.08 19.29 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 126.36 1.864 . . . . 0.0 110.411 169.74 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -60.98 -25.72 67.06 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.393 1.077 . . . . 0.0 112.685 -178.45 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 15.6 m -65.68 -16.27 63.59 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 125.227 1.411 . . . . 0.0 113.669 175.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 55.9 m-20 -82.91 -17.91 42.02 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 123.917 0.887 . . . . 0.0 112.386 172.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 72.0 m -88.48 165.59 14.78 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.858 1.263 . . . . 0.0 113.649 -174.202 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -72.47 174.08 7.92 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 124.84 1.256 . . . . 0.0 111.08 177.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.25 133.27 55.95 Favored 'General case' 0 CA--C 1.539 0.538 0 O-C-N 121.201 -0.937 . . . . 0.0 113.156 -176.427 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 74.93 -8.52 15.19 Favored Glycine 0 CA--C 1.535 1.305 0 C-N-CA 124.691 1.138 . . . . 0.0 114.413 -179.106 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 61.3 m -79.29 161.74 26.09 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 118.466 1.133 . . . . 0.0 113.987 179.59 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 19.1 m -122.56 153.72 27.36 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 126.336 1.854 . . . . 0.0 110.19 168.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 48.3 t -86.33 102.26 13.84 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 123.61 0.764 . . . . 0.0 109.998 169.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -72.62 167.9 53.33 Favored Glycine 0 CA--C 1.542 1.767 0 C-N-CA 124.368 0.985 . . . . 0.0 114.3 -177.262 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_exo -58.27 -26.96 79.1 Favored 'Trans proline' 0 C--N 1.354 0.858 0 C-N-CA 124.499 3.466 . . . . 0.0 114.989 -177.578 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 53.0 p-10 -69.51 -9.55 54.31 Favored 'General case' 0 CA--C 1.546 0.791 0 N-CA-C 114.7 1.37 . . . . 0.0 114.7 175.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 85.95 10.08 76.15 Favored Glycine 0 CA--C 1.531 1.087 0 C-N-CA 124.772 1.177 . . . . 0.0 114.006 -176.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -119.96 156.55 30.61 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.68 1.192 . . . . 0.0 112.152 174.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 78.7 m -75.2 148.26 39.69 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.663 1.185 . . . . 0.0 113.243 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.115 0 C-N-CA 126.012 1.767 . . . . 0.0 113.067 174.573 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 47.8 t . . . . . 0 CA--C 1.548 0.904 0 CA-C-O 118.316 -0.849 . . . . 0.0 112.472 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -64.81 147.48 89.58 Favored 'Trans proline' 0 C--N 1.354 0.821 0 C-N-CA 123.153 2.569 . . . . 0.0 111.384 171.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 6.0 tpm_? -81.71 54.45 2.41 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-O 122.206 1.003 . . . . 0.0 111.815 178.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 19.3 tt -81.07 151.91 4.36 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 C-N-CA 125.729 1.612 . . . . 0.0 111.105 173.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 39.7 tp -95.37 73.44 3.29 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.817 0.847 . . . . 0.0 108.721 169.44 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 60.0 tpp -102.54 116.09 31.9 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.627 1.171 . . . . 0.0 109.363 -176.453 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 61.0 ttt180 -77.82 143.6 37.73 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 123.325 0.65 . . . . 0.0 110.52 178.466 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 30.3 p -150.02 158.31 44.03 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 114.158 1.17 . . . . 0.0 114.158 -169.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 59.2 mtmt -119.63 -19.35 8.12 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 126.699 2.0 . . . . 0.0 111.57 169.307 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 19.3 pt20 -148.61 159.06 44.45 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 126.62 1.968 . . . . 0.0 110.246 179.332 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -63.08 -25.53 68.41 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.094 0.958 . . . . 0.0 112.387 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 17.8 m -67.67 -13.41 62.07 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.897 1.279 . . . . 0.0 113.566 175.069 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 51.5 m-20 -80.91 -19.4 44.39 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 123.81 0.844 . . . . 0.0 111.952 171.468 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 79.0 m -90.66 165.43 13.72 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 125.52 1.528 . . . . 0.0 113.763 -172.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 34.6 mt -76.33 -178.55 4.62 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.357 1.063 . . . . 0.0 111.88 179.635 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.63 134.28 56.93 Favored 'General case' 0 CA--C 1.539 0.527 0 O-C-N 121.253 -0.904 . . . . 0.0 112.96 -179.611 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 74.41 -8.46 13.52 Favored Glycine 0 CA--C 1.534 1.255 0 C-N-CA 124.775 1.179 . . . . 0.0 114.281 -178.528 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 63.9 m -81.76 159.62 23.79 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 114.288 1.218 . . . . 0.0 114.288 -178.322 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 18.0 m -124.52 154.98 32.29 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 126.774 2.03 . . . . 0.0 109.634 167.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 48.2 t -84.05 102.26 12.37 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 121.341 0.591 . . . . 0.0 110.188 169.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -71.72 169.03 50.92 Favored Glycine 0 CA--C 1.542 1.763 0 C-N-CA 124.987 1.28 . . . . 0.0 114.379 -178.383 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -70.74 -18.41 32.45 Favored 'Trans proline' 0 CA--C 1.537 0.672 0 C-N-CA 124.262 3.308 . . . . 0.0 113.67 -174.202 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 52.6 p-10 -69.68 -10.04 56.69 Favored 'General case' 0 CA--C 1.548 0.899 0 N-CA-C 114.192 1.182 . . . . 0.0 114.192 171.21 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 87.5 8.54 73.9 Favored Glycine 0 CA--C 1.533 1.178 0 C-N-CA 124.952 1.263 . . . . 0.0 114.208 -177.139 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 76.9 m-85 -122.58 159.84 26.95 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 118.69 1.245 . . . . 0.0 111.779 173.573 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 77.5 m -70.7 153.79 42.47 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.262 1.025 . . . . 0.0 113.215 179.263 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.154 0 C-N-CA 126.035 1.778 . . . . 0.0 113.165 175.973 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 40.5 t . . . . . 0 CA--C 1.546 0.801 0 CA-C-O 117.9 -1.048 . . . . 0.0 112.539 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -68.65 146.07 65.81 Favored 'Trans proline' 0 C--N 1.353 0.765 0 C-N-CA 123.017 2.478 . . . . 0.0 110.633 175.421 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 15.8 mmm180 -83.83 16.13 2.94 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 113.782 1.03 . . . . 0.0 113.782 -171.034 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 10.0 tp -68.19 141.66 17.34 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 125.489 1.516 . . . . 0.0 111.341 177.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 30.9 tp -75.9 131.99 40.0 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 123.359 0.663 . . . . 0.0 110.152 175.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 61.1 tpp -155.48 132.77 10.93 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.827 1.251 . . . . 0.0 109.851 -174.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 87.4 mtm180 -81.16 152.68 27.63 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.923 0.889 . . . . 0.0 111.603 177.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 29.4 p -157.38 155.29 30.29 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 113.961 1.097 . . . . 0.0 113.961 -175.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 64.8 tttm -110.53 -28.68 8.4 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 126.023 1.729 . . . . 0.0 110.726 168.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 8.1 pt20 -147.84 169.75 19.11 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 126.426 1.89 . . . . 0.0 110.601 172.541 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -61.35 -25.33 67.08 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 124.6 1.16 . . . . 0.0 112.918 -176.528 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 8.0 m -65.25 -18.59 65.43 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 125.157 1.383 . . . . 0.0 113.627 175.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 60.4 m-20 -81.73 -18.52 44.03 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 123.928 0.891 . . . . 0.0 112.368 174.398 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 73.6 m -86.9 168.02 13.79 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.118 1.367 . . . . 0.0 113.648 -175.579 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -71.17 173.72 7.3 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 124.415 1.086 . . . . 0.0 110.919 176.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.0 132.89 55.36 Favored 'General case' 0 CA--C 1.54 0.581 0 O-C-N 121.16 -0.962 . . . . 0.0 113.213 -175.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 74.42 -8.45 13.59 Favored Glycine 0 CA--C 1.534 1.247 0 C-N-CA 124.829 1.204 . . . . 0.0 114.512 -179.599 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 66.7 m -75.29 162.59 28.3 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 118.5 1.15 . . . . 0.0 113.915 -179.6 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 23.3 m -118.84 151.47 21.04 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 125.319 1.448 . . . . 0.0 110.816 168.697 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 43.7 t -89.38 104.76 17.29 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 123.725 0.81 . . . . 0.0 109.783 169.439 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -70.24 166.97 49.97 Favored Glycine 0 CA--C 1.543 1.81 0 C-N-CA 124.563 1.078 . . . . 0.0 113.842 179.043 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -69.43 -18.14 38.71 Favored 'Trans proline' 0 CA--C 1.539 0.76 0 C-N-CA 124.046 3.164 . . . . 0.0 113.357 -176.499 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 51.3 p-10 -69.22 -9.96 55.49 Favored 'General case' 0 CA--C 1.549 0.933 0 N-CA-C 114.414 1.265 . . . . 0.0 114.414 170.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 84.7 12.7 74.36 Favored Glycine 0 CA--C 1.533 1.218 0 C-N-CA 124.838 1.209 . . . . 0.0 114.096 -176.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -119.6 155.35 32.43 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.773 1.229 . . . . 0.0 112.403 175.02 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 69.7 m -76.75 154.92 33.61 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.941 1.297 . . . . 0.0 113.319 177.359 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.309 0 C-N-CA 125.711 1.624 . . . . 0.0 113.779 175.072 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 52.9 t . . . . . 0 CA--C 1.55 0.966 0 CA-C-O 118.501 -0.761 . . . . 0.0 112.306 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -71.83 147.99 51.21 Favored 'Trans proline' 0 C--N 1.353 0.811 0 C-N-CA 123.279 2.653 . . . . 0.0 111.16 173.695 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -84.53 17.76 2.55 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 114.166 1.173 . . . . 0.0 114.166 -172.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 8.9 tp -69.81 138.62 21.73 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 125.065 1.346 . . . . 0.0 111.118 175.345 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 31.5 tp -78.94 115.41 18.61 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 123.441 0.696 . . . . 0.0 109.882 177.141 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 81.6 mmm -137.17 126.09 24.21 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 125.672 1.589 . . . . 0.0 108.929 -177.468 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 25.4 ttt85 -86.77 144.99 26.81 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 118.632 0.651 . . . . 0.0 111.297 -179.443 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 24.5 p -146.66 160.56 42.04 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 125.502 1.521 . . . . 0.0 113.544 -169.205 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 61.4 mtpt -112.21 -24.72 9.68 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 125.845 1.658 . . . . 0.0 111.373 169.231 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 20.9 pt20 -152.71 166.63 31.55 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 126.397 1.879 . . . . 0.0 110.599 176.569 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -61.16 -25.07 66.76 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 124.257 1.023 . . . . 0.0 112.811 -176.318 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.8 m -65.54 -18.01 65.0 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 125.662 1.585 . . . . 0.0 113.573 176.016 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 63.0 m-20 -81.42 -19.14 43.13 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 123.991 0.917 . . . . 0.0 112.228 173.317 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 75.8 m -89.22 167.34 13.16 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.211 1.404 . . . . 0.0 113.621 -174.474 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -74.86 177.98 5.86 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 124.373 1.069 . . . . 0.0 111.206 179.623 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.47 133.7 56.34 Favored 'General case' 0 CA--C 1.539 0.547 0 O-C-N 121.186 -0.946 . . . . 0.0 112.923 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 74.77 -9.41 11.18 Favored Glycine 0 CA--C 1.533 1.186 0 C-N-CA 124.81 1.195 . . . . 0.0 114.399 -179.104 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 64.0 m -79.48 161.53 26.0 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 118.555 1.177 . . . . 0.0 113.969 -179.417 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 18.7 m -124.2 153.36 30.49 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 C-N-CA 126.313 1.845 . . . . 0.0 110.147 168.186 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 45.0 t -85.67 102.97 14.06 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.371 0.669 . . . . 0.0 109.8 169.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -71.53 172.16 45.82 Favored Glycine 0 CA--C 1.542 1.764 0 C-N-CA 125.133 1.349 . . . . 0.0 114.602 -177.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -70.37 -21.23 30.92 Favored 'Trans proline' 0 CA--C 1.538 0.712 0 C-N-CA 124.28 3.32 . . . . 0.0 113.604 -173.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 51.0 p-10 -70.95 -7.04 43.24 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 124.718 1.207 . . . . 0.0 113.97 169.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 83.72 8.46 84.48 Favored Glycine 0 CA--C 1.53 1.029 0 C-N-CA 125.389 1.471 . . . . 0.0 114.056 -177.567 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -112.18 155.82 23.32 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 119.195 1.498 . . . . 0.0 112.337 176.139 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 81.1 m -73.88 146.0 44.39 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.452 1.101 . . . . 0.0 112.8 176.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.189 0 C-N-CA 125.972 1.749 . . . . 0.0 113.11 174.927 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 45.5 t . . . . . 0 CA--C 1.549 0.91 0 CA-C-O 118.278 -0.868 . . . . 0.0 112.187 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -71.62 160.97 46.77 Favored 'Trans proline' 0 C--N 1.354 0.858 0 C-N-CA 123.106 2.537 . . . . 0.0 111.701 178.029 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 52.4 ttp180 -78.89 60.42 2.85 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 125.002 1.321 . . . . 0.0 111.474 -179.395 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 88.0 mt -125.52 122.47 62.6 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 126.551 1.941 . . . . 0.0 108.764 -177.356 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 40.3 tp -79.75 134.42 36.37 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.509 0.723 . . . . 0.0 109.544 170.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 59.4 tpp -157.45 135.17 10.68 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.231 1.012 . . . . 0.0 110.022 -170.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 27.6 mmt180 -77.3 153.56 33.76 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.633 0.773 . . . . 0.0 111.833 174.284 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 29.7 p -157.7 159.85 37.33 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 114.17 1.174 . . . . 0.0 114.17 -177.119 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 17.3 tppt? -118.34 -24.82 6.75 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 126.233 1.813 . . . . 0.0 111.036 169.026 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -148.73 170.19 18.75 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 126.26 1.824 . . . . 0.0 111.022 169.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -63.57 -25.44 68.24 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 124.85 1.26 . . . . 0.0 113.49 -173.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 77.7 p -73.09 -10.55 59.91 Favored 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 113.817 1.043 . . . . 0.0 113.817 175.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 62.8 m-20 -80.07 -20.91 44.06 Favored 'General case' 0 CA--C 1.543 0.708 0 O-C-N 121.336 -0.853 . . . . 0.0 111.601 169.241 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 71.5 m -85.88 167.28 15.28 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.242 1.417 . . . . 0.0 113.863 -174.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -70.23 170.35 11.84 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 124.21 1.004 . . . . 0.0 110.702 175.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.16 135.3 57.68 Favored 'General case' 0 CA--C 1.539 0.52 0 O-C-N 121.202 -0.936 . . . . 0.0 112.87 -177.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 76.2 -8.84 22.39 Favored Glycine 0 CA--C 1.534 1.248 0 C-N-CA 124.712 1.149 . . . . 0.0 114.352 -178.621 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 59.3 m -80.13 162.69 24.61 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 118.472 1.136 . . . . 0.0 113.988 178.401 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 19.4 m -121.28 154.13 25.04 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 126.206 1.802 . . . . 0.0 110.146 168.287 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 49.4 t -87.66 103.79 15.91 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 123.462 0.705 . . . . 0.0 110.178 169.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -70.6 167.68 50.04 Favored Glycine 0 CA--C 1.543 1.784 0 C-N-CA 124.714 1.15 . . . . 0.0 114.05 178.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -69.99 -18.77 35.74 Favored 'Trans proline' 0 CA--C 1.538 0.701 0 C-N-CA 124.12 3.213 . . . . 0.0 113.564 -175.127 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 52.6 p-10 -70.59 -8.04 48.58 Favored 'General case' 0 CA--C 1.548 0.899 0 N-CA-C 114.323 1.231 . . . . 0.0 114.323 171.17 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 81.93 12.37 81.28 Favored Glycine 0 CA--C 1.533 1.17 0 C-N-CA 124.893 1.235 . . . . 0.0 113.994 -177.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -113.79 157.93 21.64 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.848 1.259 . . . . 0.0 111.76 170.501 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 77.7 m -77.28 149.56 35.37 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.21 1.404 . . . . 0.0 113.088 174.369 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.298 0 C-N-CA 125.947 1.736 . . . . 0.0 113.153 173.972 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 36.3 t . . . . . 0 CA--C 1.547 0.844 0 CA-C-O 118.163 -0.922 . . . . 0.0 112.461 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -66.77 151.21 82.92 Favored 'Trans proline' 0 C--N 1.353 0.797 0 C-N-CA 123.203 2.602 . . . . 0.0 111.845 178.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 6.7 mmp_? -82.54 14.36 3.13 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 124.77 1.228 . . . . 0.0 114.058 -177.083 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 10.2 tp -71.78 142.74 15.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 C-N-CA 125.302 1.441 . . . . 0.0 111.223 177.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 26.9 tp -76.93 131.98 38.82 Favored 'General case' 0 CA--C 1.538 0.485 0 O-C-N 121.791 -0.568 . . . . 0.0 110.15 175.357 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 61.2 tpp -154.47 126.47 7.72 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 125.056 1.342 . . . . 0.0 108.773 -178.319 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 25.9 ttt85 -88.93 146.64 24.79 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 118.392 0.542 . . . . 0.0 111.259 -178.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 26.2 p -150.84 160.08 44.12 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.269 1.427 . . . . 0.0 113.685 -169.091 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 61.7 mtpt -116.67 -20.79 9.4 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 126.35 1.86 . . . . 0.0 111.301 169.03 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 19.5 pt20 -147.8 160.29 42.91 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 126.941 2.097 . . . . 0.0 110.201 177.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -62.23 -26.03 68.14 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 124.25 1.02 . . . . 0.0 112.439 -179.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 17.0 m -67.85 -13.85 62.48 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 124.881 1.272 . . . . 0.0 113.664 175.544 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 48.3 m-20 -82.32 -19.69 38.88 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.747 0.819 . . . . 0.0 112.117 172.523 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 81.7 m -85.86 168.88 13.84 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.308 1.443 . . . . 0.0 113.83 -173.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -71.64 175.65 5.46 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 124.468 1.107 . . . . 0.0 111.049 176.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.29 133.0 55.68 Favored 'General case' 0 CA--C 1.54 0.566 0 O-C-N 121.064 -1.023 . . . . 0.0 113.338 -176.044 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 74.02 -8.3 12.57 Favored Glycine 0 CA--C 1.535 1.288 0 C-N-CA 124.891 1.234 . . . . 0.0 114.559 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 66.4 m -75.78 162.52 28.11 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 114.238 1.199 . . . . 0.0 114.238 -178.074 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 20.3 m -120.57 151.25 23.39 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 125.579 1.551 . . . . 0.0 110.493 168.298 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 49.4 t -87.09 103.64 15.57 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 123.586 0.754 . . . . 0.0 109.8 169.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -71.74 171.7 47.1 Favored Glycine 0 CA--C 1.543 1.827 0 C-N-CA 125.063 1.316 . . . . 0.0 114.446 -178.48 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -70.43 -21.04 30.92 Favored 'Trans proline' 0 CA--C 1.539 0.733 0 C-N-CA 124.262 3.308 . . . . 0.0 113.634 -173.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 50.7 p-10 -70.69 -7.04 41.66 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 124.749 1.22 . . . . 0.0 113.987 169.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.86 10.35 83.17 Favored Glycine 0 CA--C 1.529 0.946 0 C-N-CA 125.24 1.4 . . . . 0.0 113.866 -177.048 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -113.52 154.24 27.41 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 119.374 1.587 . . . . 0.0 112.444 175.659 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 69.9 m -74.76 151.18 39.16 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.969 1.308 . . . . 0.0 113.063 177.628 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.353 0 C-N-CA 125.647 1.594 . . . . 0.0 113.864 175.132 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 42.0 t . . . . . 0 CA--C 1.55 0.952 0 CA-C-O 118.295 -0.86 . . . . 0.0 112.244 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -71.35 163.33 39.47 Favored 'Trans proline' 0 C--N 1.353 0.792 0 C-N-CA 123.315 2.677 . . . . 0.0 111.865 176.327 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 18.5 ptp180 -72.94 16.3 0.16 Allowed 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 115.175 1.546 . . . . 0.0 115.175 -176.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 89.4 mt -80.36 119.94 30.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 125.768 1.627 . . . . 0.0 109.656 -176.741 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 36.9 tp -81.88 132.32 35.27 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.729 0.812 . . . . 0.0 109.652 170.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 59.9 ttm -160.97 136.21 7.74 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.664 1.185 . . . . 0.0 109.598 -171.433 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 56.8 mtp85 -84.89 152.26 23.69 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 118.876 0.762 . . . . 0.0 112.556 175.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 24.9 p -151.32 156.83 41.59 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.206 1.402 . . . . 0.0 113.672 -169.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 28.4 ttpp -102.37 -29.63 11.53 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 126.205 1.802 . . . . 0.0 110.539 168.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 20.1 pt20 -155.94 166.7 32.7 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 126.364 1.866 . . . . 0.0 110.648 -177.484 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -60.89 -25.69 66.89 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 124.303 1.041 . . . . 0.0 112.647 -176.643 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.4 m -64.14 -18.84 64.83 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 125.834 1.654 . . . . 0.0 113.576 176.168 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 63.2 m-20 -81.48 -22.15 38.23 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.004 0.921 . . . . 0.0 112.387 174.591 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 73.0 m -86.32 167.34 14.87 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.059 1.344 . . . . 0.0 113.844 -171.297 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -70.81 172.37 8.96 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 124.261 1.024 . . . . 0.0 111.048 176.389 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.07 135.88 57.85 Favored 'General case' 0 CA--C 1.539 0.537 0 O-C-N 121.273 -0.892 . . . . 0.0 112.88 -179.188 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 75.75 -9.25 17.37 Favored Glycine 0 CA--C 1.533 1.207 0 C-N-CA 124.776 1.179 . . . . 0.0 114.265 -178.554 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 59.6 m -80.78 161.63 24.43 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 118.652 1.226 . . . . 0.0 114.023 179.479 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 18.7 m -123.27 153.2 28.52 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 C-N-CA 126.272 1.829 . . . . 0.0 110.091 168.383 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 49.1 t -87.57 103.7 15.8 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 123.386 0.675 . . . . 0.0 109.871 169.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -71.5 170.4 48.45 Favored Glycine 0 CA--C 1.542 1.743 0 C-N-CA 124.884 1.23 . . . . 0.0 114.197 -179.288 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -69.67 -20.56 35.11 Favored 'Trans proline' 0 CA--C 1.538 0.71 0 C-N-CA 124.247 3.298 . . . . 0.0 113.453 -175.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 49.3 p30 -70.31 -6.8 37.71 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 125.014 1.326 . . . . 0.0 114.053 169.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 79.9 12.64 83.22 Favored Glycine 0 CA--C 1.531 1.033 0 C-N-CA 125.188 1.375 . . . . 0.0 114.066 -178.408 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -109.05 153.56 23.47 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 118.613 1.207 . . . . 0.0 112.239 172.218 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 78.2 m -73.17 145.2 46.5 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.883 1.273 . . . . 0.0 112.238 170.013 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.238 0 C-N-CA 125.95 1.738 . . . . 0.0 113.207 175.813 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 51.6 t . . . . . 0 CA--C 1.549 0.937 0 CA-C-O 118.363 -0.827 . . . . 0.0 112.645 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_exo -57.71 145.87 87.87 Favored 'Trans proline' 0 C--N 1.354 0.858 0 C-N-CA 123.83 3.02 . . . . 0.0 112.645 171.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 34.0 ptt-85 -79.99 12.61 2.66 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 115.358 1.614 . . . . 0.0 115.358 -173.617 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 10.2 tp -75.11 142.21 14.88 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 125.223 1.409 . . . . 0.0 111.484 178.659 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 30.4 tp -81.04 133.82 35.55 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 123.577 0.751 . . . . 0.0 109.988 173.725 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 61.5 tpp -158.6 133.51 8.33 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.458 1.103 . . . . 0.0 109.516 -172.478 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 55.6 mtp85 -91.31 154.64 19.09 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 118.955 0.798 . . . . 0.0 112.879 175.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 26.4 p -154.88 159.25 40.36 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.196 1.398 . . . . 0.0 113.83 -169.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 65.0 mttp -111.63 -26.05 9.22 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 125.991 1.717 . . . . 0.0 111.028 168.804 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 21.0 pt20 -150.97 166.99 28.97 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 126.565 1.946 . . . . 0.0 110.513 175.503 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -60.76 -25.9 66.84 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 124.524 1.13 . . . . 0.0 112.73 -176.043 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.9 m -65.41 -18.1 65.05 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 125.653 1.581 . . . . 0.0 113.61 176.31 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 62.2 m-20 -82.0 -19.26 40.87 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 123.971 0.909 . . . . 0.0 112.327 173.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 75.0 m -87.02 167.08 14.55 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.921 1.289 . . . . 0.0 113.903 -173.498 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -71.34 172.99 8.4 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 124.741 1.217 . . . . 0.0 110.925 177.181 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.24 133.36 56.03 Favored 'General case' 0 CA--C 1.539 0.543 0 O-C-N 121.195 -0.94 . . . . 0.0 113.162 -175.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 74.83 -8.54 14.72 Favored Glycine 0 CA--C 1.534 1.267 0 C-N-CA 124.657 1.122 . . . . 0.0 114.45 -179.464 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 61.2 m -78.65 160.99 27.25 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 114.067 1.136 . . . . 0.0 114.067 179.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 18.8 m -120.24 154.54 23.35 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 126.258 1.823 . . . . 0.0 110.205 168.447 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 43.3 t -88.17 104.13 16.41 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 123.618 0.767 . . . . 0.0 110.28 170.019 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -70.72 169.15 48.51 Favored Glycine 0 CA--C 1.543 1.802 0 C-N-CA 124.911 1.243 . . . . 0.0 114.179 178.454 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -70.52 -20.67 30.97 Favored 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 124.228 3.285 . . . . 0.0 113.695 -174.137 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 50.5 p30 -71.35 -5.15 30.3 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 124.952 1.301 . . . . 0.0 114.058 170.397 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 79.28 11.17 85.28 Favored Glycine 0 CA--C 1.53 1.027 0 C-N-CA 125.12 1.343 . . . . 0.0 114.007 -178.636 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -106.99 155.05 20.21 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 118.652 1.226 . . . . 0.0 111.885 170.548 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 83.3 m -76.23 147.37 38.39 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.983 1.313 . . . . 0.0 112.606 173.272 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.181 0 C-N-CA 125.815 1.674 . . . . 0.0 113.279 175.26 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 45.9 t . . . . . 0 CA--C 1.551 0.995 0 CA-C-O 118.326 -0.845 . . . . 0.0 112.586 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -56.77 146.18 79.08 Favored 'Trans proline' 0 C--N 1.354 0.866 0 C-N-CA 123.947 3.098 . . . . 0.0 112.872 172.059 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 82.1 mtp180 -84.72 14.1 5.07 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 114.404 1.261 . . . . 0.0 114.404 -172.112 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 10.2 tp -77.63 143.4 12.89 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 C-N-CA 125.176 1.39 . . . . 0.0 111.144 176.353 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 29.4 tp -78.21 135.26 37.56 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 123.189 0.596 . . . . 0.0 110.22 174.648 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 61.2 tpp -154.16 126.61 8.0 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 124.78 1.232 . . . . 0.0 108.973 -177.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 25.1 ttt85 -89.61 147.4 23.94 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 118.452 0.569 . . . . 0.0 111.037 179.158 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 26.1 p -152.19 165.66 34.15 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.884 1.274 . . . . 0.0 114.309 -168.469 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 21.5 pttp -122.41 -14.4 7.85 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 126.072 1.749 . . . . 0.0 112.123 168.079 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 20.0 pt20 -155.45 162.35 40.77 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 126.642 1.977 . . . . 0.0 110.351 178.183 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 26.7 m-20 -62.23 -24.52 67.29 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.911 0.884 . . . . 0.0 112.606 -177.102 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.3 m -64.21 -18.57 64.64 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 125.82 1.648 . . . . 0.0 113.58 176.327 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 64.6 m-20 -80.78 -20.52 42.44 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.12 0.968 . . . . 0.0 112.388 174.4 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 73.8 m -89.77 165.92 13.87 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.983 1.313 . . . . 0.0 113.897 -169.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -72.56 174.95 6.78 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 124.763 1.225 . . . . 0.0 111.07 177.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.43 133.23 55.91 Favored 'General case' 0 CA--C 1.541 0.606 0 O-C-N 121.089 -1.007 . . . . 0.0 113.104 -176.228 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 74.73 -8.64 13.8 Favored Glycine 0 CA--C 1.535 1.311 0 C-N-CA 124.687 1.137 . . . . 0.0 114.408 -179.447 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 60.6 m -79.16 161.99 26.07 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 114.082 1.141 . . . . 0.0 114.082 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 18.2 m -124.92 154.42 32.8 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 126.433 1.893 . . . . 0.0 110.197 168.577 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 36.9 t -83.77 102.25 12.17 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 123.303 0.641 . . . . 0.0 110.372 170.338 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -71.91 172.25 46.74 Favored Glycine 0 CA--C 1.542 1.781 0 C-N-CA 125.339 1.447 . . . . 0.0 114.62 -179.092 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -71.38 -20.94 27.04 Favored 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 124.33 3.353 . . . . 0.0 113.973 -172.127 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 52.6 p-10 -71.96 -5.18 32.96 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 124.576 1.15 . . . . 0.0 113.899 170.416 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 83.47 5.92 88.07 Favored Glycine 0 CA--C 1.53 0.98 0 C-N-CA 125.497 1.522 . . . . 0.0 114.029 -177.694 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -109.5 155.97 20.68 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 119.195 1.497 . . . . 0.0 112.163 174.599 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 82.7 m -73.47 145.8 45.42 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.839 1.256 . . . . 0.0 112.804 176.308 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.206 0 C-N-CA 126.063 1.792 . . . . 0.0 113.146 175.905 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 48.0 t . . . . . 0 CA--C 1.55 0.964 0 CA-C-O 118.134 -0.936 . . . . 0.0 112.396 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -62.93 160.65 32.62 Favored 'Trans proline' 0 C--N 1.354 0.827 0 C-N-CA 123.288 2.659 . . . . 0.0 112.848 175.165 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 40.4 ptt180 -74.13 13.94 0.49 Allowed 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 114.865 1.431 . . . . 0.0 114.865 179.519 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 94.6 mt -86.32 122.21 38.4 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 126.352 1.861 . . . . 0.0 109.558 -174.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 47.7 tp -76.74 134.31 39.21 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.666 0.786 . . . . 0.0 109.872 171.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 57.6 ttm -157.57 132.17 8.52 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.342 1.057 . . . . 0.0 110.186 -173.592 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 57.4 ttt180 -82.71 147.98 28.16 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.723 0.809 . . . . 0.0 111.089 -179.65 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 26.3 p -151.17 158.5 44.05 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.548 1.139 . . . . 0.0 113.687 -170.034 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 58.9 mtmt -109.3 -27.32 9.58 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.815 1.646 . . . . 0.0 111.344 169.505 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 8.0 pt20 -153.41 169.47 23.06 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 126.399 1.88 . . . . 0.0 110.818 176.109 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -61.45 -25.71 67.4 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.406 1.083 . . . . 0.0 112.887 -176.489 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 7.2 m -64.8 -18.65 65.29 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 125.296 1.438 . . . . 0.0 113.484 175.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 62.0 m-20 -80.42 -21.18 42.44 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 123.909 0.883 . . . . 0.0 112.21 173.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 77.4 m -88.08 166.75 14.21 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 125.237 1.415 . . . . 0.0 113.662 -173.303 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 40.1 mt -74.4 177.37 5.98 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.47 1.108 . . . . 0.0 111.726 178.496 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.23 134.47 57.09 Favored 'General case' 0 CA--C 1.54 0.559 0 O-C-N 121.305 -0.872 . . . . 0.0 112.855 -179.786 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 74.67 -8.33 15.21 Favored Glycine 0 CA--C 1.535 1.292 0 C-N-CA 124.698 1.142 . . . . 0.0 114.314 -178.461 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 60.7 m -81.22 159.76 24.48 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 118.553 1.177 . . . . 0.0 113.993 179.496 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 18.2 m -124.48 151.63 29.88 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 126.251 1.82 . . . . 0.0 110.003 168.288 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 49.7 t -85.69 102.2 13.41 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.355 0.662 . . . . 0.0 109.561 169.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -72.65 170.11 51.44 Favored Glycine 0 CA--C 1.544 1.858 0 C-N-CA 124.411 1.005 . . . . 0.0 114.242 -176.167 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -57.9 -26.78 75.94 Favored 'Trans proline' 0 C--N 1.353 0.807 0 C-N-CA 124.518 3.479 . . . . 0.0 114.757 -178.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 52.0 p-10 -68.6 -11.37 59.92 Favored 'General case' 0 CA--C 1.548 0.9 0 N-CA-C 114.676 1.361 . . . . 0.0 114.676 174.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 84.25 14.56 71.31 Favored Glycine 0 CA--C 1.533 1.177 0 C-N-CA 124.799 1.19 . . . . 0.0 114.019 -176.335 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 64.8 m-85 -123.05 155.33 37.11 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.739 1.216 . . . . 0.0 112.225 175.142 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 85.7 m -73.91 145.19 44.97 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.116 1.366 . . . . 0.0 112.761 178.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.284 0 C-N-CA 126.111 1.815 . . . . 0.0 113.076 175.265 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 40.4 t . . . . . 0 CA--C 1.546 0.826 0 CA-C-O 117.905 -1.045 . . . . 0.0 112.542 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -67.74 146.31 72.3 Favored 'Trans proline' 0 C--N 1.353 0.813 0 C-N-CA 122.994 2.463 . . . . 0.0 110.676 175.185 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 15.3 mmm180 -83.45 17.04 2.29 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 113.48 0.919 . . . . 0.0 113.48 -173.16 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 19.4 tt -66.28 141.74 17.65 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 125.954 1.702 . . . . 0.0 111.616 178.702 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 26.5 tp -77.0 130.26 37.23 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.315 0.646 . . . . 0.0 109.975 175.313 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 61.7 tpp -160.14 132.49 6.35 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.806 1.242 . . . . 0.0 109.098 -172.762 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 55.2 mtp85 -91.14 155.35 18.69 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 118.944 0.793 . . . . 0.0 113.088 177.456 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 26.6 p -155.67 157.38 36.58 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.401 1.48 . . . . 0.0 113.407 -170.136 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 64.9 mttp -110.51 -26.22 9.61 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 125.598 1.559 . . . . 0.0 110.936 168.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 8.1 pt20 -149.99 169.28 21.57 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 126.5 1.92 . . . . 0.0 110.386 173.185 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -61.18 -25.57 67.12 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 124.533 1.133 . . . . 0.0 112.919 -176.513 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 7.1 m -64.88 -19.1 65.73 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 125.315 1.446 . . . . 0.0 113.605 175.862 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 60.3 m-20 -82.18 -18.46 42.66 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 123.929 0.892 . . . . 0.0 112.366 174.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 79.1 m -86.66 168.51 13.54 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.069 1.348 . . . . 0.0 113.706 -175.412 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -71.1 173.84 7.08 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 124.557 1.143 . . . . 0.0 110.992 176.805 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.94 132.76 54.94 Favored 'General case' 0 CA--C 1.54 0.573 0 O-C-N 121.115 -0.991 . . . . 0.0 113.236 -175.615 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 74.25 -8.33 13.44 Favored Glycine 0 CA--C 1.534 1.265 0 C-N-CA 124.87 1.224 . . . . 0.0 114.539 -179.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 67.4 m -75.42 162.32 28.47 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 114.041 1.126 . . . . 0.0 114.041 -179.205 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 22.4 m -118.43 151.99 20.56 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 125.463 1.505 . . . . 0.0 110.7 168.666 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 48.5 t -90.3 105.15 17.62 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.826 0.85 . . . . 0.0 109.999 169.488 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -70.74 168.81 49.07 Favored Glycine 0 CA--C 1.541 1.708 0 C-N-CA 124.742 1.163 . . . . 0.0 114.127 178.586 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -70.01 -20.53 33.56 Favored 'Trans proline' 0 CA--C 1.538 0.713 0 C-N-CA 124.187 3.258 . . . . 0.0 113.58 -175.151 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 49.1 p30 -70.65 -5.96 33.41 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 125.071 1.349 . . . . 0.0 114.099 169.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 78.83 13.45 83.1 Favored Glycine 0 CA--C 1.531 1.039 0 C-N-CA 125.109 1.337 . . . . 0.0 113.917 -178.289 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -109.04 153.82 23.09 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 118.629 1.215 . . . . 0.0 111.995 171.159 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 82.5 m -76.59 154.02 34.8 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.998 1.319 . . . . 0.0 112.847 173.765 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.185 0 CA-C-O 116.653 -2.193 . . . . 0.0 113.952 175.472 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 42.3 t . . . . . 0 CA--C 1.549 0.932 0 CA-C-O 118.311 -0.852 . . . . 0.0 112.19 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_endo -72.69 163.77 37.53 Favored 'Trans proline' 0 C--N 1.353 0.804 0 C-N-CA 123.132 2.555 . . . . 0.0 111.74 177.755 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 10.7 ptm85 -73.04 15.56 0.2 Allowed 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 115.109 1.522 . . . . 0.0 115.109 -178.55 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 91.6 mt -79.77 120.07 30.4 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 125.834 1.654 . . . . 0.0 109.349 -177.828 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 36.3 tp -76.82 135.11 38.91 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 123.388 0.675 . . . . 0.0 109.602 171.085 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 60.8 tpp -160.01 134.58 7.65 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.315 1.046 . . . . 0.0 109.365 -169.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 53.9 mtp85 -88.93 152.82 21.5 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 119.187 0.903 . . . . 0.0 112.418 174.625 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 26.4 p -153.8 159.87 42.04 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 125.004 1.322 . . . . 0.0 113.866 -169.636 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 61.3 mtpt -113.94 -24.2 9.2 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 126.18 1.792 . . . . 0.0 111.158 168.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 21.0 pt20 -151.0 166.46 30.64 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 126.544 1.938 . . . . 0.0 110.434 175.099 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -61.29 -25.47 67.13 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 124.332 1.053 . . . . 0.0 112.721 -176.23 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.8 m -65.42 -17.77 64.8 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 125.636 1.574 . . . . 0.0 113.641 176.233 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 63.5 m-20 -81.79 -18.71 43.15 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 123.985 0.914 . . . . 0.0 112.302 173.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 74.2 m -87.98 168.01 13.22 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.952 1.301 . . . . 0.0 114.133 -172.416 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -70.57 171.16 10.74 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 124.399 1.08 . . . . 0.0 110.742 175.733 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.13 134.8 57.4 Favored 'General case' 0 CA--C 1.539 0.543 0 O-C-N 121.171 -0.956 . . . . 0.0 113.018 -177.177 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 75.82 -8.82 19.7 Favored Glycine 0 CA--C 1.534 1.238 0 C-N-CA 124.814 1.197 . . . . 0.0 114.338 -179.172 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 60.5 m -79.48 162.07 25.67 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 114.131 1.16 . . . . 0.0 114.131 179.427 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 19.0 m -122.14 153.44 26.5 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 126.308 1.843 . . . . 0.0 110.128 168.338 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 41.1 t -86.91 102.61 14.51 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.6 0.76 . . . . 0.0 110.358 170.479 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -73.47 168.98 53.66 Favored Glycine 0 CA--C 1.545 1.94 0 C-N-CA 124.628 1.109 . . . . 0.0 114.499 -178.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -59.03 -28.6 88.32 Favored 'Trans proline' 0 C--N 1.354 0.822 0 C-N-CA 124.532 3.488 . . . . 0.0 115.129 -176.284 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 51.3 p30 -71.03 -4.79 26.78 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 125.06 1.344 . . . . 0.0 114.446 175.719 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 78.83 11.53 85.13 Favored Glycine 0 CA--C 1.531 1.054 0 C-N-CA 124.941 1.257 . . . . 0.0 113.918 -178.384 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -107.33 155.33 20.1 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 118.49 1.145 . . . . 0.0 111.796 169.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 83.7 m -76.36 145.97 39.1 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.03 1.332 . . . . 0.0 112.587 172.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.249 0 C-N-CA 125.906 1.717 . . . . 0.0 113.223 175.261 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 53.4 t . . . . . 0 CA--C 1.551 1.013 0 CA-C-O 118.399 -0.81 . . . . 0.0 112.497 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -56.93 153.3 38.54 Favored 'Trans proline' 0 C--N 1.353 0.787 0 C-N-CA 124.059 3.173 . . . . 0.0 113.152 171.312 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -78.92 38.4 0.33 Allowed 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 125.194 1.398 . . . . 0.0 112.692 179.721 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 86.7 mt -101.69 121.89 53.2 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 C-N-CA 126.366 1.866 . . . . 0.0 109.185 -176.28 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 37.5 tp -81.29 131.47 35.29 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 123.695 0.798 . . . . 0.0 109.646 171.837 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 60.3 ttm -160.1 135.31 8.03 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.644 1.178 . . . . 0.0 110.213 -171.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 30.3 mmt180 -73.57 153.44 40.23 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.588 0.755 . . . . 0.0 112.016 175.604 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 29.0 p -157.63 160.14 37.73 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.421 1.088 . . . . 0.0 113.71 -176.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 16.9 tppt? -117.23 -25.82 6.97 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 126.712 2.005 . . . . 0.0 111.035 169.155 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -144.38 159.96 41.85 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 126.583 1.953 . . . . 0.0 110.478 178.385 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -62.36 -26.59 68.54 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 124.31 1.044 . . . . 0.0 112.318 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 17.6 m -67.83 -13.18 61.92 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 124.98 1.312 . . . . 0.0 113.571 175.358 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 51.7 m-20 -80.67 -22.48 40.4 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 118.892 0.769 . . . . 0.0 111.914 171.49 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 73.1 m -86.38 167.78 14.43 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.398 1.479 . . . . 0.0 113.642 -172.601 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -70.18 172.05 8.72 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.247 1.019 . . . . 0.0 111.157 176.403 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.54 135.21 57.6 Favored 'General case' 0 CA--C 1.539 0.541 0 O-C-N 121.231 -0.918 . . . . 0.0 112.902 -179.06 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 75.37 -9.03 15.32 Favored Glycine 0 CA--C 1.533 1.196 0 C-N-CA 124.716 1.151 . . . . 0.0 114.286 -178.683 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 60.4 m -80.62 161.34 24.75 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 118.604 1.202 . . . . 0.0 113.731 178.839 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 18.7 m -122.01 154.63 26.57 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 C-N-CA 126.256 1.823 . . . . 0.0 110.196 168.797 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 47.2 t -88.3 103.78 16.13 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.405 0.682 . . . . 0.0 109.661 169.524 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -71.16 168.53 50.44 Favored Glycine 0 CA--C 1.542 1.756 0 C-N-CA 124.591 1.091 . . . . 0.0 113.938 -178.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -69.29 -18.95 38.97 Favored 'Trans proline' 0 CA--C 1.538 0.723 0 C-N-CA 124.091 3.194 . . . . 0.0 113.254 -176.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 50.9 p-10 -69.44 -9.2 52.63 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 124.892 1.277 . . . . 0.0 114.312 170.196 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 81.99 13.82 78.56 Favored Glycine 0 CA--C 1.533 1.191 0 C-N-CA 125.019 1.295 . . . . 0.0 114.042 -177.779 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -115.17 155.12 27.74 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.027 1.331 . . . . 0.0 112.003 172.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 74.8 m -73.07 146.33 45.9 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.88 1.272 . . . . 0.0 112.584 171.429 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.209 0 C-N-CA 125.97 1.748 . . . . 0.0 113.235 175.131 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 53.0 t . . . . . 0 CA--C 1.55 0.951 0 CA-C-O 118.334 -0.841 . . . . 0.0 112.356 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -69.86 151.97 68.67 Favored 'Trans proline' 0 C--N 1.353 0.814 0 C-N-CA 123.041 2.494 . . . . 0.0 111.412 174.497 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -81.85 15.5 2.21 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.704 1.202 . . . . 0.0 113.882 -176.403 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 18.0 tt -72.98 142.73 14.68 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 125.598 1.559 . . . . 0.0 111.2 176.344 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 30.0 tp -79.23 134.79 36.66 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 123.128 0.571 . . . . 0.0 110.228 174.646 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 60.5 tpp -153.65 127.3 8.74 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 124.775 1.23 . . . . 0.0 109.408 -179.109 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 45.8 ttt85 -85.5 147.18 26.57 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.747 0.819 . . . . 0.0 111.015 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 29.3 p -156.76 165.48 36.12 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 114.351 1.241 . . . . 0.0 114.351 -169.374 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 21.9 pttp -126.16 -12.7 6.31 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 126.292 1.837 . . . . 0.0 112.122 168.149 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 17.4 pt20 -157.39 161.76 39.01 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 126.394 1.878 . . . . 0.0 110.811 178.838 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 33.8 m-20 -65.57 -25.3 67.36 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 124.154 0.982 . . . . 0.0 113.441 -171.05 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 58.8 p -72.88 -9.44 58.69 Favored 'General case' 0 CA--C 1.546 0.792 0 N-CA-C 113.695 0.998 . . . . 0.0 113.695 175.831 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 66.4 m-20 -78.01 -23.54 48.25 Favored 'General case' 0 N--CA 1.473 0.724 0 O-C-N 121.299 -0.876 . . . . 0.0 111.315 168.822 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 73.2 m -87.79 166.42 14.62 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.508 1.523 . . . . 0.0 113.795 -171.242 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -71.55 172.54 9.41 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 124.609 1.164 . . . . 0.0 111.032 177.525 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.17 133.06 55.75 Favored 'General case' 0 CA--C 1.538 0.511 0 O-C-N 121.241 -0.912 . . . . 0.0 113.164 -176.305 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 75.64 -9.26 16.52 Favored Glycine 0 CA--C 1.534 1.279 0 C-N-CA 124.781 1.181 . . . . 0.0 114.339 -178.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 60.8 m -78.71 163.39 25.45 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 118.547 1.173 . . . . 0.0 113.969 179.354 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 18.3 m -124.18 154.5 31.17 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 C-N-CA 126.354 1.862 . . . . 0.0 110.211 168.389 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 45.5 t -85.33 103.65 14.45 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 123.186 0.594 . . . . 0.0 110.123 169.822 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -70.03 168.95 46.77 Favored Glycine 0 CA--C 1.544 1.858 0 C-N-CA 124.871 1.224 . . . . 0.0 114.15 179.33 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -70.13 -18.62 35.16 Favored 'Trans proline' 0 CA--C 1.538 0.697 0 C-N-CA 124.16 3.24 . . . . 0.0 113.612 -174.333 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 52.9 p-10 -69.77 -9.06 53.13 Favored 'General case' 0 CA--C 1.548 0.897 0 N-CA-C 114.278 1.214 . . . . 0.0 114.278 170.473 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 84.61 11.62 77.01 Favored Glycine 0 CA--C 1.532 1.123 0 C-N-CA 124.837 1.208 . . . . 0.0 113.938 -176.607 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -121.44 155.83 34.03 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 118.632 1.216 . . . . 0.0 112.289 175.086 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 84.8 m -75.41 147.7 39.75 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.789 1.236 . . . . 0.0 113.2 -179.549 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.199 0 C-N-CA 126.123 1.82 . . . . 0.0 113.038 174.517 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 53.2 t . . . . . 0 CA--C 1.55 0.96 0 CA-C-O 118.353 -0.832 . . . . 0.0 112.551 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo -58.4 154.33 42.08 Favored 'Trans proline' 0 C--N 1.355 0.878 0 C-N-CA 123.832 3.022 . . . . 0.0 113.156 172.676 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 95.7 mtt-85 -79.1 40.2 0.4 Allowed 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 125.037 1.335 . . . . 0.0 112.346 177.497 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 88.8 mt -104.34 123.4 58.18 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 126.627 1.971 . . . . 0.0 108.835 -177.043 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 41.0 tp -76.23 133.83 40.0 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.188 0.595 . . . . 0.0 109.837 172.598 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 59.6 tpp -155.58 130.11 9.05 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 124.461 1.104 . . . . 0.0 109.662 -174.427 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 60.7 ttt180 -83.29 146.15 28.7 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.583 0.753 . . . . 0.0 110.566 178.448 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 28.6 p -152.43 159.15 43.42 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 114.703 1.371 . . . . 0.0 114.703 -169.6 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 63.2 tttp -112.54 -28.91 7.66 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 126.594 1.957 . . . . 0.0 110.793 168.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 21.0 pt20 -149.44 166.76 28.13 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 126.194 1.797 . . . . 0.0 110.745 177.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -61.27 -25.27 66.97 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.183 0.993 . . . . 0.0 112.765 -175.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.8 m -65.35 -17.84 64.84 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 125.589 1.556 . . . . 0.0 113.567 176.165 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 62.4 m-20 -81.68 -18.81 43.18 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.086 0.955 . . . . 0.0 112.307 173.588 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 75.7 m -88.38 166.94 13.91 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.992 1.317 . . . . 0.0 113.955 -172.746 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -71.23 172.97 8.34 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 124.563 1.145 . . . . 0.0 110.952 176.342 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.5 133.53 56.18 Favored 'General case' 0 CA--C 1.54 0.564 0 O-C-N 121.143 -0.973 . . . . 0.0 113.145 -176.601 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 74.77 -8.62 14.05 Favored Glycine 0 CA--C 1.535 1.291 0 C-N-CA 124.572 1.082 . . . . 0.0 114.427 -179.372 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 60.3 m -78.96 162.21 26.14 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 118.448 1.124 . . . . 0.0 113.859 179.075 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 18.3 m -122.88 154.26 28.14 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 126.103 1.761 . . . . 0.0 110.361 168.716 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 48.7 t -84.96 103.12 13.72 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 123.491 0.716 . . . . 0.0 110.128 169.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -69.92 168.73 46.73 Favored Glycine 0 CA--C 1.543 1.824 0 C-N-CA 124.888 1.233 . . . . 0.0 114.093 179.626 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -69.8 -18.45 36.82 Favored 'Trans proline' 0 CA--C 1.537 0.662 0 C-N-CA 124.241 3.294 . . . . 0.0 113.503 -174.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 53.4 p-10 -69.54 -9.91 55.88 Favored 'General case' 0 CA--C 1.549 0.911 0 N-CA-C 114.33 1.233 . . . . 0.0 114.33 170.697 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 85.19 11.75 75.13 Favored Glycine 0 CA--C 1.533 1.163 0 C-N-CA 124.885 1.231 . . . . 0.0 114.083 -176.722 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 67.1 m-85 -123.98 157.24 34.83 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.751 1.22 . . . . 0.0 112.218 174.734 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 86.3 m -76.34 148.4 37.47 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.997 1.319 . . . . 0.0 113.49 -177.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.24 0 C-N-CA 126.111 1.815 . . . . 0.0 113.039 174.677 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 37.5 t . . . . . 0 CA--C 1.546 0.816 0 CA-C-O 118.122 -0.942 . . . . 0.0 112.56 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -69.6 151.8 70.04 Favored 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 122.915 2.41 . . . . 0.0 111.205 178.138 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 6.8 mmp_? -78.52 34.16 0.21 Allowed 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.829 1.251 . . . . 0.0 113.109 -178.27 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 96.6 mt -80.5 126.05 39.41 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 125.717 1.607 . . . . 0.0 109.003 177.789 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 37.6 tp -74.05 126.13 29.83 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 172.292 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 61.0 tpp -154.68 130.97 10.4 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.503 1.121 . . . . 0.0 109.68 -171.273 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 83.8 mtt85 -80.45 151.43 29.31 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.74 0.816 . . . . 0.0 111.48 177.035 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 29.4 p -156.51 155.13 31.45 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 113.983 1.105 . . . . 0.0 113.983 -174.132 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -109.82 -28.78 8.61 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 126.337 1.855 . . . . 0.0 110.562 168.796 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 20.9 pt20 -148.77 167.0 26.76 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 126.479 1.912 . . . . 0.0 110.665 176.156 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -61.27 -24.76 66.63 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 124.452 1.101 . . . . 0.0 112.768 -176.289 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.9 m -65.85 -17.84 64.92 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 125.583 1.553 . . . . 0.0 113.667 175.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 62.5 m-20 -81.62 -18.58 44.2 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.066 0.946 . . . . 0.0 112.343 173.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 72.8 m -87.66 168.74 12.74 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.28 1.432 . . . . 0.0 113.946 -173.695 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -70.7 174.59 5.77 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 124.311 1.044 . . . . 0.0 110.91 175.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.48 133.42 56.08 Favored 'General case' 0 CA--C 1.54 0.565 0 O-C-N 120.994 -1.066 . . . . 0.0 113.146 -176.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 74.51 -8.14 15.43 Favored Glycine 0 CA--C 1.535 1.287 0 C-N-CA 124.876 1.227 . . . . 0.0 114.474 179.764 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 66.2 m -75.95 162.77 27.81 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 114.127 1.158 . . . . 0.0 114.127 -178.762 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 22.9 m -119.9 151.12 22.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 125.233 1.413 . . . . 0.0 110.705 168.602 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 44.1 t -87.51 104.09 16.15 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.698 0.799 . . . . 0.0 109.667 169.438 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -70.77 167.69 50.52 Favored Glycine 0 CA--C 1.542 1.726 0 C-N-CA 124.636 1.112 . . . . 0.0 113.992 179.849 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -69.57 -18.45 37.87 Favored 'Trans proline' 0 CA--C 1.539 0.765 0 C-N-CA 124.146 3.231 . . . . 0.0 113.346 -176.11 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 52.3 p-10 -69.53 -9.66 54.86 Favored 'General case' 0 CA--C 1.548 0.891 0 N-CA-C 114.347 1.24 . . . . 0.0 114.347 170.711 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 84.92 11.72 75.99 Favored Glycine 0 CA--C 1.533 1.157 0 C-N-CA 124.889 1.233 . . . . 0.0 114.127 -177.05 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -118.86 155.65 30.85 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.886 1.274 . . . . 0.0 112.376 174.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 70.2 m -76.0 153.85 36.2 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.076 1.351 . . . . 0.0 113.255 176.722 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.276 0 CA-C-O 116.765 -2.131 . . . . 0.0 113.979 174.965 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 47.3 t . . . . . 0 CA--C 1.551 0.998 0 CA-C-O 118.313 -0.851 . . . . 0.0 112.621 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -56.42 150.07 52.95 Favored 'Trans proline' 0 C--N 1.353 0.795 0 C-N-CA 124.075 3.183 . . . . 0.0 113.125 171.143 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -79.53 37.97 0.36 Allowed 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 125.117 1.367 . . . . 0.0 113.009 -177.143 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 48.2 mm -98.41 123.99 51.28 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 126.12 1.768 . . . . 0.0 109.777 -177.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 36.5 tp -81.52 129.33 34.62 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 123.586 0.754 . . . . 0.0 109.624 171.198 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 60.2 ttm -160.9 136.59 8.06 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.811 1.244 . . . . 0.0 109.574 -171.768 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 57.2 mtp85 -85.46 152.53 23.13 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 118.819 0.736 . . . . 0.0 112.708 176.776 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 25.0 p -151.74 159.55 43.92 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.367 1.467 . . . . 0.0 113.374 -169.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 31.5 mmmt -110.15 -26.19 9.79 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 125.877 1.671 . . . . 0.0 111.368 169.191 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 8.5 pt20 -152.78 168.9 24.17 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 126.332 1.853 . . . . 0.0 110.742 175.367 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -61.21 -26.21 67.57 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 124.382 1.073 . . . . 0.0 112.78 -176.525 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 6.6 m -64.58 -18.69 65.12 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 125.374 1.469 . . . . 0.0 113.508 176.264 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 62.6 m-20 -80.58 -20.72 42.68 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 123.921 0.888 . . . . 0.0 112.286 174.282 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 72.1 m -87.45 168.02 13.47 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.109 1.364 . . . . 0.0 113.797 -172.684 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -70.3 172.02 8.93 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 124.357 1.063 . . . . 0.0 111.048 176.152 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.29 134.29 56.87 Favored 'General case' 0 CA--C 1.539 0.522 0 O-C-N 121.246 -0.909 . . . . 0.0 113.061 -177.793 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 75.04 -8.78 14.21 Favored Glycine 0 CA--C 1.534 1.238 0 C-N-CA 124.641 1.115 . . . . 0.0 114.411 -179.215 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 60.8 m -79.3 161.29 26.38 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 118.477 1.139 . . . . 0.0 113.794 178.814 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 19.1 m -121.7 154.21 25.87 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 126.182 1.793 . . . . 0.0 110.412 168.759 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 48.2 t -88.25 103.94 16.26 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.603 0.761 . . . . 0.0 110.001 169.724 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -70.96 169.98 47.87 Favored Glycine 0 CA--C 1.543 1.786 0 C-N-CA 124.926 1.25 . . . . 0.0 114.195 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -69.89 -20.56 34.07 Favored 'Trans proline' 0 CA--C 1.539 0.726 0 C-N-CA 124.163 3.242 . . . . 0.0 113.442 -175.221 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 49.2 p30 -70.63 -6.34 36.15 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 125.023 1.329 . . . . 0.0 114.023 169.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 79.75 12.38 83.62 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 125.271 1.415 . . . . 0.0 114.116 -178.348 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -108.51 153.68 23.0 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.77 1.228 . . . . 0.0 112.15 172.089 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 76.2 m -73.53 146.1 45.07 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.86 1.264 . . . . 0.0 112.603 171.1 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.271 0 C-N-CA 125.981 1.753 . . . . 0.0 113.303 175.557 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 44.7 t . . . . . 0 CA--C 1.55 0.959 0 CA-C-O 118.206 -0.902 . . . . 0.0 112.138 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -70.24 155.13 65.06 Favored 'Trans proline' 0 C--N 1.354 0.82 0 C-N-CA 122.962 2.442 . . . . 0.0 111.762 178.184 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 59.2 ttt85 -79.56 89.63 5.1 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.07 0.948 . . . . 0.0 110.621 179.118 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 9.2 tp -160.31 142.04 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 126.351 1.86 . . . . 0.0 110.437 -178.43 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 33.4 tp -86.8 136.74 32.88 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 123.963 0.905 . . . . 0.0 110.127 175.091 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 60.7 tpp -155.53 134.74 12.28 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.501 1.12 . . . . 0.0 110.055 -175.405 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 91.3 mtm-85 -81.38 152.16 27.6 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.131 0.972 . . . . 0.0 111.49 176.621 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 30.1 p -157.97 156.36 31.07 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 114.316 1.228 . . . . 0.0 114.316 -175.237 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 62.7 tttp -111.41 -29.08 7.93 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 126.456 1.902 . . . . 0.0 110.533 168.718 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 21.0 pt20 -148.14 166.98 26.23 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 126.535 1.934 . . . . 0.0 110.58 175.645 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -60.97 -25.33 66.77 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 124.502 1.121 . . . . 0.0 112.806 -176.192 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.9 m -65.46 -17.96 64.95 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.591 1.556 . . . . 0.0 113.669 175.837 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 61.8 m-20 -82.03 -19.47 40.34 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 123.964 0.906 . . . . 0.0 112.29 173.628 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 71.3 m -86.49 166.81 15.19 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.999 1.32 . . . . 0.0 113.607 -174.724 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -70.62 170.41 12.3 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 124.233 1.013 . . . . 0.0 110.76 176.26 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.9 134.95 57.52 Favored 'General case' 0 CA--C 1.539 0.533 0 O-C-N 121.273 -0.892 . . . . 0.0 112.885 -177.706 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 76.36 -9.06 22.41 Favored Glycine 0 CA--C 1.534 1.243 0 C-N-CA 124.698 1.142 . . . . 0.0 114.289 -178.541 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 58.8 m -79.91 162.61 24.88 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 118.567 1.184 . . . . 0.0 113.897 178.18 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 19.6 m -121.3 153.79 25.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 126.254 1.822 . . . . 0.0 110.206 168.419 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 48.9 t -87.83 104.17 16.33 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 123.552 0.741 . . . . 0.0 110.122 169.761 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -69.97 166.92 49.32 Favored Glycine 0 CA--C 1.542 1.739 0 C-N-CA 124.661 1.124 . . . . 0.0 113.875 178.277 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -69.83 -18.11 36.89 Favored 'Trans proline' 0 C--N 1.352 0.712 0 C-N-CA 124.204 3.269 . . . . 0.0 113.479 -175.444 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 53.1 p-10 -69.81 -9.28 54.07 Favored 'General case' 0 CA--C 1.548 0.87 0 N-CA-C 114.433 1.271 . . . . 0.0 114.433 171.185 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 84.85 11.6 76.46 Favored Glycine 0 CA--C 1.535 1.305 0 C-N-CA 124.813 1.197 . . . . 0.0 114.021 -177.036 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -119.16 156.28 30.11 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.701 1.2 . . . . 0.0 112.28 174.091 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 74.1 m -77.13 149.98 35.62 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.98 1.312 . . . . 0.0 113.258 177.732 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.271 0 C-N-CA 125.904 1.716 . . . . 0.0 113.097 174.015 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 43.7 t . . . . . 0 CA--C 1.55 0.964 0 CA-C-O 118.233 -0.889 . . . . 0.0 112.264 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -73.25 159.6 46.78 Favored 'Trans proline' 0 C--N 1.353 0.792 0 C-N-CA 123.099 2.533 . . . . 0.0 111.399 176.751 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -78.11 33.46 0.19 Allowed 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 125.286 1.434 . . . . 0.0 113.251 -177.861 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 97.5 mt -91.67 123.24 43.73 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 126.099 1.76 . . . . 0.0 108.837 179.641 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 37.3 tp -75.03 132.21 41.16 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 172.055 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 60.2 tpp -154.0 127.7 8.75 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 124.474 1.11 . . . . 0.0 109.406 -174.547 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 46.6 ttt85 -83.58 145.06 29.07 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.413 0.685 . . . . 0.0 110.555 178.112 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 28.0 p -149.97 158.88 44.61 Favored 'General case' 0 N--CA 1.469 0.525 0 N-CA-C 114.489 1.292 . . . . 0.0 114.489 -169.401 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -111.76 -28.85 7.92 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 126.516 1.926 . . . . 0.0 110.721 168.907 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 21.0 pt20 -149.35 166.74 28.1 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 126.29 1.836 . . . . 0.0 110.773 177.728 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -61.31 -25.25 67.0 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 124.236 1.014 . . . . 0.0 112.8 -176.184 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.8 m -65.33 -17.8 64.8 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 125.604 1.561 . . . . 0.0 113.576 176.052 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 63.3 m-20 -81.49 -18.63 44.49 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.133 0.973 . . . . 0.0 112.278 173.662 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 73.9 m -88.76 166.89 13.74 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.977 1.311 . . . . 0.0 114.123 -172.319 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -70.6 171.64 9.96 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 124.522 1.129 . . . . 0.0 110.836 175.701 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.23 135.25 57.67 Favored 'General case' 0 CA--C 1.538 0.511 0 O-C-N 121.178 -0.951 . . . . 0.0 112.939 -177.764 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 75.88 -9.2 18.46 Favored Glycine 0 CA--C 1.533 1.211 0 C-N-CA 124.809 1.195 . . . . 0.0 114.341 -178.797 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 59.8 m -80.18 162.96 24.42 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 114.185 1.18 . . . . 0.0 114.185 179.462 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 18.5 m -123.59 153.97 29.55 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 126.364 1.866 . . . . 0.0 110.088 168.222 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 49.0 t -84.32 102.52 12.76 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 123.408 0.683 . . . . 0.0 110.233 169.993 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -70.93 169.67 48.3 Favored Glycine 0 CA--C 1.542 1.779 0 C-N-CA 124.91 1.243 . . . . 0.0 114.383 -179.556 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -70.53 -19.05 32.96 Favored 'Trans proline' 0 CA--C 1.538 0.7 0 C-N-CA 124.207 3.271 . . . . 0.0 113.66 -173.819 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 53.2 p-10 -70.6 -8.12 49.24 Favored 'General case' 0 CA--C 1.548 0.889 0 N-CA-C 114.211 1.189 . . . . 0.0 114.211 170.849 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 85.25 8.97 80.69 Favored Glycine 0 CA--C 1.532 1.101 0 C-N-CA 124.974 1.274 . . . . 0.0 114.056 -176.993 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -118.62 156.78 28.61 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 118.676 1.238 . . . . 0.0 112.255 174.836 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 84.0 m -75.03 147.01 41.09 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.976 1.31 . . . . 0.0 113.169 179.168 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.189 0 C-N-CA 126.104 1.811 . . . . 0.0 113.097 174.937 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 42.7 t . . . . . 0 CA--C 1.549 0.911 0 CA-C-O 118.387 -0.816 . . . . 0.0 112.408 . . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_exo -61.8 154.99 57.09 Favored 'Trans proline' 0 C--N 1.354 0.841 0 C-N-CA 123.132 2.554 . . . . 0.0 112.121 174.551 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 75.4 mmt-85 -81.64 15.87 1.97 Allowed 'General case' 0 CA--C 1.546 0.795 0 N-CA-C 114.06 1.133 . . . . 0.0 114.06 -175.747 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 1.8 mp -82.12 127.35 39.7 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 125.764 1.625 . . . . 0.0 108.753 177.68 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 35.2 tp -75.32 136.32 40.85 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 123.576 0.75 . . . . 0.0 110.131 173.988 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 60.5 tpp -154.63 133.41 12.19 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.309 1.043 . . . . 0.0 110.231 -171.693 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 27.0 mmt180 -77.13 154.51 33.15 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.754 0.822 . . . . 0.0 111.948 174.691 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 28.8 p -158.23 157.52 32.76 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 113.946 1.091 . . . . 0.0 113.946 -177.509 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -113.37 -24.69 9.19 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 126.239 1.816 . . . . 0.0 110.986 168.779 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 20.9 pt20 -151.68 166.45 31.24 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 126.717 2.007 . . . . 0.0 110.402 175.3 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -61.19 -24.94 66.69 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.417 1.087 . . . . 0.0 112.886 -176.43 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.9 m -65.64 -17.82 64.87 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 125.553 1.541 . . . . 0.0 113.59 175.952 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 63.0 m-20 -81.36 -19.13 43.39 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 123.933 0.893 . . . . 0.0 112.275 173.382 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 73.7 m -88.66 165.98 14.41 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.934 1.294 . . . . 0.0 113.834 -173.339 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 26.1 mt -73.94 177.78 5.38 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 124.524 1.13 . . . . 0.0 111.399 179.0 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.82 133.36 56.02 Favored 'General case' 0 CA--C 1.539 0.552 0 O-C-N 121.268 -0.895 . . . . 0.0 112.923 -178.439 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 74.28 -8.06 14.71 Favored Glycine 0 CA--C 1.535 1.287 0 C-N-CA 124.708 1.147 . . . . 0.0 114.433 -179.53 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 61.8 m -79.38 160.54 26.65 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 118.512 1.156 . . . . 0.0 114.021 179.825 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 19.2 m -122.89 153.25 27.8 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 126.351 1.86 . . . . 0.0 110.096 168.393 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 49.9 t -87.15 102.87 14.87 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.45 0.7 . . . . 0.0 110.058 169.965 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -72.83 167.53 53.86 Favored Glycine 0 CA--C 1.543 1.831 0 C-N-CA 124.417 1.008 . . . . 0.0 114.142 -178.508 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -58.36 -26.79 78.89 Favored 'Trans proline' 0 C--N 1.354 0.818 0 C-N-CA 124.383 3.389 . . . . 0.0 114.902 -178.268 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 52.4 p-10 -69.72 -8.59 49.25 Favored 'General case' 0 CA--C 1.548 0.883 0 N-CA-C 114.685 1.365 . . . . 0.0 114.685 176.016 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 81.14 13.96 79.97 Favored Glycine 0 CA--C 1.533 1.18 0 C-N-CA 124.722 1.154 . . . . 0.0 113.903 -177.676 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -114.35 157.46 22.78 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.848 1.259 . . . . 0.0 111.531 169.955 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 81.5 m -76.55 147.79 37.49 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.858 1.263 . . . . 0.0 112.763 173.523 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.228 0 C-N-CA 125.973 1.749 . . . . 0.0 113.186 174.708 . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 49.2 t . . . . . 0 CA--C 1.549 0.91 0 CA-C-O 118.061 -0.971 . . . . 0.0 112.307 . . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -73.48 161.35 42.58 Favored 'Trans proline' 0 C--N 1.354 0.839 0 C-N-CA 122.9 2.4 . . . . 0.0 111.218 177.273 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -80.8 32.8 0.31 Allowed 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 124.618 1.167 . . . . 0.0 113.91 -170.999 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 45.9 mm -88.34 123.99 41.1 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 125.947 1.699 . . . . 0.0 109.769 179.673 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 42.6 tp -76.8 130.7 38.02 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 169.949 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 60.8 tpp -155.57 132.62 10.75 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.199 1.0 . . . . 0.0 110.068 -170.625 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 83.9 mtt85 -81.21 151.12 28.32 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.804 0.842 . . . . 0.0 111.343 175.771 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 29.3 p -156.14 158.17 37.21 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 114.27 1.211 . . . . 0.0 114.27 -173.284 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -119.5 -19.9 7.99 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 126.144 1.778 . . . . 0.0 111.674 169.099 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -149.61 167.86 25.18 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 126.39 1.876 . . . . 0.0 110.509 169.908 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -61.26 -25.55 67.16 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 124.362 1.065 . . . . 0.0 112.647 -178.514 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 15.7 m -65.62 -16.07 63.36 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 125.304 1.442 . . . . 0.0 113.676 175.946 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 60.3 m-20 -82.06 -18.09 44.36 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 123.888 0.875 . . . . 0.0 112.464 172.83 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 72.9 m -89.77 167.13 13.12 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.008 1.323 . . . . 0.0 113.859 -172.214 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -70.26 170.34 11.9 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 124.466 1.106 . . . . 0.0 110.843 175.862 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.84 134.7 57.28 Favored 'General case' 0 CA--C 1.538 0.512 0 O-C-N 121.221 -0.924 . . . . 0.0 112.922 -177.637 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 76.22 -9.0 21.63 Favored Glycine 0 CA--C 1.534 1.231 0 C-N-CA 124.781 1.182 . . . . 0.0 114.283 -178.711 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 60.1 m -79.87 162.55 24.96 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 118.518 1.159 . . . . 0.0 114.069 178.56 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 19.2 m -122.76 154.21 27.89 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 126.238 1.815 . . . . 0.0 110.224 168.5 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 47.2 t -85.89 102.52 13.8 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 123.579 0.752 . . . . 0.0 110.157 169.885 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -72.81 167.71 53.72 Favored Glycine 0 CA--C 1.543 1.836 0 C-N-CA 124.454 1.026 . . . . 0.0 114.218 -178.235 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -58.41 -26.87 79.59 Favored 'Trans proline' 0 C--N 1.353 0.801 0 C-N-CA 124.489 3.459 . . . . 0.0 114.969 -177.335 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 52.8 p-10 -70.34 -8.34 49.75 Favored 'General case' 0 CA--C 1.548 0.885 0 N-CA-C 114.775 1.398 . . . . 0.0 114.775 176.699 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 83.92 10.84 80.26 Favored Glycine 0 CA--C 1.533 1.21 0 C-N-CA 124.626 1.108 . . . . 0.0 114.029 -177.228 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -116.39 157.2 25.46 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.84 1.256 . . . . 0.0 112.09 172.153 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 83.1 m -76.44 147.57 37.85 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.004 1.322 . . . . 0.0 113.122 176.988 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.212 0 C-N-CA 126.013 1.768 . . . . 0.0 113.126 174.635 . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 48.5 t . . . . . 0 CA--C 1.549 0.933 0 CA-C-O 118.048 -0.977 . . . . 0.0 112.436 . . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -61.91 149.67 89.25 Favored 'Trans proline' 0 C--N 1.354 0.844 0 C-N-CA 123.191 2.594 . . . . 0.0 113.085 177.27 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 34.4 ptt-85 -83.0 10.22 8.45 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 115.593 1.701 . . . . 0.0 115.593 -172.286 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 10.1 tp -77.17 153.17 5.54 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 C-N-CA 125.424 1.49 . . . . 0.0 111.428 177.947 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 32.7 tp -82.43 134.28 35.23 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.679 0.791 . . . . 0.0 110.468 173.793 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -161.69 127.3 3.61 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.647 1.179 . . . . 0.0 110.932 -170.354 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 95.7 mtt-85 -85.81 159.58 19.69 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 125.071 1.348 . . . . 0.0 112.365 -179.375 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 28.3 p -159.58 159.14 32.88 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.663 1.185 . . . . 0.0 114.104 -177.282 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -114.2 -25.05 8.65 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 126.306 1.842 . . . . 0.0 111.081 168.767 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -151.73 168.17 25.88 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 126.547 1.939 . . . . 0.0 110.531 173.847 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -61.83 -24.76 67.09 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 124.304 1.041 . . . . 0.0 113.0 -176.465 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 6.6 m -64.57 -18.78 65.18 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 125.233 1.413 . . . . 0.0 113.529 175.444 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 62.4 m-20 -80.35 -18.94 47.61 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.001 0.92 . . . . 0.0 112.241 174.034 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 80.6 m -90.28 163.42 14.76 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 125.235 1.414 . . . . 0.0 113.656 -173.073 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 60.0 mt -76.99 -178.43 4.94 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 124.599 1.159 . . . . 0.0 111.921 179.73 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.63 134.27 56.92 Favored 'General case' 0 CA--C 1.54 0.569 0 O-C-N 121.203 -0.935 . . . . 0.0 112.868 -178.563 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 74.51 -8.42 14.08 Favored Glycine 0 CA--C 1.534 1.252 0 C-N-CA 124.749 1.166 . . . . 0.0 114.329 -178.724 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 61.6 m -81.02 159.27 24.86 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 114.184 1.179 . . . . 0.0 114.184 -178.954 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 18.2 m -125.02 153.29 32.11 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 126.472 1.909 . . . . 0.0 109.681 167.949 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 49.1 t -86.09 102.8 14.18 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 123.235 0.614 . . . . 0.0 110.237 170.646 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -70.47 166.56 50.94 Favored Glycine 0 CA--C 1.543 1.831 0 C-N-CA 124.65 1.119 . . . . 0.0 113.806 178.84 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -69.73 -18.08 37.32 Favored 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 124.135 3.223 . . . . 0.0 113.392 -176.062 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 52.7 p-10 -69.66 -9.15 53.13 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 124.897 1.279 . . . . 0.0 114.36 171.381 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 85.29 9.84 78.83 Favored Glycine 0 CA--C 1.533 1.202 0 C-N-CA 124.962 1.268 . . . . 0.0 114.227 -177.949 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -116.2 155.03 29.01 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.949 1.3 . . . . 0.0 111.879 174.147 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 82.6 m -77.07 147.14 36.85 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.272 1.029 . . . . 0.0 112.241 174.391 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.22 0 C-N-CA 125.743 1.64 . . . . 0.0 113.112 175.798 . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 44.3 t . . . . . 0 CA--C 1.55 0.945 0 CA-C-O 118.257 -0.878 . . . . 0.0 112.279 . . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -74.5 163.5 35.95 Favored 'Trans proline' 0 C--N 1.353 0.765 0 C-N-CA 122.996 2.464 . . . . 0.0 111.397 177.2 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 74.6 mtp85 -77.35 20.72 0.28 Allowed 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 125.031 1.333 . . . . 0.0 114.08 -175.242 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 48.3 mm -79.83 122.68 35.51 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 125.367 1.467 . . . . 0.0 109.874 178.749 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 42.4 tp -76.14 132.92 40.3 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.184 0.594 . . . . 0.0 109.489 170.598 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 60.3 tpp -153.33 127.52 9.11 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 124.205 1.002 . . . . 0.0 109.838 -173.307 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 59.5 ttm-85 -78.08 145.06 36.03 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.702 0.801 . . . . 0.0 110.395 177.373 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 31.3 p -153.11 159.16 42.73 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 114.411 1.263 . . . . 0.0 114.411 -171.697 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -121.2 -18.83 7.3 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 126.878 2.071 . . . . 0.0 111.49 168.895 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 19.3 pt20 -147.45 158.96 44.2 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 126.843 2.057 . . . . 0.0 110.179 177.963 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -62.86 -25.86 68.49 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.196 0.999 . . . . 0.0 112.429 -179.822 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 17.8 m -67.38 -13.46 62.04 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 124.916 1.287 . . . . 0.0 113.557 175.289 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 49.9 m-20 -81.5 -19.15 42.84 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 123.758 0.823 . . . . 0.0 112.091 172.108 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 73.9 m -88.79 167.01 13.64 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.253 1.421 . . . . 0.0 113.94 -171.302 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -70.37 170.77 11.19 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 124.444 1.098 . . . . 0.0 110.769 175.692 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.08 134.82 57.41 Favored 'General case' 0 CA--C 1.539 0.525 0 O-C-N 121.179 -0.95 . . . . 0.0 112.964 -177.348 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 76.14 -9.09 20.75 Favored Glycine 0 CA--C 1.533 1.188 0 C-N-CA 124.652 1.12 . . . . 0.0 114.378 -178.764 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 60.2 m -79.91 162.9 24.72 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 114.078 1.14 . . . . 0.0 114.078 179.079 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 18.5 m -122.73 154.33 27.88 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 126.325 1.85 . . . . 0.0 110.073 168.359 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 47.8 t -85.63 103.41 14.43 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 123.193 0.597 . . . . 0.0 110.071 169.824 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -70.83 168.16 50.11 Favored Glycine 0 CA--C 1.542 1.731 0 C-N-CA 124.841 1.21 . . . . 0.0 114.101 179.922 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -70.23 -17.9 35.13 Favored 'Trans proline' 0 C--N 1.352 0.743 0 C-N-CA 124.169 3.246 . . . . 0.0 113.5 -175.312 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 53.3 p-10 -69.38 -9.42 53.4 Favored 'General case' 0 CA--C 1.548 0.882 0 N-CA-C 114.339 1.237 . . . . 0.0 114.339 170.855 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 84.87 12.06 75.35 Favored Glycine 0 CA--C 1.532 1.141 0 C-N-CA 124.756 1.17 . . . . 0.0 114.046 -176.796 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -123.51 156.47 35.57 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.703 1.201 . . . . 0.0 112.386 174.505 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 84.1 m -75.1 147.41 40.6 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.906 1.283 . . . . 0.0 113.214 179.006 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.204 0 C-N-CA 126.058 1.789 . . . . 0.0 113.099 174.809 . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 53.3 t . . . . . 0 CA--C 1.551 0.995 0 CA-C-O 118.517 -0.754 . . . . 0.0 112.282 . . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -67.45 166.7 22.82 Favored 'Trans proline' 0 C--N 1.353 0.798 0 C-N-CA 123.435 2.756 . . . . 0.0 111.909 173.05 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 4.4 mmp_? -102.23 17.4 23.48 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 125.091 1.357 . . . . 0.0 113.187 179.94 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 10.4 tp -74.57 148.44 7.99 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 C-N-CA 125.247 1.419 . . . . 0.0 111.392 176.015 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 10.6 tt -71.29 132.13 44.45 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.636 0.774 . . . . 0.0 110.044 172.974 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 58.7 tpp -154.96 130.67 9.97 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.825 1.25 . . . . 0.0 109.591 177.421 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 84.4 mtt85 -87.32 152.92 21.87 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.301 1.04 . . . . 0.0 111.497 178.297 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 29.6 p -157.0 156.03 32.26 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 114.082 1.141 . . . . 0.0 114.082 -173.236 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -112.22 -25.67 9.18 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 126.091 1.756 . . . . 0.0 110.93 168.927 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 8.3 pt20 -150.58 168.78 23.25 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 126.569 1.947 . . . . 0.0 110.522 173.621 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -61.37 -25.24 67.04 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 124.462 1.105 . . . . 0.0 112.977 -176.494 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 7.0 m -64.72 -19.19 65.63 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 125.329 1.452 . . . . 0.0 113.514 175.778 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 61.1 m-20 -81.4 -18.65 44.74 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.024 0.93 . . . . 0.0 112.39 174.657 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 74.5 m -87.72 167.31 13.96 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 125.155 1.382 . . . . 0.0 113.827 -174.43 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -72.67 176.49 5.48 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 124.487 1.115 . . . . 0.0 111.077 177.973 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.53 133.26 55.92 Favored 'General case' 0 CA--C 1.539 0.556 0 O-C-N 121.08 -1.013 . . . . 0.0 113.207 -176.784 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 74.44 -8.29 14.42 Favored Glycine 0 CA--C 1.534 1.278 0 C-N-CA 124.871 1.224 . . . . 0.0 114.461 -179.851 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 62.2 m -76.87 163.66 26.54 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 114.089 1.144 . . . . 0.0 114.089 -178.893 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 21.4 m -121.72 152.91 25.61 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 C-N-CA 125.807 1.643 . . . . 0.0 110.325 168.263 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 44.8 t -88.5 104.4 16.77 Favored 'General case' 0 CA--C 1.537 0.442 0 C-N-CA 123.513 0.725 . . . . 0.0 109.878 169.55 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -70.07 166.26 50.26 Favored Glycine 0 CA--C 1.542 1.74 0 C-N-CA 124.635 1.112 . . . . 0.0 113.825 178.951 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -69.48 -18.2 38.43 Favored 'Trans proline' 0 CA--C 1.539 0.729 0 C-N-CA 124.128 3.219 . . . . 0.0 113.284 -176.419 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 52.4 p-10 -69.37 -9.93 55.66 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 124.869 1.268 . . . . 0.0 114.396 170.942 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 85.79 10.34 76.15 Favored Glycine 0 CA--C 1.533 1.169 0 C-N-CA 124.867 1.222 . . . . 0.0 114.229 -177.653 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -117.48 156.62 27.69 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.787 1.235 . . . . 0.0 112.038 174.509 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 74.3 m -76.43 152.97 36.03 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.619 1.167 . . . . 0.0 112.999 176.352 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.272 0 CA-C-O 116.909 -2.051 . . . . 0.0 113.626 176.168 . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 48.0 t . . . . . 0 CA--C 1.549 0.934 0 CA-C-O 118.121 -0.942 . . . . 0.0 112.4 . . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -62.19 155.47 56.29 Favored 'Trans proline' 0 C--N 1.354 0.845 0 C-N-CA 123.221 2.614 . . . . 0.0 112.76 175.227 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -82.3 13.84 3.31 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 114.707 1.373 . . . . 0.0 114.707 -170.522 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 10.0 tp -83.2 140.76 15.82 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 C-N-CA 125.309 1.444 . . . . 0.0 111.464 178.641 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 40.4 tp -82.82 132.0 35.18 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.801 0.84 . . . . 0.0 109.816 172.146 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 58.0 ttm -154.45 132.46 11.66 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.3 1.04 . . . . 0.0 110.512 -171.433 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 95.8 mtt-85 -79.4 155.07 28.54 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.006 0.922 . . . . 0.0 112.057 178.813 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 28.2 p -158.32 157.76 33.04 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 124.731 1.212 . . . . 0.0 113.661 -176.099 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 30.3 mtpp -112.1 -24.97 9.58 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 125.932 1.693 . . . . 0.0 111.16 169.094 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 20.8 pt20 -152.53 166.41 32.12 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 126.553 1.941 . . . . 0.0 110.485 175.803 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -61.06 -24.96 66.6 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 124.494 1.118 . . . . 0.0 112.799 -176.41 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.8 m -65.62 -18.0 65.0 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 125.654 1.582 . . . . 0.0 113.617 175.851 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 63.2 m-20 -80.83 -20.98 41.21 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 123.888 0.875 . . . . 0.0 112.19 173.152 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 77.8 m -88.46 165.41 14.92 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 125.227 1.411 . . . . 0.0 113.514 -174.185 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 50.6 mt -75.85 178.64 6.04 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 124.374 1.07 . . . . 0.0 111.922 179.375 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.19 134.63 57.24 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 121.375 -0.828 . . . . 0.0 112.721 -179.173 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 74.61 -8.38 14.66 Favored Glycine 0 CA--C 1.533 1.185 0 C-N-CA 124.678 1.133 . . . . 0.0 114.291 -178.363 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 60.6 m -81.11 158.8 24.88 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 118.646 1.223 . . . . 0.0 113.967 179.568 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 18.6 m -123.45 151.69 28.15 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 126.17 1.788 . . . . 0.0 109.765 168.057 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 48.9 t -87.2 103.0 15.0 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.296 0.638 . . . . 0.0 109.756 169.978 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -72.17 166.86 53.43 Favored Glycine 0 CA--C 1.543 1.823 0 C-N-CA 124.281 0.943 . . . . 0.0 114.017 -178.157 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -57.86 -26.19 72.86 Favored 'Trans proline' 0 C--N 1.354 0.854 0 C-N-CA 124.448 3.432 . . . . 0.0 114.736 -179.806 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 51.9 p-10 -68.44 -9.96 52.14 Favored 'General case' 0 CA--C 1.548 0.88 0 N-CA-C 114.839 1.422 . . . . 0.0 114.839 175.314 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 83.65 13.41 75.72 Favored Glycine 0 CA--C 1.533 1.216 0 C-N-CA 124.731 1.158 . . . . 0.0 113.929 -177.372 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -117.96 154.19 32.36 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.951 1.3 . . . . 0.0 112.225 174.168 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 84.6 m -74.33 145.96 43.46 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.878 1.271 . . . . 0.0 112.382 173.933 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.21 0 C-N-CA 125.991 1.758 . . . . 0.0 113.252 175.023 . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 41.9 t . . . . . 0 CA--C 1.55 0.953 0 CA-C-O 118.388 -0.815 . . . . 0.0 112.243 . . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -72.99 161.4 43.63 Favored 'Trans proline' 0 C--N 1.354 0.818 0 C-N-CA 123.125 2.55 . . . . 0.0 111.529 177.09 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 92.3 mtm-85 -77.5 29.86 0.15 Allowed 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 125.269 1.428 . . . . 0.0 113.501 -177.597 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 96.8 mt -90.37 122.97 42.33 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 126.158 1.783 . . . . 0.0 109.048 -179.325 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 37.6 tp -75.34 132.82 41.21 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 122.972 0.509 . . . . 0.0 109.642 171.415 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 59.9 tpp -153.83 128.56 9.41 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 124.372 1.069 . . . . 0.0 109.373 -174.485 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 46.3 ttt85 -83.88 144.78 28.99 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 123.381 0.673 . . . . 0.0 110.616 178.188 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 28.3 p -149.11 158.88 44.53 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 114.26 1.208 . . . . 0.0 114.26 -169.517 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -119.03 -19.57 8.41 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 126.117 1.767 . . . . 0.0 111.641 169.187 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -150.03 167.68 26.04 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 126.328 1.851 . . . . 0.0 110.534 169.994 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -61.31 -25.34 67.06 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.419 1.088 . . . . 0.0 112.663 -178.691 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 15.6 m -65.6 -15.95 63.23 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 125.182 1.393 . . . . 0.0 113.643 175.754 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 60.7 m-20 -82.1 -17.76 45.35 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 123.935 0.894 . . . . 0.0 112.456 172.82 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 75.1 m -89.55 166.47 13.64 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.032 1.333 . . . . 0.0 113.894 -172.117 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -70.92 171.61 10.42 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 124.488 1.115 . . . . 0.0 110.787 175.805 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.24 135.33 57.7 Favored 'General case' 0 CA--C 1.54 0.581 0 O-C-N 121.201 -0.937 . . . . 0.0 112.953 -177.665 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 75.92 -9.08 19.18 Favored Glycine 0 CA--C 1.534 1.276 0 C-N-CA 124.79 1.186 . . . . 0.0 114.307 -178.844 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 59.8 m -80.15 162.78 24.54 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 114.057 1.132 . . . . 0.0 114.057 179.375 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 19.1 m -123.07 153.6 28.28 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 126.319 1.847 . . . . 0.0 110.11 168.331 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 49.2 t -84.45 102.58 12.91 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 123.398 0.679 . . . . 0.0 110.178 169.978 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -71.14 169.45 49.15 Favored Glycine 0 CA--C 1.542 1.747 0 C-N-CA 124.955 1.264 . . . . 0.0 114.335 -179.592 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -70.56 -18.98 32.85 Favored 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 124.233 3.289 . . . . 0.0 113.669 -173.987 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 53.2 p-10 -70.54 -8.06 48.53 Favored 'General case' 0 CA--C 1.548 0.897 0 N-CA-C 114.271 1.211 . . . . 0.0 114.271 170.775 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 85.13 8.96 81.12 Favored Glycine 0 CA--C 1.531 1.081 0 C-N-CA 124.916 1.246 . . . . 0.0 114.06 -176.995 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -118.55 156.77 28.55 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 118.725 1.263 . . . . 0.0 112.29 174.7 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 79.7 m -75.35 147.17 40.31 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.027 1.331 . . . . 0.0 113.223 179.036 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.181 0 C-N-CA 126.017 1.77 . . . . 0.0 113.099 174.796 . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 41.9 t . . . . . 0 CA--C 1.55 0.962 0 CA-C-O 118.336 -0.84 . . . . 0.0 112.204 . . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -70.29 155.08 64.98 Favored 'Trans proline' 0 C--N 1.355 0.895 0 C-N-CA 123.047 2.498 . . . . 0.0 111.726 176.93 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.63 5.99 5.39 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 116.148 1.907 . . . . 0.0 116.148 -172.978 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 10.0 tp -73.97 139.12 19.86 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.825 0 C-N-CA 125.263 1.425 . . . . 0.0 111.334 -179.331 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 30.6 tp -81.1 136.65 35.95 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.683 0.793 . . . . 0.0 110.176 174.729 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 61.2 tpp -158.32 134.86 9.53 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.41 1.084 . . . . 0.0 109.483 -172.575 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 55.7 mtp85 -91.69 154.47 18.97 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 119.004 0.82 . . . . 0.0 112.807 175.662 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 26.4 p -154.16 158.04 39.78 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.117 1.367 . . . . 0.0 113.665 -169.933 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -109.45 -29.74 8.28 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 125.882 1.673 . . . . 0.0 110.654 168.891 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 8.0 pt20 -147.7 169.73 19.06 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 126.485 1.914 . . . . 0.0 110.718 173.603 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -61.27 -25.93 67.43 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.473 1.109 . . . . 0.0 112.844 -176.488 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 7.4 m -64.77 -18.88 65.47 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 125.303 1.441 . . . . 0.0 113.48 175.959 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 60.1 m-20 -82.02 -18.42 43.35 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 123.964 0.906 . . . . 0.0 112.347 174.577 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 77.8 m -87.35 167.16 14.29 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.91 1.284 . . . . 0.0 113.789 -174.498 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -71.57 172.42 9.65 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 124.498 1.119 . . . . 0.0 110.943 176.907 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.01 134.64 57.24 Favored 'General case' 0 CA--C 1.539 0.534 0 O-C-N 121.256 -0.903 . . . . 0.0 113.075 -177.049 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 75.76 -9.0 18.24 Favored Glycine 0 CA--C 1.533 1.209 0 C-N-CA 124.759 1.171 . . . . 0.0 114.362 -179.065 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 60.4 m -79.27 161.49 26.28 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 114.156 1.169 . . . . 0.0 114.156 179.636 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 19.2 m -120.55 153.4 23.71 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 126.316 1.846 . . . . 0.0 109.945 168.051 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 49.7 t -88.17 104.23 16.51 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 123.468 0.707 . . . . 0.0 110.275 169.955 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -70.83 168.85 49.27 Favored Glycine 0 CA--C 1.544 1.886 0 C-N-CA 124.907 1.241 . . . . 0.0 114.105 178.371 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -70.37 -20.54 31.85 Favored 'Trans proline' 0 CA--C 1.538 0.701 0 C-N-CA 124.172 3.248 . . . . 0.0 113.647 -174.432 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 50.4 p30 -71.12 -5.25 30.19 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 124.888 1.275 . . . . 0.0 114.078 170.323 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 79.18 11.55 84.94 Favored Glycine 0 CA--C 1.53 1.023 0 C-N-CA 125.156 1.36 . . . . 0.0 113.98 -178.668 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 99.7 m-85 -107.41 155.09 20.41 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 118.656 1.228 . . . . 0.0 111.89 170.503 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 84.0 m -76.98 147.33 36.92 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 125.079 1.351 . . . . 0.0 112.544 173.18 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.176 0 C-N-CA 125.711 1.624 . . . . 0.0 113.174 174.721 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.77 0 CA-C-O 121.13 0.295 . . . . 0.0 112.558 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 43.7 t -61.6 127.26 88.39 Favored Pre-proline 0 CA--C 1.551 0.984 0 C-N-CA 124.215 1.006 . . . . 0.0 112.271 -179.212 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -70.32 157.45 59.27 Favored 'Trans proline' 0 C--N 1.353 0.803 0 C-N-CA 123.119 2.546 . . . . 0.0 111.777 176.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -81.73 13.17 3.33 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 114.566 1.321 . . . . 0.0 114.566 -171.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 9.9 tp -80.89 141.07 15.71 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 125.566 1.547 . . . . 0.0 111.188 177.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 36.3 tp -79.66 139.12 37.51 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 123.687 0.795 . . . . 0.0 110.446 175.138 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 60.0 tpp -153.26 130.68 11.35 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.578 1.151 . . . . 0.0 109.67 -178.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 60.2 ttt180 -86.27 147.56 26.02 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.818 0.847 . . . . 0.0 110.806 179.438 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 30.2 p -154.91 161.4 41.44 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 114.517 1.303 . . . . 0.0 114.517 -169.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 63.2 pttt -123.4 -16.47 6.84 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 126.184 1.794 . . . . 0.0 112.012 168.469 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 8.1 pt20 -151.9 166.61 30.92 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 126.262 1.825 . . . . 0.0 110.62 171.012 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -62.3 -24.71 67.46 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 124.279 1.032 . . . . 0.0 112.977 -176.383 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.5 m -64.11 -19.2 65.1 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 125.264 1.426 . . . . 0.0 113.524 175.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 59.0 m-20 -79.94 -20.08 46.49 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 123.955 0.902 . . . . 0.0 112.308 174.396 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 77.6 m -88.75 165.34 14.78 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.077 1.351 . . . . 0.0 113.699 -172.411 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -72.02 172.75 9.49 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 124.567 1.147 . . . . 0.0 110.896 177.213 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.79 134.21 56.82 Favored 'General case' 0 CA--C 1.539 0.545 0 O-C-N 121.111 -0.993 . . . . 0.0 112.956 -177.33 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 75.95 -9.2 18.92 Favored Glycine 0 CA--C 1.534 1.256 0 C-N-CA 124.689 1.138 . . . . 0.0 114.323 -178.676 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 59.6 m -79.64 162.8 25.05 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 118.534 1.167 . . . . 0.0 113.976 179.038 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 19.1 m -123.61 153.27 29.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 126.332 1.853 . . . . 0.0 110.178 168.315 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 48.6 t -85.21 103.5 14.23 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 123.3 0.64 . . . . 0.0 110.006 169.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -70.08 168.16 47.99 Favored Glycine 0 CA--C 1.542 1.725 0 C-N-CA 124.752 1.168 . . . . 0.0 114.12 179.176 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -69.96 -18.02 36.33 Favored 'Trans proline' 0 CA--C 1.538 0.72 0 C-N-CA 124.241 3.294 . . . . 0.0 113.44 -175.166 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 53.5 p-10 -68.88 -10.81 59.07 Favored 'General case' 0 CA--C 1.548 0.874 0 N-CA-C 114.372 1.249 . . . . 0.0 114.372 170.471 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 85.52 12.8 71.81 Favored Glycine 0 CA--C 1.532 1.129 0 C-N-CA 124.83 1.205 . . . . 0.0 113.962 -176.573 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -125.08 157.4 36.38 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 118.544 1.172 . . . . 0.0 112.168 174.413 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 75.8 m -77.38 148.47 35.53 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.989 1.316 . . . . 0.0 113.386 -177.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.26 0 C-N-CA 126.035 1.778 . . . . 0.0 113.016 174.294 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.705 0 CA-C-O 121.213 0.34 . . . . 0.0 112.632 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 53.7 t -65.14 132.85 95.48 Favored Pre-proline 0 CA--C 1.549 0.928 0 O-C-N 121.696 -0.885 . . . . 0.0 112.439 -179.11 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -67.03 166.9 21.38 Favored 'Trans proline' 0 C--N 1.354 0.829 0 C-N-CA 123.302 2.668 . . . . 0.0 111.946 172.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 4.7 mmp_? -100.63 18.47 19.15 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.968 1.307 . . . . 0.0 113.096 179.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 18.7 tt -69.33 141.91 16.72 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 C-N-CA 125.009 1.324 . . . . 0.0 111.001 172.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 33.3 tp -79.34 129.94 34.95 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 123.265 0.626 . . . . 0.0 109.705 173.358 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 60.7 tpp -153.56 131.02 11.36 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.383 1.073 . . . . 0.0 110.196 -173.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -80.97 153.96 27.2 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 123.998 0.919 . . . . 0.0 111.776 177.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 28.7 p -158.32 156.0 29.8 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 124.408 1.083 . . . . 0.0 113.792 -175.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -111.17 -26.34 9.25 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 125.885 1.674 . . . . 0.0 111.002 168.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 8.0 pt20 -150.61 169.48 21.47 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 126.629 1.972 . . . . 0.0 110.453 173.465 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -61.39 -25.43 67.18 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 124.479 1.112 . . . . 0.0 112.875 -176.426 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 7.3 m -64.96 -18.93 65.69 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.288 1.435 . . . . 0.0 113.566 175.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 59.8 m-20 -81.83 -18.8 42.69 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 123.929 0.892 . . . . 0.0 112.35 174.526 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 75.1 m -86.88 167.57 14.21 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.114 1.365 . . . . 0.0 113.692 -175.125 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -72.24 175.36 6.15 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 124.527 1.131 . . . . 0.0 111.028 177.507 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.39 133.14 55.8 Favored 'General case' 0 CA--C 1.54 0.562 0 O-C-N 121.079 -1.013 . . . . 0.0 113.2 -176.107 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 74.45 -8.2 14.88 Favored Glycine 0 CA--C 1.534 1.243 0 C-N-CA 124.815 1.198 . . . . 0.0 114.529 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 61.5 m -76.55 163.8 26.55 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 114.009 1.115 . . . . 0.0 114.009 -179.25 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 21.6 m -121.68 152.17 25.33 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 125.681 1.593 . . . . 0.0 110.534 168.575 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 47.6 t -89.12 103.89 16.48 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 123.772 0.829 . . . . 0.0 109.811 169.55 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -71.94 166.55 53.33 Favored Glycine 0 CA--C 1.544 1.881 0 C-N-CA 124.333 0.968 . . . . 0.0 114.059 -178.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -58.12 -26.32 75.26 Favored 'Trans proline' 0 C--N 1.353 0.771 0 C-N-CA 124.407 3.404 . . . . 0.0 114.782 -178.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 52.5 p-10 -68.97 -9.87 54.41 Favored 'General case' 0 CA--C 1.549 0.907 0 N-CA-C 114.764 1.394 . . . . 0.0 114.764 175.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 83.62 13.59 75.38 Favored Glycine 0 CA--C 1.534 1.234 0 C-N-CA 124.633 1.111 . . . . 0.0 113.965 -176.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -118.75 155.61 30.81 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.9 1.28 . . . . 0.0 112.097 173.333 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 70.2 m -76.22 153.11 36.32 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.804 1.242 . . . . 0.0 113.134 177.276 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.219 0 CA-C-O 116.861 -2.077 . . . . 0.0 113.566 175.683 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.751 0 CA-C-O 121.069 0.261 . . . . 0.0 112.511 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 48.9 t -64.19 128.1 92.75 Favored Pre-proline 0 CA--C 1.549 0.913 0 C-N-CA 124.027 0.931 . . . . 0.0 112.34 -178.489 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -66.62 151.2 83.25 Favored 'Trans proline' 0 C--N 1.353 0.773 0 C-N-CA 122.616 2.211 . . . . 0.0 111.125 174.526 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 71.7 mmt-85 -81.95 44.79 0.86 Allowed 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 124.89 1.276 . . . . 0.0 113.109 -171.554 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 1.2 pp -79.87 168.04 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 126.004 1.721 . . . . 0.0 113.177 177.002 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 38.0 tp -118.85 66.08 0.77 Allowed 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.723 1.609 . . . . 0.0 108.139 169.569 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 63.3 tpp -94.48 126.62 39.87 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 125.095 1.358 . . . . 0.0 109.745 -172.336 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 95.5 mtt-85 -72.33 149.54 44.32 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 118.752 0.706 . . . . 0.0 111.862 178.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 30.0 p -154.82 157.78 38.43 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 124.278 1.031 . . . . 0.0 113.728 -176.009 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 59.5 mtmt -119.05 -20.01 8.23 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.936 1.694 . . . . 0.0 111.901 169.422 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -150.48 167.94 25.66 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 126.4 1.88 . . . . 0.0 110.506 169.853 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -61.31 -25.45 67.13 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.363 1.065 . . . . 0.0 112.668 -178.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 15.5 m -65.88 -15.98 63.42 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.279 1.432 . . . . 0.0 113.702 175.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 60.6 m-20 -81.55 -18.05 46.27 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 123.792 0.837 . . . . 0.0 112.422 172.349 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 72.2 m -91.04 165.37 13.56 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.813 1.245 . . . . 0.0 114.106 -171.448 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -73.53 174.88 7.62 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 125.211 1.405 . . . . 0.0 111.043 178.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.43 133.58 56.22 Favored 'General case' 0 CA--C 1.539 0.542 0 O-C-N 121.096 -1.003 . . . . 0.0 113.125 -177.355 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 75.13 -8.89 14.27 Favored Glycine 0 CA--C 1.534 1.248 0 C-N-CA 124.808 1.194 . . . . 0.0 114.329 -179.031 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 61.6 m -79.11 161.25 26.63 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 114.139 1.162 . . . . 0.0 114.139 -179.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 18.8 m -123.32 152.86 28.48 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 C-N-CA 126.337 1.855 . . . . 0.0 109.796 167.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 48.5 t -84.93 102.13 12.89 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.243 0.617 . . . . 0.0 110.16 170.21 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -71.77 168.24 51.74 Favored Glycine 0 CA--C 1.541 1.705 0 C-N-CA 124.774 1.178 . . . . 0.0 114.208 -179.251 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -70.09 -17.79 35.86 Favored 'Trans proline' 0 CA--C 1.539 0.736 0 C-N-CA 124.208 3.272 . . . . 0.0 113.479 -176.024 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 52.9 p-10 -69.38 -9.39 53.26 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 124.746 1.218 . . . . 0.0 114.286 171.087 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 86.24 8.67 77.85 Favored Glycine 0 CA--C 1.533 1.2 0 C-N-CA 125.11 1.338 . . . . 0.0 114.309 -177.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 75.0 m-85 -119.38 158.53 25.97 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 122.487 1.137 . . . . 0.0 112.317 174.573 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 68.2 m -73.52 147.39 44.07 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.094 1.358 . . . . 0.0 112.797 174.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.191 0 C-N-CA 125.934 1.731 . . . . 0.0 113.041 174.808 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.735 0 CA-C-O 121.051 0.251 . . . . 0.0 112.517 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 49.2 t -61.65 125.2 84.12 Favored Pre-proline 0 CA--C 1.549 0.914 0 C-N-CA 124.464 1.105 . . . . 0.0 112.797 -178.021 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_exo -55.8 142.9 82.91 Favored 'Trans proline' 0 C--N 1.353 0.804 0 C-N-CA 123.637 2.891 . . . . 0.0 112.069 170.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 69.3 mmt-85 -81.04 16.19 1.6 Allowed 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 114.115 1.154 . . . . 0.0 114.115 -174.327 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 17.8 tt -73.87 142.94 14.19 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 125.637 1.575 . . . . 0.0 111.317 176.318 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 37.9 tp -80.6 132.42 35.63 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.342 0.657 . . . . 0.0 109.92 172.396 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 60.9 tpp -152.58 126.06 8.78 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 124.344 1.058 . . . . 0.0 109.932 -175.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 1.9 tmt_? -84.72 135.78 34.0 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.971 0.908 . . . . 0.0 109.714 178.658 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 26.3 p -136.85 164.27 28.7 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 125.268 1.427 . . . . 0.0 113.144 -172.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -119.97 -25.96 5.69 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 125.993 1.717 . . . . 0.0 111.11 169.247 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -145.88 169.08 19.29 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 126.36 1.864 . . . . 0.0 110.411 169.74 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -60.98 -25.72 67.06 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.393 1.077 . . . . 0.0 112.685 -178.45 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 15.6 m -65.68 -16.27 63.59 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 125.227 1.411 . . . . 0.0 113.669 175.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 55.9 m-20 -82.91 -17.91 42.02 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 123.917 0.887 . . . . 0.0 112.386 172.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 72.0 m -88.48 165.59 14.78 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.858 1.263 . . . . 0.0 113.649 -174.202 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -72.47 174.08 7.92 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 124.84 1.256 . . . . 0.0 111.08 177.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.25 133.27 55.95 Favored 'General case' 0 CA--C 1.539 0.538 0 O-C-N 121.201 -0.937 . . . . 0.0 113.156 -176.427 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 74.93 -8.52 15.19 Favored Glycine 0 CA--C 1.535 1.305 0 C-N-CA 124.691 1.138 . . . . 0.0 114.413 -179.106 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 61.3 m -79.29 161.74 26.09 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 118.466 1.133 . . . . 0.0 113.987 179.59 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 19.1 m -122.56 153.72 27.36 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 126.336 1.854 . . . . 0.0 110.19 168.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 48.3 t -86.33 102.26 13.84 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 123.61 0.764 . . . . 0.0 109.998 169.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -72.62 167.9 53.33 Favored Glycine 0 CA--C 1.542 1.767 0 C-N-CA 124.368 0.985 . . . . 0.0 114.3 -177.262 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_exo -58.27 -26.96 79.1 Favored 'Trans proline' 0 C--N 1.354 0.858 0 C-N-CA 124.499 3.466 . . . . 0.0 114.989 -177.578 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 53.0 p-10 -69.51 -9.55 54.31 Favored 'General case' 0 CA--C 1.546 0.791 0 N-CA-C 114.7 1.37 . . . . 0.0 114.7 175.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 85.95 10.08 76.15 Favored Glycine 0 CA--C 1.531 1.087 0 C-N-CA 124.772 1.177 . . . . 0.0 114.006 -176.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -119.96 156.55 30.61 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.68 1.192 . . . . 0.0 112.152 174.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 78.7 m -75.2 148.26 39.69 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.663 1.185 . . . . 0.0 113.243 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.115 0 C-N-CA 126.012 1.767 . . . . 0.0 113.067 174.573 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.78 0 N-CA-C 112.245 -0.342 . . . . 0.0 112.245 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 47.8 t -62.37 128.24 90.99 Favored Pre-proline 0 CA--C 1.548 0.904 0 C-N-CA 124.135 0.974 . . . . 0.0 112.472 -179.149 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -64.81 147.48 89.58 Favored 'Trans proline' 0 C--N 1.354 0.821 0 C-N-CA 123.153 2.569 . . . . 0.0 111.384 171.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 6.0 tpm_? -81.71 54.45 2.41 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-O 122.206 1.003 . . . . 0.0 111.815 178.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 19.3 tt -81.07 151.91 4.36 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 C-N-CA 125.729 1.612 . . . . 0.0 111.105 173.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 39.7 tp -95.37 73.44 3.29 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.817 0.847 . . . . 0.0 108.721 169.44 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 60.0 tpp -102.54 116.09 31.9 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.627 1.171 . . . . 0.0 109.363 -176.453 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 61.0 ttt180 -77.82 143.6 37.73 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 123.325 0.65 . . . . 0.0 110.52 178.466 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 30.3 p -150.02 158.31 44.03 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 114.158 1.17 . . . . 0.0 114.158 -169.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 59.2 mtmt -119.63 -19.35 8.12 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 126.699 2.0 . . . . 0.0 111.57 169.307 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 19.3 pt20 -148.61 159.06 44.45 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 126.62 1.968 . . . . 0.0 110.246 179.332 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -63.08 -25.53 68.41 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.094 0.958 . . . . 0.0 112.387 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 17.8 m -67.67 -13.41 62.07 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.897 1.279 . . . . 0.0 113.566 175.069 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 51.5 m-20 -80.91 -19.4 44.39 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 123.81 0.844 . . . . 0.0 111.952 171.468 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 79.0 m -90.66 165.43 13.72 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 125.52 1.528 . . . . 0.0 113.763 -172.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 34.6 mt -76.33 -178.55 4.62 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.357 1.063 . . . . 0.0 111.88 179.635 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.63 134.28 56.93 Favored 'General case' 0 CA--C 1.539 0.527 0 O-C-N 121.253 -0.904 . . . . 0.0 112.96 -179.611 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 74.41 -8.46 13.52 Favored Glycine 0 CA--C 1.534 1.255 0 C-N-CA 124.775 1.179 . . . . 0.0 114.281 -178.528 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 63.9 m -81.76 159.62 23.79 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 114.288 1.218 . . . . 0.0 114.288 -178.322 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 18.0 m -124.52 154.98 32.29 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 126.774 2.03 . . . . 0.0 109.634 167.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 48.2 t -84.05 102.26 12.37 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 121.341 0.591 . . . . 0.0 110.188 169.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -71.72 169.03 50.92 Favored Glycine 0 CA--C 1.542 1.763 0 C-N-CA 124.987 1.28 . . . . 0.0 114.379 -178.383 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -70.74 -18.41 32.45 Favored 'Trans proline' 0 CA--C 1.537 0.672 0 C-N-CA 124.262 3.308 . . . . 0.0 113.67 -174.202 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 52.6 p-10 -69.68 -10.04 56.69 Favored 'General case' 0 CA--C 1.548 0.899 0 N-CA-C 114.192 1.182 . . . . 0.0 114.192 171.21 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 87.5 8.54 73.9 Favored Glycine 0 CA--C 1.533 1.178 0 C-N-CA 124.952 1.263 . . . . 0.0 114.208 -177.139 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 76.9 m-85 -122.58 159.84 26.95 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 118.69 1.245 . . . . 0.0 111.779 173.573 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 77.5 m -70.7 153.79 42.47 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.262 1.025 . . . . 0.0 113.215 179.263 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.154 0 C-N-CA 126.035 1.778 . . . . 0.0 113.165 175.973 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.726 0 CA-C-O 121.09 0.272 . . . . 0.0 112.464 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 40.5 t -64.64 124.23 85.55 Favored Pre-proline 0 CA--C 1.546 0.801 0 CA-C-O 117.9 -1.048 . . . . 0.0 112.539 -178.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -68.65 146.07 65.81 Favored 'Trans proline' 0 C--N 1.353 0.765 0 C-N-CA 123.017 2.478 . . . . 0.0 110.633 175.421 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 15.8 mmm180 -83.83 16.13 2.94 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 113.782 1.03 . . . . 0.0 113.782 -171.034 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 10.0 tp -68.19 141.66 17.34 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 125.489 1.516 . . . . 0.0 111.341 177.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 30.9 tp -75.9 131.99 40.0 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 123.359 0.663 . . . . 0.0 110.152 175.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 61.1 tpp -155.48 132.77 10.93 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.827 1.251 . . . . 0.0 109.851 -174.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 87.4 mtm180 -81.16 152.68 27.63 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.923 0.889 . . . . 0.0 111.603 177.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 29.4 p -157.38 155.29 30.29 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 113.961 1.097 . . . . 0.0 113.961 -175.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 64.8 tttm -110.53 -28.68 8.4 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 126.023 1.729 . . . . 0.0 110.726 168.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 8.1 pt20 -147.84 169.75 19.11 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 126.426 1.89 . . . . 0.0 110.601 172.541 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -61.35 -25.33 67.08 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 124.6 1.16 . . . . 0.0 112.918 -176.528 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 8.0 m -65.25 -18.59 65.43 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 125.157 1.383 . . . . 0.0 113.627 175.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 60.4 m-20 -81.73 -18.52 44.03 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 123.928 0.891 . . . . 0.0 112.368 174.398 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 73.6 m -86.9 168.02 13.79 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.118 1.367 . . . . 0.0 113.648 -175.579 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -71.17 173.72 7.3 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 124.415 1.086 . . . . 0.0 110.919 176.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.0 132.89 55.36 Favored 'General case' 0 CA--C 1.54 0.581 0 O-C-N 121.16 -0.962 . . . . 0.0 113.213 -175.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 74.42 -8.45 13.59 Favored Glycine 0 CA--C 1.534 1.247 0 C-N-CA 124.829 1.204 . . . . 0.0 114.512 -179.599 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 66.7 m -75.29 162.59 28.3 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 118.5 1.15 . . . . 0.0 113.915 -179.6 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 23.3 m -118.84 151.47 21.04 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 125.319 1.448 . . . . 0.0 110.816 168.697 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 43.7 t -89.38 104.76 17.29 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 123.725 0.81 . . . . 0.0 109.783 169.439 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -70.24 166.97 49.97 Favored Glycine 0 CA--C 1.543 1.81 0 C-N-CA 124.563 1.078 . . . . 0.0 113.842 179.043 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -69.43 -18.14 38.71 Favored 'Trans proline' 0 CA--C 1.539 0.76 0 C-N-CA 124.046 3.164 . . . . 0.0 113.357 -176.499 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 51.3 p-10 -69.22 -9.96 55.49 Favored 'General case' 0 CA--C 1.549 0.933 0 N-CA-C 114.414 1.265 . . . . 0.0 114.414 170.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 84.7 12.7 74.36 Favored Glycine 0 CA--C 1.533 1.218 0 C-N-CA 124.838 1.209 . . . . 0.0 114.096 -176.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -119.6 155.35 32.43 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.773 1.229 . . . . 0.0 112.403 175.02 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 69.7 m -76.75 154.92 33.61 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.941 1.297 . . . . 0.0 113.319 177.359 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.309 0 C-N-CA 125.711 1.624 . . . . 0.0 113.779 175.072 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.767 0 CA-C-O 121.075 0.264 . . . . 0.0 112.469 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 52.9 t -64.48 128.5 93.44 Favored Pre-proline 0 CA--C 1.55 0.966 0 C-N-CA 123.966 0.906 . . . . 0.0 112.306 -178.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -71.83 147.99 51.21 Favored 'Trans proline' 0 C--N 1.353 0.811 0 C-N-CA 123.279 2.653 . . . . 0.0 111.16 173.695 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -84.53 17.76 2.55 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 114.166 1.173 . . . . 0.0 114.166 -172.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 8.9 tp -69.81 138.62 21.73 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 125.065 1.346 . . . . 0.0 111.118 175.345 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 31.5 tp -78.94 115.41 18.61 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 123.441 0.696 . . . . 0.0 109.882 177.141 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 81.6 mmm -137.17 126.09 24.21 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 125.672 1.589 . . . . 0.0 108.929 -177.468 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 25.4 ttt85 -86.77 144.99 26.81 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 118.632 0.651 . . . . 0.0 111.297 -179.443 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 24.5 p -146.66 160.56 42.04 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 125.502 1.521 . . . . 0.0 113.544 -169.205 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 61.4 mtpt -112.21 -24.72 9.68 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 125.845 1.658 . . . . 0.0 111.373 169.231 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 20.9 pt20 -152.71 166.63 31.55 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 126.397 1.879 . . . . 0.0 110.599 176.569 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -61.16 -25.07 66.76 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 124.257 1.023 . . . . 0.0 112.811 -176.318 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.8 m -65.54 -18.01 65.0 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 125.662 1.585 . . . . 0.0 113.573 176.016 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 63.0 m-20 -81.42 -19.14 43.13 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 123.991 0.917 . . . . 0.0 112.228 173.317 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 75.8 m -89.22 167.34 13.16 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.211 1.404 . . . . 0.0 113.621 -174.474 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -74.86 177.98 5.86 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 124.373 1.069 . . . . 0.0 111.206 179.623 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.47 133.7 56.34 Favored 'General case' 0 CA--C 1.539 0.547 0 O-C-N 121.186 -0.946 . . . . 0.0 112.923 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 74.77 -9.41 11.18 Favored Glycine 0 CA--C 1.533 1.186 0 C-N-CA 124.81 1.195 . . . . 0.0 114.399 -179.104 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 64.0 m -79.48 161.53 26.0 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 118.555 1.177 . . . . 0.0 113.969 -179.417 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 18.7 m -124.2 153.36 30.49 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 C-N-CA 126.313 1.845 . . . . 0.0 110.147 168.186 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 45.0 t -85.67 102.97 14.06 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.371 0.669 . . . . 0.0 109.8 169.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -71.53 172.16 45.82 Favored Glycine 0 CA--C 1.542 1.764 0 C-N-CA 125.133 1.349 . . . . 0.0 114.602 -177.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -70.37 -21.23 30.92 Favored 'Trans proline' 0 CA--C 1.538 0.712 0 C-N-CA 124.28 3.32 . . . . 0.0 113.604 -173.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 51.0 p-10 -70.95 -7.04 43.24 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 124.718 1.207 . . . . 0.0 113.97 169.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 83.72 8.46 84.48 Favored Glycine 0 CA--C 1.53 1.029 0 C-N-CA 125.389 1.471 . . . . 0.0 114.056 -177.567 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -112.18 155.82 23.32 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 119.195 1.498 . . . . 0.0 112.337 176.139 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 81.1 m -73.88 146.0 44.39 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.452 1.101 . . . . 0.0 112.8 176.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.189 0 C-N-CA 125.972 1.749 . . . . 0.0 113.11 174.927 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.792 0 N-CA-C 112.342 -0.303 . . . . 0.0 112.342 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 45.5 t -59.9 127.3 85.3 Favored Pre-proline 0 CA--C 1.549 0.91 0 C-N-CA 124.342 1.057 . . . . 0.0 112.187 -179.362 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -71.62 160.97 46.77 Favored 'Trans proline' 0 C--N 1.354 0.858 0 C-N-CA 123.106 2.537 . . . . 0.0 111.701 178.029 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 52.4 ttp180 -78.89 60.42 2.85 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 125.002 1.321 . . . . 0.0 111.474 -179.395 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 88.0 mt -125.52 122.47 62.6 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 126.551 1.941 . . . . 0.0 108.764 -177.356 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 40.3 tp -79.75 134.42 36.37 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.509 0.723 . . . . 0.0 109.544 170.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 59.4 tpp -157.45 135.17 10.68 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.231 1.012 . . . . 0.0 110.022 -170.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 27.6 mmt180 -77.3 153.56 33.76 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.633 0.773 . . . . 0.0 111.833 174.284 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 29.7 p -157.7 159.85 37.33 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 114.17 1.174 . . . . 0.0 114.17 -177.119 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 17.3 tppt? -118.34 -24.82 6.75 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 126.233 1.813 . . . . 0.0 111.036 169.026 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -148.73 170.19 18.75 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 126.26 1.824 . . . . 0.0 111.022 169.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -63.57 -25.44 68.24 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 124.85 1.26 . . . . 0.0 113.49 -173.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 77.7 p -73.09 -10.55 59.91 Favored 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 113.817 1.043 . . . . 0.0 113.817 175.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 62.8 m-20 -80.07 -20.91 44.06 Favored 'General case' 0 CA--C 1.543 0.708 0 O-C-N 121.336 -0.853 . . . . 0.0 111.601 169.241 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 71.5 m -85.88 167.28 15.28 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.242 1.417 . . . . 0.0 113.863 -174.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -70.23 170.35 11.84 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 124.21 1.004 . . . . 0.0 110.702 175.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.16 135.3 57.68 Favored 'General case' 0 CA--C 1.539 0.52 0 O-C-N 121.202 -0.936 . . . . 0.0 112.87 -177.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 76.2 -8.84 22.39 Favored Glycine 0 CA--C 1.534 1.248 0 C-N-CA 124.712 1.149 . . . . 0.0 114.352 -178.621 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 59.3 m -80.13 162.69 24.61 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 118.472 1.136 . . . . 0.0 113.988 178.401 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 19.4 m -121.28 154.13 25.04 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 126.206 1.802 . . . . 0.0 110.146 168.287 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 49.4 t -87.66 103.79 15.91 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 123.462 0.705 . . . . 0.0 110.178 169.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -70.6 167.68 50.04 Favored Glycine 0 CA--C 1.543 1.784 0 C-N-CA 124.714 1.15 . . . . 0.0 114.05 178.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -69.99 -18.77 35.74 Favored 'Trans proline' 0 CA--C 1.538 0.701 0 C-N-CA 124.12 3.213 . . . . 0.0 113.564 -175.127 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 52.6 p-10 -70.59 -8.04 48.58 Favored 'General case' 0 CA--C 1.548 0.899 0 N-CA-C 114.323 1.231 . . . . 0.0 114.323 171.17 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 81.93 12.37 81.28 Favored Glycine 0 CA--C 1.533 1.17 0 C-N-CA 124.893 1.235 . . . . 0.0 113.994 -177.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -113.79 157.93 21.64 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.848 1.259 . . . . 0.0 111.76 170.501 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 77.7 m -77.28 149.56 35.37 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.21 1.404 . . . . 0.0 113.088 174.369 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.298 0 C-N-CA 125.947 1.736 . . . . 0.0 113.153 173.972 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.775 0 CA-C-O 121.288 0.382 . . . . 0.0 112.503 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 36.3 t -64.78 125.75 89.56 Favored Pre-proline 0 CA--C 1.547 0.844 0 CA-C-O 118.163 -0.922 . . . . 0.0 112.461 -178.601 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -66.77 151.21 82.92 Favored 'Trans proline' 0 C--N 1.353 0.797 0 C-N-CA 123.203 2.602 . . . . 0.0 111.845 178.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 6.7 mmp_? -82.54 14.36 3.13 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 124.77 1.228 . . . . 0.0 114.058 -177.083 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 10.2 tp -71.78 142.74 15.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 C-N-CA 125.302 1.441 . . . . 0.0 111.223 177.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 26.9 tp -76.93 131.98 38.82 Favored 'General case' 0 CA--C 1.538 0.485 0 O-C-N 121.791 -0.568 . . . . 0.0 110.15 175.357 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 61.2 tpp -154.47 126.47 7.72 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 125.056 1.342 . . . . 0.0 108.773 -178.319 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 25.9 ttt85 -88.93 146.64 24.79 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 118.392 0.542 . . . . 0.0 111.259 -178.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 26.2 p -150.84 160.08 44.12 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.269 1.427 . . . . 0.0 113.685 -169.091 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 61.7 mtpt -116.67 -20.79 9.4 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 126.35 1.86 . . . . 0.0 111.301 169.03 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 19.5 pt20 -147.8 160.29 42.91 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 126.941 2.097 . . . . 0.0 110.201 177.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -62.23 -26.03 68.14 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 124.25 1.02 . . . . 0.0 112.439 -179.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 17.0 m -67.85 -13.85 62.48 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 124.881 1.272 . . . . 0.0 113.664 175.544 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 48.3 m-20 -82.32 -19.69 38.88 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.747 0.819 . . . . 0.0 112.117 172.523 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 81.7 m -85.86 168.88 13.84 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.308 1.443 . . . . 0.0 113.83 -173.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -71.64 175.65 5.46 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 124.468 1.107 . . . . 0.0 111.049 176.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.29 133.0 55.68 Favored 'General case' 0 CA--C 1.54 0.566 0 O-C-N 121.064 -1.023 . . . . 0.0 113.338 -176.044 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 74.02 -8.3 12.57 Favored Glycine 0 CA--C 1.535 1.288 0 C-N-CA 124.891 1.234 . . . . 0.0 114.559 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 66.4 m -75.78 162.52 28.11 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 114.238 1.199 . . . . 0.0 114.238 -178.074 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 20.3 m -120.57 151.25 23.39 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 125.579 1.551 . . . . 0.0 110.493 168.298 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 49.4 t -87.09 103.64 15.57 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 123.586 0.754 . . . . 0.0 109.8 169.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -71.74 171.7 47.1 Favored Glycine 0 CA--C 1.543 1.827 0 C-N-CA 125.063 1.316 . . . . 0.0 114.446 -178.48 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -70.43 -21.04 30.92 Favored 'Trans proline' 0 CA--C 1.539 0.733 0 C-N-CA 124.262 3.308 . . . . 0.0 113.634 -173.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 50.7 p-10 -70.69 -7.04 41.66 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 124.749 1.22 . . . . 0.0 113.987 169.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.86 10.35 83.17 Favored Glycine 0 CA--C 1.529 0.946 0 C-N-CA 125.24 1.4 . . . . 0.0 113.866 -177.048 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -113.52 154.24 27.41 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 119.374 1.587 . . . . 0.0 112.444 175.659 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 69.9 m -74.76 151.18 39.16 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.969 1.308 . . . . 0.0 113.063 177.628 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.353 0 C-N-CA 125.647 1.594 . . . . 0.0 113.864 175.132 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.705 0 N-CA-C 112.395 -0.282 . . . . 0.0 112.395 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 42.0 t -61.73 129.05 91.18 Favored Pre-proline 0 CA--C 1.55 0.952 0 C-N-CA 124.186 0.994 . . . . 0.0 112.244 -179.466 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -71.35 163.33 39.47 Favored 'Trans proline' 0 C--N 1.353 0.792 0 C-N-CA 123.315 2.677 . . . . 0.0 111.865 176.327 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 18.5 ptp180 -72.94 16.3 0.16 Allowed 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 115.175 1.546 . . . . 0.0 115.175 -176.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 89.4 mt -80.36 119.94 30.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 125.768 1.627 . . . . 0.0 109.656 -176.741 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 36.9 tp -81.88 132.32 35.27 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.729 0.812 . . . . 0.0 109.652 170.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 59.9 ttm -160.97 136.21 7.74 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.664 1.185 . . . . 0.0 109.598 -171.433 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 56.8 mtp85 -84.89 152.26 23.69 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 118.876 0.762 . . . . 0.0 112.556 175.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 24.9 p -151.32 156.83 41.59 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.206 1.402 . . . . 0.0 113.672 -169.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 28.4 ttpp -102.37 -29.63 11.53 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 126.205 1.802 . . . . 0.0 110.539 168.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 20.1 pt20 -155.94 166.7 32.7 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 126.364 1.866 . . . . 0.0 110.648 -177.484 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -60.89 -25.69 66.89 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 124.303 1.041 . . . . 0.0 112.647 -176.643 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.4 m -64.14 -18.84 64.83 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 125.834 1.654 . . . . 0.0 113.576 176.168 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 63.2 m-20 -81.48 -22.15 38.23 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.004 0.921 . . . . 0.0 112.387 174.591 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 73.0 m -86.32 167.34 14.87 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.059 1.344 . . . . 0.0 113.844 -171.297 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -70.81 172.37 8.96 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 124.261 1.024 . . . . 0.0 111.048 176.389 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.07 135.88 57.85 Favored 'General case' 0 CA--C 1.539 0.537 0 O-C-N 121.273 -0.892 . . . . 0.0 112.88 -179.188 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 75.75 -9.25 17.37 Favored Glycine 0 CA--C 1.533 1.207 0 C-N-CA 124.776 1.179 . . . . 0.0 114.265 -178.554 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 59.6 m -80.78 161.63 24.43 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 118.652 1.226 . . . . 0.0 114.023 179.479 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 18.7 m -123.27 153.2 28.52 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 C-N-CA 126.272 1.829 . . . . 0.0 110.091 168.383 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 49.1 t -87.57 103.7 15.8 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 123.386 0.675 . . . . 0.0 109.871 169.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -71.5 170.4 48.45 Favored Glycine 0 CA--C 1.542 1.743 0 C-N-CA 124.884 1.23 . . . . 0.0 114.197 -179.288 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -69.67 -20.56 35.11 Favored 'Trans proline' 0 CA--C 1.538 0.71 0 C-N-CA 124.247 3.298 . . . . 0.0 113.453 -175.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 49.3 p30 -70.31 -6.8 37.71 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 125.014 1.326 . . . . 0.0 114.053 169.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 79.9 12.64 83.22 Favored Glycine 0 CA--C 1.531 1.033 0 C-N-CA 125.188 1.375 . . . . 0.0 114.066 -178.408 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -109.05 153.56 23.47 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 118.613 1.207 . . . . 0.0 112.239 172.218 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 78.2 m -73.17 145.2 46.5 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.883 1.273 . . . . 0.0 112.238 170.013 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.238 0 C-N-CA 125.95 1.738 . . . . 0.0 113.207 175.813 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.652 0 CA-C-O 121.019 0.233 . . . . 0.0 112.608 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 51.6 t -60.43 126.18 83.91 Favored Pre-proline 0 CA--C 1.549 0.937 0 C-N-CA 124.503 1.121 . . . . 0.0 112.645 -179.202 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_exo -57.71 145.87 87.87 Favored 'Trans proline' 0 C--N 1.354 0.858 0 C-N-CA 123.83 3.02 . . . . 0.0 112.645 171.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 34.0 ptt-85 -79.99 12.61 2.66 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 115.358 1.614 . . . . 0.0 115.358 -173.617 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 10.2 tp -75.11 142.21 14.88 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 125.223 1.409 . . . . 0.0 111.484 178.659 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 30.4 tp -81.04 133.82 35.55 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 123.577 0.751 . . . . 0.0 109.988 173.725 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 61.5 tpp -158.6 133.51 8.33 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.458 1.103 . . . . 0.0 109.516 -172.478 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 55.6 mtp85 -91.31 154.64 19.09 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 118.955 0.798 . . . . 0.0 112.879 175.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 26.4 p -154.88 159.25 40.36 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.196 1.398 . . . . 0.0 113.83 -169.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 65.0 mttp -111.63 -26.05 9.22 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 125.991 1.717 . . . . 0.0 111.028 168.804 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 21.0 pt20 -150.97 166.99 28.97 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 126.565 1.946 . . . . 0.0 110.513 175.503 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -60.76 -25.9 66.84 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 124.524 1.13 . . . . 0.0 112.73 -176.043 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.9 m -65.41 -18.1 65.05 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 125.653 1.581 . . . . 0.0 113.61 176.31 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 62.2 m-20 -82.0 -19.26 40.87 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 123.971 0.909 . . . . 0.0 112.327 173.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 75.0 m -87.02 167.08 14.55 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.921 1.289 . . . . 0.0 113.903 -173.498 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -71.34 172.99 8.4 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 124.741 1.217 . . . . 0.0 110.925 177.181 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.24 133.36 56.03 Favored 'General case' 0 CA--C 1.539 0.543 0 O-C-N 121.195 -0.94 . . . . 0.0 113.162 -175.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 74.83 -8.54 14.72 Favored Glycine 0 CA--C 1.534 1.267 0 C-N-CA 124.657 1.122 . . . . 0.0 114.45 -179.464 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 61.2 m -78.65 160.99 27.25 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 114.067 1.136 . . . . 0.0 114.067 179.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 18.8 m -120.24 154.54 23.35 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 126.258 1.823 . . . . 0.0 110.205 168.447 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 43.3 t -88.17 104.13 16.41 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 123.618 0.767 . . . . 0.0 110.28 170.019 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -70.72 169.15 48.51 Favored Glycine 0 CA--C 1.543 1.802 0 C-N-CA 124.911 1.243 . . . . 0.0 114.179 178.454 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -70.52 -20.67 30.97 Favored 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 124.228 3.285 . . . . 0.0 113.695 -174.137 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 50.5 p30 -71.35 -5.15 30.3 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 124.952 1.301 . . . . 0.0 114.058 170.397 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 79.28 11.17 85.28 Favored Glycine 0 CA--C 1.53 1.027 0 C-N-CA 125.12 1.343 . . . . 0.0 114.007 -178.636 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -106.99 155.05 20.21 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 118.652 1.226 . . . . 0.0 111.885 170.548 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 83.3 m -76.23 147.37 38.39 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.983 1.313 . . . . 0.0 112.606 173.272 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.181 0 C-N-CA 125.815 1.674 . . . . 0.0 113.279 175.26 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.71 0 N-CA-C 112.378 -0.289 . . . . 0.0 112.378 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 45.9 t -60.11 126.26 83.35 Favored Pre-proline 0 CA--C 1.551 0.995 0 C-N-CA 124.571 1.149 . . . . 0.0 112.586 -179.011 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -56.77 146.18 79.08 Favored 'Trans proline' 0 C--N 1.354 0.866 0 C-N-CA 123.947 3.098 . . . . 0.0 112.872 172.059 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 82.1 mtp180 -84.72 14.1 5.07 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 114.404 1.261 . . . . 0.0 114.404 -172.112 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 10.2 tp -77.63 143.4 12.89 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 C-N-CA 125.176 1.39 . . . . 0.0 111.144 176.353 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 29.4 tp -78.21 135.26 37.56 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 123.189 0.596 . . . . 0.0 110.22 174.648 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 61.2 tpp -154.16 126.61 8.0 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 124.78 1.232 . . . . 0.0 108.973 -177.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 25.1 ttt85 -89.61 147.4 23.94 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 118.452 0.569 . . . . 0.0 111.037 179.158 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 26.1 p -152.19 165.66 34.15 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.884 1.274 . . . . 0.0 114.309 -168.469 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 21.5 pttp -122.41 -14.4 7.85 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 126.072 1.749 . . . . 0.0 112.123 168.079 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 20.0 pt20 -155.45 162.35 40.77 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 126.642 1.977 . . . . 0.0 110.351 178.183 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 26.7 m-20 -62.23 -24.52 67.29 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.911 0.884 . . . . 0.0 112.606 -177.102 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.3 m -64.21 -18.57 64.64 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 125.82 1.648 . . . . 0.0 113.58 176.327 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 64.6 m-20 -80.78 -20.52 42.44 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.12 0.968 . . . . 0.0 112.388 174.4 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 73.8 m -89.77 165.92 13.87 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.983 1.313 . . . . 0.0 113.897 -169.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -72.56 174.95 6.78 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 124.763 1.225 . . . . 0.0 111.07 177.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.43 133.23 55.91 Favored 'General case' 0 CA--C 1.541 0.606 0 O-C-N 121.089 -1.007 . . . . 0.0 113.104 -176.228 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 74.73 -8.64 13.8 Favored Glycine 0 CA--C 1.535 1.311 0 C-N-CA 124.687 1.137 . . . . 0.0 114.408 -179.447 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 60.6 m -79.16 161.99 26.07 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 114.082 1.141 . . . . 0.0 114.082 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 18.2 m -124.92 154.42 32.8 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 126.433 1.893 . . . . 0.0 110.197 168.577 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 36.9 t -83.77 102.25 12.17 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 123.303 0.641 . . . . 0.0 110.372 170.338 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -71.91 172.25 46.74 Favored Glycine 0 CA--C 1.542 1.781 0 C-N-CA 125.339 1.447 . . . . 0.0 114.62 -179.092 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -71.38 -20.94 27.04 Favored 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 124.33 3.353 . . . . 0.0 113.973 -172.127 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 52.6 p-10 -71.96 -5.18 32.96 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 124.576 1.15 . . . . 0.0 113.899 170.416 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 83.47 5.92 88.07 Favored Glycine 0 CA--C 1.53 0.98 0 C-N-CA 125.497 1.522 . . . . 0.0 114.029 -177.694 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -109.5 155.97 20.68 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 119.195 1.497 . . . . 0.0 112.163 174.599 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 82.7 m -73.47 145.8 45.42 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.839 1.256 . . . . 0.0 112.804 176.308 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.206 0 C-N-CA 126.063 1.792 . . . . 0.0 113.146 175.905 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.688 0 N-CA-C 112.284 -0.326 . . . . 0.0 112.284 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 48.0 t -60.94 130.73 91.33 Favored Pre-proline 0 CA--C 1.55 0.964 0 C-N-CA 124.199 0.999 . . . . 0.0 112.396 -179.399 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -62.93 160.65 32.62 Favored 'Trans proline' 0 C--N 1.354 0.827 0 C-N-CA 123.288 2.659 . . . . 0.0 112.848 175.165 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 40.4 ptt180 -74.13 13.94 0.49 Allowed 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 114.865 1.431 . . . . 0.0 114.865 179.519 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 94.6 mt -86.32 122.21 38.4 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 126.352 1.861 . . . . 0.0 109.558 -174.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 47.7 tp -76.74 134.31 39.21 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.666 0.786 . . . . 0.0 109.872 171.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 57.6 ttm -157.57 132.17 8.52 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.342 1.057 . . . . 0.0 110.186 -173.592 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 57.4 ttt180 -82.71 147.98 28.16 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.723 0.809 . . . . 0.0 111.089 -179.65 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 26.3 p -151.17 158.5 44.05 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.548 1.139 . . . . 0.0 113.687 -170.034 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 58.9 mtmt -109.3 -27.32 9.58 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.815 1.646 . . . . 0.0 111.344 169.505 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 8.0 pt20 -153.41 169.47 23.06 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 126.399 1.88 . . . . 0.0 110.818 176.109 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -61.45 -25.71 67.4 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.406 1.083 . . . . 0.0 112.887 -176.489 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 7.2 m -64.8 -18.65 65.29 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 125.296 1.438 . . . . 0.0 113.484 175.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 62.0 m-20 -80.42 -21.18 42.44 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 123.909 0.883 . . . . 0.0 112.21 173.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 77.4 m -88.08 166.75 14.21 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 125.237 1.415 . . . . 0.0 113.662 -173.303 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 40.1 mt -74.4 177.37 5.98 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.47 1.108 . . . . 0.0 111.726 178.496 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.23 134.47 57.09 Favored 'General case' 0 CA--C 1.54 0.559 0 O-C-N 121.305 -0.872 . . . . 0.0 112.855 -179.786 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 74.67 -8.33 15.21 Favored Glycine 0 CA--C 1.535 1.292 0 C-N-CA 124.698 1.142 . . . . 0.0 114.314 -178.461 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 60.7 m -81.22 159.76 24.48 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 118.553 1.177 . . . . 0.0 113.993 179.496 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 18.2 m -124.48 151.63 29.88 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 126.251 1.82 . . . . 0.0 110.003 168.288 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 49.7 t -85.69 102.2 13.41 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.355 0.662 . . . . 0.0 109.561 169.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -72.65 170.11 51.44 Favored Glycine 0 CA--C 1.544 1.858 0 C-N-CA 124.411 1.005 . . . . 0.0 114.242 -176.167 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -57.9 -26.78 75.94 Favored 'Trans proline' 0 C--N 1.353 0.807 0 C-N-CA 124.518 3.479 . . . . 0.0 114.757 -178.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 52.0 p-10 -68.6 -11.37 59.92 Favored 'General case' 0 CA--C 1.548 0.9 0 N-CA-C 114.676 1.361 . . . . 0.0 114.676 174.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 84.25 14.56 71.31 Favored Glycine 0 CA--C 1.533 1.177 0 C-N-CA 124.799 1.19 . . . . 0.0 114.019 -176.335 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 64.8 m-85 -123.05 155.33 37.11 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.739 1.216 . . . . 0.0 112.225 175.142 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 85.7 m -73.91 145.19 44.97 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.116 1.366 . . . . 0.0 112.761 178.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.284 0 C-N-CA 126.111 1.815 . . . . 0.0 113.076 175.265 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.664 0 CA-C-O 121.186 0.326 . . . . 0.0 112.593 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 40.4 t -64.56 124.53 86.33 Favored Pre-proline 0 CA--C 1.546 0.826 0 CA-C-O 117.905 -1.045 . . . . 0.0 112.542 -178.707 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -67.74 146.31 72.3 Favored 'Trans proline' 0 C--N 1.353 0.813 0 C-N-CA 122.994 2.463 . . . . 0.0 110.676 175.185 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 15.3 mmm180 -83.45 17.04 2.29 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 113.48 0.919 . . . . 0.0 113.48 -173.16 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 19.4 tt -66.28 141.74 17.65 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 125.954 1.702 . . . . 0.0 111.616 178.702 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 26.5 tp -77.0 130.26 37.23 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.315 0.646 . . . . 0.0 109.975 175.313 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 61.7 tpp -160.14 132.49 6.35 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.806 1.242 . . . . 0.0 109.098 -172.762 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 55.2 mtp85 -91.14 155.35 18.69 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 118.944 0.793 . . . . 0.0 113.088 177.456 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 26.6 p -155.67 157.38 36.58 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.401 1.48 . . . . 0.0 113.407 -170.136 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 64.9 mttp -110.51 -26.22 9.61 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 125.598 1.559 . . . . 0.0 110.936 168.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 8.1 pt20 -149.99 169.28 21.57 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 126.5 1.92 . . . . 0.0 110.386 173.185 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -61.18 -25.57 67.12 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 124.533 1.133 . . . . 0.0 112.919 -176.513 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 7.1 m -64.88 -19.1 65.73 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 125.315 1.446 . . . . 0.0 113.605 175.862 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 60.3 m-20 -82.18 -18.46 42.66 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 123.929 0.892 . . . . 0.0 112.366 174.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 79.1 m -86.66 168.51 13.54 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.069 1.348 . . . . 0.0 113.706 -175.412 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -71.1 173.84 7.08 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 124.557 1.143 . . . . 0.0 110.992 176.805 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.94 132.76 54.94 Favored 'General case' 0 CA--C 1.54 0.573 0 O-C-N 121.115 -0.991 . . . . 0.0 113.236 -175.615 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 74.25 -8.33 13.44 Favored Glycine 0 CA--C 1.534 1.265 0 C-N-CA 124.87 1.224 . . . . 0.0 114.539 -179.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 67.4 m -75.42 162.32 28.47 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 114.041 1.126 . . . . 0.0 114.041 -179.205 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 22.4 m -118.43 151.99 20.56 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 125.463 1.505 . . . . 0.0 110.7 168.666 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 48.5 t -90.3 105.15 17.62 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.826 0.85 . . . . 0.0 109.999 169.488 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -70.74 168.81 49.07 Favored Glycine 0 CA--C 1.541 1.708 0 C-N-CA 124.742 1.163 . . . . 0.0 114.127 178.586 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -70.01 -20.53 33.56 Favored 'Trans proline' 0 CA--C 1.538 0.713 0 C-N-CA 124.187 3.258 . . . . 0.0 113.58 -175.151 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 49.1 p30 -70.65 -5.96 33.41 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 125.071 1.349 . . . . 0.0 114.099 169.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 78.83 13.45 83.1 Favored Glycine 0 CA--C 1.531 1.039 0 C-N-CA 125.109 1.337 . . . . 0.0 113.917 -178.289 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -109.04 153.82 23.09 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 118.629 1.215 . . . . 0.0 111.995 171.159 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 82.5 m -76.59 154.02 34.8 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.998 1.319 . . . . 0.0 112.847 173.765 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.185 0 CA-C-O 116.653 -2.193 . . . . 0.0 113.952 175.472 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.72 0 CA-C-O 121.121 0.289 . . . . 0.0 112.559 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 42.3 t -61.0 127.22 87.43 Favored Pre-proline 0 CA--C 1.549 0.932 0 C-N-CA 124.413 1.085 . . . . 0.0 112.19 -179.516 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_endo -72.69 163.77 37.53 Favored 'Trans proline' 0 C--N 1.353 0.804 0 C-N-CA 123.132 2.555 . . . . 0.0 111.74 177.755 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 10.7 ptm85 -73.04 15.56 0.2 Allowed 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 115.109 1.522 . . . . 0.0 115.109 -178.55 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 91.6 mt -79.77 120.07 30.4 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 125.834 1.654 . . . . 0.0 109.349 -177.828 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 36.3 tp -76.82 135.11 38.91 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 123.388 0.675 . . . . 0.0 109.602 171.085 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 60.8 tpp -160.01 134.58 7.65 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.315 1.046 . . . . 0.0 109.365 -169.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 53.9 mtp85 -88.93 152.82 21.5 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 119.187 0.903 . . . . 0.0 112.418 174.625 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 26.4 p -153.8 159.87 42.04 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 125.004 1.322 . . . . 0.0 113.866 -169.636 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 61.3 mtpt -113.94 -24.2 9.2 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 126.18 1.792 . . . . 0.0 111.158 168.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 21.0 pt20 -151.0 166.46 30.64 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 126.544 1.938 . . . . 0.0 110.434 175.099 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -61.29 -25.47 67.13 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 124.332 1.053 . . . . 0.0 112.721 -176.23 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.8 m -65.42 -17.77 64.8 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 125.636 1.574 . . . . 0.0 113.641 176.233 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 63.5 m-20 -81.79 -18.71 43.15 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 123.985 0.914 . . . . 0.0 112.302 173.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 74.2 m -87.98 168.01 13.22 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.952 1.301 . . . . 0.0 114.133 -172.416 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -70.57 171.16 10.74 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 124.399 1.08 . . . . 0.0 110.742 175.733 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.13 134.8 57.4 Favored 'General case' 0 CA--C 1.539 0.543 0 O-C-N 121.171 -0.956 . . . . 0.0 113.018 -177.177 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 75.82 -8.82 19.7 Favored Glycine 0 CA--C 1.534 1.238 0 C-N-CA 124.814 1.197 . . . . 0.0 114.338 -179.172 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 60.5 m -79.48 162.07 25.67 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 114.131 1.16 . . . . 0.0 114.131 179.427 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 19.0 m -122.14 153.44 26.5 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 126.308 1.843 . . . . 0.0 110.128 168.338 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 41.1 t -86.91 102.61 14.51 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.6 0.76 . . . . 0.0 110.358 170.479 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -73.47 168.98 53.66 Favored Glycine 0 CA--C 1.545 1.94 0 C-N-CA 124.628 1.109 . . . . 0.0 114.499 -178.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -59.03 -28.6 88.32 Favored 'Trans proline' 0 C--N 1.354 0.822 0 C-N-CA 124.532 3.488 . . . . 0.0 115.129 -176.284 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 51.3 p30 -71.03 -4.79 26.78 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 125.06 1.344 . . . . 0.0 114.446 175.719 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 78.83 11.53 85.13 Favored Glycine 0 CA--C 1.531 1.054 0 C-N-CA 124.941 1.257 . . . . 0.0 113.918 -178.384 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -107.33 155.33 20.1 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 118.49 1.145 . . . . 0.0 111.796 169.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 83.7 m -76.36 145.97 39.1 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.03 1.332 . . . . 0.0 112.587 172.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.249 0 C-N-CA 125.906 1.717 . . . . 0.0 113.223 175.261 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.767 0 CA-C-O 121.091 0.273 . . . . 0.0 112.469 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 53.4 t -60.77 127.42 87.24 Favored Pre-proline 0 CA--C 1.551 1.013 0 C-N-CA 124.473 1.109 . . . . 0.0 112.497 -179.276 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -56.93 153.3 38.54 Favored 'Trans proline' 0 C--N 1.353 0.787 0 C-N-CA 124.059 3.173 . . . . 0.0 113.152 171.312 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -78.92 38.4 0.33 Allowed 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 125.194 1.398 . . . . 0.0 112.692 179.721 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 86.7 mt -101.69 121.89 53.2 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 C-N-CA 126.366 1.866 . . . . 0.0 109.185 -176.28 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 37.5 tp -81.29 131.47 35.29 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 123.695 0.798 . . . . 0.0 109.646 171.837 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 60.3 ttm -160.1 135.31 8.03 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.644 1.178 . . . . 0.0 110.213 -171.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 30.3 mmt180 -73.57 153.44 40.23 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.588 0.755 . . . . 0.0 112.016 175.604 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 29.0 p -157.63 160.14 37.73 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.421 1.088 . . . . 0.0 113.71 -176.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 16.9 tppt? -117.23 -25.82 6.97 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 126.712 2.005 . . . . 0.0 111.035 169.155 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -144.38 159.96 41.85 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 126.583 1.953 . . . . 0.0 110.478 178.385 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -62.36 -26.59 68.54 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 124.31 1.044 . . . . 0.0 112.318 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 17.6 m -67.83 -13.18 61.92 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 124.98 1.312 . . . . 0.0 113.571 175.358 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 51.7 m-20 -80.67 -22.48 40.4 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 118.892 0.769 . . . . 0.0 111.914 171.49 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 73.1 m -86.38 167.78 14.43 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.398 1.479 . . . . 0.0 113.642 -172.601 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -70.18 172.05 8.72 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.247 1.019 . . . . 0.0 111.157 176.403 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.54 135.21 57.6 Favored 'General case' 0 CA--C 1.539 0.541 0 O-C-N 121.231 -0.918 . . . . 0.0 112.902 -179.06 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 75.37 -9.03 15.32 Favored Glycine 0 CA--C 1.533 1.196 0 C-N-CA 124.716 1.151 . . . . 0.0 114.286 -178.683 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 60.4 m -80.62 161.34 24.75 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 118.604 1.202 . . . . 0.0 113.731 178.839 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 18.7 m -122.01 154.63 26.57 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 C-N-CA 126.256 1.823 . . . . 0.0 110.196 168.797 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 47.2 t -88.3 103.78 16.13 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.405 0.682 . . . . 0.0 109.661 169.524 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -71.16 168.53 50.44 Favored Glycine 0 CA--C 1.542 1.756 0 C-N-CA 124.591 1.091 . . . . 0.0 113.938 -178.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -69.29 -18.95 38.97 Favored 'Trans proline' 0 CA--C 1.538 0.723 0 C-N-CA 124.091 3.194 . . . . 0.0 113.254 -176.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 50.9 p-10 -69.44 -9.2 52.63 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 124.892 1.277 . . . . 0.0 114.312 170.196 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 81.99 13.82 78.56 Favored Glycine 0 CA--C 1.533 1.191 0 C-N-CA 125.019 1.295 . . . . 0.0 114.042 -177.779 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -115.17 155.12 27.74 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.027 1.331 . . . . 0.0 112.003 172.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 74.8 m -73.07 146.33 45.9 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.88 1.272 . . . . 0.0 112.584 171.429 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.209 0 C-N-CA 125.97 1.748 . . . . 0.0 113.235 175.131 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.739 0 CA-C-O 121.032 0.24 . . . . 0.0 112.576 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 53.0 t -62.89 127.05 90.08 Favored Pre-proline 0 CA--C 1.55 0.951 0 C-N-CA 124.134 0.974 . . . . 0.0 112.356 -178.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -69.86 151.97 68.67 Favored 'Trans proline' 0 C--N 1.353 0.814 0 C-N-CA 123.041 2.494 . . . . 0.0 111.412 174.497 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -81.85 15.5 2.21 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.704 1.202 . . . . 0.0 113.882 -176.403 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 18.0 tt -72.98 142.73 14.68 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 125.598 1.559 . . . . 0.0 111.2 176.344 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 30.0 tp -79.23 134.79 36.66 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 123.128 0.571 . . . . 0.0 110.228 174.646 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 60.5 tpp -153.65 127.3 8.74 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 124.775 1.23 . . . . 0.0 109.408 -179.109 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 45.8 ttt85 -85.5 147.18 26.57 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.747 0.819 . . . . 0.0 111.015 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 29.3 p -156.76 165.48 36.12 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 114.351 1.241 . . . . 0.0 114.351 -169.374 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 21.9 pttp -126.16 -12.7 6.31 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 126.292 1.837 . . . . 0.0 112.122 168.149 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 17.4 pt20 -157.39 161.76 39.01 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 126.394 1.878 . . . . 0.0 110.811 178.838 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 33.8 m-20 -65.57 -25.3 67.36 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 124.154 0.982 . . . . 0.0 113.441 -171.05 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 58.8 p -72.88 -9.44 58.69 Favored 'General case' 0 CA--C 1.546 0.792 0 N-CA-C 113.695 0.998 . . . . 0.0 113.695 175.831 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 66.4 m-20 -78.01 -23.54 48.25 Favored 'General case' 0 N--CA 1.473 0.724 0 O-C-N 121.299 -0.876 . . . . 0.0 111.315 168.822 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 73.2 m -87.79 166.42 14.62 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.508 1.523 . . . . 0.0 113.795 -171.242 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -71.55 172.54 9.41 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 124.609 1.164 . . . . 0.0 111.032 177.525 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.17 133.06 55.75 Favored 'General case' 0 CA--C 1.538 0.511 0 O-C-N 121.241 -0.912 . . . . 0.0 113.164 -176.305 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 75.64 -9.26 16.52 Favored Glycine 0 CA--C 1.534 1.279 0 C-N-CA 124.781 1.181 . . . . 0.0 114.339 -178.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 60.8 m -78.71 163.39 25.45 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 118.547 1.173 . . . . 0.0 113.969 179.354 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 18.3 m -124.18 154.5 31.17 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 C-N-CA 126.354 1.862 . . . . 0.0 110.211 168.389 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 45.5 t -85.33 103.65 14.45 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 123.186 0.594 . . . . 0.0 110.123 169.822 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -70.03 168.95 46.77 Favored Glycine 0 CA--C 1.544 1.858 0 C-N-CA 124.871 1.224 . . . . 0.0 114.15 179.33 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -70.13 -18.62 35.16 Favored 'Trans proline' 0 CA--C 1.538 0.697 0 C-N-CA 124.16 3.24 . . . . 0.0 113.612 -174.333 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 52.9 p-10 -69.77 -9.06 53.13 Favored 'General case' 0 CA--C 1.548 0.897 0 N-CA-C 114.278 1.214 . . . . 0.0 114.278 170.473 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 84.61 11.62 77.01 Favored Glycine 0 CA--C 1.532 1.123 0 C-N-CA 124.837 1.208 . . . . 0.0 113.938 -176.607 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -121.44 155.83 34.03 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 118.632 1.216 . . . . 0.0 112.289 175.086 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 84.8 m -75.41 147.7 39.75 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.789 1.236 . . . . 0.0 113.2 -179.549 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.199 0 C-N-CA 126.123 1.82 . . . . 0.0 113.038 174.517 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.744 0 CA-C-O 121.07 0.261 . . . . 0.0 112.506 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 53.2 t -60.4 126.57 84.81 Favored Pre-proline 0 CA--C 1.55 0.96 0 C-N-CA 124.518 1.127 . . . . 0.0 112.551 -179.219 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo -58.4 154.33 42.08 Favored 'Trans proline' 0 C--N 1.355 0.878 0 C-N-CA 123.832 3.022 . . . . 0.0 113.156 172.676 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 95.7 mtt-85 -79.1 40.2 0.4 Allowed 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 125.037 1.335 . . . . 0.0 112.346 177.497 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 88.8 mt -104.34 123.4 58.18 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 126.627 1.971 . . . . 0.0 108.835 -177.043 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 41.0 tp -76.23 133.83 40.0 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.188 0.595 . . . . 0.0 109.837 172.598 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 59.6 tpp -155.58 130.11 9.05 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 124.461 1.104 . . . . 0.0 109.662 -174.427 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 60.7 ttt180 -83.29 146.15 28.7 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.583 0.753 . . . . 0.0 110.566 178.448 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 28.6 p -152.43 159.15 43.42 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 114.703 1.371 . . . . 0.0 114.703 -169.6 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 63.2 tttp -112.54 -28.91 7.66 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 126.594 1.957 . . . . 0.0 110.793 168.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 21.0 pt20 -149.44 166.76 28.13 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 126.194 1.797 . . . . 0.0 110.745 177.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -61.27 -25.27 66.97 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.183 0.993 . . . . 0.0 112.765 -175.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.8 m -65.35 -17.84 64.84 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 125.589 1.556 . . . . 0.0 113.567 176.165 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 62.4 m-20 -81.68 -18.81 43.18 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.086 0.955 . . . . 0.0 112.307 173.588 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 75.7 m -88.38 166.94 13.91 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.992 1.317 . . . . 0.0 113.955 -172.746 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -71.23 172.97 8.34 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 124.563 1.145 . . . . 0.0 110.952 176.342 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.5 133.53 56.18 Favored 'General case' 0 CA--C 1.54 0.564 0 O-C-N 121.143 -0.973 . . . . 0.0 113.145 -176.601 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 74.77 -8.62 14.05 Favored Glycine 0 CA--C 1.535 1.291 0 C-N-CA 124.572 1.082 . . . . 0.0 114.427 -179.372 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 60.3 m -78.96 162.21 26.14 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 118.448 1.124 . . . . 0.0 113.859 179.075 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 18.3 m -122.88 154.26 28.14 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 126.103 1.761 . . . . 0.0 110.361 168.716 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 48.7 t -84.96 103.12 13.72 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 123.491 0.716 . . . . 0.0 110.128 169.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -69.92 168.73 46.73 Favored Glycine 0 CA--C 1.543 1.824 0 C-N-CA 124.888 1.233 . . . . 0.0 114.093 179.626 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -69.8 -18.45 36.82 Favored 'Trans proline' 0 CA--C 1.537 0.662 0 C-N-CA 124.241 3.294 . . . . 0.0 113.503 -174.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 53.4 p-10 -69.54 -9.91 55.88 Favored 'General case' 0 CA--C 1.549 0.911 0 N-CA-C 114.33 1.233 . . . . 0.0 114.33 170.697 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 85.19 11.75 75.13 Favored Glycine 0 CA--C 1.533 1.163 0 C-N-CA 124.885 1.231 . . . . 0.0 114.083 -176.722 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 67.1 m-85 -123.98 157.24 34.83 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.751 1.22 . . . . 0.0 112.218 174.734 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 86.3 m -76.34 148.4 37.47 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.997 1.319 . . . . 0.0 113.49 -177.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.24 0 C-N-CA 126.111 1.815 . . . . 0.0 113.039 174.677 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.728 0 N-CA-C 112.478 -0.249 . . . . 0.0 112.478 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 37.5 t -63.58 125.02 86.56 Favored Pre-proline 0 CA--C 1.546 0.816 0 C-N-CA 124.097 0.959 . . . . 0.0 112.56 -178.585 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -69.6 151.8 70.04 Favored 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 122.915 2.41 . . . . 0.0 111.205 178.138 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 6.8 mmp_? -78.52 34.16 0.21 Allowed 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.829 1.251 . . . . 0.0 113.109 -178.27 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 96.6 mt -80.5 126.05 39.41 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 125.717 1.607 . . . . 0.0 109.003 177.789 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 37.6 tp -74.05 126.13 29.83 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 172.292 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 61.0 tpp -154.68 130.97 10.4 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.503 1.121 . . . . 0.0 109.68 -171.273 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 83.8 mtt85 -80.45 151.43 29.31 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.74 0.816 . . . . 0.0 111.48 177.035 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 29.4 p -156.51 155.13 31.45 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 113.983 1.105 . . . . 0.0 113.983 -174.132 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -109.82 -28.78 8.61 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 126.337 1.855 . . . . 0.0 110.562 168.796 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 20.9 pt20 -148.77 167.0 26.76 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 126.479 1.912 . . . . 0.0 110.665 176.156 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -61.27 -24.76 66.63 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 124.452 1.101 . . . . 0.0 112.768 -176.289 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.9 m -65.85 -17.84 64.92 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 125.583 1.553 . . . . 0.0 113.667 175.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 62.5 m-20 -81.62 -18.58 44.2 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.066 0.946 . . . . 0.0 112.343 173.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 72.8 m -87.66 168.74 12.74 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.28 1.432 . . . . 0.0 113.946 -173.695 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -70.7 174.59 5.77 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 124.311 1.044 . . . . 0.0 110.91 175.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.48 133.42 56.08 Favored 'General case' 0 CA--C 1.54 0.565 0 O-C-N 120.994 -1.066 . . . . 0.0 113.146 -176.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 74.51 -8.14 15.43 Favored Glycine 0 CA--C 1.535 1.287 0 C-N-CA 124.876 1.227 . . . . 0.0 114.474 179.764 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 66.2 m -75.95 162.77 27.81 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 114.127 1.158 . . . . 0.0 114.127 -178.762 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 22.9 m -119.9 151.12 22.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 125.233 1.413 . . . . 0.0 110.705 168.602 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 44.1 t -87.51 104.09 16.15 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.698 0.799 . . . . 0.0 109.667 169.438 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -70.77 167.69 50.52 Favored Glycine 0 CA--C 1.542 1.726 0 C-N-CA 124.636 1.112 . . . . 0.0 113.992 179.849 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -69.57 -18.45 37.87 Favored 'Trans proline' 0 CA--C 1.539 0.765 0 C-N-CA 124.146 3.231 . . . . 0.0 113.346 -176.11 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 52.3 p-10 -69.53 -9.66 54.86 Favored 'General case' 0 CA--C 1.548 0.891 0 N-CA-C 114.347 1.24 . . . . 0.0 114.347 170.711 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 84.92 11.72 75.99 Favored Glycine 0 CA--C 1.533 1.157 0 C-N-CA 124.889 1.233 . . . . 0.0 114.127 -177.05 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -118.86 155.65 30.85 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.886 1.274 . . . . 0.0 112.376 174.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 70.2 m -76.0 153.85 36.2 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.076 1.351 . . . . 0.0 113.255 176.722 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.276 0 CA-C-O 116.765 -2.131 . . . . 0.0 113.979 174.965 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.754 0 CA-C-O 121.076 0.264 . . . . 0.0 112.473 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 47.3 t -60.4 126.2 83.87 Favored Pre-proline 0 CA--C 1.551 0.998 0 C-N-CA 124.559 1.143 . . . . 0.0 112.621 -179.416 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -56.42 150.07 52.95 Favored 'Trans proline' 0 C--N 1.353 0.795 0 C-N-CA 124.075 3.183 . . . . 0.0 113.125 171.143 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -79.53 37.97 0.36 Allowed 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 125.117 1.367 . . . . 0.0 113.009 -177.143 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 48.2 mm -98.41 123.99 51.28 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 126.12 1.768 . . . . 0.0 109.777 -177.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 36.5 tp -81.52 129.33 34.62 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 123.586 0.754 . . . . 0.0 109.624 171.198 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 60.2 ttm -160.9 136.59 8.06 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.811 1.244 . . . . 0.0 109.574 -171.768 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 57.2 mtp85 -85.46 152.53 23.13 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 118.819 0.736 . . . . 0.0 112.708 176.776 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 25.0 p -151.74 159.55 43.92 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.367 1.467 . . . . 0.0 113.374 -169.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 31.5 mmmt -110.15 -26.19 9.79 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 125.877 1.671 . . . . 0.0 111.368 169.191 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 8.5 pt20 -152.78 168.9 24.17 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 126.332 1.853 . . . . 0.0 110.742 175.367 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -61.21 -26.21 67.57 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 124.382 1.073 . . . . 0.0 112.78 -176.525 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 6.6 m -64.58 -18.69 65.12 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 125.374 1.469 . . . . 0.0 113.508 176.264 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 62.6 m-20 -80.58 -20.72 42.68 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 123.921 0.888 . . . . 0.0 112.286 174.282 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 72.1 m -87.45 168.02 13.47 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.109 1.364 . . . . 0.0 113.797 -172.684 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -70.3 172.02 8.93 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 124.357 1.063 . . . . 0.0 111.048 176.152 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.29 134.29 56.87 Favored 'General case' 0 CA--C 1.539 0.522 0 O-C-N 121.246 -0.909 . . . . 0.0 113.061 -177.793 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 75.04 -8.78 14.21 Favored Glycine 0 CA--C 1.534 1.238 0 C-N-CA 124.641 1.115 . . . . 0.0 114.411 -179.215 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 60.8 m -79.3 161.29 26.38 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 118.477 1.139 . . . . 0.0 113.794 178.814 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 19.1 m -121.7 154.21 25.87 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 126.182 1.793 . . . . 0.0 110.412 168.759 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 48.2 t -88.25 103.94 16.26 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.603 0.761 . . . . 0.0 110.001 169.724 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -70.96 169.98 47.87 Favored Glycine 0 CA--C 1.543 1.786 0 C-N-CA 124.926 1.25 . . . . 0.0 114.195 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -69.89 -20.56 34.07 Favored 'Trans proline' 0 CA--C 1.539 0.726 0 C-N-CA 124.163 3.242 . . . . 0.0 113.442 -175.221 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 49.2 p30 -70.63 -6.34 36.15 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 125.023 1.329 . . . . 0.0 114.023 169.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 79.75 12.38 83.62 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 125.271 1.415 . . . . 0.0 114.116 -178.348 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -108.51 153.68 23.0 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.77 1.228 . . . . 0.0 112.15 172.089 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 76.2 m -73.53 146.1 45.07 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.86 1.264 . . . . 0.0 112.603 171.1 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.271 0 C-N-CA 125.981 1.753 . . . . 0.0 113.303 175.557 . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.675 0 N-CA-C 112.325 -0.31 . . . . 0.0 112.325 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 44.7 t -59.85 126.91 84.55 Favored Pre-proline 0 CA--C 1.55 0.959 0 C-N-CA 124.349 1.06 . . . . 0.0 112.138 -179.299 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -70.24 155.13 65.06 Favored 'Trans proline' 0 C--N 1.354 0.82 0 C-N-CA 122.962 2.442 . . . . 0.0 111.762 178.184 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 59.2 ttt85 -79.56 89.63 5.1 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.07 0.948 . . . . 0.0 110.621 179.118 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 9.2 tp -160.31 142.04 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 126.351 1.86 . . . . 0.0 110.437 -178.43 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 33.4 tp -86.8 136.74 32.88 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 123.963 0.905 . . . . 0.0 110.127 175.091 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 60.7 tpp -155.53 134.74 12.28 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.501 1.12 . . . . 0.0 110.055 -175.405 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 91.3 mtm-85 -81.38 152.16 27.6 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.131 0.972 . . . . 0.0 111.49 176.621 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 30.1 p -157.97 156.36 31.07 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 114.316 1.228 . . . . 0.0 114.316 -175.237 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 62.7 tttp -111.41 -29.08 7.93 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 126.456 1.902 . . . . 0.0 110.533 168.718 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 21.0 pt20 -148.14 166.98 26.23 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 126.535 1.934 . . . . 0.0 110.58 175.645 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -60.97 -25.33 66.77 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 124.502 1.121 . . . . 0.0 112.806 -176.192 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.9 m -65.46 -17.96 64.95 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.591 1.556 . . . . 0.0 113.669 175.837 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 61.8 m-20 -82.03 -19.47 40.34 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 123.964 0.906 . . . . 0.0 112.29 173.628 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 71.3 m -86.49 166.81 15.19 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.999 1.32 . . . . 0.0 113.607 -174.724 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -70.62 170.41 12.3 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 124.233 1.013 . . . . 0.0 110.76 176.26 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.9 134.95 57.52 Favored 'General case' 0 CA--C 1.539 0.533 0 O-C-N 121.273 -0.892 . . . . 0.0 112.885 -177.706 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 76.36 -9.06 22.41 Favored Glycine 0 CA--C 1.534 1.243 0 C-N-CA 124.698 1.142 . . . . 0.0 114.289 -178.541 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 58.8 m -79.91 162.61 24.88 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 118.567 1.184 . . . . 0.0 113.897 178.18 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 19.6 m -121.3 153.79 25.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 126.254 1.822 . . . . 0.0 110.206 168.419 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 48.9 t -87.83 104.17 16.33 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 123.552 0.741 . . . . 0.0 110.122 169.761 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -69.97 166.92 49.32 Favored Glycine 0 CA--C 1.542 1.739 0 C-N-CA 124.661 1.124 . . . . 0.0 113.875 178.277 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -69.83 -18.11 36.89 Favored 'Trans proline' 0 C--N 1.352 0.712 0 C-N-CA 124.204 3.269 . . . . 0.0 113.479 -175.444 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 53.1 p-10 -69.81 -9.28 54.07 Favored 'General case' 0 CA--C 1.548 0.87 0 N-CA-C 114.433 1.271 . . . . 0.0 114.433 171.185 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 84.85 11.6 76.46 Favored Glycine 0 CA--C 1.535 1.305 0 C-N-CA 124.813 1.197 . . . . 0.0 114.021 -177.036 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -119.16 156.28 30.11 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.701 1.2 . . . . 0.0 112.28 174.091 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 74.1 m -77.13 149.98 35.62 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.98 1.312 . . . . 0.0 113.258 177.732 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.271 0 C-N-CA 125.904 1.716 . . . . 0.0 113.097 174.015 . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.727 0 N-CA-C 112.227 -0.349 . . . . 0.0 112.227 . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 43.7 t -60.66 126.91 86.19 Favored Pre-proline 0 CA--C 1.55 0.964 0 C-N-CA 124.342 1.057 . . . . 0.0 112.264 -179.097 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -73.25 159.6 46.78 Favored 'Trans proline' 0 C--N 1.353 0.792 0 C-N-CA 123.099 2.533 . . . . 0.0 111.399 176.751 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -78.11 33.46 0.19 Allowed 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 125.286 1.434 . . . . 0.0 113.251 -177.861 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 97.5 mt -91.67 123.24 43.73 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 126.099 1.76 . . . . 0.0 108.837 179.641 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 37.3 tp -75.03 132.21 41.16 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 172.055 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 60.2 tpp -154.0 127.7 8.75 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 124.474 1.11 . . . . 0.0 109.406 -174.547 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 46.6 ttt85 -83.58 145.06 29.07 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.413 0.685 . . . . 0.0 110.555 178.112 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 28.0 p -149.97 158.88 44.61 Favored 'General case' 0 N--CA 1.469 0.525 0 N-CA-C 114.489 1.292 . . . . 0.0 114.489 -169.401 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -111.76 -28.85 7.92 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 126.516 1.926 . . . . 0.0 110.721 168.907 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 21.0 pt20 -149.35 166.74 28.1 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 126.29 1.836 . . . . 0.0 110.773 177.728 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -61.31 -25.25 67.0 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 124.236 1.014 . . . . 0.0 112.8 -176.184 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.8 m -65.33 -17.8 64.8 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 125.604 1.561 . . . . 0.0 113.576 176.052 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 63.3 m-20 -81.49 -18.63 44.49 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.133 0.973 . . . . 0.0 112.278 173.662 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 73.9 m -88.76 166.89 13.74 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.977 1.311 . . . . 0.0 114.123 -172.319 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -70.6 171.64 9.96 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 124.522 1.129 . . . . 0.0 110.836 175.701 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.23 135.25 57.67 Favored 'General case' 0 CA--C 1.538 0.511 0 O-C-N 121.178 -0.951 . . . . 0.0 112.939 -177.764 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 75.88 -9.2 18.46 Favored Glycine 0 CA--C 1.533 1.211 0 C-N-CA 124.809 1.195 . . . . 0.0 114.341 -178.797 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 59.8 m -80.18 162.96 24.42 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 114.185 1.18 . . . . 0.0 114.185 179.462 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 18.5 m -123.59 153.97 29.55 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 126.364 1.866 . . . . 0.0 110.088 168.222 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 49.0 t -84.32 102.52 12.76 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 123.408 0.683 . . . . 0.0 110.233 169.993 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -70.93 169.67 48.3 Favored Glycine 0 CA--C 1.542 1.779 0 C-N-CA 124.91 1.243 . . . . 0.0 114.383 -179.556 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -70.53 -19.05 32.96 Favored 'Trans proline' 0 CA--C 1.538 0.7 0 C-N-CA 124.207 3.271 . . . . 0.0 113.66 -173.819 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 53.2 p-10 -70.6 -8.12 49.24 Favored 'General case' 0 CA--C 1.548 0.889 0 N-CA-C 114.211 1.189 . . . . 0.0 114.211 170.849 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 85.25 8.97 80.69 Favored Glycine 0 CA--C 1.532 1.101 0 C-N-CA 124.974 1.274 . . . . 0.0 114.056 -176.993 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -118.62 156.78 28.61 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 118.676 1.238 . . . . 0.0 112.255 174.836 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 84.0 m -75.03 147.01 41.09 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.976 1.31 . . . . 0.0 113.169 179.168 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.189 0 C-N-CA 126.104 1.811 . . . . 0.0 113.097 174.937 . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.76 0 CA-C-O 121.137 0.299 . . . . 0.0 112.54 . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 42.7 t -62.15 127.99 90.29 Favored Pre-proline 0 CA--C 1.549 0.911 0 C-N-CA 124.285 1.034 . . . . 0.0 112.408 -178.688 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_exo -61.8 154.99 57.09 Favored 'Trans proline' 0 C--N 1.354 0.841 0 C-N-CA 123.132 2.554 . . . . 0.0 112.121 174.551 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 75.4 mmt-85 -81.64 15.87 1.97 Allowed 'General case' 0 CA--C 1.546 0.795 0 N-CA-C 114.06 1.133 . . . . 0.0 114.06 -175.747 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 1.8 mp -82.12 127.35 39.7 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 125.764 1.625 . . . . 0.0 108.753 177.68 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 35.2 tp -75.32 136.32 40.85 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 123.576 0.75 . . . . 0.0 110.131 173.988 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 60.5 tpp -154.63 133.41 12.19 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.309 1.043 . . . . 0.0 110.231 -171.693 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 27.0 mmt180 -77.13 154.51 33.15 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.754 0.822 . . . . 0.0 111.948 174.691 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 28.8 p -158.23 157.52 32.76 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 113.946 1.091 . . . . 0.0 113.946 -177.509 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -113.37 -24.69 9.19 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 126.239 1.816 . . . . 0.0 110.986 168.779 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 20.9 pt20 -151.68 166.45 31.24 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 126.717 2.007 . . . . 0.0 110.402 175.3 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -61.19 -24.94 66.69 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.417 1.087 . . . . 0.0 112.886 -176.43 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.9 m -65.64 -17.82 64.87 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 125.553 1.541 . . . . 0.0 113.59 175.952 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 63.0 m-20 -81.36 -19.13 43.39 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 123.933 0.893 . . . . 0.0 112.275 173.382 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 73.7 m -88.66 165.98 14.41 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.934 1.294 . . . . 0.0 113.834 -173.339 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 26.1 mt -73.94 177.78 5.38 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 124.524 1.13 . . . . 0.0 111.399 179.0 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.82 133.36 56.02 Favored 'General case' 0 CA--C 1.539 0.552 0 O-C-N 121.268 -0.895 . . . . 0.0 112.923 -178.439 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 74.28 -8.06 14.71 Favored Glycine 0 CA--C 1.535 1.287 0 C-N-CA 124.708 1.147 . . . . 0.0 114.433 -179.53 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 61.8 m -79.38 160.54 26.65 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 118.512 1.156 . . . . 0.0 114.021 179.825 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 19.2 m -122.89 153.25 27.8 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 126.351 1.86 . . . . 0.0 110.096 168.393 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 49.9 t -87.15 102.87 14.87 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.45 0.7 . . . . 0.0 110.058 169.965 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -72.83 167.53 53.86 Favored Glycine 0 CA--C 1.543 1.831 0 C-N-CA 124.417 1.008 . . . . 0.0 114.142 -178.508 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -58.36 -26.79 78.89 Favored 'Trans proline' 0 C--N 1.354 0.818 0 C-N-CA 124.383 3.389 . . . . 0.0 114.902 -178.268 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 52.4 p-10 -69.72 -8.59 49.25 Favored 'General case' 0 CA--C 1.548 0.883 0 N-CA-C 114.685 1.365 . . . . 0.0 114.685 176.016 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 81.14 13.96 79.97 Favored Glycine 0 CA--C 1.533 1.18 0 C-N-CA 124.722 1.154 . . . . 0.0 113.903 -177.676 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -114.35 157.46 22.78 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.848 1.259 . . . . 0.0 111.531 169.955 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 81.5 m -76.55 147.79 37.49 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.858 1.263 . . . . 0.0 112.763 173.523 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.228 0 C-N-CA 125.973 1.749 . . . . 0.0 113.186 174.708 . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.727 0 CA-C-O 121.038 0.243 . . . . 0.0 112.576 . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 49.2 t -60.75 124.29 78.6 Favored Pre-proline 0 CA--C 1.549 0.91 0 C-N-CA 124.496 1.118 . . . . 0.0 112.307 -178.96 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -73.48 161.35 42.58 Favored 'Trans proline' 0 C--N 1.354 0.839 0 C-N-CA 122.9 2.4 . . . . 0.0 111.218 177.273 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -80.8 32.8 0.31 Allowed 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 124.618 1.167 . . . . 0.0 113.91 -170.999 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 45.9 mm -88.34 123.99 41.1 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 125.947 1.699 . . . . 0.0 109.769 179.673 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 42.6 tp -76.8 130.7 38.02 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 169.949 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 60.8 tpp -155.57 132.62 10.75 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.199 1.0 . . . . 0.0 110.068 -170.625 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 83.9 mtt85 -81.21 151.12 28.32 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.804 0.842 . . . . 0.0 111.343 175.771 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 29.3 p -156.14 158.17 37.21 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 114.27 1.211 . . . . 0.0 114.27 -173.284 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -119.5 -19.9 7.99 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 126.144 1.778 . . . . 0.0 111.674 169.099 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -149.61 167.86 25.18 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 126.39 1.876 . . . . 0.0 110.509 169.908 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -61.26 -25.55 67.16 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 124.362 1.065 . . . . 0.0 112.647 -178.514 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 15.7 m -65.62 -16.07 63.36 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 125.304 1.442 . . . . 0.0 113.676 175.946 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 60.3 m-20 -82.06 -18.09 44.36 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 123.888 0.875 . . . . 0.0 112.464 172.83 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 72.9 m -89.77 167.13 13.12 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.008 1.323 . . . . 0.0 113.859 -172.214 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -70.26 170.34 11.9 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 124.466 1.106 . . . . 0.0 110.843 175.862 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.84 134.7 57.28 Favored 'General case' 0 CA--C 1.538 0.512 0 O-C-N 121.221 -0.924 . . . . 0.0 112.922 -177.637 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 76.22 -9.0 21.63 Favored Glycine 0 CA--C 1.534 1.231 0 C-N-CA 124.781 1.182 . . . . 0.0 114.283 -178.711 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 60.1 m -79.87 162.55 24.96 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 118.518 1.159 . . . . 0.0 114.069 178.56 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 19.2 m -122.76 154.21 27.89 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 126.238 1.815 . . . . 0.0 110.224 168.5 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 47.2 t -85.89 102.52 13.8 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 123.579 0.752 . . . . 0.0 110.157 169.885 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -72.81 167.71 53.72 Favored Glycine 0 CA--C 1.543 1.836 0 C-N-CA 124.454 1.026 . . . . 0.0 114.218 -178.235 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -58.41 -26.87 79.59 Favored 'Trans proline' 0 C--N 1.353 0.801 0 C-N-CA 124.489 3.459 . . . . 0.0 114.969 -177.335 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 52.8 p-10 -70.34 -8.34 49.75 Favored 'General case' 0 CA--C 1.548 0.885 0 N-CA-C 114.775 1.398 . . . . 0.0 114.775 176.699 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 83.92 10.84 80.26 Favored Glycine 0 CA--C 1.533 1.21 0 C-N-CA 124.626 1.108 . . . . 0.0 114.029 -177.228 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -116.39 157.2 25.46 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.84 1.256 . . . . 0.0 112.09 172.153 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 83.1 m -76.44 147.57 37.85 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.004 1.322 . . . . 0.0 113.122 176.988 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.212 0 C-N-CA 126.013 1.768 . . . . 0.0 113.126 174.635 . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.698 0 N-CA-C 112.43 -0.268 . . . . 0.0 112.43 . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 48.5 t -62.05 130.62 92.9 Favored Pre-proline 0 CA--C 1.549 0.933 0 CA-C-O 118.048 -0.977 . . . . 0.0 112.436 -179.124 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -61.91 149.67 89.25 Favored 'Trans proline' 0 C--N 1.354 0.844 0 C-N-CA 123.191 2.594 . . . . 0.0 113.085 177.27 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 34.4 ptt-85 -83.0 10.22 8.45 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 115.593 1.701 . . . . 0.0 115.593 -172.286 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 10.1 tp -77.17 153.17 5.54 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 C-N-CA 125.424 1.49 . . . . 0.0 111.428 177.947 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 32.7 tp -82.43 134.28 35.23 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.679 0.791 . . . . 0.0 110.468 173.793 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -161.69 127.3 3.61 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.647 1.179 . . . . 0.0 110.932 -170.354 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 95.7 mtt-85 -85.81 159.58 19.69 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 125.071 1.348 . . . . 0.0 112.365 -179.375 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 28.3 p -159.58 159.14 32.88 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.663 1.185 . . . . 0.0 114.104 -177.282 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -114.2 -25.05 8.65 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 126.306 1.842 . . . . 0.0 111.081 168.767 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -151.73 168.17 25.88 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 126.547 1.939 . . . . 0.0 110.531 173.847 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -61.83 -24.76 67.09 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 124.304 1.041 . . . . 0.0 113.0 -176.465 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 6.6 m -64.57 -18.78 65.18 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 125.233 1.413 . . . . 0.0 113.529 175.444 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 62.4 m-20 -80.35 -18.94 47.61 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.001 0.92 . . . . 0.0 112.241 174.034 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 80.6 m -90.28 163.42 14.76 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 125.235 1.414 . . . . 0.0 113.656 -173.073 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 60.0 mt -76.99 -178.43 4.94 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 124.599 1.159 . . . . 0.0 111.921 179.73 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.63 134.27 56.92 Favored 'General case' 0 CA--C 1.54 0.569 0 O-C-N 121.203 -0.935 . . . . 0.0 112.868 -178.563 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 74.51 -8.42 14.08 Favored Glycine 0 CA--C 1.534 1.252 0 C-N-CA 124.749 1.166 . . . . 0.0 114.329 -178.724 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 61.6 m -81.02 159.27 24.86 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 114.184 1.179 . . . . 0.0 114.184 -178.954 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 18.2 m -125.02 153.29 32.11 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 126.472 1.909 . . . . 0.0 109.681 167.949 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 49.1 t -86.09 102.8 14.18 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 123.235 0.614 . . . . 0.0 110.237 170.646 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -70.47 166.56 50.94 Favored Glycine 0 CA--C 1.543 1.831 0 C-N-CA 124.65 1.119 . . . . 0.0 113.806 178.84 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -69.73 -18.08 37.32 Favored 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 124.135 3.223 . . . . 0.0 113.392 -176.062 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 52.7 p-10 -69.66 -9.15 53.13 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 124.897 1.279 . . . . 0.0 114.36 171.381 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 85.29 9.84 78.83 Favored Glycine 0 CA--C 1.533 1.202 0 C-N-CA 124.962 1.268 . . . . 0.0 114.227 -177.949 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -116.2 155.03 29.01 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.949 1.3 . . . . 0.0 111.879 174.147 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 82.6 m -77.07 147.14 36.85 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.272 1.029 . . . . 0.0 112.241 174.391 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.22 0 C-N-CA 125.743 1.64 . . . . 0.0 113.112 175.798 . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.714 0 N-CA-C 112.352 -0.299 . . . . 0.0 112.352 . . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 44.3 t -60.43 126.07 83.63 Favored Pre-proline 0 CA--C 1.55 0.945 0 C-N-CA 124.342 1.057 . . . . 0.0 112.279 -179.055 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -74.5 163.5 35.95 Favored 'Trans proline' 0 C--N 1.353 0.765 0 C-N-CA 122.996 2.464 . . . . 0.0 111.397 177.2 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 74.6 mtp85 -77.35 20.72 0.28 Allowed 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 125.031 1.333 . . . . 0.0 114.08 -175.242 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 48.3 mm -79.83 122.68 35.51 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 125.367 1.467 . . . . 0.0 109.874 178.749 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 42.4 tp -76.14 132.92 40.3 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.184 0.594 . . . . 0.0 109.489 170.598 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 60.3 tpp -153.33 127.52 9.11 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 124.205 1.002 . . . . 0.0 109.838 -173.307 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 59.5 ttm-85 -78.08 145.06 36.03 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.702 0.801 . . . . 0.0 110.395 177.373 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 31.3 p -153.11 159.16 42.73 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 114.411 1.263 . . . . 0.0 114.411 -171.697 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -121.2 -18.83 7.3 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 126.878 2.071 . . . . 0.0 111.49 168.895 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 19.3 pt20 -147.45 158.96 44.2 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 126.843 2.057 . . . . 0.0 110.179 177.963 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -62.86 -25.86 68.49 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.196 0.999 . . . . 0.0 112.429 -179.822 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 17.8 m -67.38 -13.46 62.04 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 124.916 1.287 . . . . 0.0 113.557 175.289 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 49.9 m-20 -81.5 -19.15 42.84 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 123.758 0.823 . . . . 0.0 112.091 172.108 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 73.9 m -88.79 167.01 13.64 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.253 1.421 . . . . 0.0 113.94 -171.302 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -70.37 170.77 11.19 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 124.444 1.098 . . . . 0.0 110.769 175.692 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.08 134.82 57.41 Favored 'General case' 0 CA--C 1.539 0.525 0 O-C-N 121.179 -0.95 . . . . 0.0 112.964 -177.348 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 76.14 -9.09 20.75 Favored Glycine 0 CA--C 1.533 1.188 0 C-N-CA 124.652 1.12 . . . . 0.0 114.378 -178.764 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 60.2 m -79.91 162.9 24.72 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 114.078 1.14 . . . . 0.0 114.078 179.079 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 18.5 m -122.73 154.33 27.88 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 126.325 1.85 . . . . 0.0 110.073 168.359 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 47.8 t -85.63 103.41 14.43 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 123.193 0.597 . . . . 0.0 110.071 169.824 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -70.83 168.16 50.11 Favored Glycine 0 CA--C 1.542 1.731 0 C-N-CA 124.841 1.21 . . . . 0.0 114.101 179.922 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -70.23 -17.9 35.13 Favored 'Trans proline' 0 C--N 1.352 0.743 0 C-N-CA 124.169 3.246 . . . . 0.0 113.5 -175.312 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 53.3 p-10 -69.38 -9.42 53.4 Favored 'General case' 0 CA--C 1.548 0.882 0 N-CA-C 114.339 1.237 . . . . 0.0 114.339 170.855 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 84.87 12.06 75.35 Favored Glycine 0 CA--C 1.532 1.141 0 C-N-CA 124.756 1.17 . . . . 0.0 114.046 -176.796 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -123.51 156.47 35.57 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.703 1.201 . . . . 0.0 112.386 174.505 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 84.1 m -75.1 147.41 40.6 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.906 1.283 . . . . 0.0 113.214 179.006 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.204 0 C-N-CA 126.058 1.789 . . . . 0.0 113.099 174.809 . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.749 0 CA-C-O 121.21 0.339 . . . . 0.0 112.547 . . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 53.3 t -65.59 133.28 95.17 Favored Pre-proline 0 CA--C 1.551 0.995 0 C-N-CA 123.928 0.891 . . . . 0.0 112.282 -178.828 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -67.45 166.7 22.82 Favored 'Trans proline' 0 C--N 1.353 0.798 0 C-N-CA 123.435 2.756 . . . . 0.0 111.909 173.05 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 4.4 mmp_? -102.23 17.4 23.48 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 125.091 1.357 . . . . 0.0 113.187 179.94 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 10.4 tp -74.57 148.44 7.99 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 C-N-CA 125.247 1.419 . . . . 0.0 111.392 176.015 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 10.6 tt -71.29 132.13 44.45 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.636 0.774 . . . . 0.0 110.044 172.974 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 58.7 tpp -154.96 130.67 9.97 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.825 1.25 . . . . 0.0 109.591 177.421 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 84.4 mtt85 -87.32 152.92 21.87 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.301 1.04 . . . . 0.0 111.497 178.297 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 29.6 p -157.0 156.03 32.26 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 114.082 1.141 . . . . 0.0 114.082 -173.236 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -112.22 -25.67 9.18 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 126.091 1.756 . . . . 0.0 110.93 168.927 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 8.3 pt20 -150.58 168.78 23.25 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 126.569 1.947 . . . . 0.0 110.522 173.621 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -61.37 -25.24 67.04 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 124.462 1.105 . . . . 0.0 112.977 -176.494 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 7.0 m -64.72 -19.19 65.63 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 125.329 1.452 . . . . 0.0 113.514 175.778 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 61.1 m-20 -81.4 -18.65 44.74 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.024 0.93 . . . . 0.0 112.39 174.657 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 74.5 m -87.72 167.31 13.96 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 125.155 1.382 . . . . 0.0 113.827 -174.43 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -72.67 176.49 5.48 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 124.487 1.115 . . . . 0.0 111.077 177.973 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.53 133.26 55.92 Favored 'General case' 0 CA--C 1.539 0.556 0 O-C-N 121.08 -1.013 . . . . 0.0 113.207 -176.784 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 74.44 -8.29 14.42 Favored Glycine 0 CA--C 1.534 1.278 0 C-N-CA 124.871 1.224 . . . . 0.0 114.461 -179.851 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 62.2 m -76.87 163.66 26.54 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 114.089 1.144 . . . . 0.0 114.089 -178.893 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 21.4 m -121.72 152.91 25.61 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 C-N-CA 125.807 1.643 . . . . 0.0 110.325 168.263 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 44.8 t -88.5 104.4 16.77 Favored 'General case' 0 CA--C 1.537 0.442 0 C-N-CA 123.513 0.725 . . . . 0.0 109.878 169.55 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -70.07 166.26 50.26 Favored Glycine 0 CA--C 1.542 1.74 0 C-N-CA 124.635 1.112 . . . . 0.0 113.825 178.951 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -69.48 -18.2 38.43 Favored 'Trans proline' 0 CA--C 1.539 0.729 0 C-N-CA 124.128 3.219 . . . . 0.0 113.284 -176.419 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 52.4 p-10 -69.37 -9.93 55.66 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 124.869 1.268 . . . . 0.0 114.396 170.942 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 85.79 10.34 76.15 Favored Glycine 0 CA--C 1.533 1.169 0 C-N-CA 124.867 1.222 . . . . 0.0 114.229 -177.653 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -117.48 156.62 27.69 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.787 1.235 . . . . 0.0 112.038 174.509 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 74.3 m -76.43 152.97 36.03 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.619 1.167 . . . . 0.0 112.999 176.352 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.272 0 CA-C-O 116.909 -2.051 . . . . 0.0 113.626 176.168 . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.695 0 N-CA-C 112.355 -0.298 . . . . 0.0 112.355 . . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 48.0 t -61.03 130.37 91.22 Favored Pre-proline 0 CA--C 1.549 0.934 0 C-N-CA 124.134 0.974 . . . . 0.0 112.4 -179.171 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -62.19 155.47 56.29 Favored 'Trans proline' 0 C--N 1.354 0.845 0 C-N-CA 123.221 2.614 . . . . 0.0 112.76 175.227 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -82.3 13.84 3.31 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 114.707 1.373 . . . . 0.0 114.707 -170.522 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 10.0 tp -83.2 140.76 15.82 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 C-N-CA 125.309 1.444 . . . . 0.0 111.464 178.641 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 40.4 tp -82.82 132.0 35.18 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.801 0.84 . . . . 0.0 109.816 172.146 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 58.0 ttm -154.45 132.46 11.66 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.3 1.04 . . . . 0.0 110.512 -171.433 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 95.8 mtt-85 -79.4 155.07 28.54 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.006 0.922 . . . . 0.0 112.057 178.813 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 28.2 p -158.32 157.76 33.04 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 124.731 1.212 . . . . 0.0 113.661 -176.099 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 30.3 mtpp -112.1 -24.97 9.58 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 125.932 1.693 . . . . 0.0 111.16 169.094 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 20.8 pt20 -152.53 166.41 32.12 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 126.553 1.941 . . . . 0.0 110.485 175.803 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -61.06 -24.96 66.6 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 124.494 1.118 . . . . 0.0 112.799 -176.41 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.8 m -65.62 -18.0 65.0 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 125.654 1.582 . . . . 0.0 113.617 175.851 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 63.2 m-20 -80.83 -20.98 41.21 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 123.888 0.875 . . . . 0.0 112.19 173.152 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 77.8 m -88.46 165.41 14.92 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 125.227 1.411 . . . . 0.0 113.514 -174.185 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 50.6 mt -75.85 178.64 6.04 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 124.374 1.07 . . . . 0.0 111.922 179.375 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.19 134.63 57.24 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 121.375 -0.828 . . . . 0.0 112.721 -179.173 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 74.61 -8.38 14.66 Favored Glycine 0 CA--C 1.533 1.185 0 C-N-CA 124.678 1.133 . . . . 0.0 114.291 -178.363 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 60.6 m -81.11 158.8 24.88 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 118.646 1.223 . . . . 0.0 113.967 179.568 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 18.6 m -123.45 151.69 28.15 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 126.17 1.788 . . . . 0.0 109.765 168.057 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 48.9 t -87.2 103.0 15.0 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.296 0.638 . . . . 0.0 109.756 169.978 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -72.17 166.86 53.43 Favored Glycine 0 CA--C 1.543 1.823 0 C-N-CA 124.281 0.943 . . . . 0.0 114.017 -178.157 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -57.86 -26.19 72.86 Favored 'Trans proline' 0 C--N 1.354 0.854 0 C-N-CA 124.448 3.432 . . . . 0.0 114.736 -179.806 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 51.9 p-10 -68.44 -9.96 52.14 Favored 'General case' 0 CA--C 1.548 0.88 0 N-CA-C 114.839 1.422 . . . . 0.0 114.839 175.314 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 83.65 13.41 75.72 Favored Glycine 0 CA--C 1.533 1.216 0 C-N-CA 124.731 1.158 . . . . 0.0 113.929 -177.372 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -117.96 154.19 32.36 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.951 1.3 . . . . 0.0 112.225 174.168 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 84.6 m -74.33 145.96 43.46 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.878 1.271 . . . . 0.0 112.382 173.933 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.21 0 C-N-CA 125.991 1.758 . . . . 0.0 113.252 175.023 . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.692 0 N-CA-C 112.486 -0.246 . . . . 0.0 112.486 . . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 41.9 t -61.21 127.09 87.55 Favored Pre-proline 0 CA--C 1.55 0.953 0 C-N-CA 124.302 1.041 . . . . 0.0 112.243 -179.252 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -72.99 161.4 43.63 Favored 'Trans proline' 0 C--N 1.354 0.818 0 C-N-CA 123.125 2.55 . . . . 0.0 111.529 177.09 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 92.3 mtm-85 -77.5 29.86 0.15 Allowed 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 125.269 1.428 . . . . 0.0 113.501 -177.597 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 96.8 mt -90.37 122.97 42.33 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 126.158 1.783 . . . . 0.0 109.048 -179.325 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 37.6 tp -75.34 132.82 41.21 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 122.972 0.509 . . . . 0.0 109.642 171.415 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 59.9 tpp -153.83 128.56 9.41 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 124.372 1.069 . . . . 0.0 109.373 -174.485 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 46.3 ttt85 -83.88 144.78 28.99 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 123.381 0.673 . . . . 0.0 110.616 178.188 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 28.3 p -149.11 158.88 44.53 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 114.26 1.208 . . . . 0.0 114.26 -169.517 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -119.03 -19.57 8.41 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 126.117 1.767 . . . . 0.0 111.641 169.187 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -150.03 167.68 26.04 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 126.328 1.851 . . . . 0.0 110.534 169.994 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -61.31 -25.34 67.06 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.419 1.088 . . . . 0.0 112.663 -178.691 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 15.6 m -65.6 -15.95 63.23 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 125.182 1.393 . . . . 0.0 113.643 175.754 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 60.7 m-20 -82.1 -17.76 45.35 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 123.935 0.894 . . . . 0.0 112.456 172.82 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 75.1 m -89.55 166.47 13.64 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.032 1.333 . . . . 0.0 113.894 -172.117 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -70.92 171.61 10.42 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 124.488 1.115 . . . . 0.0 110.787 175.805 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.24 135.33 57.7 Favored 'General case' 0 CA--C 1.54 0.581 0 O-C-N 121.201 -0.937 . . . . 0.0 112.953 -177.665 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 75.92 -9.08 19.18 Favored Glycine 0 CA--C 1.534 1.276 0 C-N-CA 124.79 1.186 . . . . 0.0 114.307 -178.844 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 59.8 m -80.15 162.78 24.54 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 114.057 1.132 . . . . 0.0 114.057 179.375 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 19.1 m -123.07 153.6 28.28 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 126.319 1.847 . . . . 0.0 110.11 168.331 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 49.2 t -84.45 102.58 12.91 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 123.398 0.679 . . . . 0.0 110.178 169.978 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -71.14 169.45 49.15 Favored Glycine 0 CA--C 1.542 1.747 0 C-N-CA 124.955 1.264 . . . . 0.0 114.335 -179.592 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -70.56 -18.98 32.85 Favored 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 124.233 3.289 . . . . 0.0 113.669 -173.987 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 53.2 p-10 -70.54 -8.06 48.53 Favored 'General case' 0 CA--C 1.548 0.897 0 N-CA-C 114.271 1.211 . . . . 0.0 114.271 170.775 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 85.13 8.96 81.12 Favored Glycine 0 CA--C 1.531 1.081 0 C-N-CA 124.916 1.246 . . . . 0.0 114.06 -176.995 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -118.55 156.77 28.55 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 118.725 1.263 . . . . 0.0 112.29 174.7 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 79.7 m -75.35 147.17 40.31 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.027 1.331 . . . . 0.0 113.223 179.036 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.181 0 C-N-CA 126.017 1.77 . . . . 0.0 113.099 174.796 . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.656 0 N-CA-C 112.391 -0.283 . . . . 0.0 112.391 . . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 41.9 t -61.47 127.71 88.87 Favored Pre-proline 0 CA--C 1.55 0.962 0 C-N-CA 124.251 1.02 . . . . 0.0 112.204 -178.999 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -70.29 155.08 64.98 Favored 'Trans proline' 0 C--N 1.355 0.895 0 C-N-CA 123.047 2.498 . . . . 0.0 111.726 176.93 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.63 5.99 5.39 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 116.148 1.907 . . . . 0.0 116.148 -172.978 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 10.0 tp -73.97 139.12 19.86 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.825 0 C-N-CA 125.263 1.425 . . . . 0.0 111.334 -179.331 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 30.6 tp -81.1 136.65 35.95 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.683 0.793 . . . . 0.0 110.176 174.729 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 61.2 tpp -158.32 134.86 9.53 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.41 1.084 . . . . 0.0 109.483 -172.575 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 55.7 mtp85 -91.69 154.47 18.97 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 119.004 0.82 . . . . 0.0 112.807 175.662 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 26.4 p -154.16 158.04 39.78 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.117 1.367 . . . . 0.0 113.665 -169.933 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -109.45 -29.74 8.28 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 125.882 1.673 . . . . 0.0 110.654 168.891 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 8.0 pt20 -147.7 169.73 19.06 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 126.485 1.914 . . . . 0.0 110.718 173.603 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -61.27 -25.93 67.43 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.473 1.109 . . . . 0.0 112.844 -176.488 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 7.4 m -64.77 -18.88 65.47 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 125.303 1.441 . . . . 0.0 113.48 175.959 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 60.1 m-20 -82.02 -18.42 43.35 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 123.964 0.906 . . . . 0.0 112.347 174.577 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 77.8 m -87.35 167.16 14.29 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.91 1.284 . . . . 0.0 113.789 -174.498 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -71.57 172.42 9.65 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 124.498 1.119 . . . . 0.0 110.943 176.907 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.01 134.64 57.24 Favored 'General case' 0 CA--C 1.539 0.534 0 O-C-N 121.256 -0.903 . . . . 0.0 113.075 -177.049 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 75.76 -9.0 18.24 Favored Glycine 0 CA--C 1.533 1.209 0 C-N-CA 124.759 1.171 . . . . 0.0 114.362 -179.065 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 60.4 m -79.27 161.49 26.28 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 114.156 1.169 . . . . 0.0 114.156 179.636 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 19.2 m -120.55 153.4 23.71 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 126.316 1.846 . . . . 0.0 109.945 168.051 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 49.7 t -88.17 104.23 16.51 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 123.468 0.707 . . . . 0.0 110.275 169.955 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -70.83 168.85 49.27 Favored Glycine 0 CA--C 1.544 1.886 0 C-N-CA 124.907 1.241 . . . . 0.0 114.105 178.371 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -70.37 -20.54 31.85 Favored 'Trans proline' 0 CA--C 1.538 0.701 0 C-N-CA 124.172 3.248 . . . . 0.0 113.647 -174.432 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 50.4 p30 -71.12 -5.25 30.19 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 124.888 1.275 . . . . 0.0 114.078 170.323 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 79.18 11.55 84.94 Favored Glycine 0 CA--C 1.53 1.023 0 C-N-CA 125.156 1.36 . . . . 0.0 113.98 -178.668 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 99.7 m-85 -107.41 155.09 20.41 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 118.656 1.228 . . . . 0.0 111.89 170.503 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 84.0 m -76.98 147.33 36.92 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 125.079 1.351 . . . . 0.0 112.544 173.18 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.176 0 C-N-CA 125.711 1.624 . . . . 0.0 113.174 174.721 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 43.7 t . . . . . 0 CA--C 1.551 0.984 0 CA-C-O 118.289 -0.862 . . . . 0.0 112.271 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -70.32 157.45 59.27 Favored 'Trans proline' 0 C--N 1.353 0.803 0 C-N-CA 123.119 2.546 . . . . 0.0 111.777 176.668 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -81.73 13.17 3.33 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 114.566 1.321 . . . . 0.0 114.566 -171.969 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 9.9 tp -80.89 141.07 15.71 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 125.566 1.547 . . . . 0.0 111.188 177.824 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 36.3 tp -79.66 139.12 37.51 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 123.687 0.795 . . . . 0.0 110.446 175.138 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 60.0 tpp -153.26 130.68 11.35 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.578 1.151 . . . . 0.0 109.67 -178.431 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 60.2 ttt180 -86.27 147.56 26.02 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.818 0.847 . . . . 0.0 110.806 179.438 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 30.2 p -154.91 161.4 41.44 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 114.517 1.303 . . . . 0.0 114.517 -169.58 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 63.2 pttt -123.4 -16.47 6.84 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 126.184 1.794 . . . . 0.0 112.012 168.469 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 8.1 pt20 -151.9 166.61 30.92 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 126.262 1.825 . . . . 0.0 110.62 171.012 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -62.3 -24.71 67.46 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 124.279 1.032 . . . . 0.0 112.977 -176.383 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.5 m -64.11 -19.2 65.1 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 125.264 1.426 . . . . 0.0 113.524 175.713 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 59.0 m-20 -79.94 -20.08 46.49 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 123.955 0.902 . . . . 0.0 112.308 174.396 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 77.6 m -88.75 165.34 14.78 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.077 1.351 . . . . 0.0 113.699 -172.411 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -72.02 172.75 9.49 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 124.567 1.147 . . . . 0.0 110.896 177.213 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.79 134.21 56.82 Favored 'General case' 0 CA--C 1.539 0.545 0 O-C-N 121.111 -0.993 . . . . 0.0 112.956 -177.33 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 75.95 -9.2 18.92 Favored Glycine 0 CA--C 1.534 1.256 0 C-N-CA 124.689 1.138 . . . . 0.0 114.323 -178.676 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 59.6 m -79.64 162.8 25.05 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 118.534 1.167 . . . . 0.0 113.976 179.038 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 19.1 m -123.61 153.27 29.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 126.332 1.853 . . . . 0.0 110.178 168.315 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 48.6 t -85.21 103.5 14.23 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 123.3 0.64 . . . . 0.0 110.006 169.898 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -70.08 168.16 47.99 Favored Glycine 0 CA--C 1.542 1.725 0 C-N-CA 124.752 1.168 . . . . 0.0 114.12 179.176 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -69.96 -18.02 36.33 Favored 'Trans proline' 0 CA--C 1.538 0.72 0 C-N-CA 124.241 3.294 . . . . 0.0 113.44 -175.166 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 53.5 p-10 -68.88 -10.81 59.07 Favored 'General case' 0 CA--C 1.548 0.874 0 N-CA-C 114.372 1.249 . . . . 0.0 114.372 170.471 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 85.52 12.8 71.81 Favored Glycine 0 CA--C 1.532 1.129 0 C-N-CA 124.83 1.205 . . . . 0.0 113.962 -176.573 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -125.08 157.4 36.38 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 118.544 1.172 . . . . 0.0 112.168 174.413 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 75.8 m -77.38 148.47 35.53 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.989 1.316 . . . . 0.0 113.386 -177.916 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.26 0 C-N-CA 126.035 1.778 . . . . 0.0 113.016 174.294 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 53.7 t . . . . . 0 CA--C 1.549 0.928 0 CA-C-O 118.47 -0.776 . . . . 0.0 112.439 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -67.03 166.9 21.38 Favored 'Trans proline' 0 C--N 1.354 0.829 0 C-N-CA 123.302 2.668 . . . . 0.0 111.946 172.674 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 4.7 mmp_? -100.63 18.47 19.15 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.968 1.307 . . . . 0.0 113.096 179.719 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 18.7 tt -69.33 141.91 16.72 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 C-N-CA 125.009 1.324 . . . . 0.0 111.001 172.62 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 33.3 tp -79.34 129.94 34.95 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 123.265 0.626 . . . . 0.0 109.705 173.358 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 60.7 tpp -153.56 131.02 11.36 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.383 1.073 . . . . 0.0 110.196 -173.919 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -80.97 153.96 27.2 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 123.998 0.919 . . . . 0.0 111.776 177.861 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 28.7 p -158.32 156.0 29.8 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 124.408 1.083 . . . . 0.0 113.792 -175.977 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -111.17 -26.34 9.25 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 125.885 1.674 . . . . 0.0 111.002 168.984 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 8.0 pt20 -150.61 169.48 21.47 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 126.629 1.972 . . . . 0.0 110.453 173.465 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -61.39 -25.43 67.18 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 124.479 1.112 . . . . 0.0 112.875 -176.426 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 7.3 m -64.96 -18.93 65.69 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.288 1.435 . . . . 0.0 113.566 175.896 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 59.8 m-20 -81.83 -18.8 42.69 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 123.929 0.892 . . . . 0.0 112.35 174.526 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 75.1 m -86.88 167.57 14.21 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.114 1.365 . . . . 0.0 113.692 -175.125 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -72.24 175.36 6.15 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 124.527 1.131 . . . . 0.0 111.028 177.507 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.39 133.14 55.8 Favored 'General case' 0 CA--C 1.54 0.562 0 O-C-N 121.079 -1.013 . . . . 0.0 113.2 -176.107 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 74.45 -8.2 14.88 Favored Glycine 0 CA--C 1.534 1.243 0 C-N-CA 124.815 1.198 . . . . 0.0 114.529 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 61.5 m -76.55 163.8 26.55 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 114.009 1.115 . . . . 0.0 114.009 -179.25 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 21.6 m -121.68 152.17 25.33 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 125.681 1.593 . . . . 0.0 110.534 168.575 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 47.6 t -89.12 103.89 16.48 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 123.772 0.829 . . . . 0.0 109.811 169.55 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -71.94 166.55 53.33 Favored Glycine 0 CA--C 1.544 1.881 0 C-N-CA 124.333 0.968 . . . . 0.0 114.059 -178.609 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -58.12 -26.32 75.26 Favored 'Trans proline' 0 C--N 1.353 0.771 0 C-N-CA 124.407 3.404 . . . . 0.0 114.782 -178.875 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 52.5 p-10 -68.97 -9.87 54.41 Favored 'General case' 0 CA--C 1.549 0.907 0 N-CA-C 114.764 1.394 . . . . 0.0 114.764 175.792 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 83.62 13.59 75.38 Favored Glycine 0 CA--C 1.534 1.234 0 C-N-CA 124.633 1.111 . . . . 0.0 113.965 -176.826 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -118.75 155.61 30.81 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.9 1.28 . . . . 0.0 112.097 173.333 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 70.2 m -76.22 153.11 36.32 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.804 1.242 . . . . 0.0 113.134 177.276 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.219 0 CA-C-O 116.861 -2.077 . . . . 0.0 113.566 175.683 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 48.9 t . . . . . 0 CA--C 1.549 0.913 0 CA-C-O 118.424 -0.798 . . . . 0.0 112.34 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -66.62 151.2 83.25 Favored 'Trans proline' 0 C--N 1.353 0.773 0 C-N-CA 122.616 2.211 . . . . 0.0 111.125 174.526 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 71.7 mmt-85 -81.95 44.79 0.86 Allowed 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 124.89 1.276 . . . . 0.0 113.109 -171.554 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 1.2 pp -79.87 168.04 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 126.004 1.721 . . . . 0.0 113.177 177.002 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 38.0 tp -118.85 66.08 0.77 Allowed 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.723 1.609 . . . . 0.0 108.139 169.569 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 63.3 tpp -94.48 126.62 39.87 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 125.095 1.358 . . . . 0.0 109.745 -172.336 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 95.5 mtt-85 -72.33 149.54 44.32 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 118.752 0.706 . . . . 0.0 111.862 178.919 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 30.0 p -154.82 157.78 38.43 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 124.278 1.031 . . . . 0.0 113.728 -176.009 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 59.5 mtmt -119.05 -20.01 8.23 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.936 1.694 . . . . 0.0 111.901 169.422 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -150.48 167.94 25.66 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 126.4 1.88 . . . . 0.0 110.506 169.853 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -61.31 -25.45 67.13 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.363 1.065 . . . . 0.0 112.668 -178.753 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 15.5 m -65.88 -15.98 63.42 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.279 1.432 . . . . 0.0 113.702 175.666 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 60.6 m-20 -81.55 -18.05 46.27 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 123.792 0.837 . . . . 0.0 112.422 172.349 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 72.2 m -91.04 165.37 13.56 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.813 1.245 . . . . 0.0 114.106 -171.448 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -73.53 174.88 7.62 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 125.211 1.405 . . . . 0.0 111.043 178.733 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.43 133.58 56.22 Favored 'General case' 0 CA--C 1.539 0.542 0 O-C-N 121.096 -1.003 . . . . 0.0 113.125 -177.355 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 75.13 -8.89 14.27 Favored Glycine 0 CA--C 1.534 1.248 0 C-N-CA 124.808 1.194 . . . . 0.0 114.329 -179.031 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 61.6 m -79.11 161.25 26.63 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 114.139 1.162 . . . . 0.0 114.139 -179.712 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 18.8 m -123.32 152.86 28.48 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 C-N-CA 126.337 1.855 . . . . 0.0 109.796 167.974 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 48.5 t -84.93 102.13 12.89 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.243 0.617 . . . . 0.0 110.16 170.21 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -71.77 168.24 51.74 Favored Glycine 0 CA--C 1.541 1.705 0 C-N-CA 124.774 1.178 . . . . 0.0 114.208 -179.251 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -70.09 -17.79 35.86 Favored 'Trans proline' 0 CA--C 1.539 0.736 0 C-N-CA 124.208 3.272 . . . . 0.0 113.479 -176.024 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 52.9 p-10 -69.38 -9.39 53.26 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 124.746 1.218 . . . . 0.0 114.286 171.087 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 86.24 8.67 77.85 Favored Glycine 0 CA--C 1.533 1.2 0 C-N-CA 125.11 1.338 . . . . 0.0 114.309 -177.82 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 75.0 m-85 -119.38 158.53 25.97 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 122.487 1.137 . . . . 0.0 112.317 174.573 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 68.2 m -73.52 147.39 44.07 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.094 1.358 . . . . 0.0 112.797 174.721 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.191 0 C-N-CA 125.934 1.731 . . . . 0.0 113.041 174.808 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 49.2 t . . . . . 0 CA--C 1.549 0.914 0 CA-C-O 118.431 -0.795 . . . . 0.0 112.797 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_exo -55.8 142.9 82.91 Favored 'Trans proline' 0 C--N 1.353 0.804 0 C-N-CA 123.637 2.891 . . . . 0.0 112.069 170.767 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 69.3 mmt-85 -81.04 16.19 1.6 Allowed 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 114.115 1.154 . . . . 0.0 114.115 -174.327 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 17.8 tt -73.87 142.94 14.19 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 125.637 1.575 . . . . 0.0 111.317 176.318 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 37.9 tp -80.6 132.42 35.63 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.342 0.657 . . . . 0.0 109.92 172.396 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 60.9 tpp -152.58 126.06 8.78 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 124.344 1.058 . . . . 0.0 109.932 -175.904 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 1.9 tmt_? -84.72 135.78 34.0 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.971 0.908 . . . . 0.0 109.714 178.658 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 26.3 p -136.85 164.27 28.7 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 125.268 1.427 . . . . 0.0 113.144 -172.767 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -119.97 -25.96 5.69 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 125.993 1.717 . . . . 0.0 111.11 169.247 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -145.88 169.08 19.29 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 126.36 1.864 . . . . 0.0 110.411 169.74 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -60.98 -25.72 67.06 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.393 1.077 . . . . 0.0 112.685 -178.45 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 15.6 m -65.68 -16.27 63.59 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 125.227 1.411 . . . . 0.0 113.669 175.704 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 55.9 m-20 -82.91 -17.91 42.02 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 123.917 0.887 . . . . 0.0 112.386 172.751 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 72.0 m -88.48 165.59 14.78 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.858 1.263 . . . . 0.0 113.649 -174.202 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -72.47 174.08 7.92 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 124.84 1.256 . . . . 0.0 111.08 177.997 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.25 133.27 55.95 Favored 'General case' 0 CA--C 1.539 0.538 0 O-C-N 121.201 -0.937 . . . . 0.0 113.156 -176.427 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 74.93 -8.52 15.19 Favored Glycine 0 CA--C 1.535 1.305 0 C-N-CA 124.691 1.138 . . . . 0.0 114.413 -179.106 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 61.3 m -79.29 161.74 26.09 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 118.466 1.133 . . . . 0.0 113.987 179.59 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 19.1 m -122.56 153.72 27.36 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 126.336 1.854 . . . . 0.0 110.19 168.605 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 48.3 t -86.33 102.26 13.84 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 123.61 0.764 . . . . 0.0 109.998 169.996 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -72.62 167.9 53.33 Favored Glycine 0 CA--C 1.542 1.767 0 C-N-CA 124.368 0.985 . . . . 0.0 114.3 -177.262 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_exo -58.27 -26.96 79.1 Favored 'Trans proline' 0 C--N 1.354 0.858 0 C-N-CA 124.499 3.466 . . . . 0.0 114.989 -177.578 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 53.0 p-10 -69.51 -9.55 54.31 Favored 'General case' 0 CA--C 1.546 0.791 0 N-CA-C 114.7 1.37 . . . . 0.0 114.7 175.952 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 85.95 10.08 76.15 Favored Glycine 0 CA--C 1.531 1.087 0 C-N-CA 124.772 1.177 . . . . 0.0 114.006 -176.973 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -119.96 156.55 30.61 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.68 1.192 . . . . 0.0 112.152 174.747 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 78.7 m -75.2 148.26 39.69 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.663 1.185 . . . . 0.0 113.243 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.115 0 C-N-CA 126.012 1.767 . . . . 0.0 113.067 174.573 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 47.8 t . . . . . 0 CA--C 1.548 0.904 0 CA-C-O 118.316 -0.849 . . . . 0.0 112.472 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -64.81 147.48 89.58 Favored 'Trans proline' 0 C--N 1.354 0.821 0 C-N-CA 123.153 2.569 . . . . 0.0 111.384 171.766 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 6.0 tpm_? -81.71 54.45 2.41 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-O 122.206 1.003 . . . . 0.0 111.815 178.807 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 19.3 tt -81.07 151.91 4.36 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 C-N-CA 125.729 1.612 . . . . 0.0 111.105 173.967 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 39.7 tp -95.37 73.44 3.29 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.817 0.847 . . . . 0.0 108.721 169.44 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 60.0 tpp -102.54 116.09 31.9 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.627 1.171 . . . . 0.0 109.363 -176.453 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 61.0 ttt180 -77.82 143.6 37.73 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 123.325 0.65 . . . . 0.0 110.52 178.466 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 30.3 p -150.02 158.31 44.03 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 114.158 1.17 . . . . 0.0 114.158 -169.775 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 59.2 mtmt -119.63 -19.35 8.12 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 126.699 2.0 . . . . 0.0 111.57 169.307 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 19.3 pt20 -148.61 159.06 44.45 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 126.62 1.968 . . . . 0.0 110.246 179.332 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -63.08 -25.53 68.41 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.094 0.958 . . . . 0.0 112.387 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 17.8 m -67.67 -13.41 62.07 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.897 1.279 . . . . 0.0 113.566 175.069 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 51.5 m-20 -80.91 -19.4 44.39 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 123.81 0.844 . . . . 0.0 111.952 171.468 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 79.0 m -90.66 165.43 13.72 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 125.52 1.528 . . . . 0.0 113.763 -172.775 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 34.6 mt -76.33 -178.55 4.62 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.357 1.063 . . . . 0.0 111.88 179.635 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.63 134.28 56.93 Favored 'General case' 0 CA--C 1.539 0.527 0 O-C-N 121.253 -0.904 . . . . 0.0 112.96 -179.611 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 74.41 -8.46 13.52 Favored Glycine 0 CA--C 1.534 1.255 0 C-N-CA 124.775 1.179 . . . . 0.0 114.281 -178.528 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 63.9 m -81.76 159.62 23.79 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 114.288 1.218 . . . . 0.0 114.288 -178.322 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 18.0 m -124.52 154.98 32.29 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 126.774 2.03 . . . . 0.0 109.634 167.937 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 48.2 t -84.05 102.26 12.37 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 121.341 0.591 . . . . 0.0 110.188 169.953 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -71.72 169.03 50.92 Favored Glycine 0 CA--C 1.542 1.763 0 C-N-CA 124.987 1.28 . . . . 0.0 114.379 -178.383 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -70.74 -18.41 32.45 Favored 'Trans proline' 0 CA--C 1.537 0.672 0 C-N-CA 124.262 3.308 . . . . 0.0 113.67 -174.202 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 52.6 p-10 -69.68 -10.04 56.69 Favored 'General case' 0 CA--C 1.548 0.899 0 N-CA-C 114.192 1.182 . . . . 0.0 114.192 171.21 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 87.5 8.54 73.9 Favored Glycine 0 CA--C 1.533 1.178 0 C-N-CA 124.952 1.263 . . . . 0.0 114.208 -177.139 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 76.9 m-85 -122.58 159.84 26.95 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 118.69 1.245 . . . . 0.0 111.779 173.573 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 77.5 m -70.7 153.79 42.47 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.262 1.025 . . . . 0.0 113.215 179.263 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.154 0 C-N-CA 126.035 1.778 . . . . 0.0 113.165 175.973 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 40.5 t . . . . . 0 CA--C 1.546 0.801 0 CA-C-O 117.9 -1.048 . . . . 0.0 112.539 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -68.65 146.07 65.81 Favored 'Trans proline' 0 C--N 1.353 0.765 0 C-N-CA 123.017 2.478 . . . . 0.0 110.633 175.421 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 15.8 mmm180 -83.83 16.13 2.94 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 113.782 1.03 . . . . 0.0 113.782 -171.034 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 10.0 tp -68.19 141.66 17.34 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 125.489 1.516 . . . . 0.0 111.341 177.959 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 30.9 tp -75.9 131.99 40.0 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 123.359 0.663 . . . . 0.0 110.152 175.877 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 61.1 tpp -155.48 132.77 10.93 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.827 1.251 . . . . 0.0 109.851 -174.791 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 87.4 mtm180 -81.16 152.68 27.63 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.923 0.889 . . . . 0.0 111.603 177.746 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 29.4 p -157.38 155.29 30.29 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 113.961 1.097 . . . . 0.0 113.961 -175.865 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 64.8 tttm -110.53 -28.68 8.4 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 126.023 1.729 . . . . 0.0 110.726 168.967 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 8.1 pt20 -147.84 169.75 19.11 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 126.426 1.89 . . . . 0.0 110.601 172.541 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -61.35 -25.33 67.08 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 124.6 1.16 . . . . 0.0 112.918 -176.528 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 8.0 m -65.25 -18.59 65.43 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 125.157 1.383 . . . . 0.0 113.627 175.686 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 60.4 m-20 -81.73 -18.52 44.03 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 123.928 0.891 . . . . 0.0 112.368 174.398 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 73.6 m -86.9 168.02 13.79 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.118 1.367 . . . . 0.0 113.648 -175.579 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -71.17 173.72 7.3 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 124.415 1.086 . . . . 0.0 110.919 176.863 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.0 132.89 55.36 Favored 'General case' 0 CA--C 1.54 0.581 0 O-C-N 121.16 -0.962 . . . . 0.0 113.213 -175.949 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 74.42 -8.45 13.59 Favored Glycine 0 CA--C 1.534 1.247 0 C-N-CA 124.829 1.204 . . . . 0.0 114.512 -179.599 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 66.7 m -75.29 162.59 28.3 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 118.5 1.15 . . . . 0.0 113.915 -179.6 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 23.3 m -118.84 151.47 21.04 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 125.319 1.448 . . . . 0.0 110.816 168.697 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 43.7 t -89.38 104.76 17.29 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 123.725 0.81 . . . . 0.0 109.783 169.439 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -70.24 166.97 49.97 Favored Glycine 0 CA--C 1.543 1.81 0 C-N-CA 124.563 1.078 . . . . 0.0 113.842 179.043 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -69.43 -18.14 38.71 Favored 'Trans proline' 0 CA--C 1.539 0.76 0 C-N-CA 124.046 3.164 . . . . 0.0 113.357 -176.499 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 51.3 p-10 -69.22 -9.96 55.49 Favored 'General case' 0 CA--C 1.549 0.933 0 N-CA-C 114.414 1.265 . . . . 0.0 114.414 170.609 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 84.7 12.7 74.36 Favored Glycine 0 CA--C 1.533 1.218 0 C-N-CA 124.838 1.209 . . . . 0.0 114.096 -176.942 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -119.6 155.35 32.43 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.773 1.229 . . . . 0.0 112.403 175.02 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 69.7 m -76.75 154.92 33.61 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.941 1.297 . . . . 0.0 113.319 177.359 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.309 0 C-N-CA 125.711 1.624 . . . . 0.0 113.779 175.072 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 52.9 t . . . . . 0 CA--C 1.55 0.966 0 CA-C-O 118.501 -0.761 . . . . 0.0 112.306 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -71.83 147.99 51.21 Favored 'Trans proline' 0 C--N 1.353 0.811 0 C-N-CA 123.279 2.653 . . . . 0.0 111.16 173.695 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -84.53 17.76 2.55 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 114.166 1.173 . . . . 0.0 114.166 -172.859 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 8.9 tp -69.81 138.62 21.73 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 125.065 1.346 . . . . 0.0 111.118 175.345 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 31.5 tp -78.94 115.41 18.61 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 123.441 0.696 . . . . 0.0 109.882 177.141 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 81.6 mmm -137.17 126.09 24.21 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 125.672 1.589 . . . . 0.0 108.929 -177.468 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 25.4 ttt85 -86.77 144.99 26.81 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 118.632 0.651 . . . . 0.0 111.297 -179.443 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 24.5 p -146.66 160.56 42.04 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 125.502 1.521 . . . . 0.0 113.544 -169.205 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 61.4 mtpt -112.21 -24.72 9.68 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 125.845 1.658 . . . . 0.0 111.373 169.231 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 20.9 pt20 -152.71 166.63 31.55 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 126.397 1.879 . . . . 0.0 110.599 176.569 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -61.16 -25.07 66.76 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 124.257 1.023 . . . . 0.0 112.811 -176.318 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.8 m -65.54 -18.01 65.0 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 125.662 1.585 . . . . 0.0 113.573 176.016 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 63.0 m-20 -81.42 -19.14 43.13 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 123.991 0.917 . . . . 0.0 112.228 173.317 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 75.8 m -89.22 167.34 13.16 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.211 1.404 . . . . 0.0 113.621 -174.474 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.469 HD22 ' H ' ' A' ' 16' ' ' LEU . 0.9 OUTLIER -74.86 177.98 5.86 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 124.373 1.069 . . . . 0.0 111.206 179.623 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.47 133.7 56.34 Favored 'General case' 0 CA--C 1.539 0.547 0 O-C-N 121.186 -0.946 . . . . 0.0 112.923 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 74.77 -9.41 11.18 Favored Glycine 0 CA--C 1.533 1.186 0 C-N-CA 124.81 1.195 . . . . 0.0 114.399 -179.104 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 64.0 m -79.48 161.53 26.0 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 118.555 1.177 . . . . 0.0 113.969 -179.417 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 18.7 m -124.2 153.36 30.49 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 C-N-CA 126.313 1.845 . . . . 0.0 110.147 168.186 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 45.0 t -85.67 102.97 14.06 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.371 0.669 . . . . 0.0 109.8 169.835 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -71.53 172.16 45.82 Favored Glycine 0 CA--C 1.542 1.764 0 C-N-CA 125.133 1.349 . . . . 0.0 114.602 -177.948 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -70.37 -21.23 30.92 Favored 'Trans proline' 0 CA--C 1.538 0.712 0 C-N-CA 124.28 3.32 . . . . 0.0 113.604 -173.728 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 51.0 p-10 -70.95 -7.04 43.24 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 124.718 1.207 . . . . 0.0 113.97 169.99 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 83.72 8.46 84.48 Favored Glycine 0 CA--C 1.53 1.029 0 C-N-CA 125.389 1.471 . . . . 0.0 114.056 -177.567 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -112.18 155.82 23.32 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 119.195 1.498 . . . . 0.0 112.337 176.139 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 81.1 m -73.88 146.0 44.39 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.452 1.101 . . . . 0.0 112.8 176.935 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.189 0 C-N-CA 125.972 1.749 . . . . 0.0 113.11 174.927 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 45.5 t . . . . . 0 CA--C 1.549 0.91 0 CA-C-O 118.278 -0.868 . . . . 0.0 112.187 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -71.62 160.97 46.77 Favored 'Trans proline' 0 C--N 1.354 0.858 0 C-N-CA 123.106 2.537 . . . . 0.0 111.701 178.029 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 52.4 ttp180 -78.89 60.42 2.85 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 125.002 1.321 . . . . 0.0 111.474 -179.395 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 88.0 mt -125.52 122.47 62.6 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 126.551 1.941 . . . . 0.0 108.764 -177.356 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 40.3 tp -79.75 134.42 36.37 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.509 0.723 . . . . 0.0 109.544 170.928 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 59.4 tpp -157.45 135.17 10.68 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.231 1.012 . . . . 0.0 110.022 -170.813 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 27.6 mmt180 -77.3 153.56 33.76 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.633 0.773 . . . . 0.0 111.833 174.284 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 29.7 p -157.7 159.85 37.33 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 114.17 1.174 . . . . 0.0 114.17 -177.119 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 17.3 tppt? -118.34 -24.82 6.75 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 126.233 1.813 . . . . 0.0 111.036 169.026 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -148.73 170.19 18.75 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 126.26 1.824 . . . . 0.0 111.022 169.969 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -63.57 -25.44 68.24 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 124.85 1.26 . . . . 0.0 113.49 -173.722 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 77.7 p -73.09 -10.55 59.91 Favored 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 113.817 1.043 . . . . 0.0 113.817 175.945 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 62.8 m-20 -80.07 -20.91 44.06 Favored 'General case' 0 CA--C 1.543 0.708 0 O-C-N 121.336 -0.853 . . . . 0.0 111.601 169.241 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 71.5 m -85.88 167.28 15.28 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.242 1.417 . . . . 0.0 113.863 -174.808 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -70.23 170.35 11.84 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 124.21 1.004 . . . . 0.0 110.702 175.999 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.16 135.3 57.68 Favored 'General case' 0 CA--C 1.539 0.52 0 O-C-N 121.202 -0.936 . . . . 0.0 112.87 -177.951 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 76.2 -8.84 22.39 Favored Glycine 0 CA--C 1.534 1.248 0 C-N-CA 124.712 1.149 . . . . 0.0 114.352 -178.621 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 59.3 m -80.13 162.69 24.61 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 118.472 1.136 . . . . 0.0 113.988 178.401 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 19.4 m -121.28 154.13 25.04 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 126.206 1.802 . . . . 0.0 110.146 168.287 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 49.4 t -87.66 103.79 15.91 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 123.462 0.705 . . . . 0.0 110.178 169.919 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -70.6 167.68 50.04 Favored Glycine 0 CA--C 1.543 1.784 0 C-N-CA 124.714 1.15 . . . . 0.0 114.05 178.736 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -69.99 -18.77 35.74 Favored 'Trans proline' 0 CA--C 1.538 0.701 0 C-N-CA 124.12 3.213 . . . . 0.0 113.564 -175.127 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 52.6 p-10 -70.59 -8.04 48.58 Favored 'General case' 0 CA--C 1.548 0.899 0 N-CA-C 114.323 1.231 . . . . 0.0 114.323 171.17 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 81.93 12.37 81.28 Favored Glycine 0 CA--C 1.533 1.17 0 C-N-CA 124.893 1.235 . . . . 0.0 113.994 -177.759 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -113.79 157.93 21.64 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.848 1.259 . . . . 0.0 111.76 170.501 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 77.7 m -77.28 149.56 35.37 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.21 1.404 . . . . 0.0 113.088 174.369 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.298 0 C-N-CA 125.947 1.736 . . . . 0.0 113.153 173.972 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 36.3 t . . . . . 0 CA--C 1.547 0.844 0 CA-C-O 118.163 -0.922 . . . . 0.0 112.461 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -66.77 151.21 82.92 Favored 'Trans proline' 0 C--N 1.353 0.797 0 C-N-CA 123.203 2.602 . . . . 0.0 111.845 178.685 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 6.7 mmp_? -82.54 14.36 3.13 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 124.77 1.228 . . . . 0.0 114.058 -177.083 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 10.2 tp -71.78 142.74 15.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 C-N-CA 125.302 1.441 . . . . 0.0 111.223 177.822 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 26.9 tp -76.93 131.98 38.82 Favored 'General case' 0 CA--C 1.538 0.485 0 O-C-N 121.791 -0.568 . . . . 0.0 110.15 175.357 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 61.2 tpp -154.47 126.47 7.72 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 125.056 1.342 . . . . 0.0 108.773 -178.319 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 25.9 ttt85 -88.93 146.64 24.79 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 118.392 0.542 . . . . 0.0 111.259 -178.909 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 26.2 p -150.84 160.08 44.12 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.269 1.427 . . . . 0.0 113.685 -169.091 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 61.7 mtpt -116.67 -20.79 9.4 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 126.35 1.86 . . . . 0.0 111.301 169.03 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 19.5 pt20 -147.8 160.29 42.91 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 126.941 2.097 . . . . 0.0 110.201 177.493 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -62.23 -26.03 68.14 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 124.25 1.02 . . . . 0.0 112.439 -179.779 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 17.0 m -67.85 -13.85 62.48 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 124.881 1.272 . . . . 0.0 113.664 175.544 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 48.3 m-20 -82.32 -19.69 38.88 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.747 0.819 . . . . 0.0 112.117 172.523 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 81.7 m -85.86 168.88 13.84 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.308 1.443 . . . . 0.0 113.83 -173.591 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -71.64 175.65 5.46 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 124.468 1.107 . . . . 0.0 111.049 176.822 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.29 133.0 55.68 Favored 'General case' 0 CA--C 1.54 0.566 0 O-C-N 121.064 -1.023 . . . . 0.0 113.338 -176.044 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 74.02 -8.3 12.57 Favored Glycine 0 CA--C 1.535 1.288 0 C-N-CA 124.891 1.234 . . . . 0.0 114.559 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 66.4 m -75.78 162.52 28.11 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 114.238 1.199 . . . . 0.0 114.238 -178.074 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 20.3 m -120.57 151.25 23.39 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 125.579 1.551 . . . . 0.0 110.493 168.298 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 49.4 t -87.09 103.64 15.57 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 123.586 0.754 . . . . 0.0 109.8 169.727 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -71.74 171.7 47.1 Favored Glycine 0 CA--C 1.543 1.827 0 C-N-CA 125.063 1.316 . . . . 0.0 114.446 -178.48 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -70.43 -21.04 30.92 Favored 'Trans proline' 0 CA--C 1.539 0.733 0 C-N-CA 124.262 3.308 . . . . 0.0 113.634 -173.872 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 50.7 p-10 -70.69 -7.04 41.66 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 124.749 1.22 . . . . 0.0 113.987 169.883 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.86 10.35 83.17 Favored Glycine 0 CA--C 1.529 0.946 0 C-N-CA 125.24 1.4 . . . . 0.0 113.866 -177.048 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -113.52 154.24 27.41 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 119.374 1.587 . . . . 0.0 112.444 175.659 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 69.9 m -74.76 151.18 39.16 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.969 1.308 . . . . 0.0 113.063 177.628 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.353 0 C-N-CA 125.647 1.594 . . . . 0.0 113.864 175.132 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 42.0 t . . . . . 0 CA--C 1.55 0.952 0 CA-C-O 118.295 -0.86 . . . . 0.0 112.244 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -71.35 163.33 39.47 Favored 'Trans proline' 0 C--N 1.353 0.792 0 C-N-CA 123.315 2.677 . . . . 0.0 111.865 176.327 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 18.5 ptp180 -72.94 16.3 0.16 Allowed 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 115.175 1.546 . . . . 0.0 115.175 -176.853 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 89.4 mt -80.36 119.94 30.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 125.768 1.627 . . . . 0.0 109.656 -176.741 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 36.9 tp -81.88 132.32 35.27 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.729 0.812 . . . . 0.0 109.652 170.992 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 59.9 ttm -160.97 136.21 7.74 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.664 1.185 . . . . 0.0 109.598 -171.433 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 56.8 mtp85 -84.89 152.26 23.69 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 118.876 0.762 . . . . 0.0 112.556 175.944 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 24.9 p -151.32 156.83 41.59 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.206 1.402 . . . . 0.0 113.672 -169.949 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 28.4 ttpp -102.37 -29.63 11.53 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 126.205 1.802 . . . . 0.0 110.539 168.838 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 20.1 pt20 -155.94 166.7 32.7 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 126.364 1.866 . . . . 0.0 110.648 -177.484 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -60.89 -25.69 66.89 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 124.303 1.041 . . . . 0.0 112.647 -176.643 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.4 m -64.14 -18.84 64.83 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 125.834 1.654 . . . . 0.0 113.576 176.168 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 63.2 m-20 -81.48 -22.15 38.23 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.004 0.921 . . . . 0.0 112.387 174.591 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 73.0 m -86.32 167.34 14.87 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.059 1.344 . . . . 0.0 113.844 -171.297 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.413 HD22 ' H ' ' A' ' 16' ' ' LEU . 1.8 mm? -70.81 172.37 8.96 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 124.261 1.024 . . . . 0.0 111.048 176.389 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.07 135.88 57.85 Favored 'General case' 0 CA--C 1.539 0.537 0 O-C-N 121.273 -0.892 . . . . 0.0 112.88 -179.188 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 75.75 -9.25 17.37 Favored Glycine 0 CA--C 1.533 1.207 0 C-N-CA 124.776 1.179 . . . . 0.0 114.265 -178.554 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 59.6 m -80.78 161.63 24.43 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 118.652 1.226 . . . . 0.0 114.023 179.479 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 18.7 m -123.27 153.2 28.52 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 C-N-CA 126.272 1.829 . . . . 0.0 110.091 168.383 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 49.1 t -87.57 103.7 15.8 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 123.386 0.675 . . . . 0.0 109.871 169.764 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -71.5 170.4 48.45 Favored Glycine 0 CA--C 1.542 1.743 0 C-N-CA 124.884 1.23 . . . . 0.0 114.197 -179.288 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -69.67 -20.56 35.11 Favored 'Trans proline' 0 CA--C 1.538 0.71 0 C-N-CA 124.247 3.298 . . . . 0.0 113.453 -175.817 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 49.3 p30 -70.31 -6.8 37.71 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 125.014 1.326 . . . . 0.0 114.053 169.924 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 79.9 12.64 83.22 Favored Glycine 0 CA--C 1.531 1.033 0 C-N-CA 125.188 1.375 . . . . 0.0 114.066 -178.408 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -109.05 153.56 23.47 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 118.613 1.207 . . . . 0.0 112.239 172.218 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 78.2 m -73.17 145.2 46.5 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.883 1.273 . . . . 0.0 112.238 170.013 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.238 0 C-N-CA 125.95 1.738 . . . . 0.0 113.207 175.813 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 51.6 t . . . . . 0 CA--C 1.549 0.937 0 CA-C-O 118.363 -0.827 . . . . 0.0 112.645 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_exo -57.71 145.87 87.87 Favored 'Trans proline' 0 C--N 1.354 0.858 0 C-N-CA 123.83 3.02 . . . . 0.0 112.645 171.815 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 34.0 ptt-85 -79.99 12.61 2.66 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 115.358 1.614 . . . . 0.0 115.358 -173.617 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 10.2 tp -75.11 142.21 14.88 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 125.223 1.409 . . . . 0.0 111.484 178.659 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 30.4 tp -81.04 133.82 35.55 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 123.577 0.751 . . . . 0.0 109.988 173.725 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 61.5 tpp -158.6 133.51 8.33 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.458 1.103 . . . . 0.0 109.516 -172.478 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 55.6 mtp85 -91.31 154.64 19.09 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 118.955 0.798 . . . . 0.0 112.879 175.954 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 26.4 p -154.88 159.25 40.36 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.196 1.398 . . . . 0.0 113.83 -169.798 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 65.0 mttp -111.63 -26.05 9.22 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 125.991 1.717 . . . . 0.0 111.028 168.804 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 21.0 pt20 -150.97 166.99 28.97 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 126.565 1.946 . . . . 0.0 110.513 175.503 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -60.76 -25.9 66.84 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 124.524 1.13 . . . . 0.0 112.73 -176.043 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.9 m -65.41 -18.1 65.05 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 125.653 1.581 . . . . 0.0 113.61 176.31 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 62.2 m-20 -82.0 -19.26 40.87 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 123.971 0.909 . . . . 0.0 112.327 173.806 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 75.0 m -87.02 167.08 14.55 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.921 1.289 . . . . 0.0 113.903 -173.498 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -71.34 172.99 8.4 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 124.741 1.217 . . . . 0.0 110.925 177.181 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.24 133.36 56.03 Favored 'General case' 0 CA--C 1.539 0.543 0 O-C-N 121.195 -0.94 . . . . 0.0 113.162 -175.908 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 74.83 -8.54 14.72 Favored Glycine 0 CA--C 1.534 1.267 0 C-N-CA 124.657 1.122 . . . . 0.0 114.45 -179.464 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 61.2 m -78.65 160.99 27.25 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 114.067 1.136 . . . . 0.0 114.067 179.798 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 18.8 m -120.24 154.54 23.35 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 126.258 1.823 . . . . 0.0 110.205 168.447 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 43.3 t -88.17 104.13 16.41 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 123.618 0.767 . . . . 0.0 110.28 170.019 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -70.72 169.15 48.51 Favored Glycine 0 CA--C 1.543 1.802 0 C-N-CA 124.911 1.243 . . . . 0.0 114.179 178.454 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -70.52 -20.67 30.97 Favored 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 124.228 3.285 . . . . 0.0 113.695 -174.137 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 50.5 p30 -71.35 -5.15 30.3 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 124.952 1.301 . . . . 0.0 114.058 170.397 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 79.28 11.17 85.28 Favored Glycine 0 CA--C 1.53 1.027 0 C-N-CA 125.12 1.343 . . . . 0.0 114.007 -178.636 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -106.99 155.05 20.21 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 118.652 1.226 . . . . 0.0 111.885 170.548 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 83.3 m -76.23 147.37 38.39 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.983 1.313 . . . . 0.0 112.606 173.272 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.181 0 C-N-CA 125.815 1.674 . . . . 0.0 113.279 175.26 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 45.9 t . . . . . 0 CA--C 1.551 0.995 0 CA-C-O 118.326 -0.845 . . . . 0.0 112.586 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -56.77 146.18 79.08 Favored 'Trans proline' 0 C--N 1.354 0.866 0 C-N-CA 123.947 3.098 . . . . 0.0 112.872 172.059 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 82.1 mtp180 -84.72 14.1 5.07 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 114.404 1.261 . . . . 0.0 114.404 -172.112 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 10.2 tp -77.63 143.4 12.89 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 C-N-CA 125.176 1.39 . . . . 0.0 111.144 176.353 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 29.4 tp -78.21 135.26 37.56 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 123.189 0.596 . . . . 0.0 110.22 174.648 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 61.2 tpp -154.16 126.61 8.0 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 124.78 1.232 . . . . 0.0 108.973 -177.919 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 25.1 ttt85 -89.61 147.4 23.94 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 118.452 0.569 . . . . 0.0 111.037 179.158 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 26.1 p -152.19 165.66 34.15 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.884 1.274 . . . . 0.0 114.309 -168.469 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 21.5 pttp -122.41 -14.4 7.85 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 126.072 1.749 . . . . 0.0 112.123 168.079 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 20.0 pt20 -155.45 162.35 40.77 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 126.642 1.977 . . . . 0.0 110.351 178.183 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 26.7 m-20 -62.23 -24.52 67.29 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.911 0.884 . . . . 0.0 112.606 -177.102 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.3 m -64.21 -18.57 64.64 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 125.82 1.648 . . . . 0.0 113.58 176.327 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 64.6 m-20 -80.78 -20.52 42.44 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.12 0.968 . . . . 0.0 112.388 174.4 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 73.8 m -89.77 165.92 13.87 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.983 1.313 . . . . 0.0 113.897 -169.951 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -72.56 174.95 6.78 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 124.763 1.225 . . . . 0.0 111.07 177.841 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.43 133.23 55.91 Favored 'General case' 0 CA--C 1.541 0.606 0 O-C-N 121.089 -1.007 . . . . 0.0 113.104 -176.228 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 74.73 -8.64 13.8 Favored Glycine 0 CA--C 1.535 1.311 0 C-N-CA 124.687 1.137 . . . . 0.0 114.408 -179.447 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 60.6 m -79.16 161.99 26.07 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 114.082 1.141 . . . . 0.0 114.082 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 18.2 m -124.92 154.42 32.8 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 126.433 1.893 . . . . 0.0 110.197 168.577 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 36.9 t -83.77 102.25 12.17 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 123.303 0.641 . . . . 0.0 110.372 170.338 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -71.91 172.25 46.74 Favored Glycine 0 CA--C 1.542 1.781 0 C-N-CA 125.339 1.447 . . . . 0.0 114.62 -179.092 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -71.38 -20.94 27.04 Favored 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 124.33 3.353 . . . . 0.0 113.973 -172.127 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 52.6 p-10 -71.96 -5.18 32.96 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 124.576 1.15 . . . . 0.0 113.899 170.416 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 83.47 5.92 88.07 Favored Glycine 0 CA--C 1.53 0.98 0 C-N-CA 125.497 1.522 . . . . 0.0 114.029 -177.694 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -109.5 155.97 20.68 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 119.195 1.497 . . . . 0.0 112.163 174.599 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 82.7 m -73.47 145.8 45.42 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.839 1.256 . . . . 0.0 112.804 176.308 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.206 0 C-N-CA 126.063 1.792 . . . . 0.0 113.146 175.905 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 48.0 t . . . . . 0 CA--C 1.55 0.964 0 CA-C-O 118.134 -0.936 . . . . 0.0 112.396 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -62.93 160.65 32.62 Favored 'Trans proline' 0 C--N 1.354 0.827 0 C-N-CA 123.288 2.659 . . . . 0.0 112.848 175.165 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 40.4 ptt180 -74.13 13.94 0.49 Allowed 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 114.865 1.431 . . . . 0.0 114.865 179.519 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 94.6 mt -86.32 122.21 38.4 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 126.352 1.861 . . . . 0.0 109.558 -174.976 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 47.7 tp -76.74 134.31 39.21 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.666 0.786 . . . . 0.0 109.872 171.915 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 57.6 ttm -157.57 132.17 8.52 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.342 1.057 . . . . 0.0 110.186 -173.592 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 57.4 ttt180 -82.71 147.98 28.16 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.723 0.809 . . . . 0.0 111.089 -179.65 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 26.3 p -151.17 158.5 44.05 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.548 1.139 . . . . 0.0 113.687 -170.034 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 58.9 mtmt -109.3 -27.32 9.58 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.815 1.646 . . . . 0.0 111.344 169.505 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 8.0 pt20 -153.41 169.47 23.06 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 126.399 1.88 . . . . 0.0 110.818 176.109 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -61.45 -25.71 67.4 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.406 1.083 . . . . 0.0 112.887 -176.489 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 7.2 m -64.8 -18.65 65.29 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 125.296 1.438 . . . . 0.0 113.484 175.991 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 62.0 m-20 -80.42 -21.18 42.44 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 123.909 0.883 . . . . 0.0 112.21 173.843 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 77.4 m -88.08 166.75 14.21 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 125.237 1.415 . . . . 0.0 113.662 -173.303 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 40.1 mt -74.4 177.37 5.98 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.47 1.108 . . . . 0.0 111.726 178.496 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.23 134.47 57.09 Favored 'General case' 0 CA--C 1.54 0.559 0 O-C-N 121.305 -0.872 . . . . 0.0 112.855 -179.786 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 74.67 -8.33 15.21 Favored Glycine 0 CA--C 1.535 1.292 0 C-N-CA 124.698 1.142 . . . . 0.0 114.314 -178.461 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 60.7 m -81.22 159.76 24.48 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 118.553 1.177 . . . . 0.0 113.993 179.496 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 18.2 m -124.48 151.63 29.88 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 126.251 1.82 . . . . 0.0 110.003 168.288 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 49.7 t -85.69 102.2 13.41 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.355 0.662 . . . . 0.0 109.561 169.92 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -72.65 170.11 51.44 Favored Glycine 0 CA--C 1.544 1.858 0 C-N-CA 124.411 1.005 . . . . 0.0 114.242 -176.167 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -57.9 -26.78 75.94 Favored 'Trans proline' 0 C--N 1.353 0.807 0 C-N-CA 124.518 3.479 . . . . 0.0 114.757 -178.815 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 52.0 p-10 -68.6 -11.37 59.92 Favored 'General case' 0 CA--C 1.548 0.9 0 N-CA-C 114.676 1.361 . . . . 0.0 114.676 174.951 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 84.25 14.56 71.31 Favored Glycine 0 CA--C 1.533 1.177 0 C-N-CA 124.799 1.19 . . . . 0.0 114.019 -176.335 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 64.8 m-85 -123.05 155.33 37.11 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.739 1.216 . . . . 0.0 112.225 175.142 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 85.7 m -73.91 145.19 44.97 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.116 1.366 . . . . 0.0 112.761 178.889 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.284 0 C-N-CA 126.111 1.815 . . . . 0.0 113.076 175.265 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 40.4 t . . . . . 0 CA--C 1.546 0.826 0 CA-C-O 117.905 -1.045 . . . . 0.0 112.542 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -67.74 146.31 72.3 Favored 'Trans proline' 0 C--N 1.353 0.813 0 C-N-CA 122.994 2.463 . . . . 0.0 110.676 175.185 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 15.3 mmm180 -83.45 17.04 2.29 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 113.48 0.919 . . . . 0.0 113.48 -173.16 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 19.4 tt -66.28 141.74 17.65 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 125.954 1.702 . . . . 0.0 111.616 178.702 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 26.5 tp -77.0 130.26 37.23 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.315 0.646 . . . . 0.0 109.975 175.313 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 61.7 tpp -160.14 132.49 6.35 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.806 1.242 . . . . 0.0 109.098 -172.762 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 55.2 mtp85 -91.14 155.35 18.69 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 118.944 0.793 . . . . 0.0 113.088 177.456 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 26.6 p -155.67 157.38 36.58 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.401 1.48 . . . . 0.0 113.407 -170.136 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 64.9 mttp -110.51 -26.22 9.61 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 125.598 1.559 . . . . 0.0 110.936 168.863 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 8.1 pt20 -149.99 169.28 21.57 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 126.5 1.92 . . . . 0.0 110.386 173.185 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -61.18 -25.57 67.12 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 124.533 1.133 . . . . 0.0 112.919 -176.513 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 7.1 m -64.88 -19.1 65.73 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 125.315 1.446 . . . . 0.0 113.605 175.862 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 60.3 m-20 -82.18 -18.46 42.66 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 123.929 0.892 . . . . 0.0 112.366 174.878 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 79.1 m -86.66 168.51 13.54 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.069 1.348 . . . . 0.0 113.706 -175.412 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -71.1 173.84 7.08 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 124.557 1.143 . . . . 0.0 110.992 176.805 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.94 132.76 54.94 Favored 'General case' 0 CA--C 1.54 0.573 0 O-C-N 121.115 -0.991 . . . . 0.0 113.236 -175.615 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 74.25 -8.33 13.44 Favored Glycine 0 CA--C 1.534 1.265 0 C-N-CA 124.87 1.224 . . . . 0.0 114.539 -179.827 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 67.4 m -75.42 162.32 28.47 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 114.041 1.126 . . . . 0.0 114.041 -179.205 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 22.4 m -118.43 151.99 20.56 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 125.463 1.505 . . . . 0.0 110.7 168.666 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 48.5 t -90.3 105.15 17.62 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.826 0.85 . . . . 0.0 109.999 169.488 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -70.74 168.81 49.07 Favored Glycine 0 CA--C 1.541 1.708 0 C-N-CA 124.742 1.163 . . . . 0.0 114.127 178.586 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -70.01 -20.53 33.56 Favored 'Trans proline' 0 CA--C 1.538 0.713 0 C-N-CA 124.187 3.258 . . . . 0.0 113.58 -175.151 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 49.1 p30 -70.65 -5.96 33.41 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 125.071 1.349 . . . . 0.0 114.099 169.986 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 78.83 13.45 83.1 Favored Glycine 0 CA--C 1.531 1.039 0 C-N-CA 125.109 1.337 . . . . 0.0 113.917 -178.289 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -109.04 153.82 23.09 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 118.629 1.215 . . . . 0.0 111.995 171.159 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 82.5 m -76.59 154.02 34.8 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.998 1.319 . . . . 0.0 112.847 173.765 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.185 0 CA-C-O 116.653 -2.193 . . . . 0.0 113.952 175.472 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 42.3 t . . . . . 0 CA--C 1.549 0.932 0 CA-C-O 118.311 -0.852 . . . . 0.0 112.19 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_endo -72.69 163.77 37.53 Favored 'Trans proline' 0 C--N 1.353 0.804 0 C-N-CA 123.132 2.555 . . . . 0.0 111.74 177.755 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 10.7 ptm85 -73.04 15.56 0.2 Allowed 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 115.109 1.522 . . . . 0.0 115.109 -178.55 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 91.6 mt -79.77 120.07 30.4 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 125.834 1.654 . . . . 0.0 109.349 -177.828 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 36.3 tp -76.82 135.11 38.91 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 123.388 0.675 . . . . 0.0 109.602 171.085 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 60.8 tpp -160.01 134.58 7.65 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.315 1.046 . . . . 0.0 109.365 -169.921 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 53.9 mtp85 -88.93 152.82 21.5 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 119.187 0.903 . . . . 0.0 112.418 174.625 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 26.4 p -153.8 159.87 42.04 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 125.004 1.322 . . . . 0.0 113.866 -169.636 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 61.3 mtpt -113.94 -24.2 9.2 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 126.18 1.792 . . . . 0.0 111.158 168.846 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 21.0 pt20 -151.0 166.46 30.64 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 126.544 1.938 . . . . 0.0 110.434 175.099 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -61.29 -25.47 67.13 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 124.332 1.053 . . . . 0.0 112.721 -176.23 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.8 m -65.42 -17.77 64.8 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 125.636 1.574 . . . . 0.0 113.641 176.233 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 63.5 m-20 -81.79 -18.71 43.15 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 123.985 0.914 . . . . 0.0 112.302 173.87 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 74.2 m -87.98 168.01 13.22 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.952 1.301 . . . . 0.0 114.133 -172.416 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -70.57 171.16 10.74 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 124.399 1.08 . . . . 0.0 110.742 175.733 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.13 134.8 57.4 Favored 'General case' 0 CA--C 1.539 0.543 0 O-C-N 121.171 -0.956 . . . . 0.0 113.018 -177.177 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 75.82 -8.82 19.7 Favored Glycine 0 CA--C 1.534 1.238 0 C-N-CA 124.814 1.197 . . . . 0.0 114.338 -179.172 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 60.5 m -79.48 162.07 25.67 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 114.131 1.16 . . . . 0.0 114.131 179.427 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 19.0 m -122.14 153.44 26.5 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 126.308 1.843 . . . . 0.0 110.128 168.338 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 41.1 t -86.91 102.61 14.51 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.6 0.76 . . . . 0.0 110.358 170.479 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -73.47 168.98 53.66 Favored Glycine 0 CA--C 1.545 1.94 0 C-N-CA 124.628 1.109 . . . . 0.0 114.499 -178.799 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -59.03 -28.6 88.32 Favored 'Trans proline' 0 C--N 1.354 0.822 0 C-N-CA 124.532 3.488 . . . . 0.0 115.129 -176.284 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 51.3 p30 -71.03 -4.79 26.78 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 125.06 1.344 . . . . 0.0 114.446 175.719 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 78.83 11.53 85.13 Favored Glycine 0 CA--C 1.531 1.054 0 C-N-CA 124.941 1.257 . . . . 0.0 113.918 -178.384 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -107.33 155.33 20.1 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 118.49 1.145 . . . . 0.0 111.796 169.857 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 83.7 m -76.36 145.97 39.1 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.03 1.332 . . . . 0.0 112.587 172.944 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.249 0 C-N-CA 125.906 1.717 . . . . 0.0 113.223 175.261 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 53.4 t . . . . . 0 CA--C 1.551 1.013 0 CA-C-O 118.399 -0.81 . . . . 0.0 112.497 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -56.93 153.3 38.54 Favored 'Trans proline' 0 C--N 1.353 0.787 0 C-N-CA 124.059 3.173 . . . . 0.0 113.152 171.312 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -78.92 38.4 0.33 Allowed 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 125.194 1.398 . . . . 0.0 112.692 179.721 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 86.7 mt -101.69 121.89 53.2 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 C-N-CA 126.366 1.866 . . . . 0.0 109.185 -176.28 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 37.5 tp -81.29 131.47 35.29 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 123.695 0.798 . . . . 0.0 109.646 171.837 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 60.3 ttm -160.1 135.31 8.03 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.644 1.178 . . . . 0.0 110.213 -171.881 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 30.3 mmt180 -73.57 153.44 40.23 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.588 0.755 . . . . 0.0 112.016 175.604 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 29.0 p -157.63 160.14 37.73 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.421 1.088 . . . . 0.0 113.71 -176.888 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 16.9 tppt? -117.23 -25.82 6.97 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 126.712 2.005 . . . . 0.0 111.035 169.155 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -144.38 159.96 41.85 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 126.583 1.953 . . . . 0.0 110.478 178.385 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -62.36 -26.59 68.54 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 124.31 1.044 . . . . 0.0 112.318 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 17.6 m -67.83 -13.18 61.92 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 124.98 1.312 . . . . 0.0 113.571 175.358 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 51.7 m-20 -80.67 -22.48 40.4 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 118.892 0.769 . . . . 0.0 111.914 171.49 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 73.1 m -86.38 167.78 14.43 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.398 1.479 . . . . 0.0 113.642 -172.601 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.408 HD22 ' H ' ' A' ' 16' ' ' LEU . 1.9 mm? -70.18 172.05 8.72 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.247 1.019 . . . . 0.0 111.157 176.403 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.54 135.21 57.6 Favored 'General case' 0 CA--C 1.539 0.541 0 O-C-N 121.231 -0.918 . . . . 0.0 112.902 -179.06 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 75.37 -9.03 15.32 Favored Glycine 0 CA--C 1.533 1.196 0 C-N-CA 124.716 1.151 . . . . 0.0 114.286 -178.683 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 60.4 m -80.62 161.34 24.75 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 118.604 1.202 . . . . 0.0 113.731 178.839 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 18.7 m -122.01 154.63 26.57 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 C-N-CA 126.256 1.823 . . . . 0.0 110.196 168.797 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 47.2 t -88.3 103.78 16.13 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.405 0.682 . . . . 0.0 109.661 169.524 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -71.16 168.53 50.44 Favored Glycine 0 CA--C 1.542 1.756 0 C-N-CA 124.591 1.091 . . . . 0.0 113.938 -178.985 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -69.29 -18.95 38.97 Favored 'Trans proline' 0 CA--C 1.538 0.723 0 C-N-CA 124.091 3.194 . . . . 0.0 113.254 -176.831 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 50.9 p-10 -69.44 -9.2 52.63 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 124.892 1.277 . . . . 0.0 114.312 170.196 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 81.99 13.82 78.56 Favored Glycine 0 CA--C 1.533 1.191 0 C-N-CA 125.019 1.295 . . . . 0.0 114.042 -177.779 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -115.17 155.12 27.74 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.027 1.331 . . . . 0.0 112.003 172.832 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 74.8 m -73.07 146.33 45.9 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.88 1.272 . . . . 0.0 112.584 171.429 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.209 0 C-N-CA 125.97 1.748 . . . . 0.0 113.235 175.131 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 53.0 t . . . . . 0 CA--C 1.55 0.951 0 CA-C-O 118.334 -0.841 . . . . 0.0 112.356 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -69.86 151.97 68.67 Favored 'Trans proline' 0 C--N 1.353 0.814 0 C-N-CA 123.041 2.494 . . . . 0.0 111.412 174.497 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -81.85 15.5 2.21 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.704 1.202 . . . . 0.0 113.882 -176.403 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 18.0 tt -72.98 142.73 14.68 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 125.598 1.559 . . . . 0.0 111.2 176.344 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 30.0 tp -79.23 134.79 36.66 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 123.128 0.571 . . . . 0.0 110.228 174.646 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 60.5 tpp -153.65 127.3 8.74 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 124.775 1.23 . . . . 0.0 109.408 -179.109 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 45.8 ttt85 -85.5 147.18 26.57 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.747 0.819 . . . . 0.0 111.015 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 29.3 p -156.76 165.48 36.12 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 114.351 1.241 . . . . 0.0 114.351 -169.374 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 21.9 pttp -126.16 -12.7 6.31 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 126.292 1.837 . . . . 0.0 112.122 168.149 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 17.4 pt20 -157.39 161.76 39.01 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 126.394 1.878 . . . . 0.0 110.811 178.838 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 33.8 m-20 -65.57 -25.3 67.36 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 124.154 0.982 . . . . 0.0 113.441 -171.05 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 58.8 p -72.88 -9.44 58.69 Favored 'General case' 0 CA--C 1.546 0.792 0 N-CA-C 113.695 0.998 . . . . 0.0 113.695 175.831 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 66.4 m-20 -78.01 -23.54 48.25 Favored 'General case' 0 N--CA 1.473 0.724 0 O-C-N 121.299 -0.876 . . . . 0.0 111.315 168.822 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 73.2 m -87.79 166.42 14.62 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.508 1.523 . . . . 0.0 113.795 -171.242 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -71.55 172.54 9.41 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 124.609 1.164 . . . . 0.0 111.032 177.525 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.17 133.06 55.75 Favored 'General case' 0 CA--C 1.538 0.511 0 O-C-N 121.241 -0.912 . . . . 0.0 113.164 -176.305 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 75.64 -9.26 16.52 Favored Glycine 0 CA--C 1.534 1.279 0 C-N-CA 124.781 1.181 . . . . 0.0 114.339 -178.909 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 60.8 m -78.71 163.39 25.45 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 118.547 1.173 . . . . 0.0 113.969 179.354 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 18.3 m -124.18 154.5 31.17 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 C-N-CA 126.354 1.862 . . . . 0.0 110.211 168.389 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 45.5 t -85.33 103.65 14.45 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 123.186 0.594 . . . . 0.0 110.123 169.822 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -70.03 168.95 46.77 Favored Glycine 0 CA--C 1.544 1.858 0 C-N-CA 124.871 1.224 . . . . 0.0 114.15 179.33 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -70.13 -18.62 35.16 Favored 'Trans proline' 0 CA--C 1.538 0.697 0 C-N-CA 124.16 3.24 . . . . 0.0 113.612 -174.333 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 52.9 p-10 -69.77 -9.06 53.13 Favored 'General case' 0 CA--C 1.548 0.897 0 N-CA-C 114.278 1.214 . . . . 0.0 114.278 170.473 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 84.61 11.62 77.01 Favored Glycine 0 CA--C 1.532 1.123 0 C-N-CA 124.837 1.208 . . . . 0.0 113.938 -176.607 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -121.44 155.83 34.03 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 118.632 1.216 . . . . 0.0 112.289 175.086 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 84.8 m -75.41 147.7 39.75 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.789 1.236 . . . . 0.0 113.2 -179.549 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.199 0 C-N-CA 126.123 1.82 . . . . 0.0 113.038 174.517 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 53.2 t . . . . . 0 CA--C 1.55 0.96 0 CA-C-O 118.353 -0.832 . . . . 0.0 112.551 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo -58.4 154.33 42.08 Favored 'Trans proline' 0 C--N 1.355 0.878 0 C-N-CA 123.832 3.022 . . . . 0.0 113.156 172.676 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 95.7 mtt-85 -79.1 40.2 0.4 Allowed 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 125.037 1.335 . . . . 0.0 112.346 177.497 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 88.8 mt -104.34 123.4 58.18 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 126.627 1.971 . . . . 0.0 108.835 -177.043 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 41.0 tp -76.23 133.83 40.0 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.188 0.595 . . . . 0.0 109.837 172.598 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 59.6 tpp -155.58 130.11 9.05 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 124.461 1.104 . . . . 0.0 109.662 -174.427 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 60.7 ttt180 -83.29 146.15 28.7 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.583 0.753 . . . . 0.0 110.566 178.448 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 28.6 p -152.43 159.15 43.42 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 114.703 1.371 . . . . 0.0 114.703 -169.6 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 63.2 tttp -112.54 -28.91 7.66 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 126.594 1.957 . . . . 0.0 110.793 168.974 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 21.0 pt20 -149.44 166.76 28.13 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 126.194 1.797 . . . . 0.0 110.745 177.999 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -61.27 -25.27 66.97 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.183 0.993 . . . . 0.0 112.765 -175.987 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.8 m -65.35 -17.84 64.84 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 125.589 1.556 . . . . 0.0 113.567 176.165 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 62.4 m-20 -81.68 -18.81 43.18 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.086 0.955 . . . . 0.0 112.307 173.588 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 75.7 m -88.38 166.94 13.91 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.992 1.317 . . . . 0.0 113.955 -172.746 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -71.23 172.97 8.34 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 124.563 1.145 . . . . 0.0 110.952 176.342 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.5 133.53 56.18 Favored 'General case' 0 CA--C 1.54 0.564 0 O-C-N 121.143 -0.973 . . . . 0.0 113.145 -176.601 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 74.77 -8.62 14.05 Favored Glycine 0 CA--C 1.535 1.291 0 C-N-CA 124.572 1.082 . . . . 0.0 114.427 -179.372 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 60.3 m -78.96 162.21 26.14 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 118.448 1.124 . . . . 0.0 113.859 179.075 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 18.3 m -122.88 154.26 28.14 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 126.103 1.761 . . . . 0.0 110.361 168.716 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 48.7 t -84.96 103.12 13.72 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 123.491 0.716 . . . . 0.0 110.128 169.9 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -69.92 168.73 46.73 Favored Glycine 0 CA--C 1.543 1.824 0 C-N-CA 124.888 1.233 . . . . 0.0 114.093 179.626 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -69.8 -18.45 36.82 Favored 'Trans proline' 0 CA--C 1.537 0.662 0 C-N-CA 124.241 3.294 . . . . 0.0 113.503 -174.903 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 53.4 p-10 -69.54 -9.91 55.88 Favored 'General case' 0 CA--C 1.549 0.911 0 N-CA-C 114.33 1.233 . . . . 0.0 114.33 170.697 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 85.19 11.75 75.13 Favored Glycine 0 CA--C 1.533 1.163 0 C-N-CA 124.885 1.231 . . . . 0.0 114.083 -176.722 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 67.1 m-85 -123.98 157.24 34.83 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.751 1.22 . . . . 0.0 112.218 174.734 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 86.3 m -76.34 148.4 37.47 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.997 1.319 . . . . 0.0 113.49 -177.902 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.24 0 C-N-CA 126.111 1.815 . . . . 0.0 113.039 174.677 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 37.5 t . . . . . 0 CA--C 1.546 0.816 0 CA-C-O 118.122 -0.942 . . . . 0.0 112.56 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -69.6 151.8 70.04 Favored 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 122.915 2.41 . . . . 0.0 111.205 178.138 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 6.8 mmp_? -78.52 34.16 0.21 Allowed 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.829 1.251 . . . . 0.0 113.109 -178.27 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 96.6 mt -80.5 126.05 39.41 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 125.717 1.607 . . . . 0.0 109.003 177.789 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 37.6 tp -74.05 126.13 29.83 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 172.292 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 61.0 tpp -154.68 130.97 10.4 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.503 1.121 . . . . 0.0 109.68 -171.273 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 83.8 mtt85 -80.45 151.43 29.31 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.74 0.816 . . . . 0.0 111.48 177.035 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 29.4 p -156.51 155.13 31.45 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 113.983 1.105 . . . . 0.0 113.983 -174.132 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -109.82 -28.78 8.61 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 126.337 1.855 . . . . 0.0 110.562 168.796 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 20.9 pt20 -148.77 167.0 26.76 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 126.479 1.912 . . . . 0.0 110.665 176.156 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -61.27 -24.76 66.63 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 124.452 1.101 . . . . 0.0 112.768 -176.289 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.9 m -65.85 -17.84 64.92 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 125.583 1.553 . . . . 0.0 113.667 175.918 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 62.5 m-20 -81.62 -18.58 44.2 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.066 0.946 . . . . 0.0 112.343 173.898 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 72.8 m -87.66 168.74 12.74 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.28 1.432 . . . . 0.0 113.946 -173.695 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -70.7 174.59 5.77 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 124.311 1.044 . . . . 0.0 110.91 175.968 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.48 133.42 56.08 Favored 'General case' 0 CA--C 1.54 0.565 0 O-C-N 120.994 -1.066 . . . . 0.0 113.146 -176.988 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 74.51 -8.14 15.43 Favored Glycine 0 CA--C 1.535 1.287 0 C-N-CA 124.876 1.227 . . . . 0.0 114.474 179.764 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 66.2 m -75.95 162.77 27.81 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 114.127 1.158 . . . . 0.0 114.127 -178.762 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 22.9 m -119.9 151.12 22.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 125.233 1.413 . . . . 0.0 110.705 168.602 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 44.1 t -87.51 104.09 16.15 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.698 0.799 . . . . 0.0 109.667 169.438 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -70.77 167.69 50.52 Favored Glycine 0 CA--C 1.542 1.726 0 C-N-CA 124.636 1.112 . . . . 0.0 113.992 179.849 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -69.57 -18.45 37.87 Favored 'Trans proline' 0 CA--C 1.539 0.765 0 C-N-CA 124.146 3.231 . . . . 0.0 113.346 -176.11 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 52.3 p-10 -69.53 -9.66 54.86 Favored 'General case' 0 CA--C 1.548 0.891 0 N-CA-C 114.347 1.24 . . . . 0.0 114.347 170.711 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 84.92 11.72 75.99 Favored Glycine 0 CA--C 1.533 1.157 0 C-N-CA 124.889 1.233 . . . . 0.0 114.127 -177.05 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -118.86 155.65 30.85 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.886 1.274 . . . . 0.0 112.376 174.86 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 70.2 m -76.0 153.85 36.2 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.076 1.351 . . . . 0.0 113.255 176.722 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.276 0 CA-C-O 116.765 -2.131 . . . . 0.0 113.979 174.965 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 47.3 t . . . . . 0 CA--C 1.551 0.998 0 CA-C-O 118.313 -0.851 . . . . 0.0 112.621 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -56.42 150.07 52.95 Favored 'Trans proline' 0 C--N 1.353 0.795 0 C-N-CA 124.075 3.183 . . . . 0.0 113.125 171.143 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -79.53 37.97 0.36 Allowed 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 125.117 1.367 . . . . 0.0 113.009 -177.143 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 48.2 mm -98.41 123.99 51.28 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 126.12 1.768 . . . . 0.0 109.777 -177.994 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 36.5 tp -81.52 129.33 34.62 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 123.586 0.754 . . . . 0.0 109.624 171.198 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 60.2 ttm -160.9 136.59 8.06 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.811 1.244 . . . . 0.0 109.574 -171.768 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 57.2 mtp85 -85.46 152.53 23.13 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 118.819 0.736 . . . . 0.0 112.708 176.776 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 25.0 p -151.74 159.55 43.92 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.367 1.467 . . . . 0.0 113.374 -169.854 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 31.5 mmmt -110.15 -26.19 9.79 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 125.877 1.671 . . . . 0.0 111.368 169.191 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 8.5 pt20 -152.78 168.9 24.17 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 126.332 1.853 . . . . 0.0 110.742 175.367 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -61.21 -26.21 67.57 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 124.382 1.073 . . . . 0.0 112.78 -176.525 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 6.6 m -64.58 -18.69 65.12 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 125.374 1.469 . . . . 0.0 113.508 176.264 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 62.6 m-20 -80.58 -20.72 42.68 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 123.921 0.888 . . . . 0.0 112.286 174.282 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 72.1 m -87.45 168.02 13.47 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.109 1.364 . . . . 0.0 113.797 -172.684 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -70.3 172.02 8.93 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 124.357 1.063 . . . . 0.0 111.048 176.152 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.29 134.29 56.87 Favored 'General case' 0 CA--C 1.539 0.522 0 O-C-N 121.246 -0.909 . . . . 0.0 113.061 -177.793 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 75.04 -8.78 14.21 Favored Glycine 0 CA--C 1.534 1.238 0 C-N-CA 124.641 1.115 . . . . 0.0 114.411 -179.215 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 60.8 m -79.3 161.29 26.38 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 118.477 1.139 . . . . 0.0 113.794 178.814 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 19.1 m -121.7 154.21 25.87 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 126.182 1.793 . . . . 0.0 110.412 168.759 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 48.2 t -88.25 103.94 16.26 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.603 0.761 . . . . 0.0 110.001 169.724 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -70.96 169.98 47.87 Favored Glycine 0 CA--C 1.543 1.786 0 C-N-CA 124.926 1.25 . . . . 0.0 114.195 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -69.89 -20.56 34.07 Favored 'Trans proline' 0 CA--C 1.539 0.726 0 C-N-CA 124.163 3.242 . . . . 0.0 113.442 -175.221 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 49.2 p30 -70.63 -6.34 36.15 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 125.023 1.329 . . . . 0.0 114.023 169.97 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 79.75 12.38 83.62 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 125.271 1.415 . . . . 0.0 114.116 -178.348 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -108.51 153.68 23.0 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.77 1.228 . . . . 0.0 112.15 172.089 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 76.2 m -73.53 146.1 45.07 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.86 1.264 . . . . 0.0 112.603 171.1 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.271 0 C-N-CA 125.981 1.753 . . . . 0.0 113.303 175.557 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 44.7 t . . . . . 0 CA--C 1.55 0.959 0 CA-C-O 118.206 -0.902 . . . . 0.0 112.138 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -70.24 155.13 65.06 Favored 'Trans proline' 0 C--N 1.354 0.82 0 C-N-CA 122.962 2.442 . . . . 0.0 111.762 178.184 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 59.2 ttt85 -79.56 89.63 5.1 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.07 0.948 . . . . 0.0 110.621 179.118 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 9.2 tp -160.31 142.04 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 126.351 1.86 . . . . 0.0 110.437 -178.43 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 33.4 tp -86.8 136.74 32.88 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 123.963 0.905 . . . . 0.0 110.127 175.091 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 60.7 tpp -155.53 134.74 12.28 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.501 1.12 . . . . 0.0 110.055 -175.405 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 91.3 mtm-85 -81.38 152.16 27.6 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.131 0.972 . . . . 0.0 111.49 176.621 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 30.1 p -157.97 156.36 31.07 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 114.316 1.228 . . . . 0.0 114.316 -175.237 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 62.7 tttp -111.41 -29.08 7.93 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 126.456 1.902 . . . . 0.0 110.533 168.718 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 21.0 pt20 -148.14 166.98 26.23 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 126.535 1.934 . . . . 0.0 110.58 175.645 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -60.97 -25.33 66.77 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 124.502 1.121 . . . . 0.0 112.806 -176.192 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.9 m -65.46 -17.96 64.95 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.591 1.556 . . . . 0.0 113.669 175.837 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 61.8 m-20 -82.03 -19.47 40.34 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 123.964 0.906 . . . . 0.0 112.29 173.628 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 71.3 m -86.49 166.81 15.19 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.999 1.32 . . . . 0.0 113.607 -174.724 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -70.62 170.41 12.3 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 124.233 1.013 . . . . 0.0 110.76 176.26 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.9 134.95 57.52 Favored 'General case' 0 CA--C 1.539 0.533 0 O-C-N 121.273 -0.892 . . . . 0.0 112.885 -177.706 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 76.36 -9.06 22.41 Favored Glycine 0 CA--C 1.534 1.243 0 C-N-CA 124.698 1.142 . . . . 0.0 114.289 -178.541 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 58.8 m -79.91 162.61 24.88 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 118.567 1.184 . . . . 0.0 113.897 178.18 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 19.6 m -121.3 153.79 25.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 126.254 1.822 . . . . 0.0 110.206 168.419 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 48.9 t -87.83 104.17 16.33 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 123.552 0.741 . . . . 0.0 110.122 169.761 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -69.97 166.92 49.32 Favored Glycine 0 CA--C 1.542 1.739 0 C-N-CA 124.661 1.124 . . . . 0.0 113.875 178.277 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -69.83 -18.11 36.89 Favored 'Trans proline' 0 C--N 1.352 0.712 0 C-N-CA 124.204 3.269 . . . . 0.0 113.479 -175.444 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 53.1 p-10 -69.81 -9.28 54.07 Favored 'General case' 0 CA--C 1.548 0.87 0 N-CA-C 114.433 1.271 . . . . 0.0 114.433 171.185 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 84.85 11.6 76.46 Favored Glycine 0 CA--C 1.535 1.305 0 C-N-CA 124.813 1.197 . . . . 0.0 114.021 -177.036 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -119.16 156.28 30.11 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.701 1.2 . . . . 0.0 112.28 174.091 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 74.1 m -77.13 149.98 35.62 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.98 1.312 . . . . 0.0 113.258 177.732 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.271 0 C-N-CA 125.904 1.716 . . . . 0.0 113.097 174.015 . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 43.7 t . . . . . 0 CA--C 1.55 0.964 0 CA-C-O 118.233 -0.889 . . . . 0.0 112.264 . . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -73.25 159.6 46.78 Favored 'Trans proline' 0 C--N 1.353 0.792 0 C-N-CA 123.099 2.533 . . . . 0.0 111.399 176.751 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -78.11 33.46 0.19 Allowed 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 125.286 1.434 . . . . 0.0 113.251 -177.861 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 97.5 mt -91.67 123.24 43.73 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 126.099 1.76 . . . . 0.0 108.837 179.641 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 37.3 tp -75.03 132.21 41.16 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 172.055 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 60.2 tpp -154.0 127.7 8.75 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 124.474 1.11 . . . . 0.0 109.406 -174.547 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 46.6 ttt85 -83.58 145.06 29.07 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.413 0.685 . . . . 0.0 110.555 178.112 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 28.0 p -149.97 158.88 44.61 Favored 'General case' 0 N--CA 1.469 0.525 0 N-CA-C 114.489 1.292 . . . . 0.0 114.489 -169.401 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -111.76 -28.85 7.92 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 126.516 1.926 . . . . 0.0 110.721 168.907 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 21.0 pt20 -149.35 166.74 28.1 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 126.29 1.836 . . . . 0.0 110.773 177.728 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -61.31 -25.25 67.0 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 124.236 1.014 . . . . 0.0 112.8 -176.184 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.8 m -65.33 -17.8 64.8 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 125.604 1.561 . . . . 0.0 113.576 176.052 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 63.3 m-20 -81.49 -18.63 44.49 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.133 0.973 . . . . 0.0 112.278 173.662 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 73.9 m -88.76 166.89 13.74 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.977 1.311 . . . . 0.0 114.123 -172.319 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -70.6 171.64 9.96 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 124.522 1.129 . . . . 0.0 110.836 175.701 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.23 135.25 57.67 Favored 'General case' 0 CA--C 1.538 0.511 0 O-C-N 121.178 -0.951 . . . . 0.0 112.939 -177.764 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 75.88 -9.2 18.46 Favored Glycine 0 CA--C 1.533 1.211 0 C-N-CA 124.809 1.195 . . . . 0.0 114.341 -178.797 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 59.8 m -80.18 162.96 24.42 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 114.185 1.18 . . . . 0.0 114.185 179.462 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 18.5 m -123.59 153.97 29.55 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 126.364 1.866 . . . . 0.0 110.088 168.222 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 49.0 t -84.32 102.52 12.76 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 123.408 0.683 . . . . 0.0 110.233 169.993 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -70.93 169.67 48.3 Favored Glycine 0 CA--C 1.542 1.779 0 C-N-CA 124.91 1.243 . . . . 0.0 114.383 -179.556 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -70.53 -19.05 32.96 Favored 'Trans proline' 0 CA--C 1.538 0.7 0 C-N-CA 124.207 3.271 . . . . 0.0 113.66 -173.819 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 53.2 p-10 -70.6 -8.12 49.24 Favored 'General case' 0 CA--C 1.548 0.889 0 N-CA-C 114.211 1.189 . . . . 0.0 114.211 170.849 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 85.25 8.97 80.69 Favored Glycine 0 CA--C 1.532 1.101 0 C-N-CA 124.974 1.274 . . . . 0.0 114.056 -176.993 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -118.62 156.78 28.61 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 118.676 1.238 . . . . 0.0 112.255 174.836 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 84.0 m -75.03 147.01 41.09 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.976 1.31 . . . . 0.0 113.169 179.168 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.189 0 C-N-CA 126.104 1.811 . . . . 0.0 113.097 174.937 . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 42.7 t . . . . . 0 CA--C 1.549 0.911 0 CA-C-O 118.387 -0.816 . . . . 0.0 112.408 . . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_exo -61.8 154.99 57.09 Favored 'Trans proline' 0 C--N 1.354 0.841 0 C-N-CA 123.132 2.554 . . . . 0.0 112.121 174.551 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 75.4 mmt-85 -81.64 15.87 1.97 Allowed 'General case' 0 CA--C 1.546 0.795 0 N-CA-C 114.06 1.133 . . . . 0.0 114.06 -175.747 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 1.8 mp -82.12 127.35 39.7 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 125.764 1.625 . . . . 0.0 108.753 177.68 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 35.2 tp -75.32 136.32 40.85 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 123.576 0.75 . . . . 0.0 110.131 173.988 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 60.5 tpp -154.63 133.41 12.19 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.309 1.043 . . . . 0.0 110.231 -171.693 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 27.0 mmt180 -77.13 154.51 33.15 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.754 0.822 . . . . 0.0 111.948 174.691 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 28.8 p -158.23 157.52 32.76 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 113.946 1.091 . . . . 0.0 113.946 -177.509 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -113.37 -24.69 9.19 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 126.239 1.816 . . . . 0.0 110.986 168.779 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 20.9 pt20 -151.68 166.45 31.24 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 126.717 2.007 . . . . 0.0 110.402 175.3 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -61.19 -24.94 66.69 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.417 1.087 . . . . 0.0 112.886 -176.43 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.9 m -65.64 -17.82 64.87 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 125.553 1.541 . . . . 0.0 113.59 175.952 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 63.0 m-20 -81.36 -19.13 43.39 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 123.933 0.893 . . . . 0.0 112.275 173.382 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 73.7 m -88.66 165.98 14.41 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.934 1.294 . . . . 0.0 113.834 -173.339 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 26.1 mt -73.94 177.78 5.38 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 124.524 1.13 . . . . 0.0 111.399 179.0 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.82 133.36 56.02 Favored 'General case' 0 CA--C 1.539 0.552 0 O-C-N 121.268 -0.895 . . . . 0.0 112.923 -178.439 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 74.28 -8.06 14.71 Favored Glycine 0 CA--C 1.535 1.287 0 C-N-CA 124.708 1.147 . . . . 0.0 114.433 -179.53 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 61.8 m -79.38 160.54 26.65 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 118.512 1.156 . . . . 0.0 114.021 179.825 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 19.2 m -122.89 153.25 27.8 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 126.351 1.86 . . . . 0.0 110.096 168.393 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 49.9 t -87.15 102.87 14.87 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.45 0.7 . . . . 0.0 110.058 169.965 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -72.83 167.53 53.86 Favored Glycine 0 CA--C 1.543 1.831 0 C-N-CA 124.417 1.008 . . . . 0.0 114.142 -178.508 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -58.36 -26.79 78.89 Favored 'Trans proline' 0 C--N 1.354 0.818 0 C-N-CA 124.383 3.389 . . . . 0.0 114.902 -178.268 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 52.4 p-10 -69.72 -8.59 49.25 Favored 'General case' 0 CA--C 1.548 0.883 0 N-CA-C 114.685 1.365 . . . . 0.0 114.685 176.016 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 81.14 13.96 79.97 Favored Glycine 0 CA--C 1.533 1.18 0 C-N-CA 124.722 1.154 . . . . 0.0 113.903 -177.676 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -114.35 157.46 22.78 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.848 1.259 . . . . 0.0 111.531 169.955 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 81.5 m -76.55 147.79 37.49 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.858 1.263 . . . . 0.0 112.763 173.523 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.228 0 C-N-CA 125.973 1.749 . . . . 0.0 113.186 174.708 . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 49.2 t . . . . . 0 CA--C 1.549 0.91 0 CA-C-O 118.061 -0.971 . . . . 0.0 112.307 . . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -73.48 161.35 42.58 Favored 'Trans proline' 0 C--N 1.354 0.839 0 C-N-CA 122.9 2.4 . . . . 0.0 111.218 177.273 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -80.8 32.8 0.31 Allowed 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 124.618 1.167 . . . . 0.0 113.91 -170.999 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 45.9 mm -88.34 123.99 41.1 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 125.947 1.699 . . . . 0.0 109.769 179.673 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 42.6 tp -76.8 130.7 38.02 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 169.949 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 60.8 tpp -155.57 132.62 10.75 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.199 1.0 . . . . 0.0 110.068 -170.625 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 83.9 mtt85 -81.21 151.12 28.32 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.804 0.842 . . . . 0.0 111.343 175.771 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 29.3 p -156.14 158.17 37.21 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 114.27 1.211 . . . . 0.0 114.27 -173.284 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -119.5 -19.9 7.99 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 126.144 1.778 . . . . 0.0 111.674 169.099 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -149.61 167.86 25.18 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 126.39 1.876 . . . . 0.0 110.509 169.908 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -61.26 -25.55 67.16 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 124.362 1.065 . . . . 0.0 112.647 -178.514 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 15.7 m -65.62 -16.07 63.36 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 125.304 1.442 . . . . 0.0 113.676 175.946 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 60.3 m-20 -82.06 -18.09 44.36 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 123.888 0.875 . . . . 0.0 112.464 172.83 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 72.9 m -89.77 167.13 13.12 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.008 1.323 . . . . 0.0 113.859 -172.214 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -70.26 170.34 11.9 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 124.466 1.106 . . . . 0.0 110.843 175.862 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.84 134.7 57.28 Favored 'General case' 0 CA--C 1.538 0.512 0 O-C-N 121.221 -0.924 . . . . 0.0 112.922 -177.637 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 76.22 -9.0 21.63 Favored Glycine 0 CA--C 1.534 1.231 0 C-N-CA 124.781 1.182 . . . . 0.0 114.283 -178.711 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 60.1 m -79.87 162.55 24.96 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 118.518 1.159 . . . . 0.0 114.069 178.56 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 19.2 m -122.76 154.21 27.89 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 126.238 1.815 . . . . 0.0 110.224 168.5 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 47.2 t -85.89 102.52 13.8 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 123.579 0.752 . . . . 0.0 110.157 169.885 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -72.81 167.71 53.72 Favored Glycine 0 CA--C 1.543 1.836 0 C-N-CA 124.454 1.026 . . . . 0.0 114.218 -178.235 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -58.41 -26.87 79.59 Favored 'Trans proline' 0 C--N 1.353 0.801 0 C-N-CA 124.489 3.459 . . . . 0.0 114.969 -177.335 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 52.8 p-10 -70.34 -8.34 49.75 Favored 'General case' 0 CA--C 1.548 0.885 0 N-CA-C 114.775 1.398 . . . . 0.0 114.775 176.699 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 83.92 10.84 80.26 Favored Glycine 0 CA--C 1.533 1.21 0 C-N-CA 124.626 1.108 . . . . 0.0 114.029 -177.228 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -116.39 157.2 25.46 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.84 1.256 . . . . 0.0 112.09 172.153 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 83.1 m -76.44 147.57 37.85 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.004 1.322 . . . . 0.0 113.122 176.988 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.212 0 C-N-CA 126.013 1.768 . . . . 0.0 113.126 174.635 . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 48.5 t . . . . . 0 CA--C 1.549 0.933 0 CA-C-O 118.048 -0.977 . . . . 0.0 112.436 . . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -61.91 149.67 89.25 Favored 'Trans proline' 0 C--N 1.354 0.844 0 C-N-CA 123.191 2.594 . . . . 0.0 113.085 177.27 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 34.4 ptt-85 -83.0 10.22 8.45 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 115.593 1.701 . . . . 0.0 115.593 -172.286 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 10.1 tp -77.17 153.17 5.54 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 C-N-CA 125.424 1.49 . . . . 0.0 111.428 177.947 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 32.7 tp -82.43 134.28 35.23 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.679 0.791 . . . . 0.0 110.468 173.793 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -161.69 127.3 3.61 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.647 1.179 . . . . 0.0 110.932 -170.354 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 95.7 mtt-85 -85.81 159.58 19.69 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 125.071 1.348 . . . . 0.0 112.365 -179.375 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 28.3 p -159.58 159.14 32.88 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.663 1.185 . . . . 0.0 114.104 -177.282 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -114.2 -25.05 8.65 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 126.306 1.842 . . . . 0.0 111.081 168.767 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -151.73 168.17 25.88 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 126.547 1.939 . . . . 0.0 110.531 173.847 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -61.83 -24.76 67.09 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 124.304 1.041 . . . . 0.0 113.0 -176.465 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 6.6 m -64.57 -18.78 65.18 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 125.233 1.413 . . . . 0.0 113.529 175.444 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 62.4 m-20 -80.35 -18.94 47.61 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.001 0.92 . . . . 0.0 112.241 174.034 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 80.6 m -90.28 163.42 14.76 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 125.235 1.414 . . . . 0.0 113.656 -173.073 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 60.0 mt -76.99 -178.43 4.94 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 124.599 1.159 . . . . 0.0 111.921 179.73 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.63 134.27 56.92 Favored 'General case' 0 CA--C 1.54 0.569 0 O-C-N 121.203 -0.935 . . . . 0.0 112.868 -178.563 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 74.51 -8.42 14.08 Favored Glycine 0 CA--C 1.534 1.252 0 C-N-CA 124.749 1.166 . . . . 0.0 114.329 -178.724 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 61.6 m -81.02 159.27 24.86 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 114.184 1.179 . . . . 0.0 114.184 -178.954 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 18.2 m -125.02 153.29 32.11 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 126.472 1.909 . . . . 0.0 109.681 167.949 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 49.1 t -86.09 102.8 14.18 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 123.235 0.614 . . . . 0.0 110.237 170.646 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -70.47 166.56 50.94 Favored Glycine 0 CA--C 1.543 1.831 0 C-N-CA 124.65 1.119 . . . . 0.0 113.806 178.84 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -69.73 -18.08 37.32 Favored 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 124.135 3.223 . . . . 0.0 113.392 -176.062 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 52.7 p-10 -69.66 -9.15 53.13 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 124.897 1.279 . . . . 0.0 114.36 171.381 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 85.29 9.84 78.83 Favored Glycine 0 CA--C 1.533 1.202 0 C-N-CA 124.962 1.268 . . . . 0.0 114.227 -177.949 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -116.2 155.03 29.01 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.949 1.3 . . . . 0.0 111.879 174.147 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 82.6 m -77.07 147.14 36.85 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.272 1.029 . . . . 0.0 112.241 174.391 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.22 0 C-N-CA 125.743 1.64 . . . . 0.0 113.112 175.798 . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 44.3 t . . . . . 0 CA--C 1.55 0.945 0 CA-C-O 118.257 -0.878 . . . . 0.0 112.279 . . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -74.5 163.5 35.95 Favored 'Trans proline' 0 C--N 1.353 0.765 0 C-N-CA 122.996 2.464 . . . . 0.0 111.397 177.2 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 74.6 mtp85 -77.35 20.72 0.28 Allowed 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 125.031 1.333 . . . . 0.0 114.08 -175.242 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 48.3 mm -79.83 122.68 35.51 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 125.367 1.467 . . . . 0.0 109.874 178.749 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 42.4 tp -76.14 132.92 40.3 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.184 0.594 . . . . 0.0 109.489 170.598 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 60.3 tpp -153.33 127.52 9.11 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 124.205 1.002 . . . . 0.0 109.838 -173.307 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 59.5 ttm-85 -78.08 145.06 36.03 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.702 0.801 . . . . 0.0 110.395 177.373 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 31.3 p -153.11 159.16 42.73 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 114.411 1.263 . . . . 0.0 114.411 -171.697 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -121.2 -18.83 7.3 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 126.878 2.071 . . . . 0.0 111.49 168.895 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 19.3 pt20 -147.45 158.96 44.2 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 126.843 2.057 . . . . 0.0 110.179 177.963 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -62.86 -25.86 68.49 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.196 0.999 . . . . 0.0 112.429 -179.822 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 17.8 m -67.38 -13.46 62.04 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 124.916 1.287 . . . . 0.0 113.557 175.289 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 49.9 m-20 -81.5 -19.15 42.84 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 123.758 0.823 . . . . 0.0 112.091 172.108 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 73.9 m -88.79 167.01 13.64 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.253 1.421 . . . . 0.0 113.94 -171.302 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -70.37 170.77 11.19 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 124.444 1.098 . . . . 0.0 110.769 175.692 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.08 134.82 57.41 Favored 'General case' 0 CA--C 1.539 0.525 0 O-C-N 121.179 -0.95 . . . . 0.0 112.964 -177.348 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 76.14 -9.09 20.75 Favored Glycine 0 CA--C 1.533 1.188 0 C-N-CA 124.652 1.12 . . . . 0.0 114.378 -178.764 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 60.2 m -79.91 162.9 24.72 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 114.078 1.14 . . . . 0.0 114.078 179.079 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 18.5 m -122.73 154.33 27.88 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 126.325 1.85 . . . . 0.0 110.073 168.359 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 47.8 t -85.63 103.41 14.43 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 123.193 0.597 . . . . 0.0 110.071 169.824 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -70.83 168.16 50.11 Favored Glycine 0 CA--C 1.542 1.731 0 C-N-CA 124.841 1.21 . . . . 0.0 114.101 179.922 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -70.23 -17.9 35.13 Favored 'Trans proline' 0 C--N 1.352 0.743 0 C-N-CA 124.169 3.246 . . . . 0.0 113.5 -175.312 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 53.3 p-10 -69.38 -9.42 53.4 Favored 'General case' 0 CA--C 1.548 0.882 0 N-CA-C 114.339 1.237 . . . . 0.0 114.339 170.855 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 84.87 12.06 75.35 Favored Glycine 0 CA--C 1.532 1.141 0 C-N-CA 124.756 1.17 . . . . 0.0 114.046 -176.796 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -123.51 156.47 35.57 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.703 1.201 . . . . 0.0 112.386 174.505 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 84.1 m -75.1 147.41 40.6 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.906 1.283 . . . . 0.0 113.214 179.006 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.204 0 C-N-CA 126.058 1.789 . . . . 0.0 113.099 174.809 . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 53.3 t . . . . . 0 CA--C 1.551 0.995 0 CA-C-O 118.517 -0.754 . . . . 0.0 112.282 . . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -67.45 166.7 22.82 Favored 'Trans proline' 0 C--N 1.353 0.798 0 C-N-CA 123.435 2.756 . . . . 0.0 111.909 173.05 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 4.4 mmp_? -102.23 17.4 23.48 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 125.091 1.357 . . . . 0.0 113.187 179.94 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 10.4 tp -74.57 148.44 7.99 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 C-N-CA 125.247 1.419 . . . . 0.0 111.392 176.015 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 10.6 tt -71.29 132.13 44.45 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.636 0.774 . . . . 0.0 110.044 172.974 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 58.7 tpp -154.96 130.67 9.97 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.825 1.25 . . . . 0.0 109.591 177.421 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 84.4 mtt85 -87.32 152.92 21.87 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.301 1.04 . . . . 0.0 111.497 178.297 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 29.6 p -157.0 156.03 32.26 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 114.082 1.141 . . . . 0.0 114.082 -173.236 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -112.22 -25.67 9.18 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 126.091 1.756 . . . . 0.0 110.93 168.927 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 8.3 pt20 -150.58 168.78 23.25 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 126.569 1.947 . . . . 0.0 110.522 173.621 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -61.37 -25.24 67.04 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 124.462 1.105 . . . . 0.0 112.977 -176.494 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 7.0 m -64.72 -19.19 65.63 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 125.329 1.452 . . . . 0.0 113.514 175.778 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 61.1 m-20 -81.4 -18.65 44.74 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.024 0.93 . . . . 0.0 112.39 174.657 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 74.5 m -87.72 167.31 13.96 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 125.155 1.382 . . . . 0.0 113.827 -174.43 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -72.67 176.49 5.48 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 124.487 1.115 . . . . 0.0 111.077 177.973 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.53 133.26 55.92 Favored 'General case' 0 CA--C 1.539 0.556 0 O-C-N 121.08 -1.013 . . . . 0.0 113.207 -176.784 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 74.44 -8.29 14.42 Favored Glycine 0 CA--C 1.534 1.278 0 C-N-CA 124.871 1.224 . . . . 0.0 114.461 -179.851 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 62.2 m -76.87 163.66 26.54 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 114.089 1.144 . . . . 0.0 114.089 -178.893 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 21.4 m -121.72 152.91 25.61 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 C-N-CA 125.807 1.643 . . . . 0.0 110.325 168.263 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 44.8 t -88.5 104.4 16.77 Favored 'General case' 0 CA--C 1.537 0.442 0 C-N-CA 123.513 0.725 . . . . 0.0 109.878 169.55 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -70.07 166.26 50.26 Favored Glycine 0 CA--C 1.542 1.74 0 C-N-CA 124.635 1.112 . . . . 0.0 113.825 178.951 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -69.48 -18.2 38.43 Favored 'Trans proline' 0 CA--C 1.539 0.729 0 C-N-CA 124.128 3.219 . . . . 0.0 113.284 -176.419 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 52.4 p-10 -69.37 -9.93 55.66 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 124.869 1.268 . . . . 0.0 114.396 170.942 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 85.79 10.34 76.15 Favored Glycine 0 CA--C 1.533 1.169 0 C-N-CA 124.867 1.222 . . . . 0.0 114.229 -177.653 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -117.48 156.62 27.69 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.787 1.235 . . . . 0.0 112.038 174.509 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 74.3 m -76.43 152.97 36.03 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.619 1.167 . . . . 0.0 112.999 176.352 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.272 0 CA-C-O 116.909 -2.051 . . . . 0.0 113.626 176.168 . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 48.0 t . . . . . 0 CA--C 1.549 0.934 0 CA-C-O 118.121 -0.942 . . . . 0.0 112.4 . . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -62.19 155.47 56.29 Favored 'Trans proline' 0 C--N 1.354 0.845 0 C-N-CA 123.221 2.614 . . . . 0.0 112.76 175.227 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -82.3 13.84 3.31 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 114.707 1.373 . . . . 0.0 114.707 -170.522 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 10.0 tp -83.2 140.76 15.82 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 C-N-CA 125.309 1.444 . . . . 0.0 111.464 178.641 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 40.4 tp -82.82 132.0 35.18 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.801 0.84 . . . . 0.0 109.816 172.146 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 58.0 ttm -154.45 132.46 11.66 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.3 1.04 . . . . 0.0 110.512 -171.433 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 95.8 mtt-85 -79.4 155.07 28.54 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.006 0.922 . . . . 0.0 112.057 178.813 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 28.2 p -158.32 157.76 33.04 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 124.731 1.212 . . . . 0.0 113.661 -176.099 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 30.3 mtpp -112.1 -24.97 9.58 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 125.932 1.693 . . . . 0.0 111.16 169.094 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 20.8 pt20 -152.53 166.41 32.12 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 126.553 1.941 . . . . 0.0 110.485 175.803 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -61.06 -24.96 66.6 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 124.494 1.118 . . . . 0.0 112.799 -176.41 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.8 m -65.62 -18.0 65.0 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 125.654 1.582 . . . . 0.0 113.617 175.851 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 63.2 m-20 -80.83 -20.98 41.21 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 123.888 0.875 . . . . 0.0 112.19 173.152 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 77.8 m -88.46 165.41 14.92 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 125.227 1.411 . . . . 0.0 113.514 -174.185 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 50.6 mt -75.85 178.64 6.04 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 124.374 1.07 . . . . 0.0 111.922 179.375 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.19 134.63 57.24 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 121.375 -0.828 . . . . 0.0 112.721 -179.173 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 74.61 -8.38 14.66 Favored Glycine 0 CA--C 1.533 1.185 0 C-N-CA 124.678 1.133 . . . . 0.0 114.291 -178.363 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 60.6 m -81.11 158.8 24.88 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 118.646 1.223 . . . . 0.0 113.967 179.568 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 18.6 m -123.45 151.69 28.15 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 126.17 1.788 . . . . 0.0 109.765 168.057 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 48.9 t -87.2 103.0 15.0 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.296 0.638 . . . . 0.0 109.756 169.978 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -72.17 166.86 53.43 Favored Glycine 0 CA--C 1.543 1.823 0 C-N-CA 124.281 0.943 . . . . 0.0 114.017 -178.157 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -57.86 -26.19 72.86 Favored 'Trans proline' 0 C--N 1.354 0.854 0 C-N-CA 124.448 3.432 . . . . 0.0 114.736 -179.806 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 51.9 p-10 -68.44 -9.96 52.14 Favored 'General case' 0 CA--C 1.548 0.88 0 N-CA-C 114.839 1.422 . . . . 0.0 114.839 175.314 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 83.65 13.41 75.72 Favored Glycine 0 CA--C 1.533 1.216 0 C-N-CA 124.731 1.158 . . . . 0.0 113.929 -177.372 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -117.96 154.19 32.36 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.951 1.3 . . . . 0.0 112.225 174.168 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 84.6 m -74.33 145.96 43.46 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.878 1.271 . . . . 0.0 112.382 173.933 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.21 0 C-N-CA 125.991 1.758 . . . . 0.0 113.252 175.023 . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 41.9 t . . . . . 0 CA--C 1.55 0.953 0 CA-C-O 118.388 -0.815 . . . . 0.0 112.243 . . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -72.99 161.4 43.63 Favored 'Trans proline' 0 C--N 1.354 0.818 0 C-N-CA 123.125 2.55 . . . . 0.0 111.529 177.09 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 92.3 mtm-85 -77.5 29.86 0.15 Allowed 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 125.269 1.428 . . . . 0.0 113.501 -177.597 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 96.8 mt -90.37 122.97 42.33 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 126.158 1.783 . . . . 0.0 109.048 -179.325 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 37.6 tp -75.34 132.82 41.21 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 122.972 0.509 . . . . 0.0 109.642 171.415 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 59.9 tpp -153.83 128.56 9.41 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 124.372 1.069 . . . . 0.0 109.373 -174.485 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 46.3 ttt85 -83.88 144.78 28.99 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 123.381 0.673 . . . . 0.0 110.616 178.188 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 28.3 p -149.11 158.88 44.53 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 114.26 1.208 . . . . 0.0 114.26 -169.517 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -119.03 -19.57 8.41 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 126.117 1.767 . . . . 0.0 111.641 169.187 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -150.03 167.68 26.04 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 126.328 1.851 . . . . 0.0 110.534 169.994 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -61.31 -25.34 67.06 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.419 1.088 . . . . 0.0 112.663 -178.691 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 15.6 m -65.6 -15.95 63.23 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 125.182 1.393 . . . . 0.0 113.643 175.754 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 60.7 m-20 -82.1 -17.76 45.35 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 123.935 0.894 . . . . 0.0 112.456 172.82 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 75.1 m -89.55 166.47 13.64 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.032 1.333 . . . . 0.0 113.894 -172.117 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -70.92 171.61 10.42 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 124.488 1.115 . . . . 0.0 110.787 175.805 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.24 135.33 57.7 Favored 'General case' 0 CA--C 1.54 0.581 0 O-C-N 121.201 -0.937 . . . . 0.0 112.953 -177.665 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 75.92 -9.08 19.18 Favored Glycine 0 CA--C 1.534 1.276 0 C-N-CA 124.79 1.186 . . . . 0.0 114.307 -178.844 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 59.8 m -80.15 162.78 24.54 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 114.057 1.132 . . . . 0.0 114.057 179.375 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 19.1 m -123.07 153.6 28.28 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 126.319 1.847 . . . . 0.0 110.11 168.331 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 49.2 t -84.45 102.58 12.91 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 123.398 0.679 . . . . 0.0 110.178 169.978 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -71.14 169.45 49.15 Favored Glycine 0 CA--C 1.542 1.747 0 C-N-CA 124.955 1.264 . . . . 0.0 114.335 -179.592 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -70.56 -18.98 32.85 Favored 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 124.233 3.289 . . . . 0.0 113.669 -173.987 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 53.2 p-10 -70.54 -8.06 48.53 Favored 'General case' 0 CA--C 1.548 0.897 0 N-CA-C 114.271 1.211 . . . . 0.0 114.271 170.775 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 85.13 8.96 81.12 Favored Glycine 0 CA--C 1.531 1.081 0 C-N-CA 124.916 1.246 . . . . 0.0 114.06 -176.995 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -118.55 156.77 28.55 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 118.725 1.263 . . . . 0.0 112.29 174.7 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 79.7 m -75.35 147.17 40.31 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.027 1.331 . . . . 0.0 113.223 179.036 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.181 0 C-N-CA 126.017 1.77 . . . . 0.0 113.099 174.796 . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 41.9 t . . . . . 0 CA--C 1.55 0.962 0 CA-C-O 118.336 -0.84 . . . . 0.0 112.204 . . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -70.29 155.08 64.98 Favored 'Trans proline' 0 C--N 1.355 0.895 0 C-N-CA 123.047 2.498 . . . . 0.0 111.726 176.93 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.63 5.99 5.39 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 116.148 1.907 . . . . 0.0 116.148 -172.978 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 10.0 tp -73.97 139.12 19.86 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.825 0 C-N-CA 125.263 1.425 . . . . 0.0 111.334 -179.331 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 30.6 tp -81.1 136.65 35.95 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.683 0.793 . . . . 0.0 110.176 174.729 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 61.2 tpp -158.32 134.86 9.53 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.41 1.084 . . . . 0.0 109.483 -172.575 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 55.7 mtp85 -91.69 154.47 18.97 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 119.004 0.82 . . . . 0.0 112.807 175.662 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 26.4 p -154.16 158.04 39.78 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.117 1.367 . . . . 0.0 113.665 -169.933 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -109.45 -29.74 8.28 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 125.882 1.673 . . . . 0.0 110.654 168.891 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 8.0 pt20 -147.7 169.73 19.06 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 126.485 1.914 . . . . 0.0 110.718 173.603 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -61.27 -25.93 67.43 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.473 1.109 . . . . 0.0 112.844 -176.488 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 7.4 m -64.77 -18.88 65.47 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 125.303 1.441 . . . . 0.0 113.48 175.959 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 60.1 m-20 -82.02 -18.42 43.35 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 123.964 0.906 . . . . 0.0 112.347 174.577 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 77.8 m -87.35 167.16 14.29 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.91 1.284 . . . . 0.0 113.789 -174.498 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -71.57 172.42 9.65 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 124.498 1.119 . . . . 0.0 110.943 176.907 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.01 134.64 57.24 Favored 'General case' 0 CA--C 1.539 0.534 0 O-C-N 121.256 -0.903 . . . . 0.0 113.075 -177.049 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 75.76 -9.0 18.24 Favored Glycine 0 CA--C 1.533 1.209 0 C-N-CA 124.759 1.171 . . . . 0.0 114.362 -179.065 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 60.4 m -79.27 161.49 26.28 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 114.156 1.169 . . . . 0.0 114.156 179.636 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 19.2 m -120.55 153.4 23.71 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 126.316 1.846 . . . . 0.0 109.945 168.051 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 49.7 t -88.17 104.23 16.51 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 123.468 0.707 . . . . 0.0 110.275 169.955 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -70.83 168.85 49.27 Favored Glycine 0 CA--C 1.544 1.886 0 C-N-CA 124.907 1.241 . . . . 0.0 114.105 178.371 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -70.37 -20.54 31.85 Favored 'Trans proline' 0 CA--C 1.538 0.701 0 C-N-CA 124.172 3.248 . . . . 0.0 113.647 -174.432 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 50.4 p30 -71.12 -5.25 30.19 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 124.888 1.275 . . . . 0.0 114.078 170.323 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 79.18 11.55 84.94 Favored Glycine 0 CA--C 1.53 1.023 0 C-N-CA 125.156 1.36 . . . . 0.0 113.98 -178.668 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 99.7 m-85 -107.41 155.09 20.41 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 118.656 1.228 . . . . 0.0 111.89 170.503 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 84.0 m -76.98 147.33 36.92 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 125.079 1.351 . . . . 0.0 112.544 173.18 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.176 0 C-N-CA 125.711 1.624 . . . . 0.0 113.174 174.721 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.77 0 CA-C-O 121.13 0.295 . . . . 0.0 112.558 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 43.7 t -61.6 127.26 88.39 Favored Pre-proline 0 CA--C 1.551 0.984 0 C-N-CA 124.215 1.006 . . . . 0.0 112.271 -179.212 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -70.32 157.45 59.27 Favored 'Trans proline' 0 C--N 1.353 0.803 0 C-N-CA 123.119 2.546 . . . . 0.0 111.777 176.668 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -81.73 13.17 3.33 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 114.566 1.321 . . . . 0.0 114.566 -171.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 9.9 tp -80.89 141.07 15.71 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 125.566 1.547 . . . . 0.0 111.188 177.824 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 36.3 tp -79.66 139.12 37.51 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 123.687 0.795 . . . . 0.0 110.446 175.138 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 60.0 tpp -153.26 130.68 11.35 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.578 1.151 . . . . 0.0 109.67 -178.431 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 60.2 ttt180 -86.27 147.56 26.02 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.818 0.847 . . . . 0.0 110.806 179.438 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 30.2 p -154.91 161.4 41.44 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 114.517 1.303 . . . . 0.0 114.517 -169.58 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 63.2 pttt -123.4 -16.47 6.84 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 126.184 1.794 . . . . 0.0 112.012 168.469 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 8.1 pt20 -151.9 166.61 30.92 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 126.262 1.825 . . . . 0.0 110.62 171.012 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -62.3 -24.71 67.46 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 124.279 1.032 . . . . 0.0 112.977 -176.383 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.5 m -64.11 -19.2 65.1 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 125.264 1.426 . . . . 0.0 113.524 175.713 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 59.0 m-20 -79.94 -20.08 46.49 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 123.955 0.902 . . . . 0.0 112.308 174.396 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 77.6 m -88.75 165.34 14.78 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.077 1.351 . . . . 0.0 113.699 -172.411 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -72.02 172.75 9.49 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 124.567 1.147 . . . . 0.0 110.896 177.213 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.79 134.21 56.82 Favored 'General case' 0 CA--C 1.539 0.545 0 O-C-N 121.111 -0.993 . . . . 0.0 112.956 -177.33 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 75.95 -9.2 18.92 Favored Glycine 0 CA--C 1.534 1.256 0 C-N-CA 124.689 1.138 . . . . 0.0 114.323 -178.676 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 59.6 m -79.64 162.8 25.05 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 118.534 1.167 . . . . 0.0 113.976 179.038 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 19.1 m -123.61 153.27 29.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 126.332 1.853 . . . . 0.0 110.178 168.315 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 48.6 t -85.21 103.5 14.23 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 123.3 0.64 . . . . 0.0 110.006 169.898 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -70.08 168.16 47.99 Favored Glycine 0 CA--C 1.542 1.725 0 C-N-CA 124.752 1.168 . . . . 0.0 114.12 179.176 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -69.96 -18.02 36.33 Favored 'Trans proline' 0 CA--C 1.538 0.72 0 C-N-CA 124.241 3.294 . . . . 0.0 113.44 -175.166 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 53.5 p-10 -68.88 -10.81 59.07 Favored 'General case' 0 CA--C 1.548 0.874 0 N-CA-C 114.372 1.249 . . . . 0.0 114.372 170.471 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 85.52 12.8 71.81 Favored Glycine 0 CA--C 1.532 1.129 0 C-N-CA 124.83 1.205 . . . . 0.0 113.962 -176.573 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -125.08 157.4 36.38 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 118.544 1.172 . . . . 0.0 112.168 174.413 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 75.8 m -77.38 148.47 35.53 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.989 1.316 . . . . 0.0 113.386 -177.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.26 0 C-N-CA 126.035 1.778 . . . . 0.0 113.016 174.294 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.705 0 CA-C-O 121.213 0.34 . . . . 0.0 112.632 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 53.7 t -65.14 132.85 95.48 Favored Pre-proline 0 CA--C 1.549 0.928 0 O-C-N 121.696 -0.885 . . . . 0.0 112.439 -179.11 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -67.03 166.9 21.38 Favored 'Trans proline' 0 C--N 1.354 0.829 0 C-N-CA 123.302 2.668 . . . . 0.0 111.946 172.674 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 4.7 mmp_? -100.63 18.47 19.15 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.968 1.307 . . . . 0.0 113.096 179.719 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 18.7 tt -69.33 141.91 16.72 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 C-N-CA 125.009 1.324 . . . . 0.0 111.001 172.62 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 33.3 tp -79.34 129.94 34.95 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 123.265 0.626 . . . . 0.0 109.705 173.358 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 60.7 tpp -153.56 131.02 11.36 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.383 1.073 . . . . 0.0 110.196 -173.919 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -80.97 153.96 27.2 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 123.998 0.919 . . . . 0.0 111.776 177.861 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 28.7 p -158.32 156.0 29.8 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 124.408 1.083 . . . . 0.0 113.792 -175.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -111.17 -26.34 9.25 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 125.885 1.674 . . . . 0.0 111.002 168.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 8.0 pt20 -150.61 169.48 21.47 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 126.629 1.972 . . . . 0.0 110.453 173.465 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -61.39 -25.43 67.18 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 124.479 1.112 . . . . 0.0 112.875 -176.426 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 7.3 m -64.96 -18.93 65.69 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.288 1.435 . . . . 0.0 113.566 175.896 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 59.8 m-20 -81.83 -18.8 42.69 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 123.929 0.892 . . . . 0.0 112.35 174.526 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 75.1 m -86.88 167.57 14.21 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.114 1.365 . . . . 0.0 113.692 -175.125 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -72.24 175.36 6.15 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 124.527 1.131 . . . . 0.0 111.028 177.507 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.39 133.14 55.8 Favored 'General case' 0 CA--C 1.54 0.562 0 O-C-N 121.079 -1.013 . . . . 0.0 113.2 -176.107 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 74.45 -8.2 14.88 Favored Glycine 0 CA--C 1.534 1.243 0 C-N-CA 124.815 1.198 . . . . 0.0 114.529 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 61.5 m -76.55 163.8 26.55 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 114.009 1.115 . . . . 0.0 114.009 -179.25 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 21.6 m -121.68 152.17 25.33 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 125.681 1.593 . . . . 0.0 110.534 168.575 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 47.6 t -89.12 103.89 16.48 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 123.772 0.829 . . . . 0.0 109.811 169.55 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -71.94 166.55 53.33 Favored Glycine 0 CA--C 1.544 1.881 0 C-N-CA 124.333 0.968 . . . . 0.0 114.059 -178.609 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -58.12 -26.32 75.26 Favored 'Trans proline' 0 C--N 1.353 0.771 0 C-N-CA 124.407 3.404 . . . . 0.0 114.782 -178.875 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 52.5 p-10 -68.97 -9.87 54.41 Favored 'General case' 0 CA--C 1.549 0.907 0 N-CA-C 114.764 1.394 . . . . 0.0 114.764 175.792 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 83.62 13.59 75.38 Favored Glycine 0 CA--C 1.534 1.234 0 C-N-CA 124.633 1.111 . . . . 0.0 113.965 -176.826 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -118.75 155.61 30.81 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.9 1.28 . . . . 0.0 112.097 173.333 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 70.2 m -76.22 153.11 36.32 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.804 1.242 . . . . 0.0 113.134 177.276 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.219 0 CA-C-O 116.861 -2.077 . . . . 0.0 113.566 175.683 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.751 0 CA-C-O 121.069 0.261 . . . . 0.0 112.511 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 48.9 t -64.19 128.1 92.75 Favored Pre-proline 0 CA--C 1.549 0.913 0 C-N-CA 124.027 0.931 . . . . 0.0 112.34 -178.489 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -66.62 151.2 83.25 Favored 'Trans proline' 0 C--N 1.353 0.773 0 C-N-CA 122.616 2.211 . . . . 0.0 111.125 174.526 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 71.7 mmt-85 -81.95 44.79 0.86 Allowed 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 124.89 1.276 . . . . 0.0 113.109 -171.554 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 1.2 pp -79.87 168.04 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 126.004 1.721 . . . . 0.0 113.177 177.002 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 38.0 tp -118.85 66.08 0.77 Allowed 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.723 1.609 . . . . 0.0 108.139 169.569 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 63.3 tpp -94.48 126.62 39.87 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 125.095 1.358 . . . . 0.0 109.745 -172.336 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 95.5 mtt-85 -72.33 149.54 44.32 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 118.752 0.706 . . . . 0.0 111.862 178.919 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 30.0 p -154.82 157.78 38.43 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 124.278 1.031 . . . . 0.0 113.728 -176.009 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 59.5 mtmt -119.05 -20.01 8.23 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.936 1.694 . . . . 0.0 111.901 169.422 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -150.48 167.94 25.66 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 126.4 1.88 . . . . 0.0 110.506 169.853 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -61.31 -25.45 67.13 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.363 1.065 . . . . 0.0 112.668 -178.753 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 15.5 m -65.88 -15.98 63.42 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.279 1.432 . . . . 0.0 113.702 175.666 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 60.6 m-20 -81.55 -18.05 46.27 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 123.792 0.837 . . . . 0.0 112.422 172.349 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 72.2 m -91.04 165.37 13.56 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.813 1.245 . . . . 0.0 114.106 -171.448 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -73.53 174.88 7.62 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 125.211 1.405 . . . . 0.0 111.043 178.733 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.43 133.58 56.22 Favored 'General case' 0 CA--C 1.539 0.542 0 O-C-N 121.096 -1.003 . . . . 0.0 113.125 -177.355 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 75.13 -8.89 14.27 Favored Glycine 0 CA--C 1.534 1.248 0 C-N-CA 124.808 1.194 . . . . 0.0 114.329 -179.031 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 61.6 m -79.11 161.25 26.63 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 114.139 1.162 . . . . 0.0 114.139 -179.712 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 18.8 m -123.32 152.86 28.48 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 C-N-CA 126.337 1.855 . . . . 0.0 109.796 167.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 48.5 t -84.93 102.13 12.89 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.243 0.617 . . . . 0.0 110.16 170.21 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -71.77 168.24 51.74 Favored Glycine 0 CA--C 1.541 1.705 0 C-N-CA 124.774 1.178 . . . . 0.0 114.208 -179.251 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -70.09 -17.79 35.86 Favored 'Trans proline' 0 CA--C 1.539 0.736 0 C-N-CA 124.208 3.272 . . . . 0.0 113.479 -176.024 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 52.9 p-10 -69.38 -9.39 53.26 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 124.746 1.218 . . . . 0.0 114.286 171.087 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 86.24 8.67 77.85 Favored Glycine 0 CA--C 1.533 1.2 0 C-N-CA 125.11 1.338 . . . . 0.0 114.309 -177.82 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 75.0 m-85 -119.38 158.53 25.97 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 122.487 1.137 . . . . 0.0 112.317 174.573 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 68.2 m -73.52 147.39 44.07 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.094 1.358 . . . . 0.0 112.797 174.721 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.191 0 C-N-CA 125.934 1.731 . . . . 0.0 113.041 174.808 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.735 0 CA-C-O 121.051 0.251 . . . . 0.0 112.517 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 49.2 t -61.65 125.2 84.12 Favored Pre-proline 0 CA--C 1.549 0.914 0 C-N-CA 124.464 1.105 . . . . 0.0 112.797 -178.021 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_exo -55.8 142.9 82.91 Favored 'Trans proline' 0 C--N 1.353 0.804 0 C-N-CA 123.637 2.891 . . . . 0.0 112.069 170.767 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 69.3 mmt-85 -81.04 16.19 1.6 Allowed 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 114.115 1.154 . . . . 0.0 114.115 -174.327 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 17.8 tt -73.87 142.94 14.19 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 125.637 1.575 . . . . 0.0 111.317 176.318 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 37.9 tp -80.6 132.42 35.63 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.342 0.657 . . . . 0.0 109.92 172.396 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 60.9 tpp -152.58 126.06 8.78 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 124.344 1.058 . . . . 0.0 109.932 -175.904 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 1.9 tmt_? -84.72 135.78 34.0 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.971 0.908 . . . . 0.0 109.714 178.658 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 26.3 p -136.85 164.27 28.7 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 125.268 1.427 . . . . 0.0 113.144 -172.767 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -119.97 -25.96 5.69 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 125.993 1.717 . . . . 0.0 111.11 169.247 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -145.88 169.08 19.29 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 126.36 1.864 . . . . 0.0 110.411 169.74 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -60.98 -25.72 67.06 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.393 1.077 . . . . 0.0 112.685 -178.45 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 15.6 m -65.68 -16.27 63.59 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 125.227 1.411 . . . . 0.0 113.669 175.704 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 55.9 m-20 -82.91 -17.91 42.02 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 123.917 0.887 . . . . 0.0 112.386 172.751 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 72.0 m -88.48 165.59 14.78 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.858 1.263 . . . . 0.0 113.649 -174.202 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -72.47 174.08 7.92 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 124.84 1.256 . . . . 0.0 111.08 177.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.25 133.27 55.95 Favored 'General case' 0 CA--C 1.539 0.538 0 O-C-N 121.201 -0.937 . . . . 0.0 113.156 -176.427 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 74.93 -8.52 15.19 Favored Glycine 0 CA--C 1.535 1.305 0 C-N-CA 124.691 1.138 . . . . 0.0 114.413 -179.106 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 61.3 m -79.29 161.74 26.09 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 118.466 1.133 . . . . 0.0 113.987 179.59 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 19.1 m -122.56 153.72 27.36 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 126.336 1.854 . . . . 0.0 110.19 168.605 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 48.3 t -86.33 102.26 13.84 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 123.61 0.764 . . . . 0.0 109.998 169.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -72.62 167.9 53.33 Favored Glycine 0 CA--C 1.542 1.767 0 C-N-CA 124.368 0.985 . . . . 0.0 114.3 -177.262 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_exo -58.27 -26.96 79.1 Favored 'Trans proline' 0 C--N 1.354 0.858 0 C-N-CA 124.499 3.466 . . . . 0.0 114.989 -177.578 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 53.0 p-10 -69.51 -9.55 54.31 Favored 'General case' 0 CA--C 1.546 0.791 0 N-CA-C 114.7 1.37 . . . . 0.0 114.7 175.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 85.95 10.08 76.15 Favored Glycine 0 CA--C 1.531 1.087 0 C-N-CA 124.772 1.177 . . . . 0.0 114.006 -176.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -119.96 156.55 30.61 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.68 1.192 . . . . 0.0 112.152 174.747 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 78.7 m -75.2 148.26 39.69 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.663 1.185 . . . . 0.0 113.243 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.115 0 C-N-CA 126.012 1.767 . . . . 0.0 113.067 174.573 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.78 0 N-CA-C 112.245 -0.342 . . . . 0.0 112.245 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 47.8 t -62.37 128.24 90.99 Favored Pre-proline 0 CA--C 1.548 0.904 0 C-N-CA 124.135 0.974 . . . . 0.0 112.472 -179.149 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -64.81 147.48 89.58 Favored 'Trans proline' 0 C--N 1.354 0.821 0 C-N-CA 123.153 2.569 . . . . 0.0 111.384 171.766 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 6.0 tpm_? -81.71 54.45 2.41 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-O 122.206 1.003 . . . . 0.0 111.815 178.807 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 19.3 tt -81.07 151.91 4.36 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 C-N-CA 125.729 1.612 . . . . 0.0 111.105 173.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 39.7 tp -95.37 73.44 3.29 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.817 0.847 . . . . 0.0 108.721 169.44 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 60.0 tpp -102.54 116.09 31.9 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.627 1.171 . . . . 0.0 109.363 -176.453 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 61.0 ttt180 -77.82 143.6 37.73 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 123.325 0.65 . . . . 0.0 110.52 178.466 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 30.3 p -150.02 158.31 44.03 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 114.158 1.17 . . . . 0.0 114.158 -169.775 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 59.2 mtmt -119.63 -19.35 8.12 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 126.699 2.0 . . . . 0.0 111.57 169.307 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 19.3 pt20 -148.61 159.06 44.45 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 126.62 1.968 . . . . 0.0 110.246 179.332 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -63.08 -25.53 68.41 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.094 0.958 . . . . 0.0 112.387 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 17.8 m -67.67 -13.41 62.07 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.897 1.279 . . . . 0.0 113.566 175.069 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 51.5 m-20 -80.91 -19.4 44.39 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 123.81 0.844 . . . . 0.0 111.952 171.468 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 79.0 m -90.66 165.43 13.72 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 125.52 1.528 . . . . 0.0 113.763 -172.775 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 34.6 mt -76.33 -178.55 4.62 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.357 1.063 . . . . 0.0 111.88 179.635 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.63 134.28 56.93 Favored 'General case' 0 CA--C 1.539 0.527 0 O-C-N 121.253 -0.904 . . . . 0.0 112.96 -179.611 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 74.41 -8.46 13.52 Favored Glycine 0 CA--C 1.534 1.255 0 C-N-CA 124.775 1.179 . . . . 0.0 114.281 -178.528 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 63.9 m -81.76 159.62 23.79 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 114.288 1.218 . . . . 0.0 114.288 -178.322 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 18.0 m -124.52 154.98 32.29 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 126.774 2.03 . . . . 0.0 109.634 167.937 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 48.2 t -84.05 102.26 12.37 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 121.341 0.591 . . . . 0.0 110.188 169.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -71.72 169.03 50.92 Favored Glycine 0 CA--C 1.542 1.763 0 C-N-CA 124.987 1.28 . . . . 0.0 114.379 -178.383 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -70.74 -18.41 32.45 Favored 'Trans proline' 0 CA--C 1.537 0.672 0 C-N-CA 124.262 3.308 . . . . 0.0 113.67 -174.202 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 52.6 p-10 -69.68 -10.04 56.69 Favored 'General case' 0 CA--C 1.548 0.899 0 N-CA-C 114.192 1.182 . . . . 0.0 114.192 171.21 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 87.5 8.54 73.9 Favored Glycine 0 CA--C 1.533 1.178 0 C-N-CA 124.952 1.263 . . . . 0.0 114.208 -177.139 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 76.9 m-85 -122.58 159.84 26.95 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 118.69 1.245 . . . . 0.0 111.779 173.573 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 77.5 m -70.7 153.79 42.47 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.262 1.025 . . . . 0.0 113.215 179.263 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.154 0 C-N-CA 126.035 1.778 . . . . 0.0 113.165 175.973 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.726 0 CA-C-O 121.09 0.272 . . . . 0.0 112.464 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 40.5 t -64.64 124.23 85.55 Favored Pre-proline 0 CA--C 1.546 0.801 0 CA-C-O 117.9 -1.048 . . . . 0.0 112.539 -178.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -68.65 146.07 65.81 Favored 'Trans proline' 0 C--N 1.353 0.765 0 C-N-CA 123.017 2.478 . . . . 0.0 110.633 175.421 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 15.8 mmm180 -83.83 16.13 2.94 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 113.782 1.03 . . . . 0.0 113.782 -171.034 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 10.0 tp -68.19 141.66 17.34 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 125.489 1.516 . . . . 0.0 111.341 177.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 30.9 tp -75.9 131.99 40.0 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 123.359 0.663 . . . . 0.0 110.152 175.877 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 61.1 tpp -155.48 132.77 10.93 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.827 1.251 . . . . 0.0 109.851 -174.791 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 87.4 mtm180 -81.16 152.68 27.63 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.923 0.889 . . . . 0.0 111.603 177.746 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 29.4 p -157.38 155.29 30.29 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 113.961 1.097 . . . . 0.0 113.961 -175.865 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 64.8 tttm -110.53 -28.68 8.4 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 126.023 1.729 . . . . 0.0 110.726 168.967 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 8.1 pt20 -147.84 169.75 19.11 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 126.426 1.89 . . . . 0.0 110.601 172.541 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -61.35 -25.33 67.08 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 124.6 1.16 . . . . 0.0 112.918 -176.528 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 8.0 m -65.25 -18.59 65.43 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 125.157 1.383 . . . . 0.0 113.627 175.686 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 60.4 m-20 -81.73 -18.52 44.03 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 123.928 0.891 . . . . 0.0 112.368 174.398 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 73.6 m -86.9 168.02 13.79 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.118 1.367 . . . . 0.0 113.648 -175.579 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -71.17 173.72 7.3 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 124.415 1.086 . . . . 0.0 110.919 176.863 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.0 132.89 55.36 Favored 'General case' 0 CA--C 1.54 0.581 0 O-C-N 121.16 -0.962 . . . . 0.0 113.213 -175.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 74.42 -8.45 13.59 Favored Glycine 0 CA--C 1.534 1.247 0 C-N-CA 124.829 1.204 . . . . 0.0 114.512 -179.599 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 66.7 m -75.29 162.59 28.3 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 118.5 1.15 . . . . 0.0 113.915 -179.6 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 23.3 m -118.84 151.47 21.04 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 125.319 1.448 . . . . 0.0 110.816 168.697 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 43.7 t -89.38 104.76 17.29 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 123.725 0.81 . . . . 0.0 109.783 169.439 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -70.24 166.97 49.97 Favored Glycine 0 CA--C 1.543 1.81 0 C-N-CA 124.563 1.078 . . . . 0.0 113.842 179.043 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -69.43 -18.14 38.71 Favored 'Trans proline' 0 CA--C 1.539 0.76 0 C-N-CA 124.046 3.164 . . . . 0.0 113.357 -176.499 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 51.3 p-10 -69.22 -9.96 55.49 Favored 'General case' 0 CA--C 1.549 0.933 0 N-CA-C 114.414 1.265 . . . . 0.0 114.414 170.609 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 84.7 12.7 74.36 Favored Glycine 0 CA--C 1.533 1.218 0 C-N-CA 124.838 1.209 . . . . 0.0 114.096 -176.942 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -119.6 155.35 32.43 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.773 1.229 . . . . 0.0 112.403 175.02 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 69.7 m -76.75 154.92 33.61 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.941 1.297 . . . . 0.0 113.319 177.359 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.309 0 C-N-CA 125.711 1.624 . . . . 0.0 113.779 175.072 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.767 0 CA-C-O 121.075 0.264 . . . . 0.0 112.469 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 52.9 t -64.48 128.5 93.44 Favored Pre-proline 0 CA--C 1.55 0.966 0 C-N-CA 123.966 0.906 . . . . 0.0 112.306 -178.807 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -71.83 147.99 51.21 Favored 'Trans proline' 0 C--N 1.353 0.811 0 C-N-CA 123.279 2.653 . . . . 0.0 111.16 173.695 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -84.53 17.76 2.55 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 114.166 1.173 . . . . 0.0 114.166 -172.859 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 8.9 tp -69.81 138.62 21.73 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 125.065 1.346 . . . . 0.0 111.118 175.345 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 31.5 tp -78.94 115.41 18.61 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 123.441 0.696 . . . . 0.0 109.882 177.141 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 81.6 mmm -137.17 126.09 24.21 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 125.672 1.589 . . . . 0.0 108.929 -177.468 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 25.4 ttt85 -86.77 144.99 26.81 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 118.632 0.651 . . . . 0.0 111.297 -179.443 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 24.5 p -146.66 160.56 42.04 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 125.502 1.521 . . . . 0.0 113.544 -169.205 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 61.4 mtpt -112.21 -24.72 9.68 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 125.845 1.658 . . . . 0.0 111.373 169.231 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 20.9 pt20 -152.71 166.63 31.55 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 126.397 1.879 . . . . 0.0 110.599 176.569 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -61.16 -25.07 66.76 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 124.257 1.023 . . . . 0.0 112.811 -176.318 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.8 m -65.54 -18.01 65.0 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 125.662 1.585 . . . . 0.0 113.573 176.016 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 63.0 m-20 -81.42 -19.14 43.13 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 123.991 0.917 . . . . 0.0 112.228 173.317 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 75.8 m -89.22 167.34 13.16 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.211 1.404 . . . . 0.0 113.621 -174.474 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.469 HD22 ' H ' ' A' ' 16' ' ' LEU . 0.9 OUTLIER -74.86 177.98 5.86 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 124.373 1.069 . . . . 0.0 111.206 179.623 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.47 133.7 56.34 Favored 'General case' 0 CA--C 1.539 0.547 0 O-C-N 121.186 -0.946 . . . . 0.0 112.923 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 74.77 -9.41 11.18 Favored Glycine 0 CA--C 1.533 1.186 0 C-N-CA 124.81 1.195 . . . . 0.0 114.399 -179.104 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 64.0 m -79.48 161.53 26.0 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 118.555 1.177 . . . . 0.0 113.969 -179.417 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 18.7 m -124.2 153.36 30.49 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 C-N-CA 126.313 1.845 . . . . 0.0 110.147 168.186 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 45.0 t -85.67 102.97 14.06 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.371 0.669 . . . . 0.0 109.8 169.835 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -71.53 172.16 45.82 Favored Glycine 0 CA--C 1.542 1.764 0 C-N-CA 125.133 1.349 . . . . 0.0 114.602 -177.948 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -70.37 -21.23 30.92 Favored 'Trans proline' 0 CA--C 1.538 0.712 0 C-N-CA 124.28 3.32 . . . . 0.0 113.604 -173.728 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 51.0 p-10 -70.95 -7.04 43.24 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 124.718 1.207 . . . . 0.0 113.97 169.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 83.72 8.46 84.48 Favored Glycine 0 CA--C 1.53 1.029 0 C-N-CA 125.389 1.471 . . . . 0.0 114.056 -177.567 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -112.18 155.82 23.32 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 119.195 1.498 . . . . 0.0 112.337 176.139 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 81.1 m -73.88 146.0 44.39 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.452 1.101 . . . . 0.0 112.8 176.935 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.189 0 C-N-CA 125.972 1.749 . . . . 0.0 113.11 174.927 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.792 0 N-CA-C 112.342 -0.303 . . . . 0.0 112.342 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 45.5 t -59.9 127.3 85.3 Favored Pre-proline 0 CA--C 1.549 0.91 0 C-N-CA 124.342 1.057 . . . . 0.0 112.187 -179.362 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -71.62 160.97 46.77 Favored 'Trans proline' 0 C--N 1.354 0.858 0 C-N-CA 123.106 2.537 . . . . 0.0 111.701 178.029 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 52.4 ttp180 -78.89 60.42 2.85 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 125.002 1.321 . . . . 0.0 111.474 -179.395 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 88.0 mt -125.52 122.47 62.6 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 126.551 1.941 . . . . 0.0 108.764 -177.356 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 40.3 tp -79.75 134.42 36.37 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.509 0.723 . . . . 0.0 109.544 170.928 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 59.4 tpp -157.45 135.17 10.68 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.231 1.012 . . . . 0.0 110.022 -170.813 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 27.6 mmt180 -77.3 153.56 33.76 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.633 0.773 . . . . 0.0 111.833 174.284 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 29.7 p -157.7 159.85 37.33 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 114.17 1.174 . . . . 0.0 114.17 -177.119 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 17.3 tppt? -118.34 -24.82 6.75 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 126.233 1.813 . . . . 0.0 111.036 169.026 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -148.73 170.19 18.75 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 126.26 1.824 . . . . 0.0 111.022 169.969 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -63.57 -25.44 68.24 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 124.85 1.26 . . . . 0.0 113.49 -173.722 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 77.7 p -73.09 -10.55 59.91 Favored 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 113.817 1.043 . . . . 0.0 113.817 175.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 62.8 m-20 -80.07 -20.91 44.06 Favored 'General case' 0 CA--C 1.543 0.708 0 O-C-N 121.336 -0.853 . . . . 0.0 111.601 169.241 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 71.5 m -85.88 167.28 15.28 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.242 1.417 . . . . 0.0 113.863 -174.808 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -70.23 170.35 11.84 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 124.21 1.004 . . . . 0.0 110.702 175.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.16 135.3 57.68 Favored 'General case' 0 CA--C 1.539 0.52 0 O-C-N 121.202 -0.936 . . . . 0.0 112.87 -177.951 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 76.2 -8.84 22.39 Favored Glycine 0 CA--C 1.534 1.248 0 C-N-CA 124.712 1.149 . . . . 0.0 114.352 -178.621 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 59.3 m -80.13 162.69 24.61 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 118.472 1.136 . . . . 0.0 113.988 178.401 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 19.4 m -121.28 154.13 25.04 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 126.206 1.802 . . . . 0.0 110.146 168.287 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 49.4 t -87.66 103.79 15.91 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 123.462 0.705 . . . . 0.0 110.178 169.919 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -70.6 167.68 50.04 Favored Glycine 0 CA--C 1.543 1.784 0 C-N-CA 124.714 1.15 . . . . 0.0 114.05 178.736 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -69.99 -18.77 35.74 Favored 'Trans proline' 0 CA--C 1.538 0.701 0 C-N-CA 124.12 3.213 . . . . 0.0 113.564 -175.127 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 52.6 p-10 -70.59 -8.04 48.58 Favored 'General case' 0 CA--C 1.548 0.899 0 N-CA-C 114.323 1.231 . . . . 0.0 114.323 171.17 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 81.93 12.37 81.28 Favored Glycine 0 CA--C 1.533 1.17 0 C-N-CA 124.893 1.235 . . . . 0.0 113.994 -177.759 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -113.79 157.93 21.64 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.848 1.259 . . . . 0.0 111.76 170.501 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 77.7 m -77.28 149.56 35.37 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.21 1.404 . . . . 0.0 113.088 174.369 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.298 0 C-N-CA 125.947 1.736 . . . . 0.0 113.153 173.972 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.775 0 CA-C-O 121.288 0.382 . . . . 0.0 112.503 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 36.3 t -64.78 125.75 89.56 Favored Pre-proline 0 CA--C 1.547 0.844 0 CA-C-O 118.163 -0.922 . . . . 0.0 112.461 -178.601 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -66.77 151.21 82.92 Favored 'Trans proline' 0 C--N 1.353 0.797 0 C-N-CA 123.203 2.602 . . . . 0.0 111.845 178.685 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 6.7 mmp_? -82.54 14.36 3.13 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 124.77 1.228 . . . . 0.0 114.058 -177.083 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 10.2 tp -71.78 142.74 15.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 C-N-CA 125.302 1.441 . . . . 0.0 111.223 177.822 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 26.9 tp -76.93 131.98 38.82 Favored 'General case' 0 CA--C 1.538 0.485 0 O-C-N 121.791 -0.568 . . . . 0.0 110.15 175.357 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 61.2 tpp -154.47 126.47 7.72 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 125.056 1.342 . . . . 0.0 108.773 -178.319 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 25.9 ttt85 -88.93 146.64 24.79 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 118.392 0.542 . . . . 0.0 111.259 -178.909 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 26.2 p -150.84 160.08 44.12 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.269 1.427 . . . . 0.0 113.685 -169.091 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 61.7 mtpt -116.67 -20.79 9.4 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 126.35 1.86 . . . . 0.0 111.301 169.03 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 19.5 pt20 -147.8 160.29 42.91 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 126.941 2.097 . . . . 0.0 110.201 177.493 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -62.23 -26.03 68.14 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 124.25 1.02 . . . . 0.0 112.439 -179.779 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 17.0 m -67.85 -13.85 62.48 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 124.881 1.272 . . . . 0.0 113.664 175.544 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 48.3 m-20 -82.32 -19.69 38.88 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.747 0.819 . . . . 0.0 112.117 172.523 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 81.7 m -85.86 168.88 13.84 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.308 1.443 . . . . 0.0 113.83 -173.591 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -71.64 175.65 5.46 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 124.468 1.107 . . . . 0.0 111.049 176.822 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.29 133.0 55.68 Favored 'General case' 0 CA--C 1.54 0.566 0 O-C-N 121.064 -1.023 . . . . 0.0 113.338 -176.044 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 74.02 -8.3 12.57 Favored Glycine 0 CA--C 1.535 1.288 0 C-N-CA 124.891 1.234 . . . . 0.0 114.559 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 66.4 m -75.78 162.52 28.11 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 114.238 1.199 . . . . 0.0 114.238 -178.074 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 20.3 m -120.57 151.25 23.39 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 125.579 1.551 . . . . 0.0 110.493 168.298 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 49.4 t -87.09 103.64 15.57 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 123.586 0.754 . . . . 0.0 109.8 169.727 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -71.74 171.7 47.1 Favored Glycine 0 CA--C 1.543 1.827 0 C-N-CA 125.063 1.316 . . . . 0.0 114.446 -178.48 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -70.43 -21.04 30.92 Favored 'Trans proline' 0 CA--C 1.539 0.733 0 C-N-CA 124.262 3.308 . . . . 0.0 113.634 -173.872 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 50.7 p-10 -70.69 -7.04 41.66 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 124.749 1.22 . . . . 0.0 113.987 169.883 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.86 10.35 83.17 Favored Glycine 0 CA--C 1.529 0.946 0 C-N-CA 125.24 1.4 . . . . 0.0 113.866 -177.048 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -113.52 154.24 27.41 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 119.374 1.587 . . . . 0.0 112.444 175.659 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 69.9 m -74.76 151.18 39.16 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.969 1.308 . . . . 0.0 113.063 177.628 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.353 0 C-N-CA 125.647 1.594 . . . . 0.0 113.864 175.132 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.705 0 N-CA-C 112.395 -0.282 . . . . 0.0 112.395 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 42.0 t -61.73 129.05 91.18 Favored Pre-proline 0 CA--C 1.55 0.952 0 C-N-CA 124.186 0.994 . . . . 0.0 112.244 -179.466 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -71.35 163.33 39.47 Favored 'Trans proline' 0 C--N 1.353 0.792 0 C-N-CA 123.315 2.677 . . . . 0.0 111.865 176.327 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 18.5 ptp180 -72.94 16.3 0.16 Allowed 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 115.175 1.546 . . . . 0.0 115.175 -176.853 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 89.4 mt -80.36 119.94 30.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 125.768 1.627 . . . . 0.0 109.656 -176.741 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 36.9 tp -81.88 132.32 35.27 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.729 0.812 . . . . 0.0 109.652 170.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 59.9 ttm -160.97 136.21 7.74 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.664 1.185 . . . . 0.0 109.598 -171.433 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 56.8 mtp85 -84.89 152.26 23.69 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 118.876 0.762 . . . . 0.0 112.556 175.944 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 24.9 p -151.32 156.83 41.59 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.206 1.402 . . . . 0.0 113.672 -169.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 28.4 ttpp -102.37 -29.63 11.53 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 126.205 1.802 . . . . 0.0 110.539 168.838 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 20.1 pt20 -155.94 166.7 32.7 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 126.364 1.866 . . . . 0.0 110.648 -177.484 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -60.89 -25.69 66.89 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 124.303 1.041 . . . . 0.0 112.647 -176.643 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.4 m -64.14 -18.84 64.83 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 125.834 1.654 . . . . 0.0 113.576 176.168 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 63.2 m-20 -81.48 -22.15 38.23 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.004 0.921 . . . . 0.0 112.387 174.591 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 73.0 m -86.32 167.34 14.87 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.059 1.344 . . . . 0.0 113.844 -171.297 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.413 HD22 ' H ' ' A' ' 16' ' ' LEU . 1.8 mm? -70.81 172.37 8.96 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 124.261 1.024 . . . . 0.0 111.048 176.389 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.07 135.88 57.85 Favored 'General case' 0 CA--C 1.539 0.537 0 O-C-N 121.273 -0.892 . . . . 0.0 112.88 -179.188 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 75.75 -9.25 17.37 Favored Glycine 0 CA--C 1.533 1.207 0 C-N-CA 124.776 1.179 . . . . 0.0 114.265 -178.554 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 59.6 m -80.78 161.63 24.43 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 118.652 1.226 . . . . 0.0 114.023 179.479 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 18.7 m -123.27 153.2 28.52 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 C-N-CA 126.272 1.829 . . . . 0.0 110.091 168.383 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 49.1 t -87.57 103.7 15.8 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 123.386 0.675 . . . . 0.0 109.871 169.764 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -71.5 170.4 48.45 Favored Glycine 0 CA--C 1.542 1.743 0 C-N-CA 124.884 1.23 . . . . 0.0 114.197 -179.288 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -69.67 -20.56 35.11 Favored 'Trans proline' 0 CA--C 1.538 0.71 0 C-N-CA 124.247 3.298 . . . . 0.0 113.453 -175.817 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 49.3 p30 -70.31 -6.8 37.71 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 125.014 1.326 . . . . 0.0 114.053 169.924 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 79.9 12.64 83.22 Favored Glycine 0 CA--C 1.531 1.033 0 C-N-CA 125.188 1.375 . . . . 0.0 114.066 -178.408 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -109.05 153.56 23.47 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 118.613 1.207 . . . . 0.0 112.239 172.218 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 78.2 m -73.17 145.2 46.5 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.883 1.273 . . . . 0.0 112.238 170.013 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.238 0 C-N-CA 125.95 1.738 . . . . 0.0 113.207 175.813 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.652 0 CA-C-O 121.019 0.233 . . . . 0.0 112.608 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 51.6 t -60.43 126.18 83.91 Favored Pre-proline 0 CA--C 1.549 0.937 0 C-N-CA 124.503 1.121 . . . . 0.0 112.645 -179.202 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_exo -57.71 145.87 87.87 Favored 'Trans proline' 0 C--N 1.354 0.858 0 C-N-CA 123.83 3.02 . . . . 0.0 112.645 171.815 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 34.0 ptt-85 -79.99 12.61 2.66 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 115.358 1.614 . . . . 0.0 115.358 -173.617 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 10.2 tp -75.11 142.21 14.88 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 125.223 1.409 . . . . 0.0 111.484 178.659 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 30.4 tp -81.04 133.82 35.55 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 123.577 0.751 . . . . 0.0 109.988 173.725 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 61.5 tpp -158.6 133.51 8.33 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.458 1.103 . . . . 0.0 109.516 -172.478 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 55.6 mtp85 -91.31 154.64 19.09 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 118.955 0.798 . . . . 0.0 112.879 175.954 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 26.4 p -154.88 159.25 40.36 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.196 1.398 . . . . 0.0 113.83 -169.798 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 65.0 mttp -111.63 -26.05 9.22 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 125.991 1.717 . . . . 0.0 111.028 168.804 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 21.0 pt20 -150.97 166.99 28.97 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 126.565 1.946 . . . . 0.0 110.513 175.503 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -60.76 -25.9 66.84 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 124.524 1.13 . . . . 0.0 112.73 -176.043 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.9 m -65.41 -18.1 65.05 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 125.653 1.581 . . . . 0.0 113.61 176.31 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 62.2 m-20 -82.0 -19.26 40.87 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 123.971 0.909 . . . . 0.0 112.327 173.806 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 75.0 m -87.02 167.08 14.55 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.921 1.289 . . . . 0.0 113.903 -173.498 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -71.34 172.99 8.4 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 124.741 1.217 . . . . 0.0 110.925 177.181 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.24 133.36 56.03 Favored 'General case' 0 CA--C 1.539 0.543 0 O-C-N 121.195 -0.94 . . . . 0.0 113.162 -175.908 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 74.83 -8.54 14.72 Favored Glycine 0 CA--C 1.534 1.267 0 C-N-CA 124.657 1.122 . . . . 0.0 114.45 -179.464 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 61.2 m -78.65 160.99 27.25 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 114.067 1.136 . . . . 0.0 114.067 179.798 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 18.8 m -120.24 154.54 23.35 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 126.258 1.823 . . . . 0.0 110.205 168.447 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 43.3 t -88.17 104.13 16.41 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 123.618 0.767 . . . . 0.0 110.28 170.019 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -70.72 169.15 48.51 Favored Glycine 0 CA--C 1.543 1.802 0 C-N-CA 124.911 1.243 . . . . 0.0 114.179 178.454 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -70.52 -20.67 30.97 Favored 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 124.228 3.285 . . . . 0.0 113.695 -174.137 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 50.5 p30 -71.35 -5.15 30.3 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 124.952 1.301 . . . . 0.0 114.058 170.397 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 79.28 11.17 85.28 Favored Glycine 0 CA--C 1.53 1.027 0 C-N-CA 125.12 1.343 . . . . 0.0 114.007 -178.636 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -106.99 155.05 20.21 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 118.652 1.226 . . . . 0.0 111.885 170.548 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 83.3 m -76.23 147.37 38.39 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.983 1.313 . . . . 0.0 112.606 173.272 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.181 0 C-N-CA 125.815 1.674 . . . . 0.0 113.279 175.26 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.71 0 N-CA-C 112.378 -0.289 . . . . 0.0 112.378 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 45.9 t -60.11 126.26 83.35 Favored Pre-proline 0 CA--C 1.551 0.995 0 C-N-CA 124.571 1.149 . . . . 0.0 112.586 -179.011 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -56.77 146.18 79.08 Favored 'Trans proline' 0 C--N 1.354 0.866 0 C-N-CA 123.947 3.098 . . . . 0.0 112.872 172.059 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 82.1 mtp180 -84.72 14.1 5.07 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 114.404 1.261 . . . . 0.0 114.404 -172.112 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 10.2 tp -77.63 143.4 12.89 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 C-N-CA 125.176 1.39 . . . . 0.0 111.144 176.353 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 29.4 tp -78.21 135.26 37.56 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 123.189 0.596 . . . . 0.0 110.22 174.648 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 61.2 tpp -154.16 126.61 8.0 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 124.78 1.232 . . . . 0.0 108.973 -177.919 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 25.1 ttt85 -89.61 147.4 23.94 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 118.452 0.569 . . . . 0.0 111.037 179.158 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 26.1 p -152.19 165.66 34.15 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.884 1.274 . . . . 0.0 114.309 -168.469 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 21.5 pttp -122.41 -14.4 7.85 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 126.072 1.749 . . . . 0.0 112.123 168.079 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 20.0 pt20 -155.45 162.35 40.77 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 126.642 1.977 . . . . 0.0 110.351 178.183 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 26.7 m-20 -62.23 -24.52 67.29 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.911 0.884 . . . . 0.0 112.606 -177.102 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.3 m -64.21 -18.57 64.64 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 125.82 1.648 . . . . 0.0 113.58 176.327 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 64.6 m-20 -80.78 -20.52 42.44 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.12 0.968 . . . . 0.0 112.388 174.4 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 73.8 m -89.77 165.92 13.87 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.983 1.313 . . . . 0.0 113.897 -169.951 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -72.56 174.95 6.78 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 124.763 1.225 . . . . 0.0 111.07 177.841 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.43 133.23 55.91 Favored 'General case' 0 CA--C 1.541 0.606 0 O-C-N 121.089 -1.007 . . . . 0.0 113.104 -176.228 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 74.73 -8.64 13.8 Favored Glycine 0 CA--C 1.535 1.311 0 C-N-CA 124.687 1.137 . . . . 0.0 114.408 -179.447 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 60.6 m -79.16 161.99 26.07 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 114.082 1.141 . . . . 0.0 114.082 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 18.2 m -124.92 154.42 32.8 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 126.433 1.893 . . . . 0.0 110.197 168.577 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 36.9 t -83.77 102.25 12.17 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 123.303 0.641 . . . . 0.0 110.372 170.338 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -71.91 172.25 46.74 Favored Glycine 0 CA--C 1.542 1.781 0 C-N-CA 125.339 1.447 . . . . 0.0 114.62 -179.092 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -71.38 -20.94 27.04 Favored 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 124.33 3.353 . . . . 0.0 113.973 -172.127 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 52.6 p-10 -71.96 -5.18 32.96 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 124.576 1.15 . . . . 0.0 113.899 170.416 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 83.47 5.92 88.07 Favored Glycine 0 CA--C 1.53 0.98 0 C-N-CA 125.497 1.522 . . . . 0.0 114.029 -177.694 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -109.5 155.97 20.68 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 119.195 1.497 . . . . 0.0 112.163 174.599 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 82.7 m -73.47 145.8 45.42 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.839 1.256 . . . . 0.0 112.804 176.308 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.206 0 C-N-CA 126.063 1.792 . . . . 0.0 113.146 175.905 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.688 0 N-CA-C 112.284 -0.326 . . . . 0.0 112.284 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 48.0 t -60.94 130.73 91.33 Favored Pre-proline 0 CA--C 1.55 0.964 0 C-N-CA 124.199 0.999 . . . . 0.0 112.396 -179.399 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -62.93 160.65 32.62 Favored 'Trans proline' 0 C--N 1.354 0.827 0 C-N-CA 123.288 2.659 . . . . 0.0 112.848 175.165 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 40.4 ptt180 -74.13 13.94 0.49 Allowed 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 114.865 1.431 . . . . 0.0 114.865 179.519 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 94.6 mt -86.32 122.21 38.4 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 126.352 1.861 . . . . 0.0 109.558 -174.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 47.7 tp -76.74 134.31 39.21 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.666 0.786 . . . . 0.0 109.872 171.915 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 57.6 ttm -157.57 132.17 8.52 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.342 1.057 . . . . 0.0 110.186 -173.592 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 57.4 ttt180 -82.71 147.98 28.16 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.723 0.809 . . . . 0.0 111.089 -179.65 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 26.3 p -151.17 158.5 44.05 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.548 1.139 . . . . 0.0 113.687 -170.034 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 58.9 mtmt -109.3 -27.32 9.58 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.815 1.646 . . . . 0.0 111.344 169.505 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 8.0 pt20 -153.41 169.47 23.06 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 126.399 1.88 . . . . 0.0 110.818 176.109 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -61.45 -25.71 67.4 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.406 1.083 . . . . 0.0 112.887 -176.489 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 7.2 m -64.8 -18.65 65.29 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 125.296 1.438 . . . . 0.0 113.484 175.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 62.0 m-20 -80.42 -21.18 42.44 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 123.909 0.883 . . . . 0.0 112.21 173.843 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 77.4 m -88.08 166.75 14.21 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 125.237 1.415 . . . . 0.0 113.662 -173.303 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 40.1 mt -74.4 177.37 5.98 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.47 1.108 . . . . 0.0 111.726 178.496 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.23 134.47 57.09 Favored 'General case' 0 CA--C 1.54 0.559 0 O-C-N 121.305 -0.872 . . . . 0.0 112.855 -179.786 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 74.67 -8.33 15.21 Favored Glycine 0 CA--C 1.535 1.292 0 C-N-CA 124.698 1.142 . . . . 0.0 114.314 -178.461 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 60.7 m -81.22 159.76 24.48 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 118.553 1.177 . . . . 0.0 113.993 179.496 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 18.2 m -124.48 151.63 29.88 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 126.251 1.82 . . . . 0.0 110.003 168.288 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 49.7 t -85.69 102.2 13.41 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.355 0.662 . . . . 0.0 109.561 169.92 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -72.65 170.11 51.44 Favored Glycine 0 CA--C 1.544 1.858 0 C-N-CA 124.411 1.005 . . . . 0.0 114.242 -176.167 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -57.9 -26.78 75.94 Favored 'Trans proline' 0 C--N 1.353 0.807 0 C-N-CA 124.518 3.479 . . . . 0.0 114.757 -178.815 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 52.0 p-10 -68.6 -11.37 59.92 Favored 'General case' 0 CA--C 1.548 0.9 0 N-CA-C 114.676 1.361 . . . . 0.0 114.676 174.951 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 84.25 14.56 71.31 Favored Glycine 0 CA--C 1.533 1.177 0 C-N-CA 124.799 1.19 . . . . 0.0 114.019 -176.335 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 64.8 m-85 -123.05 155.33 37.11 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.739 1.216 . . . . 0.0 112.225 175.142 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 85.7 m -73.91 145.19 44.97 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.116 1.366 . . . . 0.0 112.761 178.889 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.284 0 C-N-CA 126.111 1.815 . . . . 0.0 113.076 175.265 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.664 0 CA-C-O 121.186 0.326 . . . . 0.0 112.593 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 40.4 t -64.56 124.53 86.33 Favored Pre-proline 0 CA--C 1.546 0.826 0 CA-C-O 117.905 -1.045 . . . . 0.0 112.542 -178.707 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -67.74 146.31 72.3 Favored 'Trans proline' 0 C--N 1.353 0.813 0 C-N-CA 122.994 2.463 . . . . 0.0 110.676 175.185 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 15.3 mmm180 -83.45 17.04 2.29 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 113.48 0.919 . . . . 0.0 113.48 -173.16 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 19.4 tt -66.28 141.74 17.65 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 125.954 1.702 . . . . 0.0 111.616 178.702 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 26.5 tp -77.0 130.26 37.23 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.315 0.646 . . . . 0.0 109.975 175.313 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 61.7 tpp -160.14 132.49 6.35 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.806 1.242 . . . . 0.0 109.098 -172.762 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 55.2 mtp85 -91.14 155.35 18.69 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 118.944 0.793 . . . . 0.0 113.088 177.456 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 26.6 p -155.67 157.38 36.58 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.401 1.48 . . . . 0.0 113.407 -170.136 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 64.9 mttp -110.51 -26.22 9.61 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 125.598 1.559 . . . . 0.0 110.936 168.863 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 8.1 pt20 -149.99 169.28 21.57 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 126.5 1.92 . . . . 0.0 110.386 173.185 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -61.18 -25.57 67.12 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 124.533 1.133 . . . . 0.0 112.919 -176.513 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 7.1 m -64.88 -19.1 65.73 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 125.315 1.446 . . . . 0.0 113.605 175.862 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 60.3 m-20 -82.18 -18.46 42.66 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 123.929 0.892 . . . . 0.0 112.366 174.878 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 79.1 m -86.66 168.51 13.54 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.069 1.348 . . . . 0.0 113.706 -175.412 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -71.1 173.84 7.08 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 124.557 1.143 . . . . 0.0 110.992 176.805 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.94 132.76 54.94 Favored 'General case' 0 CA--C 1.54 0.573 0 O-C-N 121.115 -0.991 . . . . 0.0 113.236 -175.615 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 74.25 -8.33 13.44 Favored Glycine 0 CA--C 1.534 1.265 0 C-N-CA 124.87 1.224 . . . . 0.0 114.539 -179.827 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 67.4 m -75.42 162.32 28.47 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 114.041 1.126 . . . . 0.0 114.041 -179.205 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 22.4 m -118.43 151.99 20.56 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 125.463 1.505 . . . . 0.0 110.7 168.666 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 48.5 t -90.3 105.15 17.62 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.826 0.85 . . . . 0.0 109.999 169.488 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -70.74 168.81 49.07 Favored Glycine 0 CA--C 1.541 1.708 0 C-N-CA 124.742 1.163 . . . . 0.0 114.127 178.586 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -70.01 -20.53 33.56 Favored 'Trans proline' 0 CA--C 1.538 0.713 0 C-N-CA 124.187 3.258 . . . . 0.0 113.58 -175.151 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 49.1 p30 -70.65 -5.96 33.41 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 125.071 1.349 . . . . 0.0 114.099 169.986 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 78.83 13.45 83.1 Favored Glycine 0 CA--C 1.531 1.039 0 C-N-CA 125.109 1.337 . . . . 0.0 113.917 -178.289 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -109.04 153.82 23.09 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 118.629 1.215 . . . . 0.0 111.995 171.159 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 82.5 m -76.59 154.02 34.8 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.998 1.319 . . . . 0.0 112.847 173.765 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.185 0 CA-C-O 116.653 -2.193 . . . . 0.0 113.952 175.472 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.72 0 CA-C-O 121.121 0.289 . . . . 0.0 112.559 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 42.3 t -61.0 127.22 87.43 Favored Pre-proline 0 CA--C 1.549 0.932 0 C-N-CA 124.413 1.085 . . . . 0.0 112.19 -179.516 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_endo -72.69 163.77 37.53 Favored 'Trans proline' 0 C--N 1.353 0.804 0 C-N-CA 123.132 2.555 . . . . 0.0 111.74 177.755 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 10.7 ptm85 -73.04 15.56 0.2 Allowed 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 115.109 1.522 . . . . 0.0 115.109 -178.55 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 91.6 mt -79.77 120.07 30.4 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 125.834 1.654 . . . . 0.0 109.349 -177.828 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 36.3 tp -76.82 135.11 38.91 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 123.388 0.675 . . . . 0.0 109.602 171.085 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 60.8 tpp -160.01 134.58 7.65 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.315 1.046 . . . . 0.0 109.365 -169.921 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 53.9 mtp85 -88.93 152.82 21.5 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 119.187 0.903 . . . . 0.0 112.418 174.625 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 26.4 p -153.8 159.87 42.04 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 125.004 1.322 . . . . 0.0 113.866 -169.636 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 61.3 mtpt -113.94 -24.2 9.2 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 126.18 1.792 . . . . 0.0 111.158 168.846 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 21.0 pt20 -151.0 166.46 30.64 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 126.544 1.938 . . . . 0.0 110.434 175.099 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -61.29 -25.47 67.13 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 124.332 1.053 . . . . 0.0 112.721 -176.23 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.8 m -65.42 -17.77 64.8 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 125.636 1.574 . . . . 0.0 113.641 176.233 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 63.5 m-20 -81.79 -18.71 43.15 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 123.985 0.914 . . . . 0.0 112.302 173.87 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 74.2 m -87.98 168.01 13.22 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.952 1.301 . . . . 0.0 114.133 -172.416 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -70.57 171.16 10.74 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 124.399 1.08 . . . . 0.0 110.742 175.733 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.13 134.8 57.4 Favored 'General case' 0 CA--C 1.539 0.543 0 O-C-N 121.171 -0.956 . . . . 0.0 113.018 -177.177 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 75.82 -8.82 19.7 Favored Glycine 0 CA--C 1.534 1.238 0 C-N-CA 124.814 1.197 . . . . 0.0 114.338 -179.172 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 60.5 m -79.48 162.07 25.67 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 114.131 1.16 . . . . 0.0 114.131 179.427 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 19.0 m -122.14 153.44 26.5 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 126.308 1.843 . . . . 0.0 110.128 168.338 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 41.1 t -86.91 102.61 14.51 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.6 0.76 . . . . 0.0 110.358 170.479 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -73.47 168.98 53.66 Favored Glycine 0 CA--C 1.545 1.94 0 C-N-CA 124.628 1.109 . . . . 0.0 114.499 -178.799 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -59.03 -28.6 88.32 Favored 'Trans proline' 0 C--N 1.354 0.822 0 C-N-CA 124.532 3.488 . . . . 0.0 115.129 -176.284 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 51.3 p30 -71.03 -4.79 26.78 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 125.06 1.344 . . . . 0.0 114.446 175.719 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 78.83 11.53 85.13 Favored Glycine 0 CA--C 1.531 1.054 0 C-N-CA 124.941 1.257 . . . . 0.0 113.918 -178.384 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -107.33 155.33 20.1 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 118.49 1.145 . . . . 0.0 111.796 169.857 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 83.7 m -76.36 145.97 39.1 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.03 1.332 . . . . 0.0 112.587 172.944 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.249 0 C-N-CA 125.906 1.717 . . . . 0.0 113.223 175.261 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.767 0 CA-C-O 121.091 0.273 . . . . 0.0 112.469 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 53.4 t -60.77 127.42 87.24 Favored Pre-proline 0 CA--C 1.551 1.013 0 C-N-CA 124.473 1.109 . . . . 0.0 112.497 -179.276 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -56.93 153.3 38.54 Favored 'Trans proline' 0 C--N 1.353 0.787 0 C-N-CA 124.059 3.173 . . . . 0.0 113.152 171.312 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -78.92 38.4 0.33 Allowed 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 125.194 1.398 . . . . 0.0 112.692 179.721 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 86.7 mt -101.69 121.89 53.2 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 C-N-CA 126.366 1.866 . . . . 0.0 109.185 -176.28 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 37.5 tp -81.29 131.47 35.29 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 123.695 0.798 . . . . 0.0 109.646 171.837 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 60.3 ttm -160.1 135.31 8.03 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.644 1.178 . . . . 0.0 110.213 -171.881 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 30.3 mmt180 -73.57 153.44 40.23 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.588 0.755 . . . . 0.0 112.016 175.604 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 29.0 p -157.63 160.14 37.73 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.421 1.088 . . . . 0.0 113.71 -176.888 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 16.9 tppt? -117.23 -25.82 6.97 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 126.712 2.005 . . . . 0.0 111.035 169.155 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -144.38 159.96 41.85 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 126.583 1.953 . . . . 0.0 110.478 178.385 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -62.36 -26.59 68.54 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 124.31 1.044 . . . . 0.0 112.318 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 17.6 m -67.83 -13.18 61.92 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 124.98 1.312 . . . . 0.0 113.571 175.358 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 51.7 m-20 -80.67 -22.48 40.4 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 118.892 0.769 . . . . 0.0 111.914 171.49 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 73.1 m -86.38 167.78 14.43 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.398 1.479 . . . . 0.0 113.642 -172.601 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.408 HD22 ' H ' ' A' ' 16' ' ' LEU . 1.9 mm? -70.18 172.05 8.72 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.247 1.019 . . . . 0.0 111.157 176.403 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.54 135.21 57.6 Favored 'General case' 0 CA--C 1.539 0.541 0 O-C-N 121.231 -0.918 . . . . 0.0 112.902 -179.06 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 75.37 -9.03 15.32 Favored Glycine 0 CA--C 1.533 1.196 0 C-N-CA 124.716 1.151 . . . . 0.0 114.286 -178.683 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 60.4 m -80.62 161.34 24.75 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 118.604 1.202 . . . . 0.0 113.731 178.839 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 18.7 m -122.01 154.63 26.57 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 C-N-CA 126.256 1.823 . . . . 0.0 110.196 168.797 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 47.2 t -88.3 103.78 16.13 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.405 0.682 . . . . 0.0 109.661 169.524 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -71.16 168.53 50.44 Favored Glycine 0 CA--C 1.542 1.756 0 C-N-CA 124.591 1.091 . . . . 0.0 113.938 -178.985 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -69.29 -18.95 38.97 Favored 'Trans proline' 0 CA--C 1.538 0.723 0 C-N-CA 124.091 3.194 . . . . 0.0 113.254 -176.831 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 50.9 p-10 -69.44 -9.2 52.63 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 124.892 1.277 . . . . 0.0 114.312 170.196 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 81.99 13.82 78.56 Favored Glycine 0 CA--C 1.533 1.191 0 C-N-CA 125.019 1.295 . . . . 0.0 114.042 -177.779 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -115.17 155.12 27.74 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.027 1.331 . . . . 0.0 112.003 172.832 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 74.8 m -73.07 146.33 45.9 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.88 1.272 . . . . 0.0 112.584 171.429 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.209 0 C-N-CA 125.97 1.748 . . . . 0.0 113.235 175.131 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.739 0 CA-C-O 121.032 0.24 . . . . 0.0 112.576 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 53.0 t -62.89 127.05 90.08 Favored Pre-proline 0 CA--C 1.55 0.951 0 C-N-CA 124.134 0.974 . . . . 0.0 112.356 -178.972 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -69.86 151.97 68.67 Favored 'Trans proline' 0 C--N 1.353 0.814 0 C-N-CA 123.041 2.494 . . . . 0.0 111.412 174.497 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -81.85 15.5 2.21 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.704 1.202 . . . . 0.0 113.882 -176.403 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 18.0 tt -72.98 142.73 14.68 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 125.598 1.559 . . . . 0.0 111.2 176.344 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 30.0 tp -79.23 134.79 36.66 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 123.128 0.571 . . . . 0.0 110.228 174.646 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 60.5 tpp -153.65 127.3 8.74 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 124.775 1.23 . . . . 0.0 109.408 -179.109 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 45.8 ttt85 -85.5 147.18 26.57 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.747 0.819 . . . . 0.0 111.015 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 29.3 p -156.76 165.48 36.12 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 114.351 1.241 . . . . 0.0 114.351 -169.374 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 21.9 pttp -126.16 -12.7 6.31 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 126.292 1.837 . . . . 0.0 112.122 168.149 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 17.4 pt20 -157.39 161.76 39.01 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 126.394 1.878 . . . . 0.0 110.811 178.838 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 33.8 m-20 -65.57 -25.3 67.36 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 124.154 0.982 . . . . 0.0 113.441 -171.05 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 58.8 p -72.88 -9.44 58.69 Favored 'General case' 0 CA--C 1.546 0.792 0 N-CA-C 113.695 0.998 . . . . 0.0 113.695 175.831 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 66.4 m-20 -78.01 -23.54 48.25 Favored 'General case' 0 N--CA 1.473 0.724 0 O-C-N 121.299 -0.876 . . . . 0.0 111.315 168.822 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 73.2 m -87.79 166.42 14.62 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.508 1.523 . . . . 0.0 113.795 -171.242 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -71.55 172.54 9.41 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 124.609 1.164 . . . . 0.0 111.032 177.525 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.17 133.06 55.75 Favored 'General case' 0 CA--C 1.538 0.511 0 O-C-N 121.241 -0.912 . . . . 0.0 113.164 -176.305 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 75.64 -9.26 16.52 Favored Glycine 0 CA--C 1.534 1.279 0 C-N-CA 124.781 1.181 . . . . 0.0 114.339 -178.909 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 60.8 m -78.71 163.39 25.45 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 118.547 1.173 . . . . 0.0 113.969 179.354 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 18.3 m -124.18 154.5 31.17 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 C-N-CA 126.354 1.862 . . . . 0.0 110.211 168.389 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 45.5 t -85.33 103.65 14.45 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 123.186 0.594 . . . . 0.0 110.123 169.822 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -70.03 168.95 46.77 Favored Glycine 0 CA--C 1.544 1.858 0 C-N-CA 124.871 1.224 . . . . 0.0 114.15 179.33 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -70.13 -18.62 35.16 Favored 'Trans proline' 0 CA--C 1.538 0.697 0 C-N-CA 124.16 3.24 . . . . 0.0 113.612 -174.333 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 52.9 p-10 -69.77 -9.06 53.13 Favored 'General case' 0 CA--C 1.548 0.897 0 N-CA-C 114.278 1.214 . . . . 0.0 114.278 170.473 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 84.61 11.62 77.01 Favored Glycine 0 CA--C 1.532 1.123 0 C-N-CA 124.837 1.208 . . . . 0.0 113.938 -176.607 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -121.44 155.83 34.03 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 118.632 1.216 . . . . 0.0 112.289 175.086 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 84.8 m -75.41 147.7 39.75 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.789 1.236 . . . . 0.0 113.2 -179.549 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.199 0 C-N-CA 126.123 1.82 . . . . 0.0 113.038 174.517 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.744 0 CA-C-O 121.07 0.261 . . . . 0.0 112.506 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 53.2 t -60.4 126.57 84.81 Favored Pre-proline 0 CA--C 1.55 0.96 0 C-N-CA 124.518 1.127 . . . . 0.0 112.551 -179.219 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo -58.4 154.33 42.08 Favored 'Trans proline' 0 C--N 1.355 0.878 0 C-N-CA 123.832 3.022 . . . . 0.0 113.156 172.676 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 95.7 mtt-85 -79.1 40.2 0.4 Allowed 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 125.037 1.335 . . . . 0.0 112.346 177.497 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 88.8 mt -104.34 123.4 58.18 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 126.627 1.971 . . . . 0.0 108.835 -177.043 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 41.0 tp -76.23 133.83 40.0 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.188 0.595 . . . . 0.0 109.837 172.598 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 59.6 tpp -155.58 130.11 9.05 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 124.461 1.104 . . . . 0.0 109.662 -174.427 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 60.7 ttt180 -83.29 146.15 28.7 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.583 0.753 . . . . 0.0 110.566 178.448 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 28.6 p -152.43 159.15 43.42 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 114.703 1.371 . . . . 0.0 114.703 -169.6 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 63.2 tttp -112.54 -28.91 7.66 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 126.594 1.957 . . . . 0.0 110.793 168.974 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 21.0 pt20 -149.44 166.76 28.13 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 126.194 1.797 . . . . 0.0 110.745 177.999 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -61.27 -25.27 66.97 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.183 0.993 . . . . 0.0 112.765 -175.987 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.8 m -65.35 -17.84 64.84 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 125.589 1.556 . . . . 0.0 113.567 176.165 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 62.4 m-20 -81.68 -18.81 43.18 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.086 0.955 . . . . 0.0 112.307 173.588 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 75.7 m -88.38 166.94 13.91 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.992 1.317 . . . . 0.0 113.955 -172.746 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -71.23 172.97 8.34 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 124.563 1.145 . . . . 0.0 110.952 176.342 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.5 133.53 56.18 Favored 'General case' 0 CA--C 1.54 0.564 0 O-C-N 121.143 -0.973 . . . . 0.0 113.145 -176.601 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 74.77 -8.62 14.05 Favored Glycine 0 CA--C 1.535 1.291 0 C-N-CA 124.572 1.082 . . . . 0.0 114.427 -179.372 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 60.3 m -78.96 162.21 26.14 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 118.448 1.124 . . . . 0.0 113.859 179.075 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 18.3 m -122.88 154.26 28.14 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 126.103 1.761 . . . . 0.0 110.361 168.716 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 48.7 t -84.96 103.12 13.72 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 123.491 0.716 . . . . 0.0 110.128 169.9 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -69.92 168.73 46.73 Favored Glycine 0 CA--C 1.543 1.824 0 C-N-CA 124.888 1.233 . . . . 0.0 114.093 179.626 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -69.8 -18.45 36.82 Favored 'Trans proline' 0 CA--C 1.537 0.662 0 C-N-CA 124.241 3.294 . . . . 0.0 113.503 -174.903 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 53.4 p-10 -69.54 -9.91 55.88 Favored 'General case' 0 CA--C 1.549 0.911 0 N-CA-C 114.33 1.233 . . . . 0.0 114.33 170.697 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 85.19 11.75 75.13 Favored Glycine 0 CA--C 1.533 1.163 0 C-N-CA 124.885 1.231 . . . . 0.0 114.083 -176.722 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 67.1 m-85 -123.98 157.24 34.83 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.751 1.22 . . . . 0.0 112.218 174.734 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 86.3 m -76.34 148.4 37.47 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.997 1.319 . . . . 0.0 113.49 -177.902 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.24 0 C-N-CA 126.111 1.815 . . . . 0.0 113.039 174.677 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.728 0 N-CA-C 112.478 -0.249 . . . . 0.0 112.478 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 37.5 t -63.58 125.02 86.56 Favored Pre-proline 0 CA--C 1.546 0.816 0 C-N-CA 124.097 0.959 . . . . 0.0 112.56 -178.585 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -69.6 151.8 70.04 Favored 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 122.915 2.41 . . . . 0.0 111.205 178.138 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 6.8 mmp_? -78.52 34.16 0.21 Allowed 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.829 1.251 . . . . 0.0 113.109 -178.27 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 96.6 mt -80.5 126.05 39.41 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 125.717 1.607 . . . . 0.0 109.003 177.789 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 37.6 tp -74.05 126.13 29.83 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 172.292 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 61.0 tpp -154.68 130.97 10.4 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.503 1.121 . . . . 0.0 109.68 -171.273 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 83.8 mtt85 -80.45 151.43 29.31 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.74 0.816 . . . . 0.0 111.48 177.035 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 29.4 p -156.51 155.13 31.45 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 113.983 1.105 . . . . 0.0 113.983 -174.132 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -109.82 -28.78 8.61 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 126.337 1.855 . . . . 0.0 110.562 168.796 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 20.9 pt20 -148.77 167.0 26.76 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 126.479 1.912 . . . . 0.0 110.665 176.156 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -61.27 -24.76 66.63 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 124.452 1.101 . . . . 0.0 112.768 -176.289 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.9 m -65.85 -17.84 64.92 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 125.583 1.553 . . . . 0.0 113.667 175.918 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 62.5 m-20 -81.62 -18.58 44.2 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.066 0.946 . . . . 0.0 112.343 173.898 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 72.8 m -87.66 168.74 12.74 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.28 1.432 . . . . 0.0 113.946 -173.695 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -70.7 174.59 5.77 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 124.311 1.044 . . . . 0.0 110.91 175.968 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.48 133.42 56.08 Favored 'General case' 0 CA--C 1.54 0.565 0 O-C-N 120.994 -1.066 . . . . 0.0 113.146 -176.988 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 74.51 -8.14 15.43 Favored Glycine 0 CA--C 1.535 1.287 0 C-N-CA 124.876 1.227 . . . . 0.0 114.474 179.764 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 66.2 m -75.95 162.77 27.81 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 114.127 1.158 . . . . 0.0 114.127 -178.762 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 22.9 m -119.9 151.12 22.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 125.233 1.413 . . . . 0.0 110.705 168.602 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 44.1 t -87.51 104.09 16.15 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.698 0.799 . . . . 0.0 109.667 169.438 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -70.77 167.69 50.52 Favored Glycine 0 CA--C 1.542 1.726 0 C-N-CA 124.636 1.112 . . . . 0.0 113.992 179.849 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -69.57 -18.45 37.87 Favored 'Trans proline' 0 CA--C 1.539 0.765 0 C-N-CA 124.146 3.231 . . . . 0.0 113.346 -176.11 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 52.3 p-10 -69.53 -9.66 54.86 Favored 'General case' 0 CA--C 1.548 0.891 0 N-CA-C 114.347 1.24 . . . . 0.0 114.347 170.711 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 84.92 11.72 75.99 Favored Glycine 0 CA--C 1.533 1.157 0 C-N-CA 124.889 1.233 . . . . 0.0 114.127 -177.05 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -118.86 155.65 30.85 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.886 1.274 . . . . 0.0 112.376 174.86 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 70.2 m -76.0 153.85 36.2 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.076 1.351 . . . . 0.0 113.255 176.722 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.276 0 CA-C-O 116.765 -2.131 . . . . 0.0 113.979 174.965 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.754 0 CA-C-O 121.076 0.264 . . . . 0.0 112.473 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 47.3 t -60.4 126.2 83.87 Favored Pre-proline 0 CA--C 1.551 0.998 0 C-N-CA 124.559 1.143 . . . . 0.0 112.621 -179.416 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -56.42 150.07 52.95 Favored 'Trans proline' 0 C--N 1.353 0.795 0 C-N-CA 124.075 3.183 . . . . 0.0 113.125 171.143 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -79.53 37.97 0.36 Allowed 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 125.117 1.367 . . . . 0.0 113.009 -177.143 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 48.2 mm -98.41 123.99 51.28 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 126.12 1.768 . . . . 0.0 109.777 -177.994 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 36.5 tp -81.52 129.33 34.62 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 123.586 0.754 . . . . 0.0 109.624 171.198 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 60.2 ttm -160.9 136.59 8.06 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.811 1.244 . . . . 0.0 109.574 -171.768 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 57.2 mtp85 -85.46 152.53 23.13 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 118.819 0.736 . . . . 0.0 112.708 176.776 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 25.0 p -151.74 159.55 43.92 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.367 1.467 . . . . 0.0 113.374 -169.854 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 31.5 mmmt -110.15 -26.19 9.79 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 125.877 1.671 . . . . 0.0 111.368 169.191 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 8.5 pt20 -152.78 168.9 24.17 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 126.332 1.853 . . . . 0.0 110.742 175.367 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -61.21 -26.21 67.57 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 124.382 1.073 . . . . 0.0 112.78 -176.525 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 6.6 m -64.58 -18.69 65.12 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 125.374 1.469 . . . . 0.0 113.508 176.264 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 62.6 m-20 -80.58 -20.72 42.68 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 123.921 0.888 . . . . 0.0 112.286 174.282 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 72.1 m -87.45 168.02 13.47 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.109 1.364 . . . . 0.0 113.797 -172.684 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -70.3 172.02 8.93 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 124.357 1.063 . . . . 0.0 111.048 176.152 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.29 134.29 56.87 Favored 'General case' 0 CA--C 1.539 0.522 0 O-C-N 121.246 -0.909 . . . . 0.0 113.061 -177.793 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 75.04 -8.78 14.21 Favored Glycine 0 CA--C 1.534 1.238 0 C-N-CA 124.641 1.115 . . . . 0.0 114.411 -179.215 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 60.8 m -79.3 161.29 26.38 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 118.477 1.139 . . . . 0.0 113.794 178.814 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 19.1 m -121.7 154.21 25.87 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 126.182 1.793 . . . . 0.0 110.412 168.759 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 48.2 t -88.25 103.94 16.26 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.603 0.761 . . . . 0.0 110.001 169.724 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -70.96 169.98 47.87 Favored Glycine 0 CA--C 1.543 1.786 0 C-N-CA 124.926 1.25 . . . . 0.0 114.195 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -69.89 -20.56 34.07 Favored 'Trans proline' 0 CA--C 1.539 0.726 0 C-N-CA 124.163 3.242 . . . . 0.0 113.442 -175.221 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 49.2 p30 -70.63 -6.34 36.15 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 125.023 1.329 . . . . 0.0 114.023 169.97 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 79.75 12.38 83.62 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 125.271 1.415 . . . . 0.0 114.116 -178.348 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -108.51 153.68 23.0 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.77 1.228 . . . . 0.0 112.15 172.089 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 76.2 m -73.53 146.1 45.07 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.86 1.264 . . . . 0.0 112.603 171.1 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.271 0 C-N-CA 125.981 1.753 . . . . 0.0 113.303 175.557 . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.675 0 N-CA-C 112.325 -0.31 . . . . 0.0 112.325 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 44.7 t -59.85 126.91 84.55 Favored Pre-proline 0 CA--C 1.55 0.959 0 C-N-CA 124.349 1.06 . . . . 0.0 112.138 -179.299 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -70.24 155.13 65.06 Favored 'Trans proline' 0 C--N 1.354 0.82 0 C-N-CA 122.962 2.442 . . . . 0.0 111.762 178.184 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 59.2 ttt85 -79.56 89.63 5.1 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.07 0.948 . . . . 0.0 110.621 179.118 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 9.2 tp -160.31 142.04 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 126.351 1.86 . . . . 0.0 110.437 -178.43 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 33.4 tp -86.8 136.74 32.88 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 123.963 0.905 . . . . 0.0 110.127 175.091 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 60.7 tpp -155.53 134.74 12.28 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.501 1.12 . . . . 0.0 110.055 -175.405 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 91.3 mtm-85 -81.38 152.16 27.6 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.131 0.972 . . . . 0.0 111.49 176.621 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 30.1 p -157.97 156.36 31.07 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 114.316 1.228 . . . . 0.0 114.316 -175.237 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 62.7 tttp -111.41 -29.08 7.93 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 126.456 1.902 . . . . 0.0 110.533 168.718 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 21.0 pt20 -148.14 166.98 26.23 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 126.535 1.934 . . . . 0.0 110.58 175.645 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -60.97 -25.33 66.77 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 124.502 1.121 . . . . 0.0 112.806 -176.192 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.9 m -65.46 -17.96 64.95 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.591 1.556 . . . . 0.0 113.669 175.837 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 61.8 m-20 -82.03 -19.47 40.34 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 123.964 0.906 . . . . 0.0 112.29 173.628 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 71.3 m -86.49 166.81 15.19 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.999 1.32 . . . . 0.0 113.607 -174.724 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -70.62 170.41 12.3 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 124.233 1.013 . . . . 0.0 110.76 176.26 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.9 134.95 57.52 Favored 'General case' 0 CA--C 1.539 0.533 0 O-C-N 121.273 -0.892 . . . . 0.0 112.885 -177.706 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 76.36 -9.06 22.41 Favored Glycine 0 CA--C 1.534 1.243 0 C-N-CA 124.698 1.142 . . . . 0.0 114.289 -178.541 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 58.8 m -79.91 162.61 24.88 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 118.567 1.184 . . . . 0.0 113.897 178.18 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 19.6 m -121.3 153.79 25.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 126.254 1.822 . . . . 0.0 110.206 168.419 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 48.9 t -87.83 104.17 16.33 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 123.552 0.741 . . . . 0.0 110.122 169.761 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -69.97 166.92 49.32 Favored Glycine 0 CA--C 1.542 1.739 0 C-N-CA 124.661 1.124 . . . . 0.0 113.875 178.277 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -69.83 -18.11 36.89 Favored 'Trans proline' 0 C--N 1.352 0.712 0 C-N-CA 124.204 3.269 . . . . 0.0 113.479 -175.444 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 53.1 p-10 -69.81 -9.28 54.07 Favored 'General case' 0 CA--C 1.548 0.87 0 N-CA-C 114.433 1.271 . . . . 0.0 114.433 171.185 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 84.85 11.6 76.46 Favored Glycine 0 CA--C 1.535 1.305 0 C-N-CA 124.813 1.197 . . . . 0.0 114.021 -177.036 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -119.16 156.28 30.11 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.701 1.2 . . . . 0.0 112.28 174.091 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 74.1 m -77.13 149.98 35.62 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.98 1.312 . . . . 0.0 113.258 177.732 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.271 0 C-N-CA 125.904 1.716 . . . . 0.0 113.097 174.015 . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.727 0 N-CA-C 112.227 -0.349 . . . . 0.0 112.227 . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 43.7 t -60.66 126.91 86.19 Favored Pre-proline 0 CA--C 1.55 0.964 0 C-N-CA 124.342 1.057 . . . . 0.0 112.264 -179.097 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -73.25 159.6 46.78 Favored 'Trans proline' 0 C--N 1.353 0.792 0 C-N-CA 123.099 2.533 . . . . 0.0 111.399 176.751 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -78.11 33.46 0.19 Allowed 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 125.286 1.434 . . . . 0.0 113.251 -177.861 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 97.5 mt -91.67 123.24 43.73 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 126.099 1.76 . . . . 0.0 108.837 179.641 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 37.3 tp -75.03 132.21 41.16 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 172.055 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 60.2 tpp -154.0 127.7 8.75 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 124.474 1.11 . . . . 0.0 109.406 -174.547 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 46.6 ttt85 -83.58 145.06 29.07 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.413 0.685 . . . . 0.0 110.555 178.112 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 28.0 p -149.97 158.88 44.61 Favored 'General case' 0 N--CA 1.469 0.525 0 N-CA-C 114.489 1.292 . . . . 0.0 114.489 -169.401 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -111.76 -28.85 7.92 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 126.516 1.926 . . . . 0.0 110.721 168.907 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 21.0 pt20 -149.35 166.74 28.1 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 126.29 1.836 . . . . 0.0 110.773 177.728 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -61.31 -25.25 67.0 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 124.236 1.014 . . . . 0.0 112.8 -176.184 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.8 m -65.33 -17.8 64.8 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 125.604 1.561 . . . . 0.0 113.576 176.052 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 63.3 m-20 -81.49 -18.63 44.49 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.133 0.973 . . . . 0.0 112.278 173.662 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 73.9 m -88.76 166.89 13.74 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.977 1.311 . . . . 0.0 114.123 -172.319 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -70.6 171.64 9.96 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 124.522 1.129 . . . . 0.0 110.836 175.701 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.23 135.25 57.67 Favored 'General case' 0 CA--C 1.538 0.511 0 O-C-N 121.178 -0.951 . . . . 0.0 112.939 -177.764 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 75.88 -9.2 18.46 Favored Glycine 0 CA--C 1.533 1.211 0 C-N-CA 124.809 1.195 . . . . 0.0 114.341 -178.797 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 59.8 m -80.18 162.96 24.42 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 114.185 1.18 . . . . 0.0 114.185 179.462 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 18.5 m -123.59 153.97 29.55 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 126.364 1.866 . . . . 0.0 110.088 168.222 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 49.0 t -84.32 102.52 12.76 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 123.408 0.683 . . . . 0.0 110.233 169.993 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -70.93 169.67 48.3 Favored Glycine 0 CA--C 1.542 1.779 0 C-N-CA 124.91 1.243 . . . . 0.0 114.383 -179.556 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -70.53 -19.05 32.96 Favored 'Trans proline' 0 CA--C 1.538 0.7 0 C-N-CA 124.207 3.271 . . . . 0.0 113.66 -173.819 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 53.2 p-10 -70.6 -8.12 49.24 Favored 'General case' 0 CA--C 1.548 0.889 0 N-CA-C 114.211 1.189 . . . . 0.0 114.211 170.849 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 85.25 8.97 80.69 Favored Glycine 0 CA--C 1.532 1.101 0 C-N-CA 124.974 1.274 . . . . 0.0 114.056 -176.993 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -118.62 156.78 28.61 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 118.676 1.238 . . . . 0.0 112.255 174.836 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 84.0 m -75.03 147.01 41.09 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.976 1.31 . . . . 0.0 113.169 179.168 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.189 0 C-N-CA 126.104 1.811 . . . . 0.0 113.097 174.937 . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.76 0 CA-C-O 121.137 0.299 . . . . 0.0 112.54 . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 42.7 t -62.15 127.99 90.29 Favored Pre-proline 0 CA--C 1.549 0.911 0 C-N-CA 124.285 1.034 . . . . 0.0 112.408 -178.688 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_exo -61.8 154.99 57.09 Favored 'Trans proline' 0 C--N 1.354 0.841 0 C-N-CA 123.132 2.554 . . . . 0.0 112.121 174.551 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 75.4 mmt-85 -81.64 15.87 1.97 Allowed 'General case' 0 CA--C 1.546 0.795 0 N-CA-C 114.06 1.133 . . . . 0.0 114.06 -175.747 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 1.8 mp -82.12 127.35 39.7 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 125.764 1.625 . . . . 0.0 108.753 177.68 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 35.2 tp -75.32 136.32 40.85 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 123.576 0.75 . . . . 0.0 110.131 173.988 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 60.5 tpp -154.63 133.41 12.19 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.309 1.043 . . . . 0.0 110.231 -171.693 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 27.0 mmt180 -77.13 154.51 33.15 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.754 0.822 . . . . 0.0 111.948 174.691 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 28.8 p -158.23 157.52 32.76 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 113.946 1.091 . . . . 0.0 113.946 -177.509 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -113.37 -24.69 9.19 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 126.239 1.816 . . . . 0.0 110.986 168.779 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 20.9 pt20 -151.68 166.45 31.24 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 126.717 2.007 . . . . 0.0 110.402 175.3 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -61.19 -24.94 66.69 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.417 1.087 . . . . 0.0 112.886 -176.43 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.9 m -65.64 -17.82 64.87 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 125.553 1.541 . . . . 0.0 113.59 175.952 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 63.0 m-20 -81.36 -19.13 43.39 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 123.933 0.893 . . . . 0.0 112.275 173.382 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 73.7 m -88.66 165.98 14.41 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.934 1.294 . . . . 0.0 113.834 -173.339 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 26.1 mt -73.94 177.78 5.38 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 124.524 1.13 . . . . 0.0 111.399 179.0 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.82 133.36 56.02 Favored 'General case' 0 CA--C 1.539 0.552 0 O-C-N 121.268 -0.895 . . . . 0.0 112.923 -178.439 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 74.28 -8.06 14.71 Favored Glycine 0 CA--C 1.535 1.287 0 C-N-CA 124.708 1.147 . . . . 0.0 114.433 -179.53 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 61.8 m -79.38 160.54 26.65 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 118.512 1.156 . . . . 0.0 114.021 179.825 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 19.2 m -122.89 153.25 27.8 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 126.351 1.86 . . . . 0.0 110.096 168.393 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 49.9 t -87.15 102.87 14.87 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.45 0.7 . . . . 0.0 110.058 169.965 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -72.83 167.53 53.86 Favored Glycine 0 CA--C 1.543 1.831 0 C-N-CA 124.417 1.008 . . . . 0.0 114.142 -178.508 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -58.36 -26.79 78.89 Favored 'Trans proline' 0 C--N 1.354 0.818 0 C-N-CA 124.383 3.389 . . . . 0.0 114.902 -178.268 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 52.4 p-10 -69.72 -8.59 49.25 Favored 'General case' 0 CA--C 1.548 0.883 0 N-CA-C 114.685 1.365 . . . . 0.0 114.685 176.016 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 81.14 13.96 79.97 Favored Glycine 0 CA--C 1.533 1.18 0 C-N-CA 124.722 1.154 . . . . 0.0 113.903 -177.676 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -114.35 157.46 22.78 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.848 1.259 . . . . 0.0 111.531 169.955 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 81.5 m -76.55 147.79 37.49 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.858 1.263 . . . . 0.0 112.763 173.523 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.228 0 C-N-CA 125.973 1.749 . . . . 0.0 113.186 174.708 . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.727 0 CA-C-O 121.038 0.243 . . . . 0.0 112.576 . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 49.2 t -60.75 124.29 78.6 Favored Pre-proline 0 CA--C 1.549 0.91 0 C-N-CA 124.496 1.118 . . . . 0.0 112.307 -178.96 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -73.48 161.35 42.58 Favored 'Trans proline' 0 C--N 1.354 0.839 0 C-N-CA 122.9 2.4 . . . . 0.0 111.218 177.273 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -80.8 32.8 0.31 Allowed 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 124.618 1.167 . . . . 0.0 113.91 -170.999 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 45.9 mm -88.34 123.99 41.1 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 125.947 1.699 . . . . 0.0 109.769 179.673 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 42.6 tp -76.8 130.7 38.02 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 169.949 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 60.8 tpp -155.57 132.62 10.75 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.199 1.0 . . . . 0.0 110.068 -170.625 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 83.9 mtt85 -81.21 151.12 28.32 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.804 0.842 . . . . 0.0 111.343 175.771 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 29.3 p -156.14 158.17 37.21 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 114.27 1.211 . . . . 0.0 114.27 -173.284 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -119.5 -19.9 7.99 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 126.144 1.778 . . . . 0.0 111.674 169.099 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -149.61 167.86 25.18 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 126.39 1.876 . . . . 0.0 110.509 169.908 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -61.26 -25.55 67.16 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 124.362 1.065 . . . . 0.0 112.647 -178.514 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 15.7 m -65.62 -16.07 63.36 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 125.304 1.442 . . . . 0.0 113.676 175.946 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 60.3 m-20 -82.06 -18.09 44.36 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 123.888 0.875 . . . . 0.0 112.464 172.83 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 72.9 m -89.77 167.13 13.12 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.008 1.323 . . . . 0.0 113.859 -172.214 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -70.26 170.34 11.9 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 124.466 1.106 . . . . 0.0 110.843 175.862 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.84 134.7 57.28 Favored 'General case' 0 CA--C 1.538 0.512 0 O-C-N 121.221 -0.924 . . . . 0.0 112.922 -177.637 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 76.22 -9.0 21.63 Favored Glycine 0 CA--C 1.534 1.231 0 C-N-CA 124.781 1.182 . . . . 0.0 114.283 -178.711 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 60.1 m -79.87 162.55 24.96 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 118.518 1.159 . . . . 0.0 114.069 178.56 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 19.2 m -122.76 154.21 27.89 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 126.238 1.815 . . . . 0.0 110.224 168.5 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 47.2 t -85.89 102.52 13.8 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 123.579 0.752 . . . . 0.0 110.157 169.885 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -72.81 167.71 53.72 Favored Glycine 0 CA--C 1.543 1.836 0 C-N-CA 124.454 1.026 . . . . 0.0 114.218 -178.235 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -58.41 -26.87 79.59 Favored 'Trans proline' 0 C--N 1.353 0.801 0 C-N-CA 124.489 3.459 . . . . 0.0 114.969 -177.335 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 52.8 p-10 -70.34 -8.34 49.75 Favored 'General case' 0 CA--C 1.548 0.885 0 N-CA-C 114.775 1.398 . . . . 0.0 114.775 176.699 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 83.92 10.84 80.26 Favored Glycine 0 CA--C 1.533 1.21 0 C-N-CA 124.626 1.108 . . . . 0.0 114.029 -177.228 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -116.39 157.2 25.46 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.84 1.256 . . . . 0.0 112.09 172.153 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 83.1 m -76.44 147.57 37.85 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.004 1.322 . . . . 0.0 113.122 176.988 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.212 0 C-N-CA 126.013 1.768 . . . . 0.0 113.126 174.635 . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.698 0 N-CA-C 112.43 -0.268 . . . . 0.0 112.43 . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 48.5 t -62.05 130.62 92.9 Favored Pre-proline 0 CA--C 1.549 0.933 0 CA-C-O 118.048 -0.977 . . . . 0.0 112.436 -179.124 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -61.91 149.67 89.25 Favored 'Trans proline' 0 C--N 1.354 0.844 0 C-N-CA 123.191 2.594 . . . . 0.0 113.085 177.27 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 34.4 ptt-85 -83.0 10.22 8.45 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 115.593 1.701 . . . . 0.0 115.593 -172.286 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 10.1 tp -77.17 153.17 5.54 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 C-N-CA 125.424 1.49 . . . . 0.0 111.428 177.947 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 32.7 tp -82.43 134.28 35.23 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.679 0.791 . . . . 0.0 110.468 173.793 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -161.69 127.3 3.61 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.647 1.179 . . . . 0.0 110.932 -170.354 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 95.7 mtt-85 -85.81 159.58 19.69 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 125.071 1.348 . . . . 0.0 112.365 -179.375 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 28.3 p -159.58 159.14 32.88 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.663 1.185 . . . . 0.0 114.104 -177.282 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -114.2 -25.05 8.65 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 126.306 1.842 . . . . 0.0 111.081 168.767 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -151.73 168.17 25.88 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 126.547 1.939 . . . . 0.0 110.531 173.847 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -61.83 -24.76 67.09 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 124.304 1.041 . . . . 0.0 113.0 -176.465 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 6.6 m -64.57 -18.78 65.18 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 125.233 1.413 . . . . 0.0 113.529 175.444 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 62.4 m-20 -80.35 -18.94 47.61 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.001 0.92 . . . . 0.0 112.241 174.034 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 80.6 m -90.28 163.42 14.76 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 125.235 1.414 . . . . 0.0 113.656 -173.073 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 60.0 mt -76.99 -178.43 4.94 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 124.599 1.159 . . . . 0.0 111.921 179.73 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.63 134.27 56.92 Favored 'General case' 0 CA--C 1.54 0.569 0 O-C-N 121.203 -0.935 . . . . 0.0 112.868 -178.563 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 74.51 -8.42 14.08 Favored Glycine 0 CA--C 1.534 1.252 0 C-N-CA 124.749 1.166 . . . . 0.0 114.329 -178.724 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 61.6 m -81.02 159.27 24.86 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 114.184 1.179 . . . . 0.0 114.184 -178.954 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 18.2 m -125.02 153.29 32.11 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 126.472 1.909 . . . . 0.0 109.681 167.949 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 49.1 t -86.09 102.8 14.18 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 123.235 0.614 . . . . 0.0 110.237 170.646 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -70.47 166.56 50.94 Favored Glycine 0 CA--C 1.543 1.831 0 C-N-CA 124.65 1.119 . . . . 0.0 113.806 178.84 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -69.73 -18.08 37.32 Favored 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 124.135 3.223 . . . . 0.0 113.392 -176.062 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 52.7 p-10 -69.66 -9.15 53.13 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 124.897 1.279 . . . . 0.0 114.36 171.381 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 85.29 9.84 78.83 Favored Glycine 0 CA--C 1.533 1.202 0 C-N-CA 124.962 1.268 . . . . 0.0 114.227 -177.949 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -116.2 155.03 29.01 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.949 1.3 . . . . 0.0 111.879 174.147 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 82.6 m -77.07 147.14 36.85 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.272 1.029 . . . . 0.0 112.241 174.391 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.22 0 C-N-CA 125.743 1.64 . . . . 0.0 113.112 175.798 . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.714 0 N-CA-C 112.352 -0.299 . . . . 0.0 112.352 . . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 44.3 t -60.43 126.07 83.63 Favored Pre-proline 0 CA--C 1.55 0.945 0 C-N-CA 124.342 1.057 . . . . 0.0 112.279 -179.055 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -74.5 163.5 35.95 Favored 'Trans proline' 0 C--N 1.353 0.765 0 C-N-CA 122.996 2.464 . . . . 0.0 111.397 177.2 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 74.6 mtp85 -77.35 20.72 0.28 Allowed 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 125.031 1.333 . . . . 0.0 114.08 -175.242 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 48.3 mm -79.83 122.68 35.51 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 125.367 1.467 . . . . 0.0 109.874 178.749 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 42.4 tp -76.14 132.92 40.3 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.184 0.594 . . . . 0.0 109.489 170.598 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 60.3 tpp -153.33 127.52 9.11 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 124.205 1.002 . . . . 0.0 109.838 -173.307 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 59.5 ttm-85 -78.08 145.06 36.03 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.702 0.801 . . . . 0.0 110.395 177.373 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 31.3 p -153.11 159.16 42.73 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 114.411 1.263 . . . . 0.0 114.411 -171.697 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -121.2 -18.83 7.3 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 126.878 2.071 . . . . 0.0 111.49 168.895 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 19.3 pt20 -147.45 158.96 44.2 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 126.843 2.057 . . . . 0.0 110.179 177.963 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -62.86 -25.86 68.49 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.196 0.999 . . . . 0.0 112.429 -179.822 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 17.8 m -67.38 -13.46 62.04 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 124.916 1.287 . . . . 0.0 113.557 175.289 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 49.9 m-20 -81.5 -19.15 42.84 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 123.758 0.823 . . . . 0.0 112.091 172.108 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 73.9 m -88.79 167.01 13.64 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.253 1.421 . . . . 0.0 113.94 -171.302 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -70.37 170.77 11.19 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 124.444 1.098 . . . . 0.0 110.769 175.692 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.08 134.82 57.41 Favored 'General case' 0 CA--C 1.539 0.525 0 O-C-N 121.179 -0.95 . . . . 0.0 112.964 -177.348 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 76.14 -9.09 20.75 Favored Glycine 0 CA--C 1.533 1.188 0 C-N-CA 124.652 1.12 . . . . 0.0 114.378 -178.764 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 60.2 m -79.91 162.9 24.72 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 114.078 1.14 . . . . 0.0 114.078 179.079 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 18.5 m -122.73 154.33 27.88 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 126.325 1.85 . . . . 0.0 110.073 168.359 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 47.8 t -85.63 103.41 14.43 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 123.193 0.597 . . . . 0.0 110.071 169.824 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -70.83 168.16 50.11 Favored Glycine 0 CA--C 1.542 1.731 0 C-N-CA 124.841 1.21 . . . . 0.0 114.101 179.922 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -70.23 -17.9 35.13 Favored 'Trans proline' 0 C--N 1.352 0.743 0 C-N-CA 124.169 3.246 . . . . 0.0 113.5 -175.312 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 53.3 p-10 -69.38 -9.42 53.4 Favored 'General case' 0 CA--C 1.548 0.882 0 N-CA-C 114.339 1.237 . . . . 0.0 114.339 170.855 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 84.87 12.06 75.35 Favored Glycine 0 CA--C 1.532 1.141 0 C-N-CA 124.756 1.17 . . . . 0.0 114.046 -176.796 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -123.51 156.47 35.57 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.703 1.201 . . . . 0.0 112.386 174.505 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 84.1 m -75.1 147.41 40.6 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.906 1.283 . . . . 0.0 113.214 179.006 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.204 0 C-N-CA 126.058 1.789 . . . . 0.0 113.099 174.809 . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.749 0 CA-C-O 121.21 0.339 . . . . 0.0 112.547 . . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 53.3 t -65.59 133.28 95.17 Favored Pre-proline 0 CA--C 1.551 0.995 0 C-N-CA 123.928 0.891 . . . . 0.0 112.282 -178.828 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -67.45 166.7 22.82 Favored 'Trans proline' 0 C--N 1.353 0.798 0 C-N-CA 123.435 2.756 . . . . 0.0 111.909 173.05 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 4.4 mmp_? -102.23 17.4 23.48 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 125.091 1.357 . . . . 0.0 113.187 179.94 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 10.4 tp -74.57 148.44 7.99 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 C-N-CA 125.247 1.419 . . . . 0.0 111.392 176.015 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 10.6 tt -71.29 132.13 44.45 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.636 0.774 . . . . 0.0 110.044 172.974 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 58.7 tpp -154.96 130.67 9.97 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.825 1.25 . . . . 0.0 109.591 177.421 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 84.4 mtt85 -87.32 152.92 21.87 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.301 1.04 . . . . 0.0 111.497 178.297 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 29.6 p -157.0 156.03 32.26 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 114.082 1.141 . . . . 0.0 114.082 -173.236 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -112.22 -25.67 9.18 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 126.091 1.756 . . . . 0.0 110.93 168.927 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 8.3 pt20 -150.58 168.78 23.25 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 126.569 1.947 . . . . 0.0 110.522 173.621 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -61.37 -25.24 67.04 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 124.462 1.105 . . . . 0.0 112.977 -176.494 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 7.0 m -64.72 -19.19 65.63 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 125.329 1.452 . . . . 0.0 113.514 175.778 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 61.1 m-20 -81.4 -18.65 44.74 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.024 0.93 . . . . 0.0 112.39 174.657 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 74.5 m -87.72 167.31 13.96 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 125.155 1.382 . . . . 0.0 113.827 -174.43 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -72.67 176.49 5.48 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 124.487 1.115 . . . . 0.0 111.077 177.973 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.53 133.26 55.92 Favored 'General case' 0 CA--C 1.539 0.556 0 O-C-N 121.08 -1.013 . . . . 0.0 113.207 -176.784 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 74.44 -8.29 14.42 Favored Glycine 0 CA--C 1.534 1.278 0 C-N-CA 124.871 1.224 . . . . 0.0 114.461 -179.851 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 62.2 m -76.87 163.66 26.54 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 114.089 1.144 . . . . 0.0 114.089 -178.893 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 21.4 m -121.72 152.91 25.61 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 C-N-CA 125.807 1.643 . . . . 0.0 110.325 168.263 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 44.8 t -88.5 104.4 16.77 Favored 'General case' 0 CA--C 1.537 0.442 0 C-N-CA 123.513 0.725 . . . . 0.0 109.878 169.55 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -70.07 166.26 50.26 Favored Glycine 0 CA--C 1.542 1.74 0 C-N-CA 124.635 1.112 . . . . 0.0 113.825 178.951 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -69.48 -18.2 38.43 Favored 'Trans proline' 0 CA--C 1.539 0.729 0 C-N-CA 124.128 3.219 . . . . 0.0 113.284 -176.419 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 52.4 p-10 -69.37 -9.93 55.66 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 124.869 1.268 . . . . 0.0 114.396 170.942 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 85.79 10.34 76.15 Favored Glycine 0 CA--C 1.533 1.169 0 C-N-CA 124.867 1.222 . . . . 0.0 114.229 -177.653 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -117.48 156.62 27.69 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.787 1.235 . . . . 0.0 112.038 174.509 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 74.3 m -76.43 152.97 36.03 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.619 1.167 . . . . 0.0 112.999 176.352 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.272 0 CA-C-O 116.909 -2.051 . . . . 0.0 113.626 176.168 . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.695 0 N-CA-C 112.355 -0.298 . . . . 0.0 112.355 . . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 48.0 t -61.03 130.37 91.22 Favored Pre-proline 0 CA--C 1.549 0.934 0 C-N-CA 124.134 0.974 . . . . 0.0 112.4 -179.171 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -62.19 155.47 56.29 Favored 'Trans proline' 0 C--N 1.354 0.845 0 C-N-CA 123.221 2.614 . . . . 0.0 112.76 175.227 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -82.3 13.84 3.31 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 114.707 1.373 . . . . 0.0 114.707 -170.522 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 10.0 tp -83.2 140.76 15.82 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 C-N-CA 125.309 1.444 . . . . 0.0 111.464 178.641 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 40.4 tp -82.82 132.0 35.18 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.801 0.84 . . . . 0.0 109.816 172.146 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 58.0 ttm -154.45 132.46 11.66 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.3 1.04 . . . . 0.0 110.512 -171.433 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 95.8 mtt-85 -79.4 155.07 28.54 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.006 0.922 . . . . 0.0 112.057 178.813 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 28.2 p -158.32 157.76 33.04 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 124.731 1.212 . . . . 0.0 113.661 -176.099 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 30.3 mtpp -112.1 -24.97 9.58 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 125.932 1.693 . . . . 0.0 111.16 169.094 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 20.8 pt20 -152.53 166.41 32.12 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 126.553 1.941 . . . . 0.0 110.485 175.803 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -61.06 -24.96 66.6 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 124.494 1.118 . . . . 0.0 112.799 -176.41 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.8 m -65.62 -18.0 65.0 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 125.654 1.582 . . . . 0.0 113.617 175.851 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 63.2 m-20 -80.83 -20.98 41.21 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 123.888 0.875 . . . . 0.0 112.19 173.152 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 77.8 m -88.46 165.41 14.92 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 125.227 1.411 . . . . 0.0 113.514 -174.185 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 50.6 mt -75.85 178.64 6.04 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 124.374 1.07 . . . . 0.0 111.922 179.375 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.19 134.63 57.24 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 121.375 -0.828 . . . . 0.0 112.721 -179.173 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 74.61 -8.38 14.66 Favored Glycine 0 CA--C 1.533 1.185 0 C-N-CA 124.678 1.133 . . . . 0.0 114.291 -178.363 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 60.6 m -81.11 158.8 24.88 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 118.646 1.223 . . . . 0.0 113.967 179.568 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 18.6 m -123.45 151.69 28.15 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 126.17 1.788 . . . . 0.0 109.765 168.057 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 48.9 t -87.2 103.0 15.0 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.296 0.638 . . . . 0.0 109.756 169.978 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -72.17 166.86 53.43 Favored Glycine 0 CA--C 1.543 1.823 0 C-N-CA 124.281 0.943 . . . . 0.0 114.017 -178.157 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -57.86 -26.19 72.86 Favored 'Trans proline' 0 C--N 1.354 0.854 0 C-N-CA 124.448 3.432 . . . . 0.0 114.736 -179.806 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 51.9 p-10 -68.44 -9.96 52.14 Favored 'General case' 0 CA--C 1.548 0.88 0 N-CA-C 114.839 1.422 . . . . 0.0 114.839 175.314 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 83.65 13.41 75.72 Favored Glycine 0 CA--C 1.533 1.216 0 C-N-CA 124.731 1.158 . . . . 0.0 113.929 -177.372 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -117.96 154.19 32.36 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.951 1.3 . . . . 0.0 112.225 174.168 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 84.6 m -74.33 145.96 43.46 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.878 1.271 . . . . 0.0 112.382 173.933 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.21 0 C-N-CA 125.991 1.758 . . . . 0.0 113.252 175.023 . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.692 0 N-CA-C 112.486 -0.246 . . . . 0.0 112.486 . . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 41.9 t -61.21 127.09 87.55 Favored Pre-proline 0 CA--C 1.55 0.953 0 C-N-CA 124.302 1.041 . . . . 0.0 112.243 -179.252 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -72.99 161.4 43.63 Favored 'Trans proline' 0 C--N 1.354 0.818 0 C-N-CA 123.125 2.55 . . . . 0.0 111.529 177.09 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 92.3 mtm-85 -77.5 29.86 0.15 Allowed 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 125.269 1.428 . . . . 0.0 113.501 -177.597 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 96.8 mt -90.37 122.97 42.33 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 126.158 1.783 . . . . 0.0 109.048 -179.325 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 37.6 tp -75.34 132.82 41.21 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 122.972 0.509 . . . . 0.0 109.642 171.415 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 59.9 tpp -153.83 128.56 9.41 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 124.372 1.069 . . . . 0.0 109.373 -174.485 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 46.3 ttt85 -83.88 144.78 28.99 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 123.381 0.673 . . . . 0.0 110.616 178.188 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 28.3 p -149.11 158.88 44.53 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 114.26 1.208 . . . . 0.0 114.26 -169.517 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -119.03 -19.57 8.41 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 126.117 1.767 . . . . 0.0 111.641 169.187 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -150.03 167.68 26.04 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 126.328 1.851 . . . . 0.0 110.534 169.994 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -61.31 -25.34 67.06 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.419 1.088 . . . . 0.0 112.663 -178.691 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 15.6 m -65.6 -15.95 63.23 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 125.182 1.393 . . . . 0.0 113.643 175.754 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 60.7 m-20 -82.1 -17.76 45.35 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 123.935 0.894 . . . . 0.0 112.456 172.82 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 75.1 m -89.55 166.47 13.64 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.032 1.333 . . . . 0.0 113.894 -172.117 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -70.92 171.61 10.42 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 124.488 1.115 . . . . 0.0 110.787 175.805 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.24 135.33 57.7 Favored 'General case' 0 CA--C 1.54 0.581 0 O-C-N 121.201 -0.937 . . . . 0.0 112.953 -177.665 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 75.92 -9.08 19.18 Favored Glycine 0 CA--C 1.534 1.276 0 C-N-CA 124.79 1.186 . . . . 0.0 114.307 -178.844 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 59.8 m -80.15 162.78 24.54 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 114.057 1.132 . . . . 0.0 114.057 179.375 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 19.1 m -123.07 153.6 28.28 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 126.319 1.847 . . . . 0.0 110.11 168.331 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 49.2 t -84.45 102.58 12.91 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 123.398 0.679 . . . . 0.0 110.178 169.978 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -71.14 169.45 49.15 Favored Glycine 0 CA--C 1.542 1.747 0 C-N-CA 124.955 1.264 . . . . 0.0 114.335 -179.592 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -70.56 -18.98 32.85 Favored 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 124.233 3.289 . . . . 0.0 113.669 -173.987 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 53.2 p-10 -70.54 -8.06 48.53 Favored 'General case' 0 CA--C 1.548 0.897 0 N-CA-C 114.271 1.211 . . . . 0.0 114.271 170.775 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 85.13 8.96 81.12 Favored Glycine 0 CA--C 1.531 1.081 0 C-N-CA 124.916 1.246 . . . . 0.0 114.06 -176.995 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -118.55 156.77 28.55 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 118.725 1.263 . . . . 0.0 112.29 174.7 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 79.7 m -75.35 147.17 40.31 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.027 1.331 . . . . 0.0 113.223 179.036 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.181 0 C-N-CA 126.017 1.77 . . . . 0.0 113.099 174.796 . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.656 0 N-CA-C 112.391 -0.283 . . . . 0.0 112.391 . . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 41.9 t -61.47 127.71 88.87 Favored Pre-proline 0 CA--C 1.55 0.962 0 C-N-CA 124.251 1.02 . . . . 0.0 112.204 -178.999 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -70.29 155.08 64.98 Favored 'Trans proline' 0 C--N 1.355 0.895 0 C-N-CA 123.047 2.498 . . . . 0.0 111.726 176.93 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.63 5.99 5.39 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 116.148 1.907 . . . . 0.0 116.148 -172.978 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 10.0 tp -73.97 139.12 19.86 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.825 0 C-N-CA 125.263 1.425 . . . . 0.0 111.334 -179.331 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 30.6 tp -81.1 136.65 35.95 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.683 0.793 . . . . 0.0 110.176 174.729 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 61.2 tpp -158.32 134.86 9.53 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.41 1.084 . . . . 0.0 109.483 -172.575 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 55.7 mtp85 -91.69 154.47 18.97 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 119.004 0.82 . . . . 0.0 112.807 175.662 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 26.4 p -154.16 158.04 39.78 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.117 1.367 . . . . 0.0 113.665 -169.933 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -109.45 -29.74 8.28 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 125.882 1.673 . . . . 0.0 110.654 168.891 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 8.0 pt20 -147.7 169.73 19.06 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 126.485 1.914 . . . . 0.0 110.718 173.603 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -61.27 -25.93 67.43 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.473 1.109 . . . . 0.0 112.844 -176.488 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 7.4 m -64.77 -18.88 65.47 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 125.303 1.441 . . . . 0.0 113.48 175.959 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 60.1 m-20 -82.02 -18.42 43.35 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 123.964 0.906 . . . . 0.0 112.347 174.577 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 77.8 m -87.35 167.16 14.29 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.91 1.284 . . . . 0.0 113.789 -174.498 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -71.57 172.42 9.65 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 124.498 1.119 . . . . 0.0 110.943 176.907 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.01 134.64 57.24 Favored 'General case' 0 CA--C 1.539 0.534 0 O-C-N 121.256 -0.903 . . . . 0.0 113.075 -177.049 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 75.76 -9.0 18.24 Favored Glycine 0 CA--C 1.533 1.209 0 C-N-CA 124.759 1.171 . . . . 0.0 114.362 -179.065 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 60.4 m -79.27 161.49 26.28 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 114.156 1.169 . . . . 0.0 114.156 179.636 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 19.2 m -120.55 153.4 23.71 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 126.316 1.846 . . . . 0.0 109.945 168.051 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 49.7 t -88.17 104.23 16.51 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 123.468 0.707 . . . . 0.0 110.275 169.955 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -70.83 168.85 49.27 Favored Glycine 0 CA--C 1.544 1.886 0 C-N-CA 124.907 1.241 . . . . 0.0 114.105 178.371 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -70.37 -20.54 31.85 Favored 'Trans proline' 0 CA--C 1.538 0.701 0 C-N-CA 124.172 3.248 . . . . 0.0 113.647 -174.432 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 50.4 p30 -71.12 -5.25 30.19 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 124.888 1.275 . . . . 0.0 114.078 170.323 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 79.18 11.55 84.94 Favored Glycine 0 CA--C 1.53 1.023 0 C-N-CA 125.156 1.36 . . . . 0.0 113.98 -178.668 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 99.7 m-85 -107.41 155.09 20.41 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 118.656 1.228 . . . . 0.0 111.89 170.503 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 84.0 m -76.98 147.33 36.92 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 125.079 1.351 . . . . 0.0 112.544 173.18 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.176 0 C-N-CA 125.711 1.624 . . . . 0.0 113.174 174.721 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 43.7 t . . . . . 0 CA--C 1.551 0.984 0 CA-C-O 118.289 -0.862 . . . . 0.0 112.271 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -70.32 157.45 59.27 Favored 'Trans proline' 0 C--N 1.353 0.803 0 C-N-CA 123.119 2.546 . . . . 0.0 111.777 176.668 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -81.73 13.17 3.33 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 114.566 1.321 . . . . 0.0 114.566 -171.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 9.9 tp -80.89 141.07 15.71 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 125.566 1.547 . . . . 0.0 111.188 177.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 36.3 tp -79.66 139.12 37.51 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 123.687 0.795 . . . . 0.0 110.446 175.138 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 60.0 tpp -153.26 130.68 11.35 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.578 1.151 . . . . 0.0 109.67 -178.431 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 60.2 ttt180 -86.27 147.56 26.02 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.818 0.847 . . . . 0.0 110.806 179.438 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 30.2 p -154.91 161.4 41.44 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 114.517 1.303 . . . . 0.0 114.517 -169.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 63.2 pttt -123.4 -16.47 6.84 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 126.184 1.794 . . . . 0.0 112.012 168.469 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 8.1 pt20 -151.9 166.61 30.92 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 126.262 1.825 . . . . 0.0 110.62 171.012 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -62.3 -24.71 67.46 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 124.279 1.032 . . . . 0.0 112.977 -176.383 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.5 m -64.11 -19.2 65.1 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 125.264 1.426 . . . . 0.0 113.524 175.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 59.0 m-20 -79.94 -20.08 46.49 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 123.955 0.902 . . . . 0.0 112.308 174.396 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 77.6 m -88.75 165.34 14.78 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.077 1.351 . . . . 0.0 113.699 -172.411 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -72.02 172.75 9.49 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 124.567 1.147 . . . . 0.0 110.896 177.213 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.79 134.21 56.82 Favored 'General case' 0 CA--C 1.539 0.545 0 O-C-N 121.111 -0.993 . . . . 0.0 112.956 -177.33 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 75.95 -9.2 18.92 Favored Glycine 0 CA--C 1.534 1.256 0 C-N-CA 124.689 1.138 . . . . 0.0 114.323 -178.676 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 59.6 m -79.64 162.8 25.05 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 118.534 1.167 . . . . 0.0 113.976 179.038 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 19.1 m -123.61 153.27 29.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 126.332 1.853 . . . . 0.0 110.178 168.315 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 48.6 t -85.21 103.5 14.23 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 123.3 0.64 . . . . 0.0 110.006 169.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -70.08 168.16 47.99 Favored Glycine 0 CA--C 1.542 1.725 0 C-N-CA 124.752 1.168 . . . . 0.0 114.12 179.176 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -69.96 -18.02 36.33 Favored 'Trans proline' 0 CA--C 1.538 0.72 0 C-N-CA 124.241 3.294 . . . . 0.0 113.44 -175.166 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 53.5 p-10 -68.88 -10.81 59.07 Favored 'General case' 0 CA--C 1.548 0.874 0 N-CA-C 114.372 1.249 . . . . 0.0 114.372 170.471 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 85.52 12.8 71.81 Favored Glycine 0 CA--C 1.532 1.129 0 C-N-CA 124.83 1.205 . . . . 0.0 113.962 -176.573 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -125.08 157.4 36.38 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 118.544 1.172 . . . . 0.0 112.168 174.413 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 75.8 m -77.38 148.47 35.53 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.989 1.316 . . . . 0.0 113.386 -177.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.26 0 C-N-CA 126.035 1.778 . . . . 0.0 113.016 174.294 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 53.7 t . . . . . 0 CA--C 1.549 0.928 0 CA-C-O 118.47 -0.776 . . . . 0.0 112.439 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -67.03 166.9 21.38 Favored 'Trans proline' 0 C--N 1.354 0.829 0 C-N-CA 123.302 2.668 . . . . 0.0 111.946 172.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 4.7 mmp_? -100.63 18.47 19.15 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.968 1.307 . . . . 0.0 113.096 179.719 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 18.7 tt -69.33 141.91 16.72 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 C-N-CA 125.009 1.324 . . . . 0.0 111.001 172.62 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 33.3 tp -79.34 129.94 34.95 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 123.265 0.626 . . . . 0.0 109.705 173.358 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 60.7 tpp -153.56 131.02 11.36 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.383 1.073 . . . . 0.0 110.196 -173.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -80.97 153.96 27.2 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 123.998 0.919 . . . . 0.0 111.776 177.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 28.7 p -158.32 156.0 29.8 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 124.408 1.083 . . . . 0.0 113.792 -175.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -111.17 -26.34 9.25 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 125.885 1.674 . . . . 0.0 111.002 168.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 8.0 pt20 -150.61 169.48 21.47 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 126.629 1.972 . . . . 0.0 110.453 173.465 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -61.39 -25.43 67.18 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 124.479 1.112 . . . . 0.0 112.875 -176.426 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 7.3 m -64.96 -18.93 65.69 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.288 1.435 . . . . 0.0 113.566 175.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 59.8 m-20 -81.83 -18.8 42.69 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 123.929 0.892 . . . . 0.0 112.35 174.526 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 75.1 m -86.88 167.57 14.21 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.114 1.365 . . . . 0.0 113.692 -175.125 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -72.24 175.36 6.15 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 124.527 1.131 . . . . 0.0 111.028 177.507 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.39 133.14 55.8 Favored 'General case' 0 CA--C 1.54 0.562 0 O-C-N 121.079 -1.013 . . . . 0.0 113.2 -176.107 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 74.45 -8.2 14.88 Favored Glycine 0 CA--C 1.534 1.243 0 C-N-CA 124.815 1.198 . . . . 0.0 114.529 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 61.5 m -76.55 163.8 26.55 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 114.009 1.115 . . . . 0.0 114.009 -179.25 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 21.6 m -121.68 152.17 25.33 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 125.681 1.593 . . . . 0.0 110.534 168.575 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 47.6 t -89.12 103.89 16.48 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 123.772 0.829 . . . . 0.0 109.811 169.55 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -71.94 166.55 53.33 Favored Glycine 0 CA--C 1.544 1.881 0 C-N-CA 124.333 0.968 . . . . 0.0 114.059 -178.609 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -58.12 -26.32 75.26 Favored 'Trans proline' 0 C--N 1.353 0.771 0 C-N-CA 124.407 3.404 . . . . 0.0 114.782 -178.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 52.5 p-10 -68.97 -9.87 54.41 Favored 'General case' 0 CA--C 1.549 0.907 0 N-CA-C 114.764 1.394 . . . . 0.0 114.764 175.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 83.62 13.59 75.38 Favored Glycine 0 CA--C 1.534 1.234 0 C-N-CA 124.633 1.111 . . . . 0.0 113.965 -176.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -118.75 155.61 30.81 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.9 1.28 . . . . 0.0 112.097 173.333 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 70.2 m -76.22 153.11 36.32 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.804 1.242 . . . . 0.0 113.134 177.276 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.219 0 CA-C-O 116.861 -2.077 . . . . 0.0 113.566 175.683 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 48.9 t . . . . . 0 CA--C 1.549 0.913 0 CA-C-O 118.424 -0.798 . . . . 0.0 112.34 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -66.62 151.2 83.25 Favored 'Trans proline' 0 C--N 1.353 0.773 0 C-N-CA 122.616 2.211 . . . . 0.0 111.125 174.526 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 71.7 mmt-85 -81.95 44.79 0.86 Allowed 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 124.89 1.276 . . . . 0.0 113.109 -171.554 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 1.2 pp -79.87 168.04 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 126.004 1.721 . . . . 0.0 113.177 177.002 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 38.0 tp -118.85 66.08 0.77 Allowed 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.723 1.609 . . . . 0.0 108.139 169.569 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 63.3 tpp -94.48 126.62 39.87 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 125.095 1.358 . . . . 0.0 109.745 -172.336 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 95.5 mtt-85 -72.33 149.54 44.32 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 118.752 0.706 . . . . 0.0 111.862 178.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 30.0 p -154.82 157.78 38.43 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 124.278 1.031 . . . . 0.0 113.728 -176.009 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 59.5 mtmt -119.05 -20.01 8.23 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.936 1.694 . . . . 0.0 111.901 169.422 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -150.48 167.94 25.66 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 126.4 1.88 . . . . 0.0 110.506 169.853 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -61.31 -25.45 67.13 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.363 1.065 . . . . 0.0 112.668 -178.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 15.5 m -65.88 -15.98 63.42 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.279 1.432 . . . . 0.0 113.702 175.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 60.6 m-20 -81.55 -18.05 46.27 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 123.792 0.837 . . . . 0.0 112.422 172.349 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 72.2 m -91.04 165.37 13.56 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.813 1.245 . . . . 0.0 114.106 -171.448 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -73.53 174.88 7.62 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 125.211 1.405 . . . . 0.0 111.043 178.733 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.43 133.58 56.22 Favored 'General case' 0 CA--C 1.539 0.542 0 O-C-N 121.096 -1.003 . . . . 0.0 113.125 -177.355 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 75.13 -8.89 14.27 Favored Glycine 0 CA--C 1.534 1.248 0 C-N-CA 124.808 1.194 . . . . 0.0 114.329 -179.031 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 61.6 m -79.11 161.25 26.63 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 114.139 1.162 . . . . 0.0 114.139 -179.712 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 18.8 m -123.32 152.86 28.48 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 C-N-CA 126.337 1.855 . . . . 0.0 109.796 167.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 48.5 t -84.93 102.13 12.89 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.243 0.617 . . . . 0.0 110.16 170.21 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -71.77 168.24 51.74 Favored Glycine 0 CA--C 1.541 1.705 0 C-N-CA 124.774 1.178 . . . . 0.0 114.208 -179.251 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -70.09 -17.79 35.86 Favored 'Trans proline' 0 CA--C 1.539 0.736 0 C-N-CA 124.208 3.272 . . . . 0.0 113.479 -176.024 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 52.9 p-10 -69.38 -9.39 53.26 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 124.746 1.218 . . . . 0.0 114.286 171.087 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 86.24 8.67 77.85 Favored Glycine 0 CA--C 1.533 1.2 0 C-N-CA 125.11 1.338 . . . . 0.0 114.309 -177.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 75.0 m-85 -119.38 158.53 25.97 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 122.487 1.137 . . . . 0.0 112.317 174.573 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 68.2 m -73.52 147.39 44.07 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.094 1.358 . . . . 0.0 112.797 174.721 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.191 0 C-N-CA 125.934 1.731 . . . . 0.0 113.041 174.808 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 49.2 t . . . . . 0 CA--C 1.549 0.914 0 CA-C-O 118.431 -0.795 . . . . 0.0 112.797 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_exo -55.8 142.9 82.91 Favored 'Trans proline' 0 C--N 1.353 0.804 0 C-N-CA 123.637 2.891 . . . . 0.0 112.069 170.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 69.3 mmt-85 -81.04 16.19 1.6 Allowed 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 114.115 1.154 . . . . 0.0 114.115 -174.327 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 17.8 tt -73.87 142.94 14.19 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 125.637 1.575 . . . . 0.0 111.317 176.318 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 37.9 tp -80.6 132.42 35.63 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.342 0.657 . . . . 0.0 109.92 172.396 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 60.9 tpp -152.58 126.06 8.78 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 124.344 1.058 . . . . 0.0 109.932 -175.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 1.9 tmt_? -84.72 135.78 34.0 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.971 0.908 . . . . 0.0 109.714 178.658 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 26.3 p -136.85 164.27 28.7 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 125.268 1.427 . . . . 0.0 113.144 -172.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -119.97 -25.96 5.69 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 125.993 1.717 . . . . 0.0 111.11 169.247 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -145.88 169.08 19.29 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 126.36 1.864 . . . . 0.0 110.411 169.74 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -60.98 -25.72 67.06 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.393 1.077 . . . . 0.0 112.685 -178.45 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 15.6 m -65.68 -16.27 63.59 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 125.227 1.411 . . . . 0.0 113.669 175.704 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 55.9 m-20 -82.91 -17.91 42.02 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 123.917 0.887 . . . . 0.0 112.386 172.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 72.0 m -88.48 165.59 14.78 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.858 1.263 . . . . 0.0 113.649 -174.202 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -72.47 174.08 7.92 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 124.84 1.256 . . . . 0.0 111.08 177.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.25 133.27 55.95 Favored 'General case' 0 CA--C 1.539 0.538 0 O-C-N 121.201 -0.937 . . . . 0.0 113.156 -176.427 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 74.93 -8.52 15.19 Favored Glycine 0 CA--C 1.535 1.305 0 C-N-CA 124.691 1.138 . . . . 0.0 114.413 -179.106 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 61.3 m -79.29 161.74 26.09 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 118.466 1.133 . . . . 0.0 113.987 179.59 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 19.1 m -122.56 153.72 27.36 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 126.336 1.854 . . . . 0.0 110.19 168.605 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 48.3 t -86.33 102.26 13.84 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 123.61 0.764 . . . . 0.0 109.998 169.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -72.62 167.9 53.33 Favored Glycine 0 CA--C 1.542 1.767 0 C-N-CA 124.368 0.985 . . . . 0.0 114.3 -177.262 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_exo -58.27 -26.96 79.1 Favored 'Trans proline' 0 C--N 1.354 0.858 0 C-N-CA 124.499 3.466 . . . . 0.0 114.989 -177.578 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 53.0 p-10 -69.51 -9.55 54.31 Favored 'General case' 0 CA--C 1.546 0.791 0 N-CA-C 114.7 1.37 . . . . 0.0 114.7 175.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 85.95 10.08 76.15 Favored Glycine 0 CA--C 1.531 1.087 0 C-N-CA 124.772 1.177 . . . . 0.0 114.006 -176.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -119.96 156.55 30.61 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.68 1.192 . . . . 0.0 112.152 174.747 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 78.7 m -75.2 148.26 39.69 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.663 1.185 . . . . 0.0 113.243 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.115 0 C-N-CA 126.012 1.767 . . . . 0.0 113.067 174.573 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 47.8 t . . . . . 0 CA--C 1.548 0.904 0 CA-C-O 118.316 -0.849 . . . . 0.0 112.472 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -64.81 147.48 89.58 Favored 'Trans proline' 0 C--N 1.354 0.821 0 C-N-CA 123.153 2.569 . . . . 0.0 111.384 171.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 6.0 tpm_? -81.71 54.45 2.41 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-O 122.206 1.003 . . . . 0.0 111.815 178.807 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 19.3 tt -81.07 151.91 4.36 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 C-N-CA 125.729 1.612 . . . . 0.0 111.105 173.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 39.7 tp -95.37 73.44 3.29 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.817 0.847 . . . . 0.0 108.721 169.44 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 60.0 tpp -102.54 116.09 31.9 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.627 1.171 . . . . 0.0 109.363 -176.453 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 61.0 ttt180 -77.82 143.6 37.73 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 123.325 0.65 . . . . 0.0 110.52 178.466 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 30.3 p -150.02 158.31 44.03 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 114.158 1.17 . . . . 0.0 114.158 -169.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 59.2 mtmt -119.63 -19.35 8.12 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 126.699 2.0 . . . . 0.0 111.57 169.307 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 19.3 pt20 -148.61 159.06 44.45 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 126.62 1.968 . . . . 0.0 110.246 179.332 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -63.08 -25.53 68.41 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.094 0.958 . . . . 0.0 112.387 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 17.8 m -67.67 -13.41 62.07 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.897 1.279 . . . . 0.0 113.566 175.069 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 51.5 m-20 -80.91 -19.4 44.39 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 123.81 0.844 . . . . 0.0 111.952 171.468 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 79.0 m -90.66 165.43 13.72 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 125.52 1.528 . . . . 0.0 113.763 -172.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 34.6 mt -76.33 -178.55 4.62 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.357 1.063 . . . . 0.0 111.88 179.635 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.63 134.28 56.93 Favored 'General case' 0 CA--C 1.539 0.527 0 O-C-N 121.253 -0.904 . . . . 0.0 112.96 -179.611 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 74.41 -8.46 13.52 Favored Glycine 0 CA--C 1.534 1.255 0 C-N-CA 124.775 1.179 . . . . 0.0 114.281 -178.528 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 63.9 m -81.76 159.62 23.79 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 114.288 1.218 . . . . 0.0 114.288 -178.322 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 18.0 m -124.52 154.98 32.29 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 126.774 2.03 . . . . 0.0 109.634 167.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 48.2 t -84.05 102.26 12.37 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 121.341 0.591 . . . . 0.0 110.188 169.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -71.72 169.03 50.92 Favored Glycine 0 CA--C 1.542 1.763 0 C-N-CA 124.987 1.28 . . . . 0.0 114.379 -178.383 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -70.74 -18.41 32.45 Favored 'Trans proline' 0 CA--C 1.537 0.672 0 C-N-CA 124.262 3.308 . . . . 0.0 113.67 -174.202 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 52.6 p-10 -69.68 -10.04 56.69 Favored 'General case' 0 CA--C 1.548 0.899 0 N-CA-C 114.192 1.182 . . . . 0.0 114.192 171.21 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 87.5 8.54 73.9 Favored Glycine 0 CA--C 1.533 1.178 0 C-N-CA 124.952 1.263 . . . . 0.0 114.208 -177.139 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 76.9 m-85 -122.58 159.84 26.95 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 118.69 1.245 . . . . 0.0 111.779 173.573 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 77.5 m -70.7 153.79 42.47 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.262 1.025 . . . . 0.0 113.215 179.263 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.154 0 C-N-CA 126.035 1.778 . . . . 0.0 113.165 175.973 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 40.5 t . . . . . 0 CA--C 1.546 0.801 0 CA-C-O 117.9 -1.048 . . . . 0.0 112.539 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -68.65 146.07 65.81 Favored 'Trans proline' 0 C--N 1.353 0.765 0 C-N-CA 123.017 2.478 . . . . 0.0 110.633 175.421 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 15.8 mmm180 -83.83 16.13 2.94 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 113.782 1.03 . . . . 0.0 113.782 -171.034 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 10.0 tp -68.19 141.66 17.34 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 125.489 1.516 . . . . 0.0 111.341 177.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 30.9 tp -75.9 131.99 40.0 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 123.359 0.663 . . . . 0.0 110.152 175.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 61.1 tpp -155.48 132.77 10.93 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.827 1.251 . . . . 0.0 109.851 -174.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 87.4 mtm180 -81.16 152.68 27.63 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.923 0.889 . . . . 0.0 111.603 177.746 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 29.4 p -157.38 155.29 30.29 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 113.961 1.097 . . . . 0.0 113.961 -175.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 64.8 tttm -110.53 -28.68 8.4 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 126.023 1.729 . . . . 0.0 110.726 168.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 8.1 pt20 -147.84 169.75 19.11 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 126.426 1.89 . . . . 0.0 110.601 172.541 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -61.35 -25.33 67.08 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 124.6 1.16 . . . . 0.0 112.918 -176.528 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 8.0 m -65.25 -18.59 65.43 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 125.157 1.383 . . . . 0.0 113.627 175.686 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 60.4 m-20 -81.73 -18.52 44.03 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 123.928 0.891 . . . . 0.0 112.368 174.398 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 73.6 m -86.9 168.02 13.79 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.118 1.367 . . . . 0.0 113.648 -175.579 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -71.17 173.72 7.3 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 124.415 1.086 . . . . 0.0 110.919 176.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.0 132.89 55.36 Favored 'General case' 0 CA--C 1.54 0.581 0 O-C-N 121.16 -0.962 . . . . 0.0 113.213 -175.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 74.42 -8.45 13.59 Favored Glycine 0 CA--C 1.534 1.247 0 C-N-CA 124.829 1.204 . . . . 0.0 114.512 -179.599 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 66.7 m -75.29 162.59 28.3 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 118.5 1.15 . . . . 0.0 113.915 -179.6 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 23.3 m -118.84 151.47 21.04 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 125.319 1.448 . . . . 0.0 110.816 168.697 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 43.7 t -89.38 104.76 17.29 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 123.725 0.81 . . . . 0.0 109.783 169.439 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -70.24 166.97 49.97 Favored Glycine 0 CA--C 1.543 1.81 0 C-N-CA 124.563 1.078 . . . . 0.0 113.842 179.043 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -69.43 -18.14 38.71 Favored 'Trans proline' 0 CA--C 1.539 0.76 0 C-N-CA 124.046 3.164 . . . . 0.0 113.357 -176.499 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 51.3 p-10 -69.22 -9.96 55.49 Favored 'General case' 0 CA--C 1.549 0.933 0 N-CA-C 114.414 1.265 . . . . 0.0 114.414 170.609 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 84.7 12.7 74.36 Favored Glycine 0 CA--C 1.533 1.218 0 C-N-CA 124.838 1.209 . . . . 0.0 114.096 -176.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -119.6 155.35 32.43 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.773 1.229 . . . . 0.0 112.403 175.02 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 69.7 m -76.75 154.92 33.61 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.941 1.297 . . . . 0.0 113.319 177.359 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.309 0 C-N-CA 125.711 1.624 . . . . 0.0 113.779 175.072 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 52.9 t . . . . . 0 CA--C 1.55 0.966 0 CA-C-O 118.501 -0.761 . . . . 0.0 112.306 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -71.83 147.99 51.21 Favored 'Trans proline' 0 C--N 1.353 0.811 0 C-N-CA 123.279 2.653 . . . . 0.0 111.16 173.695 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -84.53 17.76 2.55 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 114.166 1.173 . . . . 0.0 114.166 -172.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 8.9 tp -69.81 138.62 21.73 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 125.065 1.346 . . . . 0.0 111.118 175.345 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 31.5 tp -78.94 115.41 18.61 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 123.441 0.696 . . . . 0.0 109.882 177.141 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 81.6 mmm -137.17 126.09 24.21 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 125.672 1.589 . . . . 0.0 108.929 -177.468 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 25.4 ttt85 -86.77 144.99 26.81 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 118.632 0.651 . . . . 0.0 111.297 -179.443 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 24.5 p -146.66 160.56 42.04 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 125.502 1.521 . . . . 0.0 113.544 -169.205 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 61.4 mtpt -112.21 -24.72 9.68 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 125.845 1.658 . . . . 0.0 111.373 169.231 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 20.9 pt20 -152.71 166.63 31.55 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 126.397 1.879 . . . . 0.0 110.599 176.569 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -61.16 -25.07 66.76 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 124.257 1.023 . . . . 0.0 112.811 -176.318 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.8 m -65.54 -18.01 65.0 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 125.662 1.585 . . . . 0.0 113.573 176.016 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 63.0 m-20 -81.42 -19.14 43.13 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 123.991 0.917 . . . . 0.0 112.228 173.317 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 75.8 m -89.22 167.34 13.16 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.211 1.404 . . . . 0.0 113.621 -174.474 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.469 HD22 ' H ' ' A' ' 16' ' ' LEU . 0.9 OUTLIER -74.86 177.98 5.86 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 124.373 1.069 . . . . 0.0 111.206 179.623 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.47 133.7 56.34 Favored 'General case' 0 CA--C 1.539 0.547 0 O-C-N 121.186 -0.946 . . . . 0.0 112.923 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 74.77 -9.41 11.18 Favored Glycine 0 CA--C 1.533 1.186 0 C-N-CA 124.81 1.195 . . . . 0.0 114.399 -179.104 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 64.0 m -79.48 161.53 26.0 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 118.555 1.177 . . . . 0.0 113.969 -179.417 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 18.7 m -124.2 153.36 30.49 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 C-N-CA 126.313 1.845 . . . . 0.0 110.147 168.186 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 45.0 t -85.67 102.97 14.06 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.371 0.669 . . . . 0.0 109.8 169.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -71.53 172.16 45.82 Favored Glycine 0 CA--C 1.542 1.764 0 C-N-CA 125.133 1.349 . . . . 0.0 114.602 -177.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -70.37 -21.23 30.92 Favored 'Trans proline' 0 CA--C 1.538 0.712 0 C-N-CA 124.28 3.32 . . . . 0.0 113.604 -173.728 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 51.0 p-10 -70.95 -7.04 43.24 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 124.718 1.207 . . . . 0.0 113.97 169.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 83.72 8.46 84.48 Favored Glycine 0 CA--C 1.53 1.029 0 C-N-CA 125.389 1.471 . . . . 0.0 114.056 -177.567 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -112.18 155.82 23.32 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 119.195 1.498 . . . . 0.0 112.337 176.139 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 81.1 m -73.88 146.0 44.39 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.452 1.101 . . . . 0.0 112.8 176.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.189 0 C-N-CA 125.972 1.749 . . . . 0.0 113.11 174.927 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 45.5 t . . . . . 0 CA--C 1.549 0.91 0 CA-C-O 118.278 -0.868 . . . . 0.0 112.187 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -71.62 160.97 46.77 Favored 'Trans proline' 0 C--N 1.354 0.858 0 C-N-CA 123.106 2.537 . . . . 0.0 111.701 178.029 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 52.4 ttp180 -78.89 60.42 2.85 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 125.002 1.321 . . . . 0.0 111.474 -179.395 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 88.0 mt -125.52 122.47 62.6 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 126.551 1.941 . . . . 0.0 108.764 -177.356 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 40.3 tp -79.75 134.42 36.37 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.509 0.723 . . . . 0.0 109.544 170.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 59.4 tpp -157.45 135.17 10.68 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.231 1.012 . . . . 0.0 110.022 -170.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 27.6 mmt180 -77.3 153.56 33.76 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.633 0.773 . . . . 0.0 111.833 174.284 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 29.7 p -157.7 159.85 37.33 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 114.17 1.174 . . . . 0.0 114.17 -177.119 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 17.3 tppt? -118.34 -24.82 6.75 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 126.233 1.813 . . . . 0.0 111.036 169.026 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -148.73 170.19 18.75 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 126.26 1.824 . . . . 0.0 111.022 169.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -63.57 -25.44 68.24 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 124.85 1.26 . . . . 0.0 113.49 -173.722 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 77.7 p -73.09 -10.55 59.91 Favored 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 113.817 1.043 . . . . 0.0 113.817 175.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 62.8 m-20 -80.07 -20.91 44.06 Favored 'General case' 0 CA--C 1.543 0.708 0 O-C-N 121.336 -0.853 . . . . 0.0 111.601 169.241 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 71.5 m -85.88 167.28 15.28 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.242 1.417 . . . . 0.0 113.863 -174.808 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -70.23 170.35 11.84 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 124.21 1.004 . . . . 0.0 110.702 175.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.16 135.3 57.68 Favored 'General case' 0 CA--C 1.539 0.52 0 O-C-N 121.202 -0.936 . . . . 0.0 112.87 -177.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 76.2 -8.84 22.39 Favored Glycine 0 CA--C 1.534 1.248 0 C-N-CA 124.712 1.149 . . . . 0.0 114.352 -178.621 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 59.3 m -80.13 162.69 24.61 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 118.472 1.136 . . . . 0.0 113.988 178.401 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 19.4 m -121.28 154.13 25.04 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 126.206 1.802 . . . . 0.0 110.146 168.287 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 49.4 t -87.66 103.79 15.91 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 123.462 0.705 . . . . 0.0 110.178 169.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -70.6 167.68 50.04 Favored Glycine 0 CA--C 1.543 1.784 0 C-N-CA 124.714 1.15 . . . . 0.0 114.05 178.736 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -69.99 -18.77 35.74 Favored 'Trans proline' 0 CA--C 1.538 0.701 0 C-N-CA 124.12 3.213 . . . . 0.0 113.564 -175.127 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 52.6 p-10 -70.59 -8.04 48.58 Favored 'General case' 0 CA--C 1.548 0.899 0 N-CA-C 114.323 1.231 . . . . 0.0 114.323 171.17 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 81.93 12.37 81.28 Favored Glycine 0 CA--C 1.533 1.17 0 C-N-CA 124.893 1.235 . . . . 0.0 113.994 -177.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -113.79 157.93 21.64 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.848 1.259 . . . . 0.0 111.76 170.501 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 77.7 m -77.28 149.56 35.37 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.21 1.404 . . . . 0.0 113.088 174.369 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.298 0 C-N-CA 125.947 1.736 . . . . 0.0 113.153 173.972 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 36.3 t . . . . . 0 CA--C 1.547 0.844 0 CA-C-O 118.163 -0.922 . . . . 0.0 112.461 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -66.77 151.21 82.92 Favored 'Trans proline' 0 C--N 1.353 0.797 0 C-N-CA 123.203 2.602 . . . . 0.0 111.845 178.685 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 6.7 mmp_? -82.54 14.36 3.13 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 124.77 1.228 . . . . 0.0 114.058 -177.083 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 10.2 tp -71.78 142.74 15.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 C-N-CA 125.302 1.441 . . . . 0.0 111.223 177.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 26.9 tp -76.93 131.98 38.82 Favored 'General case' 0 CA--C 1.538 0.485 0 O-C-N 121.791 -0.568 . . . . 0.0 110.15 175.357 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 61.2 tpp -154.47 126.47 7.72 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 125.056 1.342 . . . . 0.0 108.773 -178.319 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 25.9 ttt85 -88.93 146.64 24.79 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 118.392 0.542 . . . . 0.0 111.259 -178.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 26.2 p -150.84 160.08 44.12 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.269 1.427 . . . . 0.0 113.685 -169.091 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 61.7 mtpt -116.67 -20.79 9.4 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 126.35 1.86 . . . . 0.0 111.301 169.03 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 19.5 pt20 -147.8 160.29 42.91 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 126.941 2.097 . . . . 0.0 110.201 177.493 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -62.23 -26.03 68.14 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 124.25 1.02 . . . . 0.0 112.439 -179.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 17.0 m -67.85 -13.85 62.48 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 124.881 1.272 . . . . 0.0 113.664 175.544 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 48.3 m-20 -82.32 -19.69 38.88 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.747 0.819 . . . . 0.0 112.117 172.523 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 81.7 m -85.86 168.88 13.84 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.308 1.443 . . . . 0.0 113.83 -173.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -71.64 175.65 5.46 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 124.468 1.107 . . . . 0.0 111.049 176.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.29 133.0 55.68 Favored 'General case' 0 CA--C 1.54 0.566 0 O-C-N 121.064 -1.023 . . . . 0.0 113.338 -176.044 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 74.02 -8.3 12.57 Favored Glycine 0 CA--C 1.535 1.288 0 C-N-CA 124.891 1.234 . . . . 0.0 114.559 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 66.4 m -75.78 162.52 28.11 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 114.238 1.199 . . . . 0.0 114.238 -178.074 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 20.3 m -120.57 151.25 23.39 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 125.579 1.551 . . . . 0.0 110.493 168.298 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 49.4 t -87.09 103.64 15.57 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 123.586 0.754 . . . . 0.0 109.8 169.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -71.74 171.7 47.1 Favored Glycine 0 CA--C 1.543 1.827 0 C-N-CA 125.063 1.316 . . . . 0.0 114.446 -178.48 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -70.43 -21.04 30.92 Favored 'Trans proline' 0 CA--C 1.539 0.733 0 C-N-CA 124.262 3.308 . . . . 0.0 113.634 -173.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 50.7 p-10 -70.69 -7.04 41.66 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 124.749 1.22 . . . . 0.0 113.987 169.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.86 10.35 83.17 Favored Glycine 0 CA--C 1.529 0.946 0 C-N-CA 125.24 1.4 . . . . 0.0 113.866 -177.048 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -113.52 154.24 27.41 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 119.374 1.587 . . . . 0.0 112.444 175.659 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 69.9 m -74.76 151.18 39.16 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.969 1.308 . . . . 0.0 113.063 177.628 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.353 0 C-N-CA 125.647 1.594 . . . . 0.0 113.864 175.132 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 42.0 t . . . . . 0 CA--C 1.55 0.952 0 CA-C-O 118.295 -0.86 . . . . 0.0 112.244 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -71.35 163.33 39.47 Favored 'Trans proline' 0 C--N 1.353 0.792 0 C-N-CA 123.315 2.677 . . . . 0.0 111.865 176.327 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 18.5 ptp180 -72.94 16.3 0.16 Allowed 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 115.175 1.546 . . . . 0.0 115.175 -176.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 89.4 mt -80.36 119.94 30.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 125.768 1.627 . . . . 0.0 109.656 -176.741 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 36.9 tp -81.88 132.32 35.27 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.729 0.812 . . . . 0.0 109.652 170.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 59.9 ttm -160.97 136.21 7.74 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.664 1.185 . . . . 0.0 109.598 -171.433 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 56.8 mtp85 -84.89 152.26 23.69 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 118.876 0.762 . . . . 0.0 112.556 175.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 24.9 p -151.32 156.83 41.59 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.206 1.402 . . . . 0.0 113.672 -169.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 28.4 ttpp -102.37 -29.63 11.53 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 126.205 1.802 . . . . 0.0 110.539 168.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 20.1 pt20 -155.94 166.7 32.7 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 126.364 1.866 . . . . 0.0 110.648 -177.484 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -60.89 -25.69 66.89 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 124.303 1.041 . . . . 0.0 112.647 -176.643 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.4 m -64.14 -18.84 64.83 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 125.834 1.654 . . . . 0.0 113.576 176.168 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 63.2 m-20 -81.48 -22.15 38.23 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.004 0.921 . . . . 0.0 112.387 174.591 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 73.0 m -86.32 167.34 14.87 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.059 1.344 . . . . 0.0 113.844 -171.297 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.413 HD22 ' H ' ' A' ' 16' ' ' LEU . 1.8 mm? -70.81 172.37 8.96 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 124.261 1.024 . . . . 0.0 111.048 176.389 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.07 135.88 57.85 Favored 'General case' 0 CA--C 1.539 0.537 0 O-C-N 121.273 -0.892 . . . . 0.0 112.88 -179.188 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 75.75 -9.25 17.37 Favored Glycine 0 CA--C 1.533 1.207 0 C-N-CA 124.776 1.179 . . . . 0.0 114.265 -178.554 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 59.6 m -80.78 161.63 24.43 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 118.652 1.226 . . . . 0.0 114.023 179.479 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 18.7 m -123.27 153.2 28.52 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 C-N-CA 126.272 1.829 . . . . 0.0 110.091 168.383 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 49.1 t -87.57 103.7 15.8 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 123.386 0.675 . . . . 0.0 109.871 169.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -71.5 170.4 48.45 Favored Glycine 0 CA--C 1.542 1.743 0 C-N-CA 124.884 1.23 . . . . 0.0 114.197 -179.288 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -69.67 -20.56 35.11 Favored 'Trans proline' 0 CA--C 1.538 0.71 0 C-N-CA 124.247 3.298 . . . . 0.0 113.453 -175.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 49.3 p30 -70.31 -6.8 37.71 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 125.014 1.326 . . . . 0.0 114.053 169.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 79.9 12.64 83.22 Favored Glycine 0 CA--C 1.531 1.033 0 C-N-CA 125.188 1.375 . . . . 0.0 114.066 -178.408 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -109.05 153.56 23.47 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 118.613 1.207 . . . . 0.0 112.239 172.218 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 78.2 m -73.17 145.2 46.5 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.883 1.273 . . . . 0.0 112.238 170.013 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.238 0 C-N-CA 125.95 1.738 . . . . 0.0 113.207 175.813 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 51.6 t . . . . . 0 CA--C 1.549 0.937 0 CA-C-O 118.363 -0.827 . . . . 0.0 112.645 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_exo -57.71 145.87 87.87 Favored 'Trans proline' 0 C--N 1.354 0.858 0 C-N-CA 123.83 3.02 . . . . 0.0 112.645 171.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 34.0 ptt-85 -79.99 12.61 2.66 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 115.358 1.614 . . . . 0.0 115.358 -173.617 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 10.2 tp -75.11 142.21 14.88 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 125.223 1.409 . . . . 0.0 111.484 178.659 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 30.4 tp -81.04 133.82 35.55 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 123.577 0.751 . . . . 0.0 109.988 173.725 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 61.5 tpp -158.6 133.51 8.33 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.458 1.103 . . . . 0.0 109.516 -172.478 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 55.6 mtp85 -91.31 154.64 19.09 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 118.955 0.798 . . . . 0.0 112.879 175.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 26.4 p -154.88 159.25 40.36 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.196 1.398 . . . . 0.0 113.83 -169.798 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 65.0 mttp -111.63 -26.05 9.22 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 125.991 1.717 . . . . 0.0 111.028 168.804 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 21.0 pt20 -150.97 166.99 28.97 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 126.565 1.946 . . . . 0.0 110.513 175.503 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -60.76 -25.9 66.84 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 124.524 1.13 . . . . 0.0 112.73 -176.043 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.9 m -65.41 -18.1 65.05 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 125.653 1.581 . . . . 0.0 113.61 176.31 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 62.2 m-20 -82.0 -19.26 40.87 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 123.971 0.909 . . . . 0.0 112.327 173.806 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 75.0 m -87.02 167.08 14.55 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.921 1.289 . . . . 0.0 113.903 -173.498 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -71.34 172.99 8.4 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 124.741 1.217 . . . . 0.0 110.925 177.181 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.24 133.36 56.03 Favored 'General case' 0 CA--C 1.539 0.543 0 O-C-N 121.195 -0.94 . . . . 0.0 113.162 -175.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 74.83 -8.54 14.72 Favored Glycine 0 CA--C 1.534 1.267 0 C-N-CA 124.657 1.122 . . . . 0.0 114.45 -179.464 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 61.2 m -78.65 160.99 27.25 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 114.067 1.136 . . . . 0.0 114.067 179.798 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 18.8 m -120.24 154.54 23.35 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 126.258 1.823 . . . . 0.0 110.205 168.447 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 43.3 t -88.17 104.13 16.41 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 123.618 0.767 . . . . 0.0 110.28 170.019 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -70.72 169.15 48.51 Favored Glycine 0 CA--C 1.543 1.802 0 C-N-CA 124.911 1.243 . . . . 0.0 114.179 178.454 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -70.52 -20.67 30.97 Favored 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 124.228 3.285 . . . . 0.0 113.695 -174.137 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 50.5 p30 -71.35 -5.15 30.3 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 124.952 1.301 . . . . 0.0 114.058 170.397 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 79.28 11.17 85.28 Favored Glycine 0 CA--C 1.53 1.027 0 C-N-CA 125.12 1.343 . . . . 0.0 114.007 -178.636 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -106.99 155.05 20.21 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 118.652 1.226 . . . . 0.0 111.885 170.548 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 83.3 m -76.23 147.37 38.39 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.983 1.313 . . . . 0.0 112.606 173.272 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.181 0 C-N-CA 125.815 1.674 . . . . 0.0 113.279 175.26 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 45.9 t . . . . . 0 CA--C 1.551 0.995 0 CA-C-O 118.326 -0.845 . . . . 0.0 112.586 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -56.77 146.18 79.08 Favored 'Trans proline' 0 C--N 1.354 0.866 0 C-N-CA 123.947 3.098 . . . . 0.0 112.872 172.059 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 82.1 mtp180 -84.72 14.1 5.07 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 114.404 1.261 . . . . 0.0 114.404 -172.112 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 10.2 tp -77.63 143.4 12.89 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 C-N-CA 125.176 1.39 . . . . 0.0 111.144 176.353 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 29.4 tp -78.21 135.26 37.56 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 123.189 0.596 . . . . 0.0 110.22 174.648 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 61.2 tpp -154.16 126.61 8.0 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 124.78 1.232 . . . . 0.0 108.973 -177.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 25.1 ttt85 -89.61 147.4 23.94 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 118.452 0.569 . . . . 0.0 111.037 179.158 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 26.1 p -152.19 165.66 34.15 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.884 1.274 . . . . 0.0 114.309 -168.469 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 21.5 pttp -122.41 -14.4 7.85 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 126.072 1.749 . . . . 0.0 112.123 168.079 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 20.0 pt20 -155.45 162.35 40.77 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 126.642 1.977 . . . . 0.0 110.351 178.183 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 26.7 m-20 -62.23 -24.52 67.29 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.911 0.884 . . . . 0.0 112.606 -177.102 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.3 m -64.21 -18.57 64.64 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 125.82 1.648 . . . . 0.0 113.58 176.327 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 64.6 m-20 -80.78 -20.52 42.44 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.12 0.968 . . . . 0.0 112.388 174.4 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 73.8 m -89.77 165.92 13.87 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.983 1.313 . . . . 0.0 113.897 -169.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -72.56 174.95 6.78 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 124.763 1.225 . . . . 0.0 111.07 177.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.43 133.23 55.91 Favored 'General case' 0 CA--C 1.541 0.606 0 O-C-N 121.089 -1.007 . . . . 0.0 113.104 -176.228 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 74.73 -8.64 13.8 Favored Glycine 0 CA--C 1.535 1.311 0 C-N-CA 124.687 1.137 . . . . 0.0 114.408 -179.447 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 60.6 m -79.16 161.99 26.07 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 114.082 1.141 . . . . 0.0 114.082 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 18.2 m -124.92 154.42 32.8 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 126.433 1.893 . . . . 0.0 110.197 168.577 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 36.9 t -83.77 102.25 12.17 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 123.303 0.641 . . . . 0.0 110.372 170.338 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -71.91 172.25 46.74 Favored Glycine 0 CA--C 1.542 1.781 0 C-N-CA 125.339 1.447 . . . . 0.0 114.62 -179.092 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -71.38 -20.94 27.04 Favored 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 124.33 3.353 . . . . 0.0 113.973 -172.127 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 52.6 p-10 -71.96 -5.18 32.96 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 124.576 1.15 . . . . 0.0 113.899 170.416 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 83.47 5.92 88.07 Favored Glycine 0 CA--C 1.53 0.98 0 C-N-CA 125.497 1.522 . . . . 0.0 114.029 -177.694 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -109.5 155.97 20.68 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 119.195 1.497 . . . . 0.0 112.163 174.599 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 82.7 m -73.47 145.8 45.42 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.839 1.256 . . . . 0.0 112.804 176.308 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.206 0 C-N-CA 126.063 1.792 . . . . 0.0 113.146 175.905 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 48.0 t . . . . . 0 CA--C 1.55 0.964 0 CA-C-O 118.134 -0.936 . . . . 0.0 112.396 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -62.93 160.65 32.62 Favored 'Trans proline' 0 C--N 1.354 0.827 0 C-N-CA 123.288 2.659 . . . . 0.0 112.848 175.165 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 40.4 ptt180 -74.13 13.94 0.49 Allowed 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 114.865 1.431 . . . . 0.0 114.865 179.519 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 94.6 mt -86.32 122.21 38.4 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 126.352 1.861 . . . . 0.0 109.558 -174.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 47.7 tp -76.74 134.31 39.21 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.666 0.786 . . . . 0.0 109.872 171.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 57.6 ttm -157.57 132.17 8.52 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.342 1.057 . . . . 0.0 110.186 -173.592 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 57.4 ttt180 -82.71 147.98 28.16 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.723 0.809 . . . . 0.0 111.089 -179.65 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 26.3 p -151.17 158.5 44.05 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.548 1.139 . . . . 0.0 113.687 -170.034 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 58.9 mtmt -109.3 -27.32 9.58 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.815 1.646 . . . . 0.0 111.344 169.505 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 8.0 pt20 -153.41 169.47 23.06 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 126.399 1.88 . . . . 0.0 110.818 176.109 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -61.45 -25.71 67.4 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.406 1.083 . . . . 0.0 112.887 -176.489 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 7.2 m -64.8 -18.65 65.29 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 125.296 1.438 . . . . 0.0 113.484 175.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 62.0 m-20 -80.42 -21.18 42.44 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 123.909 0.883 . . . . 0.0 112.21 173.843 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 77.4 m -88.08 166.75 14.21 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 125.237 1.415 . . . . 0.0 113.662 -173.303 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 40.1 mt -74.4 177.37 5.98 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.47 1.108 . . . . 0.0 111.726 178.496 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.23 134.47 57.09 Favored 'General case' 0 CA--C 1.54 0.559 0 O-C-N 121.305 -0.872 . . . . 0.0 112.855 -179.786 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 74.67 -8.33 15.21 Favored Glycine 0 CA--C 1.535 1.292 0 C-N-CA 124.698 1.142 . . . . 0.0 114.314 -178.461 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 60.7 m -81.22 159.76 24.48 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 118.553 1.177 . . . . 0.0 113.993 179.496 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 18.2 m -124.48 151.63 29.88 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 126.251 1.82 . . . . 0.0 110.003 168.288 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 49.7 t -85.69 102.2 13.41 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.355 0.662 . . . . 0.0 109.561 169.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -72.65 170.11 51.44 Favored Glycine 0 CA--C 1.544 1.858 0 C-N-CA 124.411 1.005 . . . . 0.0 114.242 -176.167 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -57.9 -26.78 75.94 Favored 'Trans proline' 0 C--N 1.353 0.807 0 C-N-CA 124.518 3.479 . . . . 0.0 114.757 -178.815 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 52.0 p-10 -68.6 -11.37 59.92 Favored 'General case' 0 CA--C 1.548 0.9 0 N-CA-C 114.676 1.361 . . . . 0.0 114.676 174.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 84.25 14.56 71.31 Favored Glycine 0 CA--C 1.533 1.177 0 C-N-CA 124.799 1.19 . . . . 0.0 114.019 -176.335 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 64.8 m-85 -123.05 155.33 37.11 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.739 1.216 . . . . 0.0 112.225 175.142 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 85.7 m -73.91 145.19 44.97 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.116 1.366 . . . . 0.0 112.761 178.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.284 0 C-N-CA 126.111 1.815 . . . . 0.0 113.076 175.265 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 40.4 t . . . . . 0 CA--C 1.546 0.826 0 CA-C-O 117.905 -1.045 . . . . 0.0 112.542 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -67.74 146.31 72.3 Favored 'Trans proline' 0 C--N 1.353 0.813 0 C-N-CA 122.994 2.463 . . . . 0.0 110.676 175.185 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 15.3 mmm180 -83.45 17.04 2.29 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 113.48 0.919 . . . . 0.0 113.48 -173.16 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 19.4 tt -66.28 141.74 17.65 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 125.954 1.702 . . . . 0.0 111.616 178.702 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 26.5 tp -77.0 130.26 37.23 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.315 0.646 . . . . 0.0 109.975 175.313 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 61.7 tpp -160.14 132.49 6.35 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.806 1.242 . . . . 0.0 109.098 -172.762 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 55.2 mtp85 -91.14 155.35 18.69 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 118.944 0.793 . . . . 0.0 113.088 177.456 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 26.6 p -155.67 157.38 36.58 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.401 1.48 . . . . 0.0 113.407 -170.136 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 64.9 mttp -110.51 -26.22 9.61 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 125.598 1.559 . . . . 0.0 110.936 168.863 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 8.1 pt20 -149.99 169.28 21.57 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 126.5 1.92 . . . . 0.0 110.386 173.185 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -61.18 -25.57 67.12 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 124.533 1.133 . . . . 0.0 112.919 -176.513 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 7.1 m -64.88 -19.1 65.73 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 125.315 1.446 . . . . 0.0 113.605 175.862 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 60.3 m-20 -82.18 -18.46 42.66 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 123.929 0.892 . . . . 0.0 112.366 174.878 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 79.1 m -86.66 168.51 13.54 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.069 1.348 . . . . 0.0 113.706 -175.412 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -71.1 173.84 7.08 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 124.557 1.143 . . . . 0.0 110.992 176.805 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.94 132.76 54.94 Favored 'General case' 0 CA--C 1.54 0.573 0 O-C-N 121.115 -0.991 . . . . 0.0 113.236 -175.615 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 74.25 -8.33 13.44 Favored Glycine 0 CA--C 1.534 1.265 0 C-N-CA 124.87 1.224 . . . . 0.0 114.539 -179.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 67.4 m -75.42 162.32 28.47 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 114.041 1.126 . . . . 0.0 114.041 -179.205 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 22.4 m -118.43 151.99 20.56 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 125.463 1.505 . . . . 0.0 110.7 168.666 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 48.5 t -90.3 105.15 17.62 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.826 0.85 . . . . 0.0 109.999 169.488 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -70.74 168.81 49.07 Favored Glycine 0 CA--C 1.541 1.708 0 C-N-CA 124.742 1.163 . . . . 0.0 114.127 178.586 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -70.01 -20.53 33.56 Favored 'Trans proline' 0 CA--C 1.538 0.713 0 C-N-CA 124.187 3.258 . . . . 0.0 113.58 -175.151 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 49.1 p30 -70.65 -5.96 33.41 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 125.071 1.349 . . . . 0.0 114.099 169.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 78.83 13.45 83.1 Favored Glycine 0 CA--C 1.531 1.039 0 C-N-CA 125.109 1.337 . . . . 0.0 113.917 -178.289 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -109.04 153.82 23.09 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 118.629 1.215 . . . . 0.0 111.995 171.159 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 82.5 m -76.59 154.02 34.8 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.998 1.319 . . . . 0.0 112.847 173.765 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.185 0 CA-C-O 116.653 -2.193 . . . . 0.0 113.952 175.472 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 42.3 t . . . . . 0 CA--C 1.549 0.932 0 CA-C-O 118.311 -0.852 . . . . 0.0 112.19 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_endo -72.69 163.77 37.53 Favored 'Trans proline' 0 C--N 1.353 0.804 0 C-N-CA 123.132 2.555 . . . . 0.0 111.74 177.755 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 10.7 ptm85 -73.04 15.56 0.2 Allowed 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 115.109 1.522 . . . . 0.0 115.109 -178.55 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 91.6 mt -79.77 120.07 30.4 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 125.834 1.654 . . . . 0.0 109.349 -177.828 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 36.3 tp -76.82 135.11 38.91 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 123.388 0.675 . . . . 0.0 109.602 171.085 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 60.8 tpp -160.01 134.58 7.65 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.315 1.046 . . . . 0.0 109.365 -169.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 53.9 mtp85 -88.93 152.82 21.5 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 119.187 0.903 . . . . 0.0 112.418 174.625 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 26.4 p -153.8 159.87 42.04 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 125.004 1.322 . . . . 0.0 113.866 -169.636 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 61.3 mtpt -113.94 -24.2 9.2 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 126.18 1.792 . . . . 0.0 111.158 168.846 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 21.0 pt20 -151.0 166.46 30.64 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 126.544 1.938 . . . . 0.0 110.434 175.099 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -61.29 -25.47 67.13 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 124.332 1.053 . . . . 0.0 112.721 -176.23 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.8 m -65.42 -17.77 64.8 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 125.636 1.574 . . . . 0.0 113.641 176.233 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 63.5 m-20 -81.79 -18.71 43.15 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 123.985 0.914 . . . . 0.0 112.302 173.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 74.2 m -87.98 168.01 13.22 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.952 1.301 . . . . 0.0 114.133 -172.416 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -70.57 171.16 10.74 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 124.399 1.08 . . . . 0.0 110.742 175.733 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.13 134.8 57.4 Favored 'General case' 0 CA--C 1.539 0.543 0 O-C-N 121.171 -0.956 . . . . 0.0 113.018 -177.177 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 75.82 -8.82 19.7 Favored Glycine 0 CA--C 1.534 1.238 0 C-N-CA 124.814 1.197 . . . . 0.0 114.338 -179.172 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 60.5 m -79.48 162.07 25.67 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 114.131 1.16 . . . . 0.0 114.131 179.427 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 19.0 m -122.14 153.44 26.5 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 126.308 1.843 . . . . 0.0 110.128 168.338 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 41.1 t -86.91 102.61 14.51 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.6 0.76 . . . . 0.0 110.358 170.479 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -73.47 168.98 53.66 Favored Glycine 0 CA--C 1.545 1.94 0 C-N-CA 124.628 1.109 . . . . 0.0 114.499 -178.799 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -59.03 -28.6 88.32 Favored 'Trans proline' 0 C--N 1.354 0.822 0 C-N-CA 124.532 3.488 . . . . 0.0 115.129 -176.284 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 51.3 p30 -71.03 -4.79 26.78 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 125.06 1.344 . . . . 0.0 114.446 175.719 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 78.83 11.53 85.13 Favored Glycine 0 CA--C 1.531 1.054 0 C-N-CA 124.941 1.257 . . . . 0.0 113.918 -178.384 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -107.33 155.33 20.1 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 118.49 1.145 . . . . 0.0 111.796 169.857 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 83.7 m -76.36 145.97 39.1 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.03 1.332 . . . . 0.0 112.587 172.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.249 0 C-N-CA 125.906 1.717 . . . . 0.0 113.223 175.261 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 53.4 t . . . . . 0 CA--C 1.551 1.013 0 CA-C-O 118.399 -0.81 . . . . 0.0 112.497 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -56.93 153.3 38.54 Favored 'Trans proline' 0 C--N 1.353 0.787 0 C-N-CA 124.059 3.173 . . . . 0.0 113.152 171.312 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -78.92 38.4 0.33 Allowed 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 125.194 1.398 . . . . 0.0 112.692 179.721 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 86.7 mt -101.69 121.89 53.2 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 C-N-CA 126.366 1.866 . . . . 0.0 109.185 -176.28 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 37.5 tp -81.29 131.47 35.29 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 123.695 0.798 . . . . 0.0 109.646 171.837 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 60.3 ttm -160.1 135.31 8.03 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.644 1.178 . . . . 0.0 110.213 -171.881 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 30.3 mmt180 -73.57 153.44 40.23 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.588 0.755 . . . . 0.0 112.016 175.604 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 29.0 p -157.63 160.14 37.73 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.421 1.088 . . . . 0.0 113.71 -176.888 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 16.9 tppt? -117.23 -25.82 6.97 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 126.712 2.005 . . . . 0.0 111.035 169.155 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -144.38 159.96 41.85 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 126.583 1.953 . . . . 0.0 110.478 178.385 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -62.36 -26.59 68.54 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 124.31 1.044 . . . . 0.0 112.318 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 17.6 m -67.83 -13.18 61.92 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 124.98 1.312 . . . . 0.0 113.571 175.358 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 51.7 m-20 -80.67 -22.48 40.4 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 118.892 0.769 . . . . 0.0 111.914 171.49 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 73.1 m -86.38 167.78 14.43 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.398 1.479 . . . . 0.0 113.642 -172.601 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.408 HD22 ' H ' ' A' ' 16' ' ' LEU . 1.9 mm? -70.18 172.05 8.72 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.247 1.019 . . . . 0.0 111.157 176.403 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.54 135.21 57.6 Favored 'General case' 0 CA--C 1.539 0.541 0 O-C-N 121.231 -0.918 . . . . 0.0 112.902 -179.06 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 75.37 -9.03 15.32 Favored Glycine 0 CA--C 1.533 1.196 0 C-N-CA 124.716 1.151 . . . . 0.0 114.286 -178.683 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 60.4 m -80.62 161.34 24.75 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 118.604 1.202 . . . . 0.0 113.731 178.839 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 18.7 m -122.01 154.63 26.57 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 C-N-CA 126.256 1.823 . . . . 0.0 110.196 168.797 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 47.2 t -88.3 103.78 16.13 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.405 0.682 . . . . 0.0 109.661 169.524 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -71.16 168.53 50.44 Favored Glycine 0 CA--C 1.542 1.756 0 C-N-CA 124.591 1.091 . . . . 0.0 113.938 -178.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -69.29 -18.95 38.97 Favored 'Trans proline' 0 CA--C 1.538 0.723 0 C-N-CA 124.091 3.194 . . . . 0.0 113.254 -176.831 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 50.9 p-10 -69.44 -9.2 52.63 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 124.892 1.277 . . . . 0.0 114.312 170.196 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 81.99 13.82 78.56 Favored Glycine 0 CA--C 1.533 1.191 0 C-N-CA 125.019 1.295 . . . . 0.0 114.042 -177.779 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -115.17 155.12 27.74 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.027 1.331 . . . . 0.0 112.003 172.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 74.8 m -73.07 146.33 45.9 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.88 1.272 . . . . 0.0 112.584 171.429 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.209 0 C-N-CA 125.97 1.748 . . . . 0.0 113.235 175.131 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 53.0 t . . . . . 0 CA--C 1.55 0.951 0 CA-C-O 118.334 -0.841 . . . . 0.0 112.356 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -69.86 151.97 68.67 Favored 'Trans proline' 0 C--N 1.353 0.814 0 C-N-CA 123.041 2.494 . . . . 0.0 111.412 174.497 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -81.85 15.5 2.21 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.704 1.202 . . . . 0.0 113.882 -176.403 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 18.0 tt -72.98 142.73 14.68 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 125.598 1.559 . . . . 0.0 111.2 176.344 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 30.0 tp -79.23 134.79 36.66 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 123.128 0.571 . . . . 0.0 110.228 174.646 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 60.5 tpp -153.65 127.3 8.74 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 124.775 1.23 . . . . 0.0 109.408 -179.109 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 45.8 ttt85 -85.5 147.18 26.57 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.747 0.819 . . . . 0.0 111.015 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 29.3 p -156.76 165.48 36.12 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 114.351 1.241 . . . . 0.0 114.351 -169.374 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 21.9 pttp -126.16 -12.7 6.31 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 126.292 1.837 . . . . 0.0 112.122 168.149 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 17.4 pt20 -157.39 161.76 39.01 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 126.394 1.878 . . . . 0.0 110.811 178.838 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 33.8 m-20 -65.57 -25.3 67.36 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 124.154 0.982 . . . . 0.0 113.441 -171.05 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 58.8 p -72.88 -9.44 58.69 Favored 'General case' 0 CA--C 1.546 0.792 0 N-CA-C 113.695 0.998 . . . . 0.0 113.695 175.831 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 66.4 m-20 -78.01 -23.54 48.25 Favored 'General case' 0 N--CA 1.473 0.724 0 O-C-N 121.299 -0.876 . . . . 0.0 111.315 168.822 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 73.2 m -87.79 166.42 14.62 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.508 1.523 . . . . 0.0 113.795 -171.242 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -71.55 172.54 9.41 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 124.609 1.164 . . . . 0.0 111.032 177.525 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.17 133.06 55.75 Favored 'General case' 0 CA--C 1.538 0.511 0 O-C-N 121.241 -0.912 . . . . 0.0 113.164 -176.305 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 75.64 -9.26 16.52 Favored Glycine 0 CA--C 1.534 1.279 0 C-N-CA 124.781 1.181 . . . . 0.0 114.339 -178.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 60.8 m -78.71 163.39 25.45 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 118.547 1.173 . . . . 0.0 113.969 179.354 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 18.3 m -124.18 154.5 31.17 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 C-N-CA 126.354 1.862 . . . . 0.0 110.211 168.389 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 45.5 t -85.33 103.65 14.45 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 123.186 0.594 . . . . 0.0 110.123 169.822 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -70.03 168.95 46.77 Favored Glycine 0 CA--C 1.544 1.858 0 C-N-CA 124.871 1.224 . . . . 0.0 114.15 179.33 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -70.13 -18.62 35.16 Favored 'Trans proline' 0 CA--C 1.538 0.697 0 C-N-CA 124.16 3.24 . . . . 0.0 113.612 -174.333 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 52.9 p-10 -69.77 -9.06 53.13 Favored 'General case' 0 CA--C 1.548 0.897 0 N-CA-C 114.278 1.214 . . . . 0.0 114.278 170.473 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 84.61 11.62 77.01 Favored Glycine 0 CA--C 1.532 1.123 0 C-N-CA 124.837 1.208 . . . . 0.0 113.938 -176.607 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -121.44 155.83 34.03 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 118.632 1.216 . . . . 0.0 112.289 175.086 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 84.8 m -75.41 147.7 39.75 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.789 1.236 . . . . 0.0 113.2 -179.549 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.199 0 C-N-CA 126.123 1.82 . . . . 0.0 113.038 174.517 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 53.2 t . . . . . 0 CA--C 1.55 0.96 0 CA-C-O 118.353 -0.832 . . . . 0.0 112.551 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo -58.4 154.33 42.08 Favored 'Trans proline' 0 C--N 1.355 0.878 0 C-N-CA 123.832 3.022 . . . . 0.0 113.156 172.676 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 95.7 mtt-85 -79.1 40.2 0.4 Allowed 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 125.037 1.335 . . . . 0.0 112.346 177.497 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 88.8 mt -104.34 123.4 58.18 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 126.627 1.971 . . . . 0.0 108.835 -177.043 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 41.0 tp -76.23 133.83 40.0 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.188 0.595 . . . . 0.0 109.837 172.598 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 59.6 tpp -155.58 130.11 9.05 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 124.461 1.104 . . . . 0.0 109.662 -174.427 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 60.7 ttt180 -83.29 146.15 28.7 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.583 0.753 . . . . 0.0 110.566 178.448 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 28.6 p -152.43 159.15 43.42 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 114.703 1.371 . . . . 0.0 114.703 -169.6 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 63.2 tttp -112.54 -28.91 7.66 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 126.594 1.957 . . . . 0.0 110.793 168.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 21.0 pt20 -149.44 166.76 28.13 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 126.194 1.797 . . . . 0.0 110.745 177.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -61.27 -25.27 66.97 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.183 0.993 . . . . 0.0 112.765 -175.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.8 m -65.35 -17.84 64.84 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 125.589 1.556 . . . . 0.0 113.567 176.165 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 62.4 m-20 -81.68 -18.81 43.18 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.086 0.955 . . . . 0.0 112.307 173.588 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 75.7 m -88.38 166.94 13.91 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.992 1.317 . . . . 0.0 113.955 -172.746 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -71.23 172.97 8.34 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 124.563 1.145 . . . . 0.0 110.952 176.342 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.5 133.53 56.18 Favored 'General case' 0 CA--C 1.54 0.564 0 O-C-N 121.143 -0.973 . . . . 0.0 113.145 -176.601 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 74.77 -8.62 14.05 Favored Glycine 0 CA--C 1.535 1.291 0 C-N-CA 124.572 1.082 . . . . 0.0 114.427 -179.372 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 60.3 m -78.96 162.21 26.14 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 118.448 1.124 . . . . 0.0 113.859 179.075 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 18.3 m -122.88 154.26 28.14 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 126.103 1.761 . . . . 0.0 110.361 168.716 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 48.7 t -84.96 103.12 13.72 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 123.491 0.716 . . . . 0.0 110.128 169.9 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -69.92 168.73 46.73 Favored Glycine 0 CA--C 1.543 1.824 0 C-N-CA 124.888 1.233 . . . . 0.0 114.093 179.626 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -69.8 -18.45 36.82 Favored 'Trans proline' 0 CA--C 1.537 0.662 0 C-N-CA 124.241 3.294 . . . . 0.0 113.503 -174.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 53.4 p-10 -69.54 -9.91 55.88 Favored 'General case' 0 CA--C 1.549 0.911 0 N-CA-C 114.33 1.233 . . . . 0.0 114.33 170.697 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 85.19 11.75 75.13 Favored Glycine 0 CA--C 1.533 1.163 0 C-N-CA 124.885 1.231 . . . . 0.0 114.083 -176.722 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 67.1 m-85 -123.98 157.24 34.83 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.751 1.22 . . . . 0.0 112.218 174.734 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 86.3 m -76.34 148.4 37.47 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.997 1.319 . . . . 0.0 113.49 -177.902 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.24 0 C-N-CA 126.111 1.815 . . . . 0.0 113.039 174.677 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 37.5 t . . . . . 0 CA--C 1.546 0.816 0 CA-C-O 118.122 -0.942 . . . . 0.0 112.56 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -69.6 151.8 70.04 Favored 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 122.915 2.41 . . . . 0.0 111.205 178.138 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 6.8 mmp_? -78.52 34.16 0.21 Allowed 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.829 1.251 . . . . 0.0 113.109 -178.27 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 96.6 mt -80.5 126.05 39.41 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 125.717 1.607 . . . . 0.0 109.003 177.789 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 37.6 tp -74.05 126.13 29.83 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 172.292 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 61.0 tpp -154.68 130.97 10.4 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.503 1.121 . . . . 0.0 109.68 -171.273 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 83.8 mtt85 -80.45 151.43 29.31 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.74 0.816 . . . . 0.0 111.48 177.035 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 29.4 p -156.51 155.13 31.45 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 113.983 1.105 . . . . 0.0 113.983 -174.132 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -109.82 -28.78 8.61 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 126.337 1.855 . . . . 0.0 110.562 168.796 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 20.9 pt20 -148.77 167.0 26.76 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 126.479 1.912 . . . . 0.0 110.665 176.156 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -61.27 -24.76 66.63 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 124.452 1.101 . . . . 0.0 112.768 -176.289 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.9 m -65.85 -17.84 64.92 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 125.583 1.553 . . . . 0.0 113.667 175.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 62.5 m-20 -81.62 -18.58 44.2 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.066 0.946 . . . . 0.0 112.343 173.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 72.8 m -87.66 168.74 12.74 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.28 1.432 . . . . 0.0 113.946 -173.695 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -70.7 174.59 5.77 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 124.311 1.044 . . . . 0.0 110.91 175.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.48 133.42 56.08 Favored 'General case' 0 CA--C 1.54 0.565 0 O-C-N 120.994 -1.066 . . . . 0.0 113.146 -176.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 74.51 -8.14 15.43 Favored Glycine 0 CA--C 1.535 1.287 0 C-N-CA 124.876 1.227 . . . . 0.0 114.474 179.764 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 66.2 m -75.95 162.77 27.81 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 114.127 1.158 . . . . 0.0 114.127 -178.762 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 22.9 m -119.9 151.12 22.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 125.233 1.413 . . . . 0.0 110.705 168.602 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 44.1 t -87.51 104.09 16.15 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.698 0.799 . . . . 0.0 109.667 169.438 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -70.77 167.69 50.52 Favored Glycine 0 CA--C 1.542 1.726 0 C-N-CA 124.636 1.112 . . . . 0.0 113.992 179.849 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -69.57 -18.45 37.87 Favored 'Trans proline' 0 CA--C 1.539 0.765 0 C-N-CA 124.146 3.231 . . . . 0.0 113.346 -176.11 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 52.3 p-10 -69.53 -9.66 54.86 Favored 'General case' 0 CA--C 1.548 0.891 0 N-CA-C 114.347 1.24 . . . . 0.0 114.347 170.711 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 84.92 11.72 75.99 Favored Glycine 0 CA--C 1.533 1.157 0 C-N-CA 124.889 1.233 . . . . 0.0 114.127 -177.05 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -118.86 155.65 30.85 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.886 1.274 . . . . 0.0 112.376 174.86 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 70.2 m -76.0 153.85 36.2 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.076 1.351 . . . . 0.0 113.255 176.722 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.276 0 CA-C-O 116.765 -2.131 . . . . 0.0 113.979 174.965 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 47.3 t . . . . . 0 CA--C 1.551 0.998 0 CA-C-O 118.313 -0.851 . . . . 0.0 112.621 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -56.42 150.07 52.95 Favored 'Trans proline' 0 C--N 1.353 0.795 0 C-N-CA 124.075 3.183 . . . . 0.0 113.125 171.143 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -79.53 37.97 0.36 Allowed 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 125.117 1.367 . . . . 0.0 113.009 -177.143 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 48.2 mm -98.41 123.99 51.28 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 126.12 1.768 . . . . 0.0 109.777 -177.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 36.5 tp -81.52 129.33 34.62 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 123.586 0.754 . . . . 0.0 109.624 171.198 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 60.2 ttm -160.9 136.59 8.06 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.811 1.244 . . . . 0.0 109.574 -171.768 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 57.2 mtp85 -85.46 152.53 23.13 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 118.819 0.736 . . . . 0.0 112.708 176.776 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 25.0 p -151.74 159.55 43.92 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.367 1.467 . . . . 0.0 113.374 -169.854 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 31.5 mmmt -110.15 -26.19 9.79 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 125.877 1.671 . . . . 0.0 111.368 169.191 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 8.5 pt20 -152.78 168.9 24.17 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 126.332 1.853 . . . . 0.0 110.742 175.367 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -61.21 -26.21 67.57 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 124.382 1.073 . . . . 0.0 112.78 -176.525 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 6.6 m -64.58 -18.69 65.12 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 125.374 1.469 . . . . 0.0 113.508 176.264 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 62.6 m-20 -80.58 -20.72 42.68 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 123.921 0.888 . . . . 0.0 112.286 174.282 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 72.1 m -87.45 168.02 13.47 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.109 1.364 . . . . 0.0 113.797 -172.684 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -70.3 172.02 8.93 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 124.357 1.063 . . . . 0.0 111.048 176.152 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.29 134.29 56.87 Favored 'General case' 0 CA--C 1.539 0.522 0 O-C-N 121.246 -0.909 . . . . 0.0 113.061 -177.793 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 75.04 -8.78 14.21 Favored Glycine 0 CA--C 1.534 1.238 0 C-N-CA 124.641 1.115 . . . . 0.0 114.411 -179.215 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 60.8 m -79.3 161.29 26.38 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 118.477 1.139 . . . . 0.0 113.794 178.814 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 19.1 m -121.7 154.21 25.87 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 126.182 1.793 . . . . 0.0 110.412 168.759 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 48.2 t -88.25 103.94 16.26 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.603 0.761 . . . . 0.0 110.001 169.724 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -70.96 169.98 47.87 Favored Glycine 0 CA--C 1.543 1.786 0 C-N-CA 124.926 1.25 . . . . 0.0 114.195 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -69.89 -20.56 34.07 Favored 'Trans proline' 0 CA--C 1.539 0.726 0 C-N-CA 124.163 3.242 . . . . 0.0 113.442 -175.221 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 49.2 p30 -70.63 -6.34 36.15 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 125.023 1.329 . . . . 0.0 114.023 169.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 79.75 12.38 83.62 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 125.271 1.415 . . . . 0.0 114.116 -178.348 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -108.51 153.68 23.0 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.77 1.228 . . . . 0.0 112.15 172.089 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 76.2 m -73.53 146.1 45.07 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.86 1.264 . . . . 0.0 112.603 171.1 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.271 0 C-N-CA 125.981 1.753 . . . . 0.0 113.303 175.557 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 44.7 t . . . . . 0 CA--C 1.55 0.959 0 CA-C-O 118.206 -0.902 . . . . 0.0 112.138 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -70.24 155.13 65.06 Favored 'Trans proline' 0 C--N 1.354 0.82 0 C-N-CA 122.962 2.442 . . . . 0.0 111.762 178.184 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 59.2 ttt85 -79.56 89.63 5.1 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.07 0.948 . . . . 0.0 110.621 179.118 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 9.2 tp -160.31 142.04 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 126.351 1.86 . . . . 0.0 110.437 -178.43 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 33.4 tp -86.8 136.74 32.88 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 123.963 0.905 . . . . 0.0 110.127 175.091 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 60.7 tpp -155.53 134.74 12.28 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.501 1.12 . . . . 0.0 110.055 -175.405 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 91.3 mtm-85 -81.38 152.16 27.6 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.131 0.972 . . . . 0.0 111.49 176.621 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 30.1 p -157.97 156.36 31.07 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 114.316 1.228 . . . . 0.0 114.316 -175.237 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 62.7 tttp -111.41 -29.08 7.93 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 126.456 1.902 . . . . 0.0 110.533 168.718 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 21.0 pt20 -148.14 166.98 26.23 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 126.535 1.934 . . . . 0.0 110.58 175.645 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -60.97 -25.33 66.77 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 124.502 1.121 . . . . 0.0 112.806 -176.192 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.9 m -65.46 -17.96 64.95 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.591 1.556 . . . . 0.0 113.669 175.837 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 61.8 m-20 -82.03 -19.47 40.34 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 123.964 0.906 . . . . 0.0 112.29 173.628 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 71.3 m -86.49 166.81 15.19 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.999 1.32 . . . . 0.0 113.607 -174.724 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -70.62 170.41 12.3 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 124.233 1.013 . . . . 0.0 110.76 176.26 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.9 134.95 57.52 Favored 'General case' 0 CA--C 1.539 0.533 0 O-C-N 121.273 -0.892 . . . . 0.0 112.885 -177.706 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 76.36 -9.06 22.41 Favored Glycine 0 CA--C 1.534 1.243 0 C-N-CA 124.698 1.142 . . . . 0.0 114.289 -178.541 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 58.8 m -79.91 162.61 24.88 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 118.567 1.184 . . . . 0.0 113.897 178.18 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 19.6 m -121.3 153.79 25.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 126.254 1.822 . . . . 0.0 110.206 168.419 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 48.9 t -87.83 104.17 16.33 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 123.552 0.741 . . . . 0.0 110.122 169.761 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -69.97 166.92 49.32 Favored Glycine 0 CA--C 1.542 1.739 0 C-N-CA 124.661 1.124 . . . . 0.0 113.875 178.277 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -69.83 -18.11 36.89 Favored 'Trans proline' 0 C--N 1.352 0.712 0 C-N-CA 124.204 3.269 . . . . 0.0 113.479 -175.444 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 53.1 p-10 -69.81 -9.28 54.07 Favored 'General case' 0 CA--C 1.548 0.87 0 N-CA-C 114.433 1.271 . . . . 0.0 114.433 171.185 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 84.85 11.6 76.46 Favored Glycine 0 CA--C 1.535 1.305 0 C-N-CA 124.813 1.197 . . . . 0.0 114.021 -177.036 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -119.16 156.28 30.11 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.701 1.2 . . . . 0.0 112.28 174.091 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 74.1 m -77.13 149.98 35.62 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.98 1.312 . . . . 0.0 113.258 177.732 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.271 0 C-N-CA 125.904 1.716 . . . . 0.0 113.097 174.015 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 43.7 t . . . . . 0 CA--C 1.55 0.964 0 CA-C-O 118.233 -0.889 . . . . 0.0 112.264 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -73.25 159.6 46.78 Favored 'Trans proline' 0 C--N 1.353 0.792 0 C-N-CA 123.099 2.533 . . . . 0.0 111.399 176.751 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -78.11 33.46 0.19 Allowed 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 125.286 1.434 . . . . 0.0 113.251 -177.861 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 97.5 mt -91.67 123.24 43.73 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 126.099 1.76 . . . . 0.0 108.837 179.641 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 37.3 tp -75.03 132.21 41.16 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 172.055 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 60.2 tpp -154.0 127.7 8.75 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 124.474 1.11 . . . . 0.0 109.406 -174.547 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 46.6 ttt85 -83.58 145.06 29.07 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.413 0.685 . . . . 0.0 110.555 178.112 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 28.0 p -149.97 158.88 44.61 Favored 'General case' 0 N--CA 1.469 0.525 0 N-CA-C 114.489 1.292 . . . . 0.0 114.489 -169.401 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -111.76 -28.85 7.92 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 126.516 1.926 . . . . 0.0 110.721 168.907 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 21.0 pt20 -149.35 166.74 28.1 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 126.29 1.836 . . . . 0.0 110.773 177.728 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -61.31 -25.25 67.0 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 124.236 1.014 . . . . 0.0 112.8 -176.184 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.8 m -65.33 -17.8 64.8 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 125.604 1.561 . . . . 0.0 113.576 176.052 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 63.3 m-20 -81.49 -18.63 44.49 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.133 0.973 . . . . 0.0 112.278 173.662 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 73.9 m -88.76 166.89 13.74 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.977 1.311 . . . . 0.0 114.123 -172.319 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -70.6 171.64 9.96 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 124.522 1.129 . . . . 0.0 110.836 175.701 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.23 135.25 57.67 Favored 'General case' 0 CA--C 1.538 0.511 0 O-C-N 121.178 -0.951 . . . . 0.0 112.939 -177.764 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 75.88 -9.2 18.46 Favored Glycine 0 CA--C 1.533 1.211 0 C-N-CA 124.809 1.195 . . . . 0.0 114.341 -178.797 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 59.8 m -80.18 162.96 24.42 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 114.185 1.18 . . . . 0.0 114.185 179.462 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 18.5 m -123.59 153.97 29.55 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 126.364 1.866 . . . . 0.0 110.088 168.222 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 49.0 t -84.32 102.52 12.76 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 123.408 0.683 . . . . 0.0 110.233 169.993 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -70.93 169.67 48.3 Favored Glycine 0 CA--C 1.542 1.779 0 C-N-CA 124.91 1.243 . . . . 0.0 114.383 -179.556 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -70.53 -19.05 32.96 Favored 'Trans proline' 0 CA--C 1.538 0.7 0 C-N-CA 124.207 3.271 . . . . 0.0 113.66 -173.819 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 53.2 p-10 -70.6 -8.12 49.24 Favored 'General case' 0 CA--C 1.548 0.889 0 N-CA-C 114.211 1.189 . . . . 0.0 114.211 170.849 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 85.25 8.97 80.69 Favored Glycine 0 CA--C 1.532 1.101 0 C-N-CA 124.974 1.274 . . . . 0.0 114.056 -176.993 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -118.62 156.78 28.61 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 118.676 1.238 . . . . 0.0 112.255 174.836 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 84.0 m -75.03 147.01 41.09 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.976 1.31 . . . . 0.0 113.169 179.168 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.189 0 C-N-CA 126.104 1.811 . . . . 0.0 113.097 174.937 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 42.7 t . . . . . 0 CA--C 1.549 0.911 0 CA-C-O 118.387 -0.816 . . . . 0.0 112.408 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_exo -61.8 154.99 57.09 Favored 'Trans proline' 0 C--N 1.354 0.841 0 C-N-CA 123.132 2.554 . . . . 0.0 112.121 174.551 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 75.4 mmt-85 -81.64 15.87 1.97 Allowed 'General case' 0 CA--C 1.546 0.795 0 N-CA-C 114.06 1.133 . . . . 0.0 114.06 -175.747 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 1.8 mp -82.12 127.35 39.7 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 125.764 1.625 . . . . 0.0 108.753 177.68 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 35.2 tp -75.32 136.32 40.85 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 123.576 0.75 . . . . 0.0 110.131 173.988 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 60.5 tpp -154.63 133.41 12.19 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.309 1.043 . . . . 0.0 110.231 -171.693 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 27.0 mmt180 -77.13 154.51 33.15 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.754 0.822 . . . . 0.0 111.948 174.691 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 28.8 p -158.23 157.52 32.76 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 113.946 1.091 . . . . 0.0 113.946 -177.509 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -113.37 -24.69 9.19 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 126.239 1.816 . . . . 0.0 110.986 168.779 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 20.9 pt20 -151.68 166.45 31.24 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 126.717 2.007 . . . . 0.0 110.402 175.3 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -61.19 -24.94 66.69 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.417 1.087 . . . . 0.0 112.886 -176.43 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.9 m -65.64 -17.82 64.87 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 125.553 1.541 . . . . 0.0 113.59 175.952 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 63.0 m-20 -81.36 -19.13 43.39 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 123.933 0.893 . . . . 0.0 112.275 173.382 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 73.7 m -88.66 165.98 14.41 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.934 1.294 . . . . 0.0 113.834 -173.339 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 26.1 mt -73.94 177.78 5.38 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 124.524 1.13 . . . . 0.0 111.399 179.0 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.82 133.36 56.02 Favored 'General case' 0 CA--C 1.539 0.552 0 O-C-N 121.268 -0.895 . . . . 0.0 112.923 -178.439 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 74.28 -8.06 14.71 Favored Glycine 0 CA--C 1.535 1.287 0 C-N-CA 124.708 1.147 . . . . 0.0 114.433 -179.53 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 61.8 m -79.38 160.54 26.65 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 118.512 1.156 . . . . 0.0 114.021 179.825 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 19.2 m -122.89 153.25 27.8 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 126.351 1.86 . . . . 0.0 110.096 168.393 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 49.9 t -87.15 102.87 14.87 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.45 0.7 . . . . 0.0 110.058 169.965 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -72.83 167.53 53.86 Favored Glycine 0 CA--C 1.543 1.831 0 C-N-CA 124.417 1.008 . . . . 0.0 114.142 -178.508 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -58.36 -26.79 78.89 Favored 'Trans proline' 0 C--N 1.354 0.818 0 C-N-CA 124.383 3.389 . . . . 0.0 114.902 -178.268 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 52.4 p-10 -69.72 -8.59 49.25 Favored 'General case' 0 CA--C 1.548 0.883 0 N-CA-C 114.685 1.365 . . . . 0.0 114.685 176.016 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 81.14 13.96 79.97 Favored Glycine 0 CA--C 1.533 1.18 0 C-N-CA 124.722 1.154 . . . . 0.0 113.903 -177.676 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -114.35 157.46 22.78 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.848 1.259 . . . . 0.0 111.531 169.955 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 81.5 m -76.55 147.79 37.49 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.858 1.263 . . . . 0.0 112.763 173.523 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.228 0 C-N-CA 125.973 1.749 . . . . 0.0 113.186 174.708 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 49.2 t . . . . . 0 CA--C 1.549 0.91 0 CA-C-O 118.061 -0.971 . . . . 0.0 112.307 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -73.48 161.35 42.58 Favored 'Trans proline' 0 C--N 1.354 0.839 0 C-N-CA 122.9 2.4 . . . . 0.0 111.218 177.273 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -80.8 32.8 0.31 Allowed 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 124.618 1.167 . . . . 0.0 113.91 -170.999 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 45.9 mm -88.34 123.99 41.1 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 125.947 1.699 . . . . 0.0 109.769 179.673 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 42.6 tp -76.8 130.7 38.02 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 169.949 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 60.8 tpp -155.57 132.62 10.75 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.199 1.0 . . . . 0.0 110.068 -170.625 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 83.9 mtt85 -81.21 151.12 28.32 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.804 0.842 . . . . 0.0 111.343 175.771 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 29.3 p -156.14 158.17 37.21 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 114.27 1.211 . . . . 0.0 114.27 -173.284 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -119.5 -19.9 7.99 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 126.144 1.778 . . . . 0.0 111.674 169.099 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -149.61 167.86 25.18 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 126.39 1.876 . . . . 0.0 110.509 169.908 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -61.26 -25.55 67.16 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 124.362 1.065 . . . . 0.0 112.647 -178.514 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 15.7 m -65.62 -16.07 63.36 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 125.304 1.442 . . . . 0.0 113.676 175.946 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 60.3 m-20 -82.06 -18.09 44.36 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 123.888 0.875 . . . . 0.0 112.464 172.83 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 72.9 m -89.77 167.13 13.12 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.008 1.323 . . . . 0.0 113.859 -172.214 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -70.26 170.34 11.9 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 124.466 1.106 . . . . 0.0 110.843 175.862 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.84 134.7 57.28 Favored 'General case' 0 CA--C 1.538 0.512 0 O-C-N 121.221 -0.924 . . . . 0.0 112.922 -177.637 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 76.22 -9.0 21.63 Favored Glycine 0 CA--C 1.534 1.231 0 C-N-CA 124.781 1.182 . . . . 0.0 114.283 -178.711 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 60.1 m -79.87 162.55 24.96 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 118.518 1.159 . . . . 0.0 114.069 178.56 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 19.2 m -122.76 154.21 27.89 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 126.238 1.815 . . . . 0.0 110.224 168.5 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 47.2 t -85.89 102.52 13.8 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 123.579 0.752 . . . . 0.0 110.157 169.885 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -72.81 167.71 53.72 Favored Glycine 0 CA--C 1.543 1.836 0 C-N-CA 124.454 1.026 . . . . 0.0 114.218 -178.235 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -58.41 -26.87 79.59 Favored 'Trans proline' 0 C--N 1.353 0.801 0 C-N-CA 124.489 3.459 . . . . 0.0 114.969 -177.335 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 52.8 p-10 -70.34 -8.34 49.75 Favored 'General case' 0 CA--C 1.548 0.885 0 N-CA-C 114.775 1.398 . . . . 0.0 114.775 176.699 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 83.92 10.84 80.26 Favored Glycine 0 CA--C 1.533 1.21 0 C-N-CA 124.626 1.108 . . . . 0.0 114.029 -177.228 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -116.39 157.2 25.46 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.84 1.256 . . . . 0.0 112.09 172.153 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 83.1 m -76.44 147.57 37.85 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.004 1.322 . . . . 0.0 113.122 176.988 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.212 0 C-N-CA 126.013 1.768 . . . . 0.0 113.126 174.635 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 48.5 t . . . . . 0 CA--C 1.549 0.933 0 CA-C-O 118.048 -0.977 . . . . 0.0 112.436 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -61.91 149.67 89.25 Favored 'Trans proline' 0 C--N 1.354 0.844 0 C-N-CA 123.191 2.594 . . . . 0.0 113.085 177.27 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 34.4 ptt-85 -83.0 10.22 8.45 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 115.593 1.701 . . . . 0.0 115.593 -172.286 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 10.1 tp -77.17 153.17 5.54 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 C-N-CA 125.424 1.49 . . . . 0.0 111.428 177.947 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 32.7 tp -82.43 134.28 35.23 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.679 0.791 . . . . 0.0 110.468 173.793 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -161.69 127.3 3.61 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.647 1.179 . . . . 0.0 110.932 -170.354 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 95.7 mtt-85 -85.81 159.58 19.69 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 125.071 1.348 . . . . 0.0 112.365 -179.375 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 28.3 p -159.58 159.14 32.88 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.663 1.185 . . . . 0.0 114.104 -177.282 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -114.2 -25.05 8.65 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 126.306 1.842 . . . . 0.0 111.081 168.767 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -151.73 168.17 25.88 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 126.547 1.939 . . . . 0.0 110.531 173.847 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -61.83 -24.76 67.09 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 124.304 1.041 . . . . 0.0 113.0 -176.465 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 6.6 m -64.57 -18.78 65.18 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 125.233 1.413 . . . . 0.0 113.529 175.444 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 62.4 m-20 -80.35 -18.94 47.61 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.001 0.92 . . . . 0.0 112.241 174.034 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 80.6 m -90.28 163.42 14.76 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 125.235 1.414 . . . . 0.0 113.656 -173.073 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 60.0 mt -76.99 -178.43 4.94 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 124.599 1.159 . . . . 0.0 111.921 179.73 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.63 134.27 56.92 Favored 'General case' 0 CA--C 1.54 0.569 0 O-C-N 121.203 -0.935 . . . . 0.0 112.868 -178.563 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 74.51 -8.42 14.08 Favored Glycine 0 CA--C 1.534 1.252 0 C-N-CA 124.749 1.166 . . . . 0.0 114.329 -178.724 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 61.6 m -81.02 159.27 24.86 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 114.184 1.179 . . . . 0.0 114.184 -178.954 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 18.2 m -125.02 153.29 32.11 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 126.472 1.909 . . . . 0.0 109.681 167.949 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 49.1 t -86.09 102.8 14.18 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 123.235 0.614 . . . . 0.0 110.237 170.646 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -70.47 166.56 50.94 Favored Glycine 0 CA--C 1.543 1.831 0 C-N-CA 124.65 1.119 . . . . 0.0 113.806 178.84 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -69.73 -18.08 37.32 Favored 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 124.135 3.223 . . . . 0.0 113.392 -176.062 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 52.7 p-10 -69.66 -9.15 53.13 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 124.897 1.279 . . . . 0.0 114.36 171.381 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 85.29 9.84 78.83 Favored Glycine 0 CA--C 1.533 1.202 0 C-N-CA 124.962 1.268 . . . . 0.0 114.227 -177.949 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -116.2 155.03 29.01 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.949 1.3 . . . . 0.0 111.879 174.147 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 82.6 m -77.07 147.14 36.85 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.272 1.029 . . . . 0.0 112.241 174.391 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.22 0 C-N-CA 125.743 1.64 . . . . 0.0 113.112 175.798 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 44.3 t . . . . . 0 CA--C 1.55 0.945 0 CA-C-O 118.257 -0.878 . . . . 0.0 112.279 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -74.5 163.5 35.95 Favored 'Trans proline' 0 C--N 1.353 0.765 0 C-N-CA 122.996 2.464 . . . . 0.0 111.397 177.2 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 74.6 mtp85 -77.35 20.72 0.28 Allowed 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 125.031 1.333 . . . . 0.0 114.08 -175.242 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 48.3 mm -79.83 122.68 35.51 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 125.367 1.467 . . . . 0.0 109.874 178.749 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 42.4 tp -76.14 132.92 40.3 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.184 0.594 . . . . 0.0 109.489 170.598 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 60.3 tpp -153.33 127.52 9.11 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 124.205 1.002 . . . . 0.0 109.838 -173.307 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 59.5 ttm-85 -78.08 145.06 36.03 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.702 0.801 . . . . 0.0 110.395 177.373 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 31.3 p -153.11 159.16 42.73 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 114.411 1.263 . . . . 0.0 114.411 -171.697 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -121.2 -18.83 7.3 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 126.878 2.071 . . . . 0.0 111.49 168.895 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 19.3 pt20 -147.45 158.96 44.2 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 126.843 2.057 . . . . 0.0 110.179 177.963 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -62.86 -25.86 68.49 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.196 0.999 . . . . 0.0 112.429 -179.822 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 17.8 m -67.38 -13.46 62.04 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 124.916 1.287 . . . . 0.0 113.557 175.289 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 49.9 m-20 -81.5 -19.15 42.84 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 123.758 0.823 . . . . 0.0 112.091 172.108 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 73.9 m -88.79 167.01 13.64 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.253 1.421 . . . . 0.0 113.94 -171.302 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -70.37 170.77 11.19 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 124.444 1.098 . . . . 0.0 110.769 175.692 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.08 134.82 57.41 Favored 'General case' 0 CA--C 1.539 0.525 0 O-C-N 121.179 -0.95 . . . . 0.0 112.964 -177.348 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 76.14 -9.09 20.75 Favored Glycine 0 CA--C 1.533 1.188 0 C-N-CA 124.652 1.12 . . . . 0.0 114.378 -178.764 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 60.2 m -79.91 162.9 24.72 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 114.078 1.14 . . . . 0.0 114.078 179.079 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 18.5 m -122.73 154.33 27.88 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 126.325 1.85 . . . . 0.0 110.073 168.359 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 47.8 t -85.63 103.41 14.43 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 123.193 0.597 . . . . 0.0 110.071 169.824 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -70.83 168.16 50.11 Favored Glycine 0 CA--C 1.542 1.731 0 C-N-CA 124.841 1.21 . . . . 0.0 114.101 179.922 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -70.23 -17.9 35.13 Favored 'Trans proline' 0 C--N 1.352 0.743 0 C-N-CA 124.169 3.246 . . . . 0.0 113.5 -175.312 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 53.3 p-10 -69.38 -9.42 53.4 Favored 'General case' 0 CA--C 1.548 0.882 0 N-CA-C 114.339 1.237 . . . . 0.0 114.339 170.855 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 84.87 12.06 75.35 Favored Glycine 0 CA--C 1.532 1.141 0 C-N-CA 124.756 1.17 . . . . 0.0 114.046 -176.796 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -123.51 156.47 35.57 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.703 1.201 . . . . 0.0 112.386 174.505 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 84.1 m -75.1 147.41 40.6 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.906 1.283 . . . . 0.0 113.214 179.006 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.204 0 C-N-CA 126.058 1.789 . . . . 0.0 113.099 174.809 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 53.3 t . . . . . 0 CA--C 1.551 0.995 0 CA-C-O 118.517 -0.754 . . . . 0.0 112.282 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -67.45 166.7 22.82 Favored 'Trans proline' 0 C--N 1.353 0.798 0 C-N-CA 123.435 2.756 . . . . 0.0 111.909 173.05 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 4.4 mmp_? -102.23 17.4 23.48 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 125.091 1.357 . . . . 0.0 113.187 179.94 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 10.4 tp -74.57 148.44 7.99 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 C-N-CA 125.247 1.419 . . . . 0.0 111.392 176.015 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 10.6 tt -71.29 132.13 44.45 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.636 0.774 . . . . 0.0 110.044 172.974 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 58.7 tpp -154.96 130.67 9.97 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.825 1.25 . . . . 0.0 109.591 177.421 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 84.4 mtt85 -87.32 152.92 21.87 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.301 1.04 . . . . 0.0 111.497 178.297 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 29.6 p -157.0 156.03 32.26 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 114.082 1.141 . . . . 0.0 114.082 -173.236 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -112.22 -25.67 9.18 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 126.091 1.756 . . . . 0.0 110.93 168.927 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 8.3 pt20 -150.58 168.78 23.25 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 126.569 1.947 . . . . 0.0 110.522 173.621 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -61.37 -25.24 67.04 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 124.462 1.105 . . . . 0.0 112.977 -176.494 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 7.0 m -64.72 -19.19 65.63 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 125.329 1.452 . . . . 0.0 113.514 175.778 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 61.1 m-20 -81.4 -18.65 44.74 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.024 0.93 . . . . 0.0 112.39 174.657 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 74.5 m -87.72 167.31 13.96 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 125.155 1.382 . . . . 0.0 113.827 -174.43 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -72.67 176.49 5.48 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 124.487 1.115 . . . . 0.0 111.077 177.973 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.53 133.26 55.92 Favored 'General case' 0 CA--C 1.539 0.556 0 O-C-N 121.08 -1.013 . . . . 0.0 113.207 -176.784 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 74.44 -8.29 14.42 Favored Glycine 0 CA--C 1.534 1.278 0 C-N-CA 124.871 1.224 . . . . 0.0 114.461 -179.851 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 62.2 m -76.87 163.66 26.54 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 114.089 1.144 . . . . 0.0 114.089 -178.893 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 21.4 m -121.72 152.91 25.61 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 C-N-CA 125.807 1.643 . . . . 0.0 110.325 168.263 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 44.8 t -88.5 104.4 16.77 Favored 'General case' 0 CA--C 1.537 0.442 0 C-N-CA 123.513 0.725 . . . . 0.0 109.878 169.55 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -70.07 166.26 50.26 Favored Glycine 0 CA--C 1.542 1.74 0 C-N-CA 124.635 1.112 . . . . 0.0 113.825 178.951 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -69.48 -18.2 38.43 Favored 'Trans proline' 0 CA--C 1.539 0.729 0 C-N-CA 124.128 3.219 . . . . 0.0 113.284 -176.419 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 52.4 p-10 -69.37 -9.93 55.66 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 124.869 1.268 . . . . 0.0 114.396 170.942 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 85.79 10.34 76.15 Favored Glycine 0 CA--C 1.533 1.169 0 C-N-CA 124.867 1.222 . . . . 0.0 114.229 -177.653 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -117.48 156.62 27.69 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.787 1.235 . . . . 0.0 112.038 174.509 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 74.3 m -76.43 152.97 36.03 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.619 1.167 . . . . 0.0 112.999 176.352 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.272 0 CA-C-O 116.909 -2.051 . . . . 0.0 113.626 176.168 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 48.0 t . . . . . 0 CA--C 1.549 0.934 0 CA-C-O 118.121 -0.942 . . . . 0.0 112.4 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -62.19 155.47 56.29 Favored 'Trans proline' 0 C--N 1.354 0.845 0 C-N-CA 123.221 2.614 . . . . 0.0 112.76 175.227 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -82.3 13.84 3.31 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 114.707 1.373 . . . . 0.0 114.707 -170.522 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 10.0 tp -83.2 140.76 15.82 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 C-N-CA 125.309 1.444 . . . . 0.0 111.464 178.641 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 40.4 tp -82.82 132.0 35.18 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.801 0.84 . . . . 0.0 109.816 172.146 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 58.0 ttm -154.45 132.46 11.66 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.3 1.04 . . . . 0.0 110.512 -171.433 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 95.8 mtt-85 -79.4 155.07 28.54 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.006 0.922 . . . . 0.0 112.057 178.813 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 28.2 p -158.32 157.76 33.04 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 124.731 1.212 . . . . 0.0 113.661 -176.099 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 30.3 mtpp -112.1 -24.97 9.58 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 125.932 1.693 . . . . 0.0 111.16 169.094 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 20.8 pt20 -152.53 166.41 32.12 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 126.553 1.941 . . . . 0.0 110.485 175.803 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -61.06 -24.96 66.6 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 124.494 1.118 . . . . 0.0 112.799 -176.41 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.8 m -65.62 -18.0 65.0 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 125.654 1.582 . . . . 0.0 113.617 175.851 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 63.2 m-20 -80.83 -20.98 41.21 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 123.888 0.875 . . . . 0.0 112.19 173.152 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 77.8 m -88.46 165.41 14.92 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 125.227 1.411 . . . . 0.0 113.514 -174.185 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 50.6 mt -75.85 178.64 6.04 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 124.374 1.07 . . . . 0.0 111.922 179.375 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.19 134.63 57.24 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 121.375 -0.828 . . . . 0.0 112.721 -179.173 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 74.61 -8.38 14.66 Favored Glycine 0 CA--C 1.533 1.185 0 C-N-CA 124.678 1.133 . . . . 0.0 114.291 -178.363 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 60.6 m -81.11 158.8 24.88 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 118.646 1.223 . . . . 0.0 113.967 179.568 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 18.6 m -123.45 151.69 28.15 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 126.17 1.788 . . . . 0.0 109.765 168.057 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 48.9 t -87.2 103.0 15.0 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.296 0.638 . . . . 0.0 109.756 169.978 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -72.17 166.86 53.43 Favored Glycine 0 CA--C 1.543 1.823 0 C-N-CA 124.281 0.943 . . . . 0.0 114.017 -178.157 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -57.86 -26.19 72.86 Favored 'Trans proline' 0 C--N 1.354 0.854 0 C-N-CA 124.448 3.432 . . . . 0.0 114.736 -179.806 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 51.9 p-10 -68.44 -9.96 52.14 Favored 'General case' 0 CA--C 1.548 0.88 0 N-CA-C 114.839 1.422 . . . . 0.0 114.839 175.314 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 83.65 13.41 75.72 Favored Glycine 0 CA--C 1.533 1.216 0 C-N-CA 124.731 1.158 . . . . 0.0 113.929 -177.372 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -117.96 154.19 32.36 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.951 1.3 . . . . 0.0 112.225 174.168 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 84.6 m -74.33 145.96 43.46 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.878 1.271 . . . . 0.0 112.382 173.933 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.21 0 C-N-CA 125.991 1.758 . . . . 0.0 113.252 175.023 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 41.9 t . . . . . 0 CA--C 1.55 0.953 0 CA-C-O 118.388 -0.815 . . . . 0.0 112.243 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -72.99 161.4 43.63 Favored 'Trans proline' 0 C--N 1.354 0.818 0 C-N-CA 123.125 2.55 . . . . 0.0 111.529 177.09 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 92.3 mtm-85 -77.5 29.86 0.15 Allowed 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 125.269 1.428 . . . . 0.0 113.501 -177.597 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 96.8 mt -90.37 122.97 42.33 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 126.158 1.783 . . . . 0.0 109.048 -179.325 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 37.6 tp -75.34 132.82 41.21 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 122.972 0.509 . . . . 0.0 109.642 171.415 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 59.9 tpp -153.83 128.56 9.41 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 124.372 1.069 . . . . 0.0 109.373 -174.485 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 46.3 ttt85 -83.88 144.78 28.99 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 123.381 0.673 . . . . 0.0 110.616 178.188 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 28.3 p -149.11 158.88 44.53 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 114.26 1.208 . . . . 0.0 114.26 -169.517 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -119.03 -19.57 8.41 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 126.117 1.767 . . . . 0.0 111.641 169.187 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -150.03 167.68 26.04 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 126.328 1.851 . . . . 0.0 110.534 169.994 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -61.31 -25.34 67.06 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.419 1.088 . . . . 0.0 112.663 -178.691 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 15.6 m -65.6 -15.95 63.23 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 125.182 1.393 . . . . 0.0 113.643 175.754 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 60.7 m-20 -82.1 -17.76 45.35 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 123.935 0.894 . . . . 0.0 112.456 172.82 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 75.1 m -89.55 166.47 13.64 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.032 1.333 . . . . 0.0 113.894 -172.117 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -70.92 171.61 10.42 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 124.488 1.115 . . . . 0.0 110.787 175.805 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.24 135.33 57.7 Favored 'General case' 0 CA--C 1.54 0.581 0 O-C-N 121.201 -0.937 . . . . 0.0 112.953 -177.665 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 75.92 -9.08 19.18 Favored Glycine 0 CA--C 1.534 1.276 0 C-N-CA 124.79 1.186 . . . . 0.0 114.307 -178.844 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 59.8 m -80.15 162.78 24.54 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 114.057 1.132 . . . . 0.0 114.057 179.375 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 19.1 m -123.07 153.6 28.28 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 126.319 1.847 . . . . 0.0 110.11 168.331 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 49.2 t -84.45 102.58 12.91 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 123.398 0.679 . . . . 0.0 110.178 169.978 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -71.14 169.45 49.15 Favored Glycine 0 CA--C 1.542 1.747 0 C-N-CA 124.955 1.264 . . . . 0.0 114.335 -179.592 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -70.56 -18.98 32.85 Favored 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 124.233 3.289 . . . . 0.0 113.669 -173.987 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 53.2 p-10 -70.54 -8.06 48.53 Favored 'General case' 0 CA--C 1.548 0.897 0 N-CA-C 114.271 1.211 . . . . 0.0 114.271 170.775 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 85.13 8.96 81.12 Favored Glycine 0 CA--C 1.531 1.081 0 C-N-CA 124.916 1.246 . . . . 0.0 114.06 -176.995 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -118.55 156.77 28.55 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 118.725 1.263 . . . . 0.0 112.29 174.7 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 79.7 m -75.35 147.17 40.31 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.027 1.331 . . . . 0.0 113.223 179.036 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.181 0 C-N-CA 126.017 1.77 . . . . 0.0 113.099 174.796 . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 41.9 t . . . . . 0 CA--C 1.55 0.962 0 CA-C-O 118.336 -0.84 . . . . 0.0 112.204 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -70.29 155.08 64.98 Favored 'Trans proline' 0 C--N 1.355 0.895 0 C-N-CA 123.047 2.498 . . . . 0.0 111.726 176.93 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.63 5.99 5.39 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 116.148 1.907 . . . . 0.0 116.148 -172.978 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 10.0 tp -73.97 139.12 19.86 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.825 0 C-N-CA 125.263 1.425 . . . . 0.0 111.334 -179.331 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 30.6 tp -81.1 136.65 35.95 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.683 0.793 . . . . 0.0 110.176 174.729 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 61.2 tpp -158.32 134.86 9.53 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.41 1.084 . . . . 0.0 109.483 -172.575 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 55.7 mtp85 -91.69 154.47 18.97 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 119.004 0.82 . . . . 0.0 112.807 175.662 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 26.4 p -154.16 158.04 39.78 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.117 1.367 . . . . 0.0 113.665 -169.933 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -109.45 -29.74 8.28 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 125.882 1.673 . . . . 0.0 110.654 168.891 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 8.0 pt20 -147.7 169.73 19.06 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 126.485 1.914 . . . . 0.0 110.718 173.603 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -61.27 -25.93 67.43 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.473 1.109 . . . . 0.0 112.844 -176.488 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 7.4 m -64.77 -18.88 65.47 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 125.303 1.441 . . . . 0.0 113.48 175.959 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 60.1 m-20 -82.02 -18.42 43.35 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 123.964 0.906 . . . . 0.0 112.347 174.577 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 77.8 m -87.35 167.16 14.29 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.91 1.284 . . . . 0.0 113.789 -174.498 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -71.57 172.42 9.65 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 124.498 1.119 . . . . 0.0 110.943 176.907 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.01 134.64 57.24 Favored 'General case' 0 CA--C 1.539 0.534 0 O-C-N 121.256 -0.903 . . . . 0.0 113.075 -177.049 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 75.76 -9.0 18.24 Favored Glycine 0 CA--C 1.533 1.209 0 C-N-CA 124.759 1.171 . . . . 0.0 114.362 -179.065 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 60.4 m -79.27 161.49 26.28 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 114.156 1.169 . . . . 0.0 114.156 179.636 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 19.2 m -120.55 153.4 23.71 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 126.316 1.846 . . . . 0.0 109.945 168.051 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 49.7 t -88.17 104.23 16.51 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 123.468 0.707 . . . . 0.0 110.275 169.955 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -70.83 168.85 49.27 Favored Glycine 0 CA--C 1.544 1.886 0 C-N-CA 124.907 1.241 . . . . 0.0 114.105 178.371 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -70.37 -20.54 31.85 Favored 'Trans proline' 0 CA--C 1.538 0.701 0 C-N-CA 124.172 3.248 . . . . 0.0 113.647 -174.432 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 50.4 p30 -71.12 -5.25 30.19 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 124.888 1.275 . . . . 0.0 114.078 170.323 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 79.18 11.55 84.94 Favored Glycine 0 CA--C 1.53 1.023 0 C-N-CA 125.156 1.36 . . . . 0.0 113.98 -178.668 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 99.7 m-85 -107.41 155.09 20.41 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 118.656 1.228 . . . . 0.0 111.89 170.503 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 84.0 m -76.98 147.33 36.92 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 125.079 1.351 . . . . 0.0 112.544 173.18 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.176 0 C-N-CA 125.711 1.624 . . . . 0.0 113.174 174.721 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.77 0 CA-C-O 121.13 0.295 . . . . 0.0 112.558 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 43.7 t -61.6 127.26 88.39 Favored Pre-proline 0 CA--C 1.551 0.984 0 C-N-CA 124.215 1.006 . . . . 0.0 112.271 -179.212 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -70.32 157.45 59.27 Favored 'Trans proline' 0 C--N 1.353 0.803 0 C-N-CA 123.119 2.546 . . . . 0.0 111.777 176.668 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -81.73 13.17 3.33 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 114.566 1.321 . . . . 0.0 114.566 -171.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 9.9 tp -80.89 141.07 15.71 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 125.566 1.547 . . . . 0.0 111.188 177.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 36.3 tp -79.66 139.12 37.51 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 123.687 0.795 . . . . 0.0 110.446 175.138 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 60.0 tpp -153.26 130.68 11.35 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.578 1.151 . . . . 0.0 109.67 -178.431 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 60.2 ttt180 -86.27 147.56 26.02 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.818 0.847 . . . . 0.0 110.806 179.438 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 30.2 p -154.91 161.4 41.44 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 114.517 1.303 . . . . 0.0 114.517 -169.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 63.2 pttt -123.4 -16.47 6.84 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 126.184 1.794 . . . . 0.0 112.012 168.469 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 8.1 pt20 -151.9 166.61 30.92 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 126.262 1.825 . . . . 0.0 110.62 171.012 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -62.3 -24.71 67.46 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 124.279 1.032 . . . . 0.0 112.977 -176.383 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.5 m -64.11 -19.2 65.1 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 125.264 1.426 . . . . 0.0 113.524 175.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 59.0 m-20 -79.94 -20.08 46.49 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 123.955 0.902 . . . . 0.0 112.308 174.396 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 77.6 m -88.75 165.34 14.78 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.077 1.351 . . . . 0.0 113.699 -172.411 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -72.02 172.75 9.49 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 124.567 1.147 . . . . 0.0 110.896 177.213 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.79 134.21 56.82 Favored 'General case' 0 CA--C 1.539 0.545 0 O-C-N 121.111 -0.993 . . . . 0.0 112.956 -177.33 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 75.95 -9.2 18.92 Favored Glycine 0 CA--C 1.534 1.256 0 C-N-CA 124.689 1.138 . . . . 0.0 114.323 -178.676 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 59.6 m -79.64 162.8 25.05 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 118.534 1.167 . . . . 0.0 113.976 179.038 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 19.1 m -123.61 153.27 29.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 126.332 1.853 . . . . 0.0 110.178 168.315 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 48.6 t -85.21 103.5 14.23 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 123.3 0.64 . . . . 0.0 110.006 169.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -70.08 168.16 47.99 Favored Glycine 0 CA--C 1.542 1.725 0 C-N-CA 124.752 1.168 . . . . 0.0 114.12 179.176 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -69.96 -18.02 36.33 Favored 'Trans proline' 0 CA--C 1.538 0.72 0 C-N-CA 124.241 3.294 . . . . 0.0 113.44 -175.166 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 53.5 p-10 -68.88 -10.81 59.07 Favored 'General case' 0 CA--C 1.548 0.874 0 N-CA-C 114.372 1.249 . . . . 0.0 114.372 170.471 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 85.52 12.8 71.81 Favored Glycine 0 CA--C 1.532 1.129 0 C-N-CA 124.83 1.205 . . . . 0.0 113.962 -176.573 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -125.08 157.4 36.38 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 118.544 1.172 . . . . 0.0 112.168 174.413 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 75.8 m -77.38 148.47 35.53 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.989 1.316 . . . . 0.0 113.386 -177.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.26 0 C-N-CA 126.035 1.778 . . . . 0.0 113.016 174.294 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.705 0 CA-C-O 121.213 0.34 . . . . 0.0 112.632 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 53.7 t -65.14 132.85 95.48 Favored Pre-proline 0 CA--C 1.549 0.928 0 O-C-N 121.696 -0.885 . . . . 0.0 112.439 -179.11 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -67.03 166.9 21.38 Favored 'Trans proline' 0 C--N 1.354 0.829 0 C-N-CA 123.302 2.668 . . . . 0.0 111.946 172.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 4.7 mmp_? -100.63 18.47 19.15 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.968 1.307 . . . . 0.0 113.096 179.719 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 18.7 tt -69.33 141.91 16.72 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 C-N-CA 125.009 1.324 . . . . 0.0 111.001 172.62 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 33.3 tp -79.34 129.94 34.95 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 123.265 0.626 . . . . 0.0 109.705 173.358 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 60.7 tpp -153.56 131.02 11.36 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.383 1.073 . . . . 0.0 110.196 -173.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -80.97 153.96 27.2 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 123.998 0.919 . . . . 0.0 111.776 177.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 28.7 p -158.32 156.0 29.8 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 124.408 1.083 . . . . 0.0 113.792 -175.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -111.17 -26.34 9.25 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 125.885 1.674 . . . . 0.0 111.002 168.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 8.0 pt20 -150.61 169.48 21.47 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 126.629 1.972 . . . . 0.0 110.453 173.465 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -61.39 -25.43 67.18 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 124.479 1.112 . . . . 0.0 112.875 -176.426 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 7.3 m -64.96 -18.93 65.69 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.288 1.435 . . . . 0.0 113.566 175.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 59.8 m-20 -81.83 -18.8 42.69 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 123.929 0.892 . . . . 0.0 112.35 174.526 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 75.1 m -86.88 167.57 14.21 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.114 1.365 . . . . 0.0 113.692 -175.125 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -72.24 175.36 6.15 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 124.527 1.131 . . . . 0.0 111.028 177.507 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.39 133.14 55.8 Favored 'General case' 0 CA--C 1.54 0.562 0 O-C-N 121.079 -1.013 . . . . 0.0 113.2 -176.107 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 74.45 -8.2 14.88 Favored Glycine 0 CA--C 1.534 1.243 0 C-N-CA 124.815 1.198 . . . . 0.0 114.529 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 61.5 m -76.55 163.8 26.55 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 114.009 1.115 . . . . 0.0 114.009 -179.25 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 21.6 m -121.68 152.17 25.33 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 125.681 1.593 . . . . 0.0 110.534 168.575 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 47.6 t -89.12 103.89 16.48 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 123.772 0.829 . . . . 0.0 109.811 169.55 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -71.94 166.55 53.33 Favored Glycine 0 CA--C 1.544 1.881 0 C-N-CA 124.333 0.968 . . . . 0.0 114.059 -178.609 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -58.12 -26.32 75.26 Favored 'Trans proline' 0 C--N 1.353 0.771 0 C-N-CA 124.407 3.404 . . . . 0.0 114.782 -178.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 52.5 p-10 -68.97 -9.87 54.41 Favored 'General case' 0 CA--C 1.549 0.907 0 N-CA-C 114.764 1.394 . . . . 0.0 114.764 175.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 83.62 13.59 75.38 Favored Glycine 0 CA--C 1.534 1.234 0 C-N-CA 124.633 1.111 . . . . 0.0 113.965 -176.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -118.75 155.61 30.81 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.9 1.28 . . . . 0.0 112.097 173.333 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 70.2 m -76.22 153.11 36.32 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.804 1.242 . . . . 0.0 113.134 177.276 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.219 0 CA-C-O 116.861 -2.077 . . . . 0.0 113.566 175.683 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.751 0 CA-C-O 121.069 0.261 . . . . 0.0 112.511 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 48.9 t -64.19 128.1 92.75 Favored Pre-proline 0 CA--C 1.549 0.913 0 C-N-CA 124.027 0.931 . . . . 0.0 112.34 -178.489 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -66.62 151.2 83.25 Favored 'Trans proline' 0 C--N 1.353 0.773 0 C-N-CA 122.616 2.211 . . . . 0.0 111.125 174.526 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 71.7 mmt-85 -81.95 44.79 0.86 Allowed 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 124.89 1.276 . . . . 0.0 113.109 -171.554 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 1.2 pp -79.87 168.04 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 126.004 1.721 . . . . 0.0 113.177 177.002 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 38.0 tp -118.85 66.08 0.77 Allowed 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.723 1.609 . . . . 0.0 108.139 169.569 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 63.3 tpp -94.48 126.62 39.87 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 125.095 1.358 . . . . 0.0 109.745 -172.336 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 95.5 mtt-85 -72.33 149.54 44.32 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 118.752 0.706 . . . . 0.0 111.862 178.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 30.0 p -154.82 157.78 38.43 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 124.278 1.031 . . . . 0.0 113.728 -176.009 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 59.5 mtmt -119.05 -20.01 8.23 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.936 1.694 . . . . 0.0 111.901 169.422 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -150.48 167.94 25.66 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 126.4 1.88 . . . . 0.0 110.506 169.853 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -61.31 -25.45 67.13 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.363 1.065 . . . . 0.0 112.668 -178.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 15.5 m -65.88 -15.98 63.42 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.279 1.432 . . . . 0.0 113.702 175.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 60.6 m-20 -81.55 -18.05 46.27 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 123.792 0.837 . . . . 0.0 112.422 172.349 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 72.2 m -91.04 165.37 13.56 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.813 1.245 . . . . 0.0 114.106 -171.448 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -73.53 174.88 7.62 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 125.211 1.405 . . . . 0.0 111.043 178.733 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.43 133.58 56.22 Favored 'General case' 0 CA--C 1.539 0.542 0 O-C-N 121.096 -1.003 . . . . 0.0 113.125 -177.355 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 75.13 -8.89 14.27 Favored Glycine 0 CA--C 1.534 1.248 0 C-N-CA 124.808 1.194 . . . . 0.0 114.329 -179.031 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 61.6 m -79.11 161.25 26.63 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 114.139 1.162 . . . . 0.0 114.139 -179.712 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 18.8 m -123.32 152.86 28.48 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 C-N-CA 126.337 1.855 . . . . 0.0 109.796 167.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 48.5 t -84.93 102.13 12.89 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.243 0.617 . . . . 0.0 110.16 170.21 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -71.77 168.24 51.74 Favored Glycine 0 CA--C 1.541 1.705 0 C-N-CA 124.774 1.178 . . . . 0.0 114.208 -179.251 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -70.09 -17.79 35.86 Favored 'Trans proline' 0 CA--C 1.539 0.736 0 C-N-CA 124.208 3.272 . . . . 0.0 113.479 -176.024 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 52.9 p-10 -69.38 -9.39 53.26 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 124.746 1.218 . . . . 0.0 114.286 171.087 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 86.24 8.67 77.85 Favored Glycine 0 CA--C 1.533 1.2 0 C-N-CA 125.11 1.338 . . . . 0.0 114.309 -177.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 75.0 m-85 -119.38 158.53 25.97 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 122.487 1.137 . . . . 0.0 112.317 174.573 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 68.2 m -73.52 147.39 44.07 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.094 1.358 . . . . 0.0 112.797 174.721 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.191 0 C-N-CA 125.934 1.731 . . . . 0.0 113.041 174.808 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.735 0 CA-C-O 121.051 0.251 . . . . 0.0 112.517 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 49.2 t -61.65 125.2 84.12 Favored Pre-proline 0 CA--C 1.549 0.914 0 C-N-CA 124.464 1.105 . . . . 0.0 112.797 -178.021 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_exo -55.8 142.9 82.91 Favored 'Trans proline' 0 C--N 1.353 0.804 0 C-N-CA 123.637 2.891 . . . . 0.0 112.069 170.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 69.3 mmt-85 -81.04 16.19 1.6 Allowed 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 114.115 1.154 . . . . 0.0 114.115 -174.327 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 17.8 tt -73.87 142.94 14.19 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 125.637 1.575 . . . . 0.0 111.317 176.318 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 37.9 tp -80.6 132.42 35.63 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.342 0.657 . . . . 0.0 109.92 172.396 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 60.9 tpp -152.58 126.06 8.78 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 124.344 1.058 . . . . 0.0 109.932 -175.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 1.9 tmt_? -84.72 135.78 34.0 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.971 0.908 . . . . 0.0 109.714 178.658 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 26.3 p -136.85 164.27 28.7 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 125.268 1.427 . . . . 0.0 113.144 -172.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -119.97 -25.96 5.69 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 125.993 1.717 . . . . 0.0 111.11 169.247 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -145.88 169.08 19.29 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 126.36 1.864 . . . . 0.0 110.411 169.74 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -60.98 -25.72 67.06 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.393 1.077 . . . . 0.0 112.685 -178.45 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 15.6 m -65.68 -16.27 63.59 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 125.227 1.411 . . . . 0.0 113.669 175.704 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 55.9 m-20 -82.91 -17.91 42.02 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 123.917 0.887 . . . . 0.0 112.386 172.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 72.0 m -88.48 165.59 14.78 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.858 1.263 . . . . 0.0 113.649 -174.202 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -72.47 174.08 7.92 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 124.84 1.256 . . . . 0.0 111.08 177.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.25 133.27 55.95 Favored 'General case' 0 CA--C 1.539 0.538 0 O-C-N 121.201 -0.937 . . . . 0.0 113.156 -176.427 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 74.93 -8.52 15.19 Favored Glycine 0 CA--C 1.535 1.305 0 C-N-CA 124.691 1.138 . . . . 0.0 114.413 -179.106 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 61.3 m -79.29 161.74 26.09 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 118.466 1.133 . . . . 0.0 113.987 179.59 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 19.1 m -122.56 153.72 27.36 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 126.336 1.854 . . . . 0.0 110.19 168.605 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 48.3 t -86.33 102.26 13.84 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 123.61 0.764 . . . . 0.0 109.998 169.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -72.62 167.9 53.33 Favored Glycine 0 CA--C 1.542 1.767 0 C-N-CA 124.368 0.985 . . . . 0.0 114.3 -177.262 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_exo -58.27 -26.96 79.1 Favored 'Trans proline' 0 C--N 1.354 0.858 0 C-N-CA 124.499 3.466 . . . . 0.0 114.989 -177.578 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 53.0 p-10 -69.51 -9.55 54.31 Favored 'General case' 0 CA--C 1.546 0.791 0 N-CA-C 114.7 1.37 . . . . 0.0 114.7 175.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 85.95 10.08 76.15 Favored Glycine 0 CA--C 1.531 1.087 0 C-N-CA 124.772 1.177 . . . . 0.0 114.006 -176.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -119.96 156.55 30.61 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.68 1.192 . . . . 0.0 112.152 174.747 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 78.7 m -75.2 148.26 39.69 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.663 1.185 . . . . 0.0 113.243 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.115 0 C-N-CA 126.012 1.767 . . . . 0.0 113.067 174.573 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.78 0 N-CA-C 112.245 -0.342 . . . . 0.0 112.245 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 47.8 t -62.37 128.24 90.99 Favored Pre-proline 0 CA--C 1.548 0.904 0 C-N-CA 124.135 0.974 . . . . 0.0 112.472 -179.149 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -64.81 147.48 89.58 Favored 'Trans proline' 0 C--N 1.354 0.821 0 C-N-CA 123.153 2.569 . . . . 0.0 111.384 171.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 6.0 tpm_? -81.71 54.45 2.41 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-O 122.206 1.003 . . . . 0.0 111.815 178.807 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 19.3 tt -81.07 151.91 4.36 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 C-N-CA 125.729 1.612 . . . . 0.0 111.105 173.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 39.7 tp -95.37 73.44 3.29 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.817 0.847 . . . . 0.0 108.721 169.44 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 60.0 tpp -102.54 116.09 31.9 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.627 1.171 . . . . 0.0 109.363 -176.453 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 61.0 ttt180 -77.82 143.6 37.73 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 123.325 0.65 . . . . 0.0 110.52 178.466 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 30.3 p -150.02 158.31 44.03 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 114.158 1.17 . . . . 0.0 114.158 -169.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 59.2 mtmt -119.63 -19.35 8.12 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 126.699 2.0 . . . . 0.0 111.57 169.307 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 19.3 pt20 -148.61 159.06 44.45 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 126.62 1.968 . . . . 0.0 110.246 179.332 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -63.08 -25.53 68.41 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.094 0.958 . . . . 0.0 112.387 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 17.8 m -67.67 -13.41 62.07 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.897 1.279 . . . . 0.0 113.566 175.069 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 51.5 m-20 -80.91 -19.4 44.39 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 123.81 0.844 . . . . 0.0 111.952 171.468 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 79.0 m -90.66 165.43 13.72 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 125.52 1.528 . . . . 0.0 113.763 -172.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 34.6 mt -76.33 -178.55 4.62 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.357 1.063 . . . . 0.0 111.88 179.635 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.63 134.28 56.93 Favored 'General case' 0 CA--C 1.539 0.527 0 O-C-N 121.253 -0.904 . . . . 0.0 112.96 -179.611 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 74.41 -8.46 13.52 Favored Glycine 0 CA--C 1.534 1.255 0 C-N-CA 124.775 1.179 . . . . 0.0 114.281 -178.528 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 63.9 m -81.76 159.62 23.79 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 114.288 1.218 . . . . 0.0 114.288 -178.322 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 18.0 m -124.52 154.98 32.29 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 126.774 2.03 . . . . 0.0 109.634 167.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 48.2 t -84.05 102.26 12.37 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 121.341 0.591 . . . . 0.0 110.188 169.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -71.72 169.03 50.92 Favored Glycine 0 CA--C 1.542 1.763 0 C-N-CA 124.987 1.28 . . . . 0.0 114.379 -178.383 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -70.74 -18.41 32.45 Favored 'Trans proline' 0 CA--C 1.537 0.672 0 C-N-CA 124.262 3.308 . . . . 0.0 113.67 -174.202 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 52.6 p-10 -69.68 -10.04 56.69 Favored 'General case' 0 CA--C 1.548 0.899 0 N-CA-C 114.192 1.182 . . . . 0.0 114.192 171.21 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 87.5 8.54 73.9 Favored Glycine 0 CA--C 1.533 1.178 0 C-N-CA 124.952 1.263 . . . . 0.0 114.208 -177.139 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 76.9 m-85 -122.58 159.84 26.95 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 118.69 1.245 . . . . 0.0 111.779 173.573 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 77.5 m -70.7 153.79 42.47 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.262 1.025 . . . . 0.0 113.215 179.263 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.154 0 C-N-CA 126.035 1.778 . . . . 0.0 113.165 175.973 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.726 0 CA-C-O 121.09 0.272 . . . . 0.0 112.464 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 40.5 t -64.64 124.23 85.55 Favored Pre-proline 0 CA--C 1.546 0.801 0 CA-C-O 117.9 -1.048 . . . . 0.0 112.539 -178.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -68.65 146.07 65.81 Favored 'Trans proline' 0 C--N 1.353 0.765 0 C-N-CA 123.017 2.478 . . . . 0.0 110.633 175.421 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 15.8 mmm180 -83.83 16.13 2.94 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 113.782 1.03 . . . . 0.0 113.782 -171.034 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 10.0 tp -68.19 141.66 17.34 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 125.489 1.516 . . . . 0.0 111.341 177.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 30.9 tp -75.9 131.99 40.0 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 123.359 0.663 . . . . 0.0 110.152 175.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 61.1 tpp -155.48 132.77 10.93 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.827 1.251 . . . . 0.0 109.851 -174.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 87.4 mtm180 -81.16 152.68 27.63 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.923 0.889 . . . . 0.0 111.603 177.746 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 29.4 p -157.38 155.29 30.29 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 113.961 1.097 . . . . 0.0 113.961 -175.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 64.8 tttm -110.53 -28.68 8.4 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 126.023 1.729 . . . . 0.0 110.726 168.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 8.1 pt20 -147.84 169.75 19.11 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 126.426 1.89 . . . . 0.0 110.601 172.541 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -61.35 -25.33 67.08 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 124.6 1.16 . . . . 0.0 112.918 -176.528 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 8.0 m -65.25 -18.59 65.43 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 125.157 1.383 . . . . 0.0 113.627 175.686 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 60.4 m-20 -81.73 -18.52 44.03 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 123.928 0.891 . . . . 0.0 112.368 174.398 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 73.6 m -86.9 168.02 13.79 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.118 1.367 . . . . 0.0 113.648 -175.579 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -71.17 173.72 7.3 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 124.415 1.086 . . . . 0.0 110.919 176.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.0 132.89 55.36 Favored 'General case' 0 CA--C 1.54 0.581 0 O-C-N 121.16 -0.962 . . . . 0.0 113.213 -175.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 74.42 -8.45 13.59 Favored Glycine 0 CA--C 1.534 1.247 0 C-N-CA 124.829 1.204 . . . . 0.0 114.512 -179.599 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 66.7 m -75.29 162.59 28.3 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 118.5 1.15 . . . . 0.0 113.915 -179.6 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 23.3 m -118.84 151.47 21.04 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 125.319 1.448 . . . . 0.0 110.816 168.697 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 43.7 t -89.38 104.76 17.29 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 123.725 0.81 . . . . 0.0 109.783 169.439 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -70.24 166.97 49.97 Favored Glycine 0 CA--C 1.543 1.81 0 C-N-CA 124.563 1.078 . . . . 0.0 113.842 179.043 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -69.43 -18.14 38.71 Favored 'Trans proline' 0 CA--C 1.539 0.76 0 C-N-CA 124.046 3.164 . . . . 0.0 113.357 -176.499 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 51.3 p-10 -69.22 -9.96 55.49 Favored 'General case' 0 CA--C 1.549 0.933 0 N-CA-C 114.414 1.265 . . . . 0.0 114.414 170.609 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 84.7 12.7 74.36 Favored Glycine 0 CA--C 1.533 1.218 0 C-N-CA 124.838 1.209 . . . . 0.0 114.096 -176.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -119.6 155.35 32.43 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.773 1.229 . . . . 0.0 112.403 175.02 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 69.7 m -76.75 154.92 33.61 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.941 1.297 . . . . 0.0 113.319 177.359 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.309 0 C-N-CA 125.711 1.624 . . . . 0.0 113.779 175.072 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.767 0 CA-C-O 121.075 0.264 . . . . 0.0 112.469 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 52.9 t -64.48 128.5 93.44 Favored Pre-proline 0 CA--C 1.55 0.966 0 C-N-CA 123.966 0.906 . . . . 0.0 112.306 -178.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -71.83 147.99 51.21 Favored 'Trans proline' 0 C--N 1.353 0.811 0 C-N-CA 123.279 2.653 . . . . 0.0 111.16 173.695 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -84.53 17.76 2.55 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 114.166 1.173 . . . . 0.0 114.166 -172.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 8.9 tp -69.81 138.62 21.73 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 125.065 1.346 . . . . 0.0 111.118 175.345 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 31.5 tp -78.94 115.41 18.61 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 123.441 0.696 . . . . 0.0 109.882 177.141 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 81.6 mmm -137.17 126.09 24.21 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 125.672 1.589 . . . . 0.0 108.929 -177.468 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 25.4 ttt85 -86.77 144.99 26.81 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 118.632 0.651 . . . . 0.0 111.297 -179.443 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 24.5 p -146.66 160.56 42.04 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 125.502 1.521 . . . . 0.0 113.544 -169.205 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 61.4 mtpt -112.21 -24.72 9.68 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 125.845 1.658 . . . . 0.0 111.373 169.231 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 20.9 pt20 -152.71 166.63 31.55 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 126.397 1.879 . . . . 0.0 110.599 176.569 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -61.16 -25.07 66.76 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 124.257 1.023 . . . . 0.0 112.811 -176.318 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.8 m -65.54 -18.01 65.0 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 125.662 1.585 . . . . 0.0 113.573 176.016 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 63.0 m-20 -81.42 -19.14 43.13 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 123.991 0.917 . . . . 0.0 112.228 173.317 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 75.8 m -89.22 167.34 13.16 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.211 1.404 . . . . 0.0 113.621 -174.474 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.469 HD22 ' H ' ' A' ' 16' ' ' LEU . 0.9 OUTLIER -74.86 177.98 5.86 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 124.373 1.069 . . . . 0.0 111.206 179.623 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.47 133.7 56.34 Favored 'General case' 0 CA--C 1.539 0.547 0 O-C-N 121.186 -0.946 . . . . 0.0 112.923 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 74.77 -9.41 11.18 Favored Glycine 0 CA--C 1.533 1.186 0 C-N-CA 124.81 1.195 . . . . 0.0 114.399 -179.104 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 64.0 m -79.48 161.53 26.0 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 118.555 1.177 . . . . 0.0 113.969 -179.417 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 18.7 m -124.2 153.36 30.49 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 C-N-CA 126.313 1.845 . . . . 0.0 110.147 168.186 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 45.0 t -85.67 102.97 14.06 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.371 0.669 . . . . 0.0 109.8 169.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -71.53 172.16 45.82 Favored Glycine 0 CA--C 1.542 1.764 0 C-N-CA 125.133 1.349 . . . . 0.0 114.602 -177.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -70.37 -21.23 30.92 Favored 'Trans proline' 0 CA--C 1.538 0.712 0 C-N-CA 124.28 3.32 . . . . 0.0 113.604 -173.728 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 51.0 p-10 -70.95 -7.04 43.24 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 124.718 1.207 . . . . 0.0 113.97 169.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 83.72 8.46 84.48 Favored Glycine 0 CA--C 1.53 1.029 0 C-N-CA 125.389 1.471 . . . . 0.0 114.056 -177.567 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -112.18 155.82 23.32 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 119.195 1.498 . . . . 0.0 112.337 176.139 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 81.1 m -73.88 146.0 44.39 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.452 1.101 . . . . 0.0 112.8 176.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.189 0 C-N-CA 125.972 1.749 . . . . 0.0 113.11 174.927 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.792 0 N-CA-C 112.342 -0.303 . . . . 0.0 112.342 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 45.5 t -59.9 127.3 85.3 Favored Pre-proline 0 CA--C 1.549 0.91 0 C-N-CA 124.342 1.057 . . . . 0.0 112.187 -179.362 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -71.62 160.97 46.77 Favored 'Trans proline' 0 C--N 1.354 0.858 0 C-N-CA 123.106 2.537 . . . . 0.0 111.701 178.029 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 52.4 ttp180 -78.89 60.42 2.85 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 125.002 1.321 . . . . 0.0 111.474 -179.395 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 88.0 mt -125.52 122.47 62.6 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 126.551 1.941 . . . . 0.0 108.764 -177.356 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 40.3 tp -79.75 134.42 36.37 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.509 0.723 . . . . 0.0 109.544 170.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 59.4 tpp -157.45 135.17 10.68 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.231 1.012 . . . . 0.0 110.022 -170.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 27.6 mmt180 -77.3 153.56 33.76 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.633 0.773 . . . . 0.0 111.833 174.284 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 29.7 p -157.7 159.85 37.33 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 114.17 1.174 . . . . 0.0 114.17 -177.119 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 17.3 tppt? -118.34 -24.82 6.75 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 126.233 1.813 . . . . 0.0 111.036 169.026 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -148.73 170.19 18.75 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 126.26 1.824 . . . . 0.0 111.022 169.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -63.57 -25.44 68.24 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 124.85 1.26 . . . . 0.0 113.49 -173.722 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 77.7 p -73.09 -10.55 59.91 Favored 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 113.817 1.043 . . . . 0.0 113.817 175.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 62.8 m-20 -80.07 -20.91 44.06 Favored 'General case' 0 CA--C 1.543 0.708 0 O-C-N 121.336 -0.853 . . . . 0.0 111.601 169.241 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 71.5 m -85.88 167.28 15.28 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.242 1.417 . . . . 0.0 113.863 -174.808 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -70.23 170.35 11.84 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 124.21 1.004 . . . . 0.0 110.702 175.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.16 135.3 57.68 Favored 'General case' 0 CA--C 1.539 0.52 0 O-C-N 121.202 -0.936 . . . . 0.0 112.87 -177.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 76.2 -8.84 22.39 Favored Glycine 0 CA--C 1.534 1.248 0 C-N-CA 124.712 1.149 . . . . 0.0 114.352 -178.621 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 59.3 m -80.13 162.69 24.61 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 118.472 1.136 . . . . 0.0 113.988 178.401 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 19.4 m -121.28 154.13 25.04 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 126.206 1.802 . . . . 0.0 110.146 168.287 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 49.4 t -87.66 103.79 15.91 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 123.462 0.705 . . . . 0.0 110.178 169.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -70.6 167.68 50.04 Favored Glycine 0 CA--C 1.543 1.784 0 C-N-CA 124.714 1.15 . . . . 0.0 114.05 178.736 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -69.99 -18.77 35.74 Favored 'Trans proline' 0 CA--C 1.538 0.701 0 C-N-CA 124.12 3.213 . . . . 0.0 113.564 -175.127 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 52.6 p-10 -70.59 -8.04 48.58 Favored 'General case' 0 CA--C 1.548 0.899 0 N-CA-C 114.323 1.231 . . . . 0.0 114.323 171.17 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 81.93 12.37 81.28 Favored Glycine 0 CA--C 1.533 1.17 0 C-N-CA 124.893 1.235 . . . . 0.0 113.994 -177.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -113.79 157.93 21.64 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.848 1.259 . . . . 0.0 111.76 170.501 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 77.7 m -77.28 149.56 35.37 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.21 1.404 . . . . 0.0 113.088 174.369 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.298 0 C-N-CA 125.947 1.736 . . . . 0.0 113.153 173.972 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.775 0 CA-C-O 121.288 0.382 . . . . 0.0 112.503 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 36.3 t -64.78 125.75 89.56 Favored Pre-proline 0 CA--C 1.547 0.844 0 CA-C-O 118.163 -0.922 . . . . 0.0 112.461 -178.601 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -66.77 151.21 82.92 Favored 'Trans proline' 0 C--N 1.353 0.797 0 C-N-CA 123.203 2.602 . . . . 0.0 111.845 178.685 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 6.7 mmp_? -82.54 14.36 3.13 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 124.77 1.228 . . . . 0.0 114.058 -177.083 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 10.2 tp -71.78 142.74 15.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 C-N-CA 125.302 1.441 . . . . 0.0 111.223 177.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 26.9 tp -76.93 131.98 38.82 Favored 'General case' 0 CA--C 1.538 0.485 0 O-C-N 121.791 -0.568 . . . . 0.0 110.15 175.357 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 61.2 tpp -154.47 126.47 7.72 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 125.056 1.342 . . . . 0.0 108.773 -178.319 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 25.9 ttt85 -88.93 146.64 24.79 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 118.392 0.542 . . . . 0.0 111.259 -178.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 26.2 p -150.84 160.08 44.12 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.269 1.427 . . . . 0.0 113.685 -169.091 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 61.7 mtpt -116.67 -20.79 9.4 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 126.35 1.86 . . . . 0.0 111.301 169.03 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 19.5 pt20 -147.8 160.29 42.91 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 126.941 2.097 . . . . 0.0 110.201 177.493 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -62.23 -26.03 68.14 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 124.25 1.02 . . . . 0.0 112.439 -179.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 17.0 m -67.85 -13.85 62.48 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 124.881 1.272 . . . . 0.0 113.664 175.544 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 48.3 m-20 -82.32 -19.69 38.88 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.747 0.819 . . . . 0.0 112.117 172.523 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 81.7 m -85.86 168.88 13.84 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.308 1.443 . . . . 0.0 113.83 -173.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -71.64 175.65 5.46 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 124.468 1.107 . . . . 0.0 111.049 176.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.29 133.0 55.68 Favored 'General case' 0 CA--C 1.54 0.566 0 O-C-N 121.064 -1.023 . . . . 0.0 113.338 -176.044 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 74.02 -8.3 12.57 Favored Glycine 0 CA--C 1.535 1.288 0 C-N-CA 124.891 1.234 . . . . 0.0 114.559 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 66.4 m -75.78 162.52 28.11 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 114.238 1.199 . . . . 0.0 114.238 -178.074 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 20.3 m -120.57 151.25 23.39 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 125.579 1.551 . . . . 0.0 110.493 168.298 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 49.4 t -87.09 103.64 15.57 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 123.586 0.754 . . . . 0.0 109.8 169.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -71.74 171.7 47.1 Favored Glycine 0 CA--C 1.543 1.827 0 C-N-CA 125.063 1.316 . . . . 0.0 114.446 -178.48 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -70.43 -21.04 30.92 Favored 'Trans proline' 0 CA--C 1.539 0.733 0 C-N-CA 124.262 3.308 . . . . 0.0 113.634 -173.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 50.7 p-10 -70.69 -7.04 41.66 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 124.749 1.22 . . . . 0.0 113.987 169.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.86 10.35 83.17 Favored Glycine 0 CA--C 1.529 0.946 0 C-N-CA 125.24 1.4 . . . . 0.0 113.866 -177.048 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -113.52 154.24 27.41 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 119.374 1.587 . . . . 0.0 112.444 175.659 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 69.9 m -74.76 151.18 39.16 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.969 1.308 . . . . 0.0 113.063 177.628 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.353 0 C-N-CA 125.647 1.594 . . . . 0.0 113.864 175.132 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.705 0 N-CA-C 112.395 -0.282 . . . . 0.0 112.395 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 42.0 t -61.73 129.05 91.18 Favored Pre-proline 0 CA--C 1.55 0.952 0 C-N-CA 124.186 0.994 . . . . 0.0 112.244 -179.466 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -71.35 163.33 39.47 Favored 'Trans proline' 0 C--N 1.353 0.792 0 C-N-CA 123.315 2.677 . . . . 0.0 111.865 176.327 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 18.5 ptp180 -72.94 16.3 0.16 Allowed 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 115.175 1.546 . . . . 0.0 115.175 -176.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 89.4 mt -80.36 119.94 30.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 125.768 1.627 . . . . 0.0 109.656 -176.741 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 36.9 tp -81.88 132.32 35.27 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.729 0.812 . . . . 0.0 109.652 170.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 59.9 ttm -160.97 136.21 7.74 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.664 1.185 . . . . 0.0 109.598 -171.433 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 56.8 mtp85 -84.89 152.26 23.69 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 118.876 0.762 . . . . 0.0 112.556 175.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 24.9 p -151.32 156.83 41.59 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.206 1.402 . . . . 0.0 113.672 -169.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 28.4 ttpp -102.37 -29.63 11.53 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 126.205 1.802 . . . . 0.0 110.539 168.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 20.1 pt20 -155.94 166.7 32.7 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 126.364 1.866 . . . . 0.0 110.648 -177.484 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -60.89 -25.69 66.89 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 124.303 1.041 . . . . 0.0 112.647 -176.643 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.4 m -64.14 -18.84 64.83 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 125.834 1.654 . . . . 0.0 113.576 176.168 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 63.2 m-20 -81.48 -22.15 38.23 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.004 0.921 . . . . 0.0 112.387 174.591 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 73.0 m -86.32 167.34 14.87 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.059 1.344 . . . . 0.0 113.844 -171.297 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.413 HD22 ' H ' ' A' ' 16' ' ' LEU . 1.8 mm? -70.81 172.37 8.96 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 124.261 1.024 . . . . 0.0 111.048 176.389 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.07 135.88 57.85 Favored 'General case' 0 CA--C 1.539 0.537 0 O-C-N 121.273 -0.892 . . . . 0.0 112.88 -179.188 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 75.75 -9.25 17.37 Favored Glycine 0 CA--C 1.533 1.207 0 C-N-CA 124.776 1.179 . . . . 0.0 114.265 -178.554 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 59.6 m -80.78 161.63 24.43 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 118.652 1.226 . . . . 0.0 114.023 179.479 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 18.7 m -123.27 153.2 28.52 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 C-N-CA 126.272 1.829 . . . . 0.0 110.091 168.383 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 49.1 t -87.57 103.7 15.8 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 123.386 0.675 . . . . 0.0 109.871 169.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -71.5 170.4 48.45 Favored Glycine 0 CA--C 1.542 1.743 0 C-N-CA 124.884 1.23 . . . . 0.0 114.197 -179.288 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -69.67 -20.56 35.11 Favored 'Trans proline' 0 CA--C 1.538 0.71 0 C-N-CA 124.247 3.298 . . . . 0.0 113.453 -175.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 49.3 p30 -70.31 -6.8 37.71 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 125.014 1.326 . . . . 0.0 114.053 169.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 79.9 12.64 83.22 Favored Glycine 0 CA--C 1.531 1.033 0 C-N-CA 125.188 1.375 . . . . 0.0 114.066 -178.408 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -109.05 153.56 23.47 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 118.613 1.207 . . . . 0.0 112.239 172.218 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 78.2 m -73.17 145.2 46.5 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.883 1.273 . . . . 0.0 112.238 170.013 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.238 0 C-N-CA 125.95 1.738 . . . . 0.0 113.207 175.813 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.652 0 CA-C-O 121.019 0.233 . . . . 0.0 112.608 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 51.6 t -60.43 126.18 83.91 Favored Pre-proline 0 CA--C 1.549 0.937 0 C-N-CA 124.503 1.121 . . . . 0.0 112.645 -179.202 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_exo -57.71 145.87 87.87 Favored 'Trans proline' 0 C--N 1.354 0.858 0 C-N-CA 123.83 3.02 . . . . 0.0 112.645 171.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 34.0 ptt-85 -79.99 12.61 2.66 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 115.358 1.614 . . . . 0.0 115.358 -173.617 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 10.2 tp -75.11 142.21 14.88 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 125.223 1.409 . . . . 0.0 111.484 178.659 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 30.4 tp -81.04 133.82 35.55 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 123.577 0.751 . . . . 0.0 109.988 173.725 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 61.5 tpp -158.6 133.51 8.33 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.458 1.103 . . . . 0.0 109.516 -172.478 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 55.6 mtp85 -91.31 154.64 19.09 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 118.955 0.798 . . . . 0.0 112.879 175.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 26.4 p -154.88 159.25 40.36 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.196 1.398 . . . . 0.0 113.83 -169.798 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 65.0 mttp -111.63 -26.05 9.22 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 125.991 1.717 . . . . 0.0 111.028 168.804 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 21.0 pt20 -150.97 166.99 28.97 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 126.565 1.946 . . . . 0.0 110.513 175.503 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -60.76 -25.9 66.84 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 124.524 1.13 . . . . 0.0 112.73 -176.043 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.9 m -65.41 -18.1 65.05 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 125.653 1.581 . . . . 0.0 113.61 176.31 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 62.2 m-20 -82.0 -19.26 40.87 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 123.971 0.909 . . . . 0.0 112.327 173.806 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 75.0 m -87.02 167.08 14.55 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.921 1.289 . . . . 0.0 113.903 -173.498 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -71.34 172.99 8.4 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 124.741 1.217 . . . . 0.0 110.925 177.181 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.24 133.36 56.03 Favored 'General case' 0 CA--C 1.539 0.543 0 O-C-N 121.195 -0.94 . . . . 0.0 113.162 -175.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 74.83 -8.54 14.72 Favored Glycine 0 CA--C 1.534 1.267 0 C-N-CA 124.657 1.122 . . . . 0.0 114.45 -179.464 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 61.2 m -78.65 160.99 27.25 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 114.067 1.136 . . . . 0.0 114.067 179.798 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 18.8 m -120.24 154.54 23.35 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 126.258 1.823 . . . . 0.0 110.205 168.447 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 43.3 t -88.17 104.13 16.41 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 123.618 0.767 . . . . 0.0 110.28 170.019 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -70.72 169.15 48.51 Favored Glycine 0 CA--C 1.543 1.802 0 C-N-CA 124.911 1.243 . . . . 0.0 114.179 178.454 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -70.52 -20.67 30.97 Favored 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 124.228 3.285 . . . . 0.0 113.695 -174.137 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 50.5 p30 -71.35 -5.15 30.3 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 124.952 1.301 . . . . 0.0 114.058 170.397 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 79.28 11.17 85.28 Favored Glycine 0 CA--C 1.53 1.027 0 C-N-CA 125.12 1.343 . . . . 0.0 114.007 -178.636 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -106.99 155.05 20.21 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 118.652 1.226 . . . . 0.0 111.885 170.548 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 83.3 m -76.23 147.37 38.39 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.983 1.313 . . . . 0.0 112.606 173.272 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.181 0 C-N-CA 125.815 1.674 . . . . 0.0 113.279 175.26 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.71 0 N-CA-C 112.378 -0.289 . . . . 0.0 112.378 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 45.9 t -60.11 126.26 83.35 Favored Pre-proline 0 CA--C 1.551 0.995 0 C-N-CA 124.571 1.149 . . . . 0.0 112.586 -179.011 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -56.77 146.18 79.08 Favored 'Trans proline' 0 C--N 1.354 0.866 0 C-N-CA 123.947 3.098 . . . . 0.0 112.872 172.059 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 82.1 mtp180 -84.72 14.1 5.07 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 114.404 1.261 . . . . 0.0 114.404 -172.112 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 10.2 tp -77.63 143.4 12.89 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 C-N-CA 125.176 1.39 . . . . 0.0 111.144 176.353 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 29.4 tp -78.21 135.26 37.56 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 123.189 0.596 . . . . 0.0 110.22 174.648 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 61.2 tpp -154.16 126.61 8.0 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 124.78 1.232 . . . . 0.0 108.973 -177.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 25.1 ttt85 -89.61 147.4 23.94 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 118.452 0.569 . . . . 0.0 111.037 179.158 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 26.1 p -152.19 165.66 34.15 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.884 1.274 . . . . 0.0 114.309 -168.469 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 21.5 pttp -122.41 -14.4 7.85 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 126.072 1.749 . . . . 0.0 112.123 168.079 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 20.0 pt20 -155.45 162.35 40.77 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 126.642 1.977 . . . . 0.0 110.351 178.183 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 26.7 m-20 -62.23 -24.52 67.29 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.911 0.884 . . . . 0.0 112.606 -177.102 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.3 m -64.21 -18.57 64.64 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 125.82 1.648 . . . . 0.0 113.58 176.327 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 64.6 m-20 -80.78 -20.52 42.44 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.12 0.968 . . . . 0.0 112.388 174.4 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 73.8 m -89.77 165.92 13.87 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.983 1.313 . . . . 0.0 113.897 -169.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -72.56 174.95 6.78 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 124.763 1.225 . . . . 0.0 111.07 177.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.43 133.23 55.91 Favored 'General case' 0 CA--C 1.541 0.606 0 O-C-N 121.089 -1.007 . . . . 0.0 113.104 -176.228 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 74.73 -8.64 13.8 Favored Glycine 0 CA--C 1.535 1.311 0 C-N-CA 124.687 1.137 . . . . 0.0 114.408 -179.447 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 60.6 m -79.16 161.99 26.07 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 114.082 1.141 . . . . 0.0 114.082 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 18.2 m -124.92 154.42 32.8 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 126.433 1.893 . . . . 0.0 110.197 168.577 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 36.9 t -83.77 102.25 12.17 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 123.303 0.641 . . . . 0.0 110.372 170.338 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -71.91 172.25 46.74 Favored Glycine 0 CA--C 1.542 1.781 0 C-N-CA 125.339 1.447 . . . . 0.0 114.62 -179.092 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -71.38 -20.94 27.04 Favored 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 124.33 3.353 . . . . 0.0 113.973 -172.127 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 52.6 p-10 -71.96 -5.18 32.96 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 124.576 1.15 . . . . 0.0 113.899 170.416 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 83.47 5.92 88.07 Favored Glycine 0 CA--C 1.53 0.98 0 C-N-CA 125.497 1.522 . . . . 0.0 114.029 -177.694 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -109.5 155.97 20.68 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 119.195 1.497 . . . . 0.0 112.163 174.599 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 82.7 m -73.47 145.8 45.42 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.839 1.256 . . . . 0.0 112.804 176.308 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.206 0 C-N-CA 126.063 1.792 . . . . 0.0 113.146 175.905 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.688 0 N-CA-C 112.284 -0.326 . . . . 0.0 112.284 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 48.0 t -60.94 130.73 91.33 Favored Pre-proline 0 CA--C 1.55 0.964 0 C-N-CA 124.199 0.999 . . . . 0.0 112.396 -179.399 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -62.93 160.65 32.62 Favored 'Trans proline' 0 C--N 1.354 0.827 0 C-N-CA 123.288 2.659 . . . . 0.0 112.848 175.165 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 40.4 ptt180 -74.13 13.94 0.49 Allowed 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 114.865 1.431 . . . . 0.0 114.865 179.519 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 94.6 mt -86.32 122.21 38.4 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 126.352 1.861 . . . . 0.0 109.558 -174.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 47.7 tp -76.74 134.31 39.21 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.666 0.786 . . . . 0.0 109.872 171.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 57.6 ttm -157.57 132.17 8.52 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.342 1.057 . . . . 0.0 110.186 -173.592 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 57.4 ttt180 -82.71 147.98 28.16 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.723 0.809 . . . . 0.0 111.089 -179.65 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 26.3 p -151.17 158.5 44.05 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.548 1.139 . . . . 0.0 113.687 -170.034 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 58.9 mtmt -109.3 -27.32 9.58 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.815 1.646 . . . . 0.0 111.344 169.505 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 8.0 pt20 -153.41 169.47 23.06 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 126.399 1.88 . . . . 0.0 110.818 176.109 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -61.45 -25.71 67.4 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.406 1.083 . . . . 0.0 112.887 -176.489 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 7.2 m -64.8 -18.65 65.29 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 125.296 1.438 . . . . 0.0 113.484 175.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 62.0 m-20 -80.42 -21.18 42.44 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 123.909 0.883 . . . . 0.0 112.21 173.843 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 77.4 m -88.08 166.75 14.21 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 125.237 1.415 . . . . 0.0 113.662 -173.303 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 40.1 mt -74.4 177.37 5.98 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.47 1.108 . . . . 0.0 111.726 178.496 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.23 134.47 57.09 Favored 'General case' 0 CA--C 1.54 0.559 0 O-C-N 121.305 -0.872 . . . . 0.0 112.855 -179.786 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 74.67 -8.33 15.21 Favored Glycine 0 CA--C 1.535 1.292 0 C-N-CA 124.698 1.142 . . . . 0.0 114.314 -178.461 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 60.7 m -81.22 159.76 24.48 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 118.553 1.177 . . . . 0.0 113.993 179.496 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 18.2 m -124.48 151.63 29.88 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 126.251 1.82 . . . . 0.0 110.003 168.288 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 49.7 t -85.69 102.2 13.41 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.355 0.662 . . . . 0.0 109.561 169.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -72.65 170.11 51.44 Favored Glycine 0 CA--C 1.544 1.858 0 C-N-CA 124.411 1.005 . . . . 0.0 114.242 -176.167 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -57.9 -26.78 75.94 Favored 'Trans proline' 0 C--N 1.353 0.807 0 C-N-CA 124.518 3.479 . . . . 0.0 114.757 -178.815 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 52.0 p-10 -68.6 -11.37 59.92 Favored 'General case' 0 CA--C 1.548 0.9 0 N-CA-C 114.676 1.361 . . . . 0.0 114.676 174.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 84.25 14.56 71.31 Favored Glycine 0 CA--C 1.533 1.177 0 C-N-CA 124.799 1.19 . . . . 0.0 114.019 -176.335 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 64.8 m-85 -123.05 155.33 37.11 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.739 1.216 . . . . 0.0 112.225 175.142 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 85.7 m -73.91 145.19 44.97 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.116 1.366 . . . . 0.0 112.761 178.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.284 0 C-N-CA 126.111 1.815 . . . . 0.0 113.076 175.265 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.664 0 CA-C-O 121.186 0.326 . . . . 0.0 112.593 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 40.4 t -64.56 124.53 86.33 Favored Pre-proline 0 CA--C 1.546 0.826 0 CA-C-O 117.905 -1.045 . . . . 0.0 112.542 -178.707 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -67.74 146.31 72.3 Favored 'Trans proline' 0 C--N 1.353 0.813 0 C-N-CA 122.994 2.463 . . . . 0.0 110.676 175.185 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 15.3 mmm180 -83.45 17.04 2.29 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 113.48 0.919 . . . . 0.0 113.48 -173.16 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 19.4 tt -66.28 141.74 17.65 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 125.954 1.702 . . . . 0.0 111.616 178.702 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 26.5 tp -77.0 130.26 37.23 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.315 0.646 . . . . 0.0 109.975 175.313 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 61.7 tpp -160.14 132.49 6.35 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.806 1.242 . . . . 0.0 109.098 -172.762 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 55.2 mtp85 -91.14 155.35 18.69 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 118.944 0.793 . . . . 0.0 113.088 177.456 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 26.6 p -155.67 157.38 36.58 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.401 1.48 . . . . 0.0 113.407 -170.136 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 64.9 mttp -110.51 -26.22 9.61 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 125.598 1.559 . . . . 0.0 110.936 168.863 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 8.1 pt20 -149.99 169.28 21.57 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 126.5 1.92 . . . . 0.0 110.386 173.185 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -61.18 -25.57 67.12 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 124.533 1.133 . . . . 0.0 112.919 -176.513 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 7.1 m -64.88 -19.1 65.73 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 125.315 1.446 . . . . 0.0 113.605 175.862 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 60.3 m-20 -82.18 -18.46 42.66 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 123.929 0.892 . . . . 0.0 112.366 174.878 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 79.1 m -86.66 168.51 13.54 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.069 1.348 . . . . 0.0 113.706 -175.412 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -71.1 173.84 7.08 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 124.557 1.143 . . . . 0.0 110.992 176.805 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.94 132.76 54.94 Favored 'General case' 0 CA--C 1.54 0.573 0 O-C-N 121.115 -0.991 . . . . 0.0 113.236 -175.615 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 74.25 -8.33 13.44 Favored Glycine 0 CA--C 1.534 1.265 0 C-N-CA 124.87 1.224 . . . . 0.0 114.539 -179.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 67.4 m -75.42 162.32 28.47 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 114.041 1.126 . . . . 0.0 114.041 -179.205 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 22.4 m -118.43 151.99 20.56 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 125.463 1.505 . . . . 0.0 110.7 168.666 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 48.5 t -90.3 105.15 17.62 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.826 0.85 . . . . 0.0 109.999 169.488 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -70.74 168.81 49.07 Favored Glycine 0 CA--C 1.541 1.708 0 C-N-CA 124.742 1.163 . . . . 0.0 114.127 178.586 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -70.01 -20.53 33.56 Favored 'Trans proline' 0 CA--C 1.538 0.713 0 C-N-CA 124.187 3.258 . . . . 0.0 113.58 -175.151 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 49.1 p30 -70.65 -5.96 33.41 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 125.071 1.349 . . . . 0.0 114.099 169.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 78.83 13.45 83.1 Favored Glycine 0 CA--C 1.531 1.039 0 C-N-CA 125.109 1.337 . . . . 0.0 113.917 -178.289 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -109.04 153.82 23.09 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 118.629 1.215 . . . . 0.0 111.995 171.159 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 82.5 m -76.59 154.02 34.8 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.998 1.319 . . . . 0.0 112.847 173.765 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.185 0 CA-C-O 116.653 -2.193 . . . . 0.0 113.952 175.472 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.72 0 CA-C-O 121.121 0.289 . . . . 0.0 112.559 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 42.3 t -61.0 127.22 87.43 Favored Pre-proline 0 CA--C 1.549 0.932 0 C-N-CA 124.413 1.085 . . . . 0.0 112.19 -179.516 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_endo -72.69 163.77 37.53 Favored 'Trans proline' 0 C--N 1.353 0.804 0 C-N-CA 123.132 2.555 . . . . 0.0 111.74 177.755 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 10.7 ptm85 -73.04 15.56 0.2 Allowed 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 115.109 1.522 . . . . 0.0 115.109 -178.55 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 91.6 mt -79.77 120.07 30.4 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 125.834 1.654 . . . . 0.0 109.349 -177.828 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 36.3 tp -76.82 135.11 38.91 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 123.388 0.675 . . . . 0.0 109.602 171.085 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 60.8 tpp -160.01 134.58 7.65 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.315 1.046 . . . . 0.0 109.365 -169.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 53.9 mtp85 -88.93 152.82 21.5 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 119.187 0.903 . . . . 0.0 112.418 174.625 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 26.4 p -153.8 159.87 42.04 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 125.004 1.322 . . . . 0.0 113.866 -169.636 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 61.3 mtpt -113.94 -24.2 9.2 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 126.18 1.792 . . . . 0.0 111.158 168.846 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 21.0 pt20 -151.0 166.46 30.64 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 126.544 1.938 . . . . 0.0 110.434 175.099 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -61.29 -25.47 67.13 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 124.332 1.053 . . . . 0.0 112.721 -176.23 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.8 m -65.42 -17.77 64.8 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 125.636 1.574 . . . . 0.0 113.641 176.233 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 63.5 m-20 -81.79 -18.71 43.15 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 123.985 0.914 . . . . 0.0 112.302 173.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 74.2 m -87.98 168.01 13.22 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.952 1.301 . . . . 0.0 114.133 -172.416 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -70.57 171.16 10.74 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 124.399 1.08 . . . . 0.0 110.742 175.733 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.13 134.8 57.4 Favored 'General case' 0 CA--C 1.539 0.543 0 O-C-N 121.171 -0.956 . . . . 0.0 113.018 -177.177 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 75.82 -8.82 19.7 Favored Glycine 0 CA--C 1.534 1.238 0 C-N-CA 124.814 1.197 . . . . 0.0 114.338 -179.172 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 60.5 m -79.48 162.07 25.67 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 114.131 1.16 . . . . 0.0 114.131 179.427 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 19.0 m -122.14 153.44 26.5 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 126.308 1.843 . . . . 0.0 110.128 168.338 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 41.1 t -86.91 102.61 14.51 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.6 0.76 . . . . 0.0 110.358 170.479 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -73.47 168.98 53.66 Favored Glycine 0 CA--C 1.545 1.94 0 C-N-CA 124.628 1.109 . . . . 0.0 114.499 -178.799 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -59.03 -28.6 88.32 Favored 'Trans proline' 0 C--N 1.354 0.822 0 C-N-CA 124.532 3.488 . . . . 0.0 115.129 -176.284 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 51.3 p30 -71.03 -4.79 26.78 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 125.06 1.344 . . . . 0.0 114.446 175.719 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 78.83 11.53 85.13 Favored Glycine 0 CA--C 1.531 1.054 0 C-N-CA 124.941 1.257 . . . . 0.0 113.918 -178.384 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -107.33 155.33 20.1 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 118.49 1.145 . . . . 0.0 111.796 169.857 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 83.7 m -76.36 145.97 39.1 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.03 1.332 . . . . 0.0 112.587 172.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.249 0 C-N-CA 125.906 1.717 . . . . 0.0 113.223 175.261 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.767 0 CA-C-O 121.091 0.273 . . . . 0.0 112.469 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 53.4 t -60.77 127.42 87.24 Favored Pre-proline 0 CA--C 1.551 1.013 0 C-N-CA 124.473 1.109 . . . . 0.0 112.497 -179.276 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -56.93 153.3 38.54 Favored 'Trans proline' 0 C--N 1.353 0.787 0 C-N-CA 124.059 3.173 . . . . 0.0 113.152 171.312 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -78.92 38.4 0.33 Allowed 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 125.194 1.398 . . . . 0.0 112.692 179.721 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 86.7 mt -101.69 121.89 53.2 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 C-N-CA 126.366 1.866 . . . . 0.0 109.185 -176.28 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 37.5 tp -81.29 131.47 35.29 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 123.695 0.798 . . . . 0.0 109.646 171.837 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 60.3 ttm -160.1 135.31 8.03 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.644 1.178 . . . . 0.0 110.213 -171.881 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 30.3 mmt180 -73.57 153.44 40.23 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.588 0.755 . . . . 0.0 112.016 175.604 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 29.0 p -157.63 160.14 37.73 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.421 1.088 . . . . 0.0 113.71 -176.888 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 16.9 tppt? -117.23 -25.82 6.97 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 126.712 2.005 . . . . 0.0 111.035 169.155 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -144.38 159.96 41.85 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 126.583 1.953 . . . . 0.0 110.478 178.385 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -62.36 -26.59 68.54 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 124.31 1.044 . . . . 0.0 112.318 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 17.6 m -67.83 -13.18 61.92 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 124.98 1.312 . . . . 0.0 113.571 175.358 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 51.7 m-20 -80.67 -22.48 40.4 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 118.892 0.769 . . . . 0.0 111.914 171.49 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 73.1 m -86.38 167.78 14.43 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.398 1.479 . . . . 0.0 113.642 -172.601 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.408 HD22 ' H ' ' A' ' 16' ' ' LEU . 1.9 mm? -70.18 172.05 8.72 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.247 1.019 . . . . 0.0 111.157 176.403 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.54 135.21 57.6 Favored 'General case' 0 CA--C 1.539 0.541 0 O-C-N 121.231 -0.918 . . . . 0.0 112.902 -179.06 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 75.37 -9.03 15.32 Favored Glycine 0 CA--C 1.533 1.196 0 C-N-CA 124.716 1.151 . . . . 0.0 114.286 -178.683 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 60.4 m -80.62 161.34 24.75 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 118.604 1.202 . . . . 0.0 113.731 178.839 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 18.7 m -122.01 154.63 26.57 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 C-N-CA 126.256 1.823 . . . . 0.0 110.196 168.797 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 47.2 t -88.3 103.78 16.13 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.405 0.682 . . . . 0.0 109.661 169.524 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -71.16 168.53 50.44 Favored Glycine 0 CA--C 1.542 1.756 0 C-N-CA 124.591 1.091 . . . . 0.0 113.938 -178.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -69.29 -18.95 38.97 Favored 'Trans proline' 0 CA--C 1.538 0.723 0 C-N-CA 124.091 3.194 . . . . 0.0 113.254 -176.831 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 50.9 p-10 -69.44 -9.2 52.63 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 124.892 1.277 . . . . 0.0 114.312 170.196 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 81.99 13.82 78.56 Favored Glycine 0 CA--C 1.533 1.191 0 C-N-CA 125.019 1.295 . . . . 0.0 114.042 -177.779 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -115.17 155.12 27.74 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.027 1.331 . . . . 0.0 112.003 172.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 74.8 m -73.07 146.33 45.9 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.88 1.272 . . . . 0.0 112.584 171.429 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.209 0 C-N-CA 125.97 1.748 . . . . 0.0 113.235 175.131 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.739 0 CA-C-O 121.032 0.24 . . . . 0.0 112.576 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 53.0 t -62.89 127.05 90.08 Favored Pre-proline 0 CA--C 1.55 0.951 0 C-N-CA 124.134 0.974 . . . . 0.0 112.356 -178.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -69.86 151.97 68.67 Favored 'Trans proline' 0 C--N 1.353 0.814 0 C-N-CA 123.041 2.494 . . . . 0.0 111.412 174.497 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -81.85 15.5 2.21 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.704 1.202 . . . . 0.0 113.882 -176.403 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 18.0 tt -72.98 142.73 14.68 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 125.598 1.559 . . . . 0.0 111.2 176.344 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 30.0 tp -79.23 134.79 36.66 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 123.128 0.571 . . . . 0.0 110.228 174.646 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 60.5 tpp -153.65 127.3 8.74 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 124.775 1.23 . . . . 0.0 109.408 -179.109 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 45.8 ttt85 -85.5 147.18 26.57 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.747 0.819 . . . . 0.0 111.015 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 29.3 p -156.76 165.48 36.12 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 114.351 1.241 . . . . 0.0 114.351 -169.374 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 21.9 pttp -126.16 -12.7 6.31 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 126.292 1.837 . . . . 0.0 112.122 168.149 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 17.4 pt20 -157.39 161.76 39.01 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 126.394 1.878 . . . . 0.0 110.811 178.838 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 33.8 m-20 -65.57 -25.3 67.36 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 124.154 0.982 . . . . 0.0 113.441 -171.05 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 58.8 p -72.88 -9.44 58.69 Favored 'General case' 0 CA--C 1.546 0.792 0 N-CA-C 113.695 0.998 . . . . 0.0 113.695 175.831 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 66.4 m-20 -78.01 -23.54 48.25 Favored 'General case' 0 N--CA 1.473 0.724 0 O-C-N 121.299 -0.876 . . . . 0.0 111.315 168.822 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 73.2 m -87.79 166.42 14.62 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.508 1.523 . . . . 0.0 113.795 -171.242 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -71.55 172.54 9.41 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 124.609 1.164 . . . . 0.0 111.032 177.525 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.17 133.06 55.75 Favored 'General case' 0 CA--C 1.538 0.511 0 O-C-N 121.241 -0.912 . . . . 0.0 113.164 -176.305 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 75.64 -9.26 16.52 Favored Glycine 0 CA--C 1.534 1.279 0 C-N-CA 124.781 1.181 . . . . 0.0 114.339 -178.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 60.8 m -78.71 163.39 25.45 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 118.547 1.173 . . . . 0.0 113.969 179.354 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 18.3 m -124.18 154.5 31.17 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 C-N-CA 126.354 1.862 . . . . 0.0 110.211 168.389 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 45.5 t -85.33 103.65 14.45 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 123.186 0.594 . . . . 0.0 110.123 169.822 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -70.03 168.95 46.77 Favored Glycine 0 CA--C 1.544 1.858 0 C-N-CA 124.871 1.224 . . . . 0.0 114.15 179.33 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -70.13 -18.62 35.16 Favored 'Trans proline' 0 CA--C 1.538 0.697 0 C-N-CA 124.16 3.24 . . . . 0.0 113.612 -174.333 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 52.9 p-10 -69.77 -9.06 53.13 Favored 'General case' 0 CA--C 1.548 0.897 0 N-CA-C 114.278 1.214 . . . . 0.0 114.278 170.473 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 84.61 11.62 77.01 Favored Glycine 0 CA--C 1.532 1.123 0 C-N-CA 124.837 1.208 . . . . 0.0 113.938 -176.607 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -121.44 155.83 34.03 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 118.632 1.216 . . . . 0.0 112.289 175.086 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 84.8 m -75.41 147.7 39.75 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.789 1.236 . . . . 0.0 113.2 -179.549 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.199 0 C-N-CA 126.123 1.82 . . . . 0.0 113.038 174.517 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.744 0 CA-C-O 121.07 0.261 . . . . 0.0 112.506 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 53.2 t -60.4 126.57 84.81 Favored Pre-proline 0 CA--C 1.55 0.96 0 C-N-CA 124.518 1.127 . . . . 0.0 112.551 -179.219 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo -58.4 154.33 42.08 Favored 'Trans proline' 0 C--N 1.355 0.878 0 C-N-CA 123.832 3.022 . . . . 0.0 113.156 172.676 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 95.7 mtt-85 -79.1 40.2 0.4 Allowed 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 125.037 1.335 . . . . 0.0 112.346 177.497 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 88.8 mt -104.34 123.4 58.18 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 126.627 1.971 . . . . 0.0 108.835 -177.043 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 41.0 tp -76.23 133.83 40.0 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.188 0.595 . . . . 0.0 109.837 172.598 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 59.6 tpp -155.58 130.11 9.05 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 124.461 1.104 . . . . 0.0 109.662 -174.427 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 60.7 ttt180 -83.29 146.15 28.7 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.583 0.753 . . . . 0.0 110.566 178.448 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 28.6 p -152.43 159.15 43.42 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 114.703 1.371 . . . . 0.0 114.703 -169.6 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 63.2 tttp -112.54 -28.91 7.66 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 126.594 1.957 . . . . 0.0 110.793 168.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 21.0 pt20 -149.44 166.76 28.13 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 126.194 1.797 . . . . 0.0 110.745 177.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -61.27 -25.27 66.97 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.183 0.993 . . . . 0.0 112.765 -175.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.8 m -65.35 -17.84 64.84 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 125.589 1.556 . . . . 0.0 113.567 176.165 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 62.4 m-20 -81.68 -18.81 43.18 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.086 0.955 . . . . 0.0 112.307 173.588 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 75.7 m -88.38 166.94 13.91 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.992 1.317 . . . . 0.0 113.955 -172.746 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -71.23 172.97 8.34 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 124.563 1.145 . . . . 0.0 110.952 176.342 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.5 133.53 56.18 Favored 'General case' 0 CA--C 1.54 0.564 0 O-C-N 121.143 -0.973 . . . . 0.0 113.145 -176.601 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 74.77 -8.62 14.05 Favored Glycine 0 CA--C 1.535 1.291 0 C-N-CA 124.572 1.082 . . . . 0.0 114.427 -179.372 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 60.3 m -78.96 162.21 26.14 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 118.448 1.124 . . . . 0.0 113.859 179.075 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 18.3 m -122.88 154.26 28.14 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 126.103 1.761 . . . . 0.0 110.361 168.716 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 48.7 t -84.96 103.12 13.72 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 123.491 0.716 . . . . 0.0 110.128 169.9 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -69.92 168.73 46.73 Favored Glycine 0 CA--C 1.543 1.824 0 C-N-CA 124.888 1.233 . . . . 0.0 114.093 179.626 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -69.8 -18.45 36.82 Favored 'Trans proline' 0 CA--C 1.537 0.662 0 C-N-CA 124.241 3.294 . . . . 0.0 113.503 -174.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 53.4 p-10 -69.54 -9.91 55.88 Favored 'General case' 0 CA--C 1.549 0.911 0 N-CA-C 114.33 1.233 . . . . 0.0 114.33 170.697 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 85.19 11.75 75.13 Favored Glycine 0 CA--C 1.533 1.163 0 C-N-CA 124.885 1.231 . . . . 0.0 114.083 -176.722 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 67.1 m-85 -123.98 157.24 34.83 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.751 1.22 . . . . 0.0 112.218 174.734 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 86.3 m -76.34 148.4 37.47 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.997 1.319 . . . . 0.0 113.49 -177.902 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.24 0 C-N-CA 126.111 1.815 . . . . 0.0 113.039 174.677 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.728 0 N-CA-C 112.478 -0.249 . . . . 0.0 112.478 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 37.5 t -63.58 125.02 86.56 Favored Pre-proline 0 CA--C 1.546 0.816 0 C-N-CA 124.097 0.959 . . . . 0.0 112.56 -178.585 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -69.6 151.8 70.04 Favored 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 122.915 2.41 . . . . 0.0 111.205 178.138 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 6.8 mmp_? -78.52 34.16 0.21 Allowed 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.829 1.251 . . . . 0.0 113.109 -178.27 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 96.6 mt -80.5 126.05 39.41 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 125.717 1.607 . . . . 0.0 109.003 177.789 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 37.6 tp -74.05 126.13 29.83 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 172.292 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 61.0 tpp -154.68 130.97 10.4 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.503 1.121 . . . . 0.0 109.68 -171.273 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 83.8 mtt85 -80.45 151.43 29.31 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.74 0.816 . . . . 0.0 111.48 177.035 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 29.4 p -156.51 155.13 31.45 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 113.983 1.105 . . . . 0.0 113.983 -174.132 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -109.82 -28.78 8.61 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 126.337 1.855 . . . . 0.0 110.562 168.796 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 20.9 pt20 -148.77 167.0 26.76 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 126.479 1.912 . . . . 0.0 110.665 176.156 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -61.27 -24.76 66.63 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 124.452 1.101 . . . . 0.0 112.768 -176.289 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.9 m -65.85 -17.84 64.92 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 125.583 1.553 . . . . 0.0 113.667 175.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 62.5 m-20 -81.62 -18.58 44.2 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.066 0.946 . . . . 0.0 112.343 173.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 72.8 m -87.66 168.74 12.74 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.28 1.432 . . . . 0.0 113.946 -173.695 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -70.7 174.59 5.77 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 124.311 1.044 . . . . 0.0 110.91 175.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.48 133.42 56.08 Favored 'General case' 0 CA--C 1.54 0.565 0 O-C-N 120.994 -1.066 . . . . 0.0 113.146 -176.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 74.51 -8.14 15.43 Favored Glycine 0 CA--C 1.535 1.287 0 C-N-CA 124.876 1.227 . . . . 0.0 114.474 179.764 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 66.2 m -75.95 162.77 27.81 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 114.127 1.158 . . . . 0.0 114.127 -178.762 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 22.9 m -119.9 151.12 22.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 125.233 1.413 . . . . 0.0 110.705 168.602 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 44.1 t -87.51 104.09 16.15 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.698 0.799 . . . . 0.0 109.667 169.438 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -70.77 167.69 50.52 Favored Glycine 0 CA--C 1.542 1.726 0 C-N-CA 124.636 1.112 . . . . 0.0 113.992 179.849 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -69.57 -18.45 37.87 Favored 'Trans proline' 0 CA--C 1.539 0.765 0 C-N-CA 124.146 3.231 . . . . 0.0 113.346 -176.11 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 52.3 p-10 -69.53 -9.66 54.86 Favored 'General case' 0 CA--C 1.548 0.891 0 N-CA-C 114.347 1.24 . . . . 0.0 114.347 170.711 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 84.92 11.72 75.99 Favored Glycine 0 CA--C 1.533 1.157 0 C-N-CA 124.889 1.233 . . . . 0.0 114.127 -177.05 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -118.86 155.65 30.85 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.886 1.274 . . . . 0.0 112.376 174.86 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 70.2 m -76.0 153.85 36.2 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.076 1.351 . . . . 0.0 113.255 176.722 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.276 0 CA-C-O 116.765 -2.131 . . . . 0.0 113.979 174.965 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.754 0 CA-C-O 121.076 0.264 . . . . 0.0 112.473 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 47.3 t -60.4 126.2 83.87 Favored Pre-proline 0 CA--C 1.551 0.998 0 C-N-CA 124.559 1.143 . . . . 0.0 112.621 -179.416 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -56.42 150.07 52.95 Favored 'Trans proline' 0 C--N 1.353 0.795 0 C-N-CA 124.075 3.183 . . . . 0.0 113.125 171.143 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -79.53 37.97 0.36 Allowed 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 125.117 1.367 . . . . 0.0 113.009 -177.143 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 48.2 mm -98.41 123.99 51.28 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 126.12 1.768 . . . . 0.0 109.777 -177.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 36.5 tp -81.52 129.33 34.62 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 123.586 0.754 . . . . 0.0 109.624 171.198 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 60.2 ttm -160.9 136.59 8.06 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.811 1.244 . . . . 0.0 109.574 -171.768 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 57.2 mtp85 -85.46 152.53 23.13 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 118.819 0.736 . . . . 0.0 112.708 176.776 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 25.0 p -151.74 159.55 43.92 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.367 1.467 . . . . 0.0 113.374 -169.854 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 31.5 mmmt -110.15 -26.19 9.79 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 125.877 1.671 . . . . 0.0 111.368 169.191 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 8.5 pt20 -152.78 168.9 24.17 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 126.332 1.853 . . . . 0.0 110.742 175.367 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -61.21 -26.21 67.57 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 124.382 1.073 . . . . 0.0 112.78 -176.525 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 6.6 m -64.58 -18.69 65.12 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 125.374 1.469 . . . . 0.0 113.508 176.264 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 62.6 m-20 -80.58 -20.72 42.68 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 123.921 0.888 . . . . 0.0 112.286 174.282 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 72.1 m -87.45 168.02 13.47 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.109 1.364 . . . . 0.0 113.797 -172.684 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -70.3 172.02 8.93 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 124.357 1.063 . . . . 0.0 111.048 176.152 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.29 134.29 56.87 Favored 'General case' 0 CA--C 1.539 0.522 0 O-C-N 121.246 -0.909 . . . . 0.0 113.061 -177.793 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 75.04 -8.78 14.21 Favored Glycine 0 CA--C 1.534 1.238 0 C-N-CA 124.641 1.115 . . . . 0.0 114.411 -179.215 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 60.8 m -79.3 161.29 26.38 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 118.477 1.139 . . . . 0.0 113.794 178.814 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 19.1 m -121.7 154.21 25.87 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 126.182 1.793 . . . . 0.0 110.412 168.759 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 48.2 t -88.25 103.94 16.26 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.603 0.761 . . . . 0.0 110.001 169.724 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -70.96 169.98 47.87 Favored Glycine 0 CA--C 1.543 1.786 0 C-N-CA 124.926 1.25 . . . . 0.0 114.195 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -69.89 -20.56 34.07 Favored 'Trans proline' 0 CA--C 1.539 0.726 0 C-N-CA 124.163 3.242 . . . . 0.0 113.442 -175.221 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 49.2 p30 -70.63 -6.34 36.15 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 125.023 1.329 . . . . 0.0 114.023 169.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 79.75 12.38 83.62 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 125.271 1.415 . . . . 0.0 114.116 -178.348 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -108.51 153.68 23.0 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.77 1.228 . . . . 0.0 112.15 172.089 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 76.2 m -73.53 146.1 45.07 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.86 1.264 . . . . 0.0 112.603 171.1 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.271 0 C-N-CA 125.981 1.753 . . . . 0.0 113.303 175.557 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.675 0 N-CA-C 112.325 -0.31 . . . . 0.0 112.325 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 44.7 t -59.85 126.91 84.55 Favored Pre-proline 0 CA--C 1.55 0.959 0 C-N-CA 124.349 1.06 . . . . 0.0 112.138 -179.299 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -70.24 155.13 65.06 Favored 'Trans proline' 0 C--N 1.354 0.82 0 C-N-CA 122.962 2.442 . . . . 0.0 111.762 178.184 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 59.2 ttt85 -79.56 89.63 5.1 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.07 0.948 . . . . 0.0 110.621 179.118 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 9.2 tp -160.31 142.04 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 126.351 1.86 . . . . 0.0 110.437 -178.43 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 33.4 tp -86.8 136.74 32.88 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 123.963 0.905 . . . . 0.0 110.127 175.091 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 60.7 tpp -155.53 134.74 12.28 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.501 1.12 . . . . 0.0 110.055 -175.405 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 91.3 mtm-85 -81.38 152.16 27.6 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.131 0.972 . . . . 0.0 111.49 176.621 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 30.1 p -157.97 156.36 31.07 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 114.316 1.228 . . . . 0.0 114.316 -175.237 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 62.7 tttp -111.41 -29.08 7.93 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 126.456 1.902 . . . . 0.0 110.533 168.718 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 21.0 pt20 -148.14 166.98 26.23 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 126.535 1.934 . . . . 0.0 110.58 175.645 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -60.97 -25.33 66.77 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 124.502 1.121 . . . . 0.0 112.806 -176.192 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.9 m -65.46 -17.96 64.95 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.591 1.556 . . . . 0.0 113.669 175.837 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 61.8 m-20 -82.03 -19.47 40.34 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 123.964 0.906 . . . . 0.0 112.29 173.628 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 71.3 m -86.49 166.81 15.19 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.999 1.32 . . . . 0.0 113.607 -174.724 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -70.62 170.41 12.3 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 124.233 1.013 . . . . 0.0 110.76 176.26 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.9 134.95 57.52 Favored 'General case' 0 CA--C 1.539 0.533 0 O-C-N 121.273 -0.892 . . . . 0.0 112.885 -177.706 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 76.36 -9.06 22.41 Favored Glycine 0 CA--C 1.534 1.243 0 C-N-CA 124.698 1.142 . . . . 0.0 114.289 -178.541 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 58.8 m -79.91 162.61 24.88 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 118.567 1.184 . . . . 0.0 113.897 178.18 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 19.6 m -121.3 153.79 25.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 126.254 1.822 . . . . 0.0 110.206 168.419 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 48.9 t -87.83 104.17 16.33 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 123.552 0.741 . . . . 0.0 110.122 169.761 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -69.97 166.92 49.32 Favored Glycine 0 CA--C 1.542 1.739 0 C-N-CA 124.661 1.124 . . . . 0.0 113.875 178.277 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -69.83 -18.11 36.89 Favored 'Trans proline' 0 C--N 1.352 0.712 0 C-N-CA 124.204 3.269 . . . . 0.0 113.479 -175.444 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 53.1 p-10 -69.81 -9.28 54.07 Favored 'General case' 0 CA--C 1.548 0.87 0 N-CA-C 114.433 1.271 . . . . 0.0 114.433 171.185 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 84.85 11.6 76.46 Favored Glycine 0 CA--C 1.535 1.305 0 C-N-CA 124.813 1.197 . . . . 0.0 114.021 -177.036 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -119.16 156.28 30.11 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.701 1.2 . . . . 0.0 112.28 174.091 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 74.1 m -77.13 149.98 35.62 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.98 1.312 . . . . 0.0 113.258 177.732 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.271 0 C-N-CA 125.904 1.716 . . . . 0.0 113.097 174.015 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.727 0 N-CA-C 112.227 -0.349 . . . . 0.0 112.227 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 43.7 t -60.66 126.91 86.19 Favored Pre-proline 0 CA--C 1.55 0.964 0 C-N-CA 124.342 1.057 . . . . 0.0 112.264 -179.097 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -73.25 159.6 46.78 Favored 'Trans proline' 0 C--N 1.353 0.792 0 C-N-CA 123.099 2.533 . . . . 0.0 111.399 176.751 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -78.11 33.46 0.19 Allowed 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 125.286 1.434 . . . . 0.0 113.251 -177.861 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 97.5 mt -91.67 123.24 43.73 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 126.099 1.76 . . . . 0.0 108.837 179.641 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 37.3 tp -75.03 132.21 41.16 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 172.055 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 60.2 tpp -154.0 127.7 8.75 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 124.474 1.11 . . . . 0.0 109.406 -174.547 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 46.6 ttt85 -83.58 145.06 29.07 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.413 0.685 . . . . 0.0 110.555 178.112 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 28.0 p -149.97 158.88 44.61 Favored 'General case' 0 N--CA 1.469 0.525 0 N-CA-C 114.489 1.292 . . . . 0.0 114.489 -169.401 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -111.76 -28.85 7.92 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 126.516 1.926 . . . . 0.0 110.721 168.907 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 21.0 pt20 -149.35 166.74 28.1 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 126.29 1.836 . . . . 0.0 110.773 177.728 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -61.31 -25.25 67.0 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 124.236 1.014 . . . . 0.0 112.8 -176.184 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.8 m -65.33 -17.8 64.8 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 125.604 1.561 . . . . 0.0 113.576 176.052 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 63.3 m-20 -81.49 -18.63 44.49 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.133 0.973 . . . . 0.0 112.278 173.662 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 73.9 m -88.76 166.89 13.74 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.977 1.311 . . . . 0.0 114.123 -172.319 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -70.6 171.64 9.96 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 124.522 1.129 . . . . 0.0 110.836 175.701 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.23 135.25 57.67 Favored 'General case' 0 CA--C 1.538 0.511 0 O-C-N 121.178 -0.951 . . . . 0.0 112.939 -177.764 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 75.88 -9.2 18.46 Favored Glycine 0 CA--C 1.533 1.211 0 C-N-CA 124.809 1.195 . . . . 0.0 114.341 -178.797 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 59.8 m -80.18 162.96 24.42 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 114.185 1.18 . . . . 0.0 114.185 179.462 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 18.5 m -123.59 153.97 29.55 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 126.364 1.866 . . . . 0.0 110.088 168.222 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 49.0 t -84.32 102.52 12.76 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 123.408 0.683 . . . . 0.0 110.233 169.993 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -70.93 169.67 48.3 Favored Glycine 0 CA--C 1.542 1.779 0 C-N-CA 124.91 1.243 . . . . 0.0 114.383 -179.556 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -70.53 -19.05 32.96 Favored 'Trans proline' 0 CA--C 1.538 0.7 0 C-N-CA 124.207 3.271 . . . . 0.0 113.66 -173.819 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 53.2 p-10 -70.6 -8.12 49.24 Favored 'General case' 0 CA--C 1.548 0.889 0 N-CA-C 114.211 1.189 . . . . 0.0 114.211 170.849 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 85.25 8.97 80.69 Favored Glycine 0 CA--C 1.532 1.101 0 C-N-CA 124.974 1.274 . . . . 0.0 114.056 -176.993 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -118.62 156.78 28.61 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 118.676 1.238 . . . . 0.0 112.255 174.836 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 84.0 m -75.03 147.01 41.09 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.976 1.31 . . . . 0.0 113.169 179.168 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.189 0 C-N-CA 126.104 1.811 . . . . 0.0 113.097 174.937 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.76 0 CA-C-O 121.137 0.299 . . . . 0.0 112.54 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 42.7 t -62.15 127.99 90.29 Favored Pre-proline 0 CA--C 1.549 0.911 0 C-N-CA 124.285 1.034 . . . . 0.0 112.408 -178.688 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_exo -61.8 154.99 57.09 Favored 'Trans proline' 0 C--N 1.354 0.841 0 C-N-CA 123.132 2.554 . . . . 0.0 112.121 174.551 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 75.4 mmt-85 -81.64 15.87 1.97 Allowed 'General case' 0 CA--C 1.546 0.795 0 N-CA-C 114.06 1.133 . . . . 0.0 114.06 -175.747 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 1.8 mp -82.12 127.35 39.7 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 125.764 1.625 . . . . 0.0 108.753 177.68 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 35.2 tp -75.32 136.32 40.85 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 123.576 0.75 . . . . 0.0 110.131 173.988 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 60.5 tpp -154.63 133.41 12.19 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.309 1.043 . . . . 0.0 110.231 -171.693 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 27.0 mmt180 -77.13 154.51 33.15 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.754 0.822 . . . . 0.0 111.948 174.691 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 28.8 p -158.23 157.52 32.76 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 113.946 1.091 . . . . 0.0 113.946 -177.509 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -113.37 -24.69 9.19 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 126.239 1.816 . . . . 0.0 110.986 168.779 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 20.9 pt20 -151.68 166.45 31.24 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 126.717 2.007 . . . . 0.0 110.402 175.3 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -61.19 -24.94 66.69 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.417 1.087 . . . . 0.0 112.886 -176.43 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.9 m -65.64 -17.82 64.87 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 125.553 1.541 . . . . 0.0 113.59 175.952 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 63.0 m-20 -81.36 -19.13 43.39 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 123.933 0.893 . . . . 0.0 112.275 173.382 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 73.7 m -88.66 165.98 14.41 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.934 1.294 . . . . 0.0 113.834 -173.339 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 26.1 mt -73.94 177.78 5.38 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 124.524 1.13 . . . . 0.0 111.399 179.0 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.82 133.36 56.02 Favored 'General case' 0 CA--C 1.539 0.552 0 O-C-N 121.268 -0.895 . . . . 0.0 112.923 -178.439 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 74.28 -8.06 14.71 Favored Glycine 0 CA--C 1.535 1.287 0 C-N-CA 124.708 1.147 . . . . 0.0 114.433 -179.53 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 61.8 m -79.38 160.54 26.65 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 118.512 1.156 . . . . 0.0 114.021 179.825 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 19.2 m -122.89 153.25 27.8 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 126.351 1.86 . . . . 0.0 110.096 168.393 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 49.9 t -87.15 102.87 14.87 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.45 0.7 . . . . 0.0 110.058 169.965 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -72.83 167.53 53.86 Favored Glycine 0 CA--C 1.543 1.831 0 C-N-CA 124.417 1.008 . . . . 0.0 114.142 -178.508 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -58.36 -26.79 78.89 Favored 'Trans proline' 0 C--N 1.354 0.818 0 C-N-CA 124.383 3.389 . . . . 0.0 114.902 -178.268 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 52.4 p-10 -69.72 -8.59 49.25 Favored 'General case' 0 CA--C 1.548 0.883 0 N-CA-C 114.685 1.365 . . . . 0.0 114.685 176.016 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 81.14 13.96 79.97 Favored Glycine 0 CA--C 1.533 1.18 0 C-N-CA 124.722 1.154 . . . . 0.0 113.903 -177.676 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -114.35 157.46 22.78 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.848 1.259 . . . . 0.0 111.531 169.955 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 81.5 m -76.55 147.79 37.49 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.858 1.263 . . . . 0.0 112.763 173.523 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.228 0 C-N-CA 125.973 1.749 . . . . 0.0 113.186 174.708 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.727 0 CA-C-O 121.038 0.243 . . . . 0.0 112.576 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 49.2 t -60.75 124.29 78.6 Favored Pre-proline 0 CA--C 1.549 0.91 0 C-N-CA 124.496 1.118 . . . . 0.0 112.307 -178.96 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -73.48 161.35 42.58 Favored 'Trans proline' 0 C--N 1.354 0.839 0 C-N-CA 122.9 2.4 . . . . 0.0 111.218 177.273 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -80.8 32.8 0.31 Allowed 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 124.618 1.167 . . . . 0.0 113.91 -170.999 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 45.9 mm -88.34 123.99 41.1 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 125.947 1.699 . . . . 0.0 109.769 179.673 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 42.6 tp -76.8 130.7 38.02 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 169.949 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 60.8 tpp -155.57 132.62 10.75 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.199 1.0 . . . . 0.0 110.068 -170.625 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 83.9 mtt85 -81.21 151.12 28.32 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.804 0.842 . . . . 0.0 111.343 175.771 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 29.3 p -156.14 158.17 37.21 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 114.27 1.211 . . . . 0.0 114.27 -173.284 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -119.5 -19.9 7.99 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 126.144 1.778 . . . . 0.0 111.674 169.099 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -149.61 167.86 25.18 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 126.39 1.876 . . . . 0.0 110.509 169.908 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -61.26 -25.55 67.16 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 124.362 1.065 . . . . 0.0 112.647 -178.514 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 15.7 m -65.62 -16.07 63.36 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 125.304 1.442 . . . . 0.0 113.676 175.946 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 60.3 m-20 -82.06 -18.09 44.36 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 123.888 0.875 . . . . 0.0 112.464 172.83 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 72.9 m -89.77 167.13 13.12 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.008 1.323 . . . . 0.0 113.859 -172.214 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -70.26 170.34 11.9 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 124.466 1.106 . . . . 0.0 110.843 175.862 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.84 134.7 57.28 Favored 'General case' 0 CA--C 1.538 0.512 0 O-C-N 121.221 -0.924 . . . . 0.0 112.922 -177.637 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 76.22 -9.0 21.63 Favored Glycine 0 CA--C 1.534 1.231 0 C-N-CA 124.781 1.182 . . . . 0.0 114.283 -178.711 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 60.1 m -79.87 162.55 24.96 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 118.518 1.159 . . . . 0.0 114.069 178.56 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 19.2 m -122.76 154.21 27.89 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 126.238 1.815 . . . . 0.0 110.224 168.5 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 47.2 t -85.89 102.52 13.8 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 123.579 0.752 . . . . 0.0 110.157 169.885 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -72.81 167.71 53.72 Favored Glycine 0 CA--C 1.543 1.836 0 C-N-CA 124.454 1.026 . . . . 0.0 114.218 -178.235 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -58.41 -26.87 79.59 Favored 'Trans proline' 0 C--N 1.353 0.801 0 C-N-CA 124.489 3.459 . . . . 0.0 114.969 -177.335 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 52.8 p-10 -70.34 -8.34 49.75 Favored 'General case' 0 CA--C 1.548 0.885 0 N-CA-C 114.775 1.398 . . . . 0.0 114.775 176.699 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 83.92 10.84 80.26 Favored Glycine 0 CA--C 1.533 1.21 0 C-N-CA 124.626 1.108 . . . . 0.0 114.029 -177.228 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -116.39 157.2 25.46 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.84 1.256 . . . . 0.0 112.09 172.153 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 83.1 m -76.44 147.57 37.85 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.004 1.322 . . . . 0.0 113.122 176.988 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.212 0 C-N-CA 126.013 1.768 . . . . 0.0 113.126 174.635 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.698 0 N-CA-C 112.43 -0.268 . . . . 0.0 112.43 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 48.5 t -62.05 130.62 92.9 Favored Pre-proline 0 CA--C 1.549 0.933 0 CA-C-O 118.048 -0.977 . . . . 0.0 112.436 -179.124 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -61.91 149.67 89.25 Favored 'Trans proline' 0 C--N 1.354 0.844 0 C-N-CA 123.191 2.594 . . . . 0.0 113.085 177.27 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 34.4 ptt-85 -83.0 10.22 8.45 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 115.593 1.701 . . . . 0.0 115.593 -172.286 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 10.1 tp -77.17 153.17 5.54 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 C-N-CA 125.424 1.49 . . . . 0.0 111.428 177.947 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 32.7 tp -82.43 134.28 35.23 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.679 0.791 . . . . 0.0 110.468 173.793 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -161.69 127.3 3.61 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.647 1.179 . . . . 0.0 110.932 -170.354 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 95.7 mtt-85 -85.81 159.58 19.69 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 125.071 1.348 . . . . 0.0 112.365 -179.375 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 28.3 p -159.58 159.14 32.88 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.663 1.185 . . . . 0.0 114.104 -177.282 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -114.2 -25.05 8.65 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 126.306 1.842 . . . . 0.0 111.081 168.767 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -151.73 168.17 25.88 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 126.547 1.939 . . . . 0.0 110.531 173.847 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -61.83 -24.76 67.09 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 124.304 1.041 . . . . 0.0 113.0 -176.465 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 6.6 m -64.57 -18.78 65.18 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 125.233 1.413 . . . . 0.0 113.529 175.444 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 62.4 m-20 -80.35 -18.94 47.61 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.001 0.92 . . . . 0.0 112.241 174.034 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 80.6 m -90.28 163.42 14.76 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 125.235 1.414 . . . . 0.0 113.656 -173.073 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 60.0 mt -76.99 -178.43 4.94 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 124.599 1.159 . . . . 0.0 111.921 179.73 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.63 134.27 56.92 Favored 'General case' 0 CA--C 1.54 0.569 0 O-C-N 121.203 -0.935 . . . . 0.0 112.868 -178.563 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 74.51 -8.42 14.08 Favored Glycine 0 CA--C 1.534 1.252 0 C-N-CA 124.749 1.166 . . . . 0.0 114.329 -178.724 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 61.6 m -81.02 159.27 24.86 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 114.184 1.179 . . . . 0.0 114.184 -178.954 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 18.2 m -125.02 153.29 32.11 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 126.472 1.909 . . . . 0.0 109.681 167.949 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 49.1 t -86.09 102.8 14.18 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 123.235 0.614 . . . . 0.0 110.237 170.646 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -70.47 166.56 50.94 Favored Glycine 0 CA--C 1.543 1.831 0 C-N-CA 124.65 1.119 . . . . 0.0 113.806 178.84 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -69.73 -18.08 37.32 Favored 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 124.135 3.223 . . . . 0.0 113.392 -176.062 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 52.7 p-10 -69.66 -9.15 53.13 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 124.897 1.279 . . . . 0.0 114.36 171.381 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 85.29 9.84 78.83 Favored Glycine 0 CA--C 1.533 1.202 0 C-N-CA 124.962 1.268 . . . . 0.0 114.227 -177.949 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -116.2 155.03 29.01 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.949 1.3 . . . . 0.0 111.879 174.147 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 82.6 m -77.07 147.14 36.85 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.272 1.029 . . . . 0.0 112.241 174.391 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.22 0 C-N-CA 125.743 1.64 . . . . 0.0 113.112 175.798 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.714 0 N-CA-C 112.352 -0.299 . . . . 0.0 112.352 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 44.3 t -60.43 126.07 83.63 Favored Pre-proline 0 CA--C 1.55 0.945 0 C-N-CA 124.342 1.057 . . . . 0.0 112.279 -179.055 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -74.5 163.5 35.95 Favored 'Trans proline' 0 C--N 1.353 0.765 0 C-N-CA 122.996 2.464 . . . . 0.0 111.397 177.2 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 74.6 mtp85 -77.35 20.72 0.28 Allowed 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 125.031 1.333 . . . . 0.0 114.08 -175.242 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 48.3 mm -79.83 122.68 35.51 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 125.367 1.467 . . . . 0.0 109.874 178.749 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 42.4 tp -76.14 132.92 40.3 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.184 0.594 . . . . 0.0 109.489 170.598 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 60.3 tpp -153.33 127.52 9.11 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 124.205 1.002 . . . . 0.0 109.838 -173.307 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 59.5 ttm-85 -78.08 145.06 36.03 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.702 0.801 . . . . 0.0 110.395 177.373 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 31.3 p -153.11 159.16 42.73 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 114.411 1.263 . . . . 0.0 114.411 -171.697 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -121.2 -18.83 7.3 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 126.878 2.071 . . . . 0.0 111.49 168.895 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 19.3 pt20 -147.45 158.96 44.2 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 126.843 2.057 . . . . 0.0 110.179 177.963 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -62.86 -25.86 68.49 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.196 0.999 . . . . 0.0 112.429 -179.822 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 17.8 m -67.38 -13.46 62.04 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 124.916 1.287 . . . . 0.0 113.557 175.289 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 49.9 m-20 -81.5 -19.15 42.84 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 123.758 0.823 . . . . 0.0 112.091 172.108 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 73.9 m -88.79 167.01 13.64 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.253 1.421 . . . . 0.0 113.94 -171.302 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -70.37 170.77 11.19 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 124.444 1.098 . . . . 0.0 110.769 175.692 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.08 134.82 57.41 Favored 'General case' 0 CA--C 1.539 0.525 0 O-C-N 121.179 -0.95 . . . . 0.0 112.964 -177.348 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 76.14 -9.09 20.75 Favored Glycine 0 CA--C 1.533 1.188 0 C-N-CA 124.652 1.12 . . . . 0.0 114.378 -178.764 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 60.2 m -79.91 162.9 24.72 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 114.078 1.14 . . . . 0.0 114.078 179.079 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 18.5 m -122.73 154.33 27.88 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 126.325 1.85 . . . . 0.0 110.073 168.359 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 47.8 t -85.63 103.41 14.43 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 123.193 0.597 . . . . 0.0 110.071 169.824 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -70.83 168.16 50.11 Favored Glycine 0 CA--C 1.542 1.731 0 C-N-CA 124.841 1.21 . . . . 0.0 114.101 179.922 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -70.23 -17.9 35.13 Favored 'Trans proline' 0 C--N 1.352 0.743 0 C-N-CA 124.169 3.246 . . . . 0.0 113.5 -175.312 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 53.3 p-10 -69.38 -9.42 53.4 Favored 'General case' 0 CA--C 1.548 0.882 0 N-CA-C 114.339 1.237 . . . . 0.0 114.339 170.855 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 84.87 12.06 75.35 Favored Glycine 0 CA--C 1.532 1.141 0 C-N-CA 124.756 1.17 . . . . 0.0 114.046 -176.796 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -123.51 156.47 35.57 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.703 1.201 . . . . 0.0 112.386 174.505 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 84.1 m -75.1 147.41 40.6 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.906 1.283 . . . . 0.0 113.214 179.006 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.204 0 C-N-CA 126.058 1.789 . . . . 0.0 113.099 174.809 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.749 0 CA-C-O 121.21 0.339 . . . . 0.0 112.547 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 53.3 t -65.59 133.28 95.17 Favored Pre-proline 0 CA--C 1.551 0.995 0 C-N-CA 123.928 0.891 . . . . 0.0 112.282 -178.828 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -67.45 166.7 22.82 Favored 'Trans proline' 0 C--N 1.353 0.798 0 C-N-CA 123.435 2.756 . . . . 0.0 111.909 173.05 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 4.4 mmp_? -102.23 17.4 23.48 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 125.091 1.357 . . . . 0.0 113.187 179.94 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 10.4 tp -74.57 148.44 7.99 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 C-N-CA 125.247 1.419 . . . . 0.0 111.392 176.015 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 10.6 tt -71.29 132.13 44.45 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.636 0.774 . . . . 0.0 110.044 172.974 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 58.7 tpp -154.96 130.67 9.97 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.825 1.25 . . . . 0.0 109.591 177.421 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 84.4 mtt85 -87.32 152.92 21.87 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.301 1.04 . . . . 0.0 111.497 178.297 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 29.6 p -157.0 156.03 32.26 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 114.082 1.141 . . . . 0.0 114.082 -173.236 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -112.22 -25.67 9.18 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 126.091 1.756 . . . . 0.0 110.93 168.927 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 8.3 pt20 -150.58 168.78 23.25 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 126.569 1.947 . . . . 0.0 110.522 173.621 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -61.37 -25.24 67.04 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 124.462 1.105 . . . . 0.0 112.977 -176.494 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 7.0 m -64.72 -19.19 65.63 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 125.329 1.452 . . . . 0.0 113.514 175.778 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 61.1 m-20 -81.4 -18.65 44.74 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.024 0.93 . . . . 0.0 112.39 174.657 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 74.5 m -87.72 167.31 13.96 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 125.155 1.382 . . . . 0.0 113.827 -174.43 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -72.67 176.49 5.48 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 124.487 1.115 . . . . 0.0 111.077 177.973 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.53 133.26 55.92 Favored 'General case' 0 CA--C 1.539 0.556 0 O-C-N 121.08 -1.013 . . . . 0.0 113.207 -176.784 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 74.44 -8.29 14.42 Favored Glycine 0 CA--C 1.534 1.278 0 C-N-CA 124.871 1.224 . . . . 0.0 114.461 -179.851 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 62.2 m -76.87 163.66 26.54 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 114.089 1.144 . . . . 0.0 114.089 -178.893 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 21.4 m -121.72 152.91 25.61 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 C-N-CA 125.807 1.643 . . . . 0.0 110.325 168.263 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 44.8 t -88.5 104.4 16.77 Favored 'General case' 0 CA--C 1.537 0.442 0 C-N-CA 123.513 0.725 . . . . 0.0 109.878 169.55 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -70.07 166.26 50.26 Favored Glycine 0 CA--C 1.542 1.74 0 C-N-CA 124.635 1.112 . . . . 0.0 113.825 178.951 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -69.48 -18.2 38.43 Favored 'Trans proline' 0 CA--C 1.539 0.729 0 C-N-CA 124.128 3.219 . . . . 0.0 113.284 -176.419 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 52.4 p-10 -69.37 -9.93 55.66 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 124.869 1.268 . . . . 0.0 114.396 170.942 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 85.79 10.34 76.15 Favored Glycine 0 CA--C 1.533 1.169 0 C-N-CA 124.867 1.222 . . . . 0.0 114.229 -177.653 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -117.48 156.62 27.69 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.787 1.235 . . . . 0.0 112.038 174.509 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 74.3 m -76.43 152.97 36.03 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.619 1.167 . . . . 0.0 112.999 176.352 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.272 0 CA-C-O 116.909 -2.051 . . . . 0.0 113.626 176.168 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.695 0 N-CA-C 112.355 -0.298 . . . . 0.0 112.355 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 48.0 t -61.03 130.37 91.22 Favored Pre-proline 0 CA--C 1.549 0.934 0 C-N-CA 124.134 0.974 . . . . 0.0 112.4 -179.171 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -62.19 155.47 56.29 Favored 'Trans proline' 0 C--N 1.354 0.845 0 C-N-CA 123.221 2.614 . . . . 0.0 112.76 175.227 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -82.3 13.84 3.31 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 114.707 1.373 . . . . 0.0 114.707 -170.522 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 10.0 tp -83.2 140.76 15.82 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 C-N-CA 125.309 1.444 . . . . 0.0 111.464 178.641 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 40.4 tp -82.82 132.0 35.18 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.801 0.84 . . . . 0.0 109.816 172.146 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 58.0 ttm -154.45 132.46 11.66 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.3 1.04 . . . . 0.0 110.512 -171.433 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 95.8 mtt-85 -79.4 155.07 28.54 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.006 0.922 . . . . 0.0 112.057 178.813 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 28.2 p -158.32 157.76 33.04 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 124.731 1.212 . . . . 0.0 113.661 -176.099 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 30.3 mtpp -112.1 -24.97 9.58 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 125.932 1.693 . . . . 0.0 111.16 169.094 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 20.8 pt20 -152.53 166.41 32.12 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 126.553 1.941 . . . . 0.0 110.485 175.803 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -61.06 -24.96 66.6 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 124.494 1.118 . . . . 0.0 112.799 -176.41 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.8 m -65.62 -18.0 65.0 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 125.654 1.582 . . . . 0.0 113.617 175.851 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 63.2 m-20 -80.83 -20.98 41.21 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 123.888 0.875 . . . . 0.0 112.19 173.152 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 77.8 m -88.46 165.41 14.92 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 125.227 1.411 . . . . 0.0 113.514 -174.185 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 50.6 mt -75.85 178.64 6.04 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 124.374 1.07 . . . . 0.0 111.922 179.375 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.19 134.63 57.24 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 121.375 -0.828 . . . . 0.0 112.721 -179.173 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 74.61 -8.38 14.66 Favored Glycine 0 CA--C 1.533 1.185 0 C-N-CA 124.678 1.133 . . . . 0.0 114.291 -178.363 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 60.6 m -81.11 158.8 24.88 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 118.646 1.223 . . . . 0.0 113.967 179.568 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 18.6 m -123.45 151.69 28.15 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 126.17 1.788 . . . . 0.0 109.765 168.057 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 48.9 t -87.2 103.0 15.0 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.296 0.638 . . . . 0.0 109.756 169.978 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -72.17 166.86 53.43 Favored Glycine 0 CA--C 1.543 1.823 0 C-N-CA 124.281 0.943 . . . . 0.0 114.017 -178.157 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -57.86 -26.19 72.86 Favored 'Trans proline' 0 C--N 1.354 0.854 0 C-N-CA 124.448 3.432 . . . . 0.0 114.736 -179.806 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 51.9 p-10 -68.44 -9.96 52.14 Favored 'General case' 0 CA--C 1.548 0.88 0 N-CA-C 114.839 1.422 . . . . 0.0 114.839 175.314 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 83.65 13.41 75.72 Favored Glycine 0 CA--C 1.533 1.216 0 C-N-CA 124.731 1.158 . . . . 0.0 113.929 -177.372 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -117.96 154.19 32.36 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.951 1.3 . . . . 0.0 112.225 174.168 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 84.6 m -74.33 145.96 43.46 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.878 1.271 . . . . 0.0 112.382 173.933 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.21 0 C-N-CA 125.991 1.758 . . . . 0.0 113.252 175.023 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.692 0 N-CA-C 112.486 -0.246 . . . . 0.0 112.486 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 41.9 t -61.21 127.09 87.55 Favored Pre-proline 0 CA--C 1.55 0.953 0 C-N-CA 124.302 1.041 . . . . 0.0 112.243 -179.252 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -72.99 161.4 43.63 Favored 'Trans proline' 0 C--N 1.354 0.818 0 C-N-CA 123.125 2.55 . . . . 0.0 111.529 177.09 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 92.3 mtm-85 -77.5 29.86 0.15 Allowed 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 125.269 1.428 . . . . 0.0 113.501 -177.597 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 96.8 mt -90.37 122.97 42.33 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 126.158 1.783 . . . . 0.0 109.048 -179.325 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 37.6 tp -75.34 132.82 41.21 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 122.972 0.509 . . . . 0.0 109.642 171.415 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 59.9 tpp -153.83 128.56 9.41 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 124.372 1.069 . . . . 0.0 109.373 -174.485 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 46.3 ttt85 -83.88 144.78 28.99 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 123.381 0.673 . . . . 0.0 110.616 178.188 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 28.3 p -149.11 158.88 44.53 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 114.26 1.208 . . . . 0.0 114.26 -169.517 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -119.03 -19.57 8.41 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 126.117 1.767 . . . . 0.0 111.641 169.187 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -150.03 167.68 26.04 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 126.328 1.851 . . . . 0.0 110.534 169.994 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -61.31 -25.34 67.06 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.419 1.088 . . . . 0.0 112.663 -178.691 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 15.6 m -65.6 -15.95 63.23 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 125.182 1.393 . . . . 0.0 113.643 175.754 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 60.7 m-20 -82.1 -17.76 45.35 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 123.935 0.894 . . . . 0.0 112.456 172.82 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 75.1 m -89.55 166.47 13.64 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.032 1.333 . . . . 0.0 113.894 -172.117 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -70.92 171.61 10.42 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 124.488 1.115 . . . . 0.0 110.787 175.805 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.24 135.33 57.7 Favored 'General case' 0 CA--C 1.54 0.581 0 O-C-N 121.201 -0.937 . . . . 0.0 112.953 -177.665 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 75.92 -9.08 19.18 Favored Glycine 0 CA--C 1.534 1.276 0 C-N-CA 124.79 1.186 . . . . 0.0 114.307 -178.844 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 59.8 m -80.15 162.78 24.54 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 114.057 1.132 . . . . 0.0 114.057 179.375 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 19.1 m -123.07 153.6 28.28 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 126.319 1.847 . . . . 0.0 110.11 168.331 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 49.2 t -84.45 102.58 12.91 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 123.398 0.679 . . . . 0.0 110.178 169.978 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -71.14 169.45 49.15 Favored Glycine 0 CA--C 1.542 1.747 0 C-N-CA 124.955 1.264 . . . . 0.0 114.335 -179.592 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -70.56 -18.98 32.85 Favored 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 124.233 3.289 . . . . 0.0 113.669 -173.987 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 53.2 p-10 -70.54 -8.06 48.53 Favored 'General case' 0 CA--C 1.548 0.897 0 N-CA-C 114.271 1.211 . . . . 0.0 114.271 170.775 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 85.13 8.96 81.12 Favored Glycine 0 CA--C 1.531 1.081 0 C-N-CA 124.916 1.246 . . . . 0.0 114.06 -176.995 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -118.55 156.77 28.55 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 118.725 1.263 . . . . 0.0 112.29 174.7 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 79.7 m -75.35 147.17 40.31 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.027 1.331 . . . . 0.0 113.223 179.036 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.181 0 C-N-CA 126.017 1.77 . . . . 0.0 113.099 174.796 . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.656 0 N-CA-C 112.391 -0.283 . . . . 0.0 112.391 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 41.9 t -61.47 127.71 88.87 Favored Pre-proline 0 CA--C 1.55 0.962 0 C-N-CA 124.251 1.02 . . . . 0.0 112.204 -178.999 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -70.29 155.08 64.98 Favored 'Trans proline' 0 C--N 1.355 0.895 0 C-N-CA 123.047 2.498 . . . . 0.0 111.726 176.93 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.63 5.99 5.39 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 116.148 1.907 . . . . 0.0 116.148 -172.978 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 10.0 tp -73.97 139.12 19.86 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.825 0 C-N-CA 125.263 1.425 . . . . 0.0 111.334 -179.331 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 30.6 tp -81.1 136.65 35.95 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.683 0.793 . . . . 0.0 110.176 174.729 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 61.2 tpp -158.32 134.86 9.53 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.41 1.084 . . . . 0.0 109.483 -172.575 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 55.7 mtp85 -91.69 154.47 18.97 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 119.004 0.82 . . . . 0.0 112.807 175.662 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 26.4 p -154.16 158.04 39.78 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.117 1.367 . . . . 0.0 113.665 -169.933 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -109.45 -29.74 8.28 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 125.882 1.673 . . . . 0.0 110.654 168.891 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 8.0 pt20 -147.7 169.73 19.06 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 126.485 1.914 . . . . 0.0 110.718 173.603 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -61.27 -25.93 67.43 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.473 1.109 . . . . 0.0 112.844 -176.488 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 7.4 m -64.77 -18.88 65.47 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 125.303 1.441 . . . . 0.0 113.48 175.959 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 60.1 m-20 -82.02 -18.42 43.35 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 123.964 0.906 . . . . 0.0 112.347 174.577 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 77.8 m -87.35 167.16 14.29 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.91 1.284 . . . . 0.0 113.789 -174.498 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -71.57 172.42 9.65 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 124.498 1.119 . . . . 0.0 110.943 176.907 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.01 134.64 57.24 Favored 'General case' 0 CA--C 1.539 0.534 0 O-C-N 121.256 -0.903 . . . . 0.0 113.075 -177.049 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 75.76 -9.0 18.24 Favored Glycine 0 CA--C 1.533 1.209 0 C-N-CA 124.759 1.171 . . . . 0.0 114.362 -179.065 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 60.4 m -79.27 161.49 26.28 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 114.156 1.169 . . . . 0.0 114.156 179.636 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 19.2 m -120.55 153.4 23.71 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 126.316 1.846 . . . . 0.0 109.945 168.051 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 49.7 t -88.17 104.23 16.51 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 123.468 0.707 . . . . 0.0 110.275 169.955 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -70.83 168.85 49.27 Favored Glycine 0 CA--C 1.544 1.886 0 C-N-CA 124.907 1.241 . . . . 0.0 114.105 178.371 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -70.37 -20.54 31.85 Favored 'Trans proline' 0 CA--C 1.538 0.701 0 C-N-CA 124.172 3.248 . . . . 0.0 113.647 -174.432 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 50.4 p30 -71.12 -5.25 30.19 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 124.888 1.275 . . . . 0.0 114.078 170.323 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 79.18 11.55 84.94 Favored Glycine 0 CA--C 1.53 1.023 0 C-N-CA 125.156 1.36 . . . . 0.0 113.98 -178.668 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 99.7 m-85 -107.41 155.09 20.41 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 118.656 1.228 . . . . 0.0 111.89 170.503 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 84.0 m -76.98 147.33 36.92 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 125.079 1.351 . . . . 0.0 112.544 173.18 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.176 0 C-N-CA 125.711 1.624 . . . . 0.0 113.174 174.721 . . . . . . . . 0 0 . 1 stop_ save_